1 |
Docetaxel FDA Label
|
2 |
Doxorubicin FDA Label
|
3 |
Everolimus FDA Label
|
4 |
Ixabepilone FDA Label
|
5 |
Paclitaxel FDA Label
|
6 |
Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo.Oncogene. 2013 May 23;32(21):2622-30. doi: 10.1038/onc.2012.284. Epub 2012 Jul 9.
|
7 |
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.J Exp Clin Cancer Res. 2019 Apr 25;38(1):173. doi: 10.1186/s13046-019-1156-5.
|
8 |
Spatial memory deficits in mice induced by chemotherapeutic agents are prevented by acetylcholinesterase inhibitors.Cancer Chemother Pharmacol. 2019 Sep;84(3):579-589. doi: 10.1007/s00280-019-03881-8. Epub 2019 Jul 13.
|
9 |
ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis.Tumour Biol. 2017 Apr;39(4):1010428317698338. doi: 10.1177/1010428317698338.
|
10 |
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5139-44. doi: 10.1073/pnas.1222085110. Epub 2013 Mar 12.
|
11 |
Use of non-selective -blockers is associated with decreased tumor proliferative indices in early stage breast cancer.Oncotarget. 2017 Jan 24;8(4):6446-6460. doi: 10.18632/oncotarget.14119.
|
12 |
Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.Mol Cancer. 2014 May 8;13:106. doi: 10.1186/1476-4598-13-106.
|
13 |
Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching.Oncotarget. 2017 Sep 1;8(44):76606-76621. doi: 10.18632/oncotarget.20609. eCollection 2017 Sep 29.
|
14 |
AKR1C3 (type 5 17-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders.Mol Cell Endocrinol. 2019 Jun 1;489:82-91. doi: 10.1016/j.mce.2018.07.002. Epub 2018 Sep 19.
|
15 |
Changes of N6-methyladenosine modulators promote breast cancer progression.BMC Cancer. 2019 Apr 5;19(1):326. doi: 10.1186/s12885-019-5538-z.
|
16 |
Human cytomegalovirus infection is correlated with enhanced cyclooxygenase-2 and 5-lipoxygenase protein expression in breast cancer.J Cancer Res Clin Oncol. 2019 Aug;145(8):2083-2095. doi: 10.1007/s00432-019-02946-8. Epub 2019 Jun 15.
|
17 |
Expression of AMHR2 and C-KIT in cervical lesions in Uyghur Women of Xinjiang, China.Medicine (Baltimore). 2018 Jun;97(22):e10793. doi: 10.1097/MD.0000000000010793.
|
18 |
Angiomotin-p130 inhibits -catenin stability by competing with Axin for binding to tankyrase in breast cancer.Cell Death Dis. 2019 Feb 21;10(3):179. doi: 10.1038/s41419-019-1427-2.
|
19 |
Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.Oncogene. 2019 Mar;38(13):2351-2363. doi: 10.1038/s41388-018-0592-6. Epub 2018 Dec 5.
|
20 |
Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.J Cancer Res Clin Oncol. 2014 Jun;140(6):957-67. doi: 10.1007/s00432-014-1650-2. Epub 2014 Mar 26.
|
21 |
Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.Oncotarget. 2017 Jun 6;8(23):37250-37262. doi: 10.18632/oncotarget.16763.
|
22 |
Significant prognostic values of aquaporin mRNA expression in breast cancer.Cancer Manag Res. 2019 Feb 14;11:1503-1515. doi: 10.2147/CMAR.S193396. eCollection 2019.
|
23 |
Acetylation of ACAP4 regulates CCL18-elicited breast cancer cell migration and invasion.J Mol Cell Biol. 2018 Dec 1;10(6):559-572. doi: 10.1093/jmcb/mjy058.
|
24 |
Three gold indicators for breast cancer prognosis: a case-control study with ROC analysis for novel ratios related to CBC with (ALP and LDH).Mol Biol Rep. 2019 Apr;46(2):2013-2027. doi: 10.1007/s11033-019-04650-9. Epub 2019 Jan 31.
|
25 |
HER2 Upregulates ATF4 to Promote Cell Migration via Activation of ZEB1 and Downregulation of E-Cadherin.Int J Mol Sci. 2019 May 6;20(9):2223. doi: 10.3390/ijms20092223.
|
26 |
ATP2A3 gene as an important player for resveratrol anticancer activity in breast cancer cells.Mol Carcinog. 2017 Jul;56(7):1703-1711. doi: 10.1002/mc.22625. Epub 2017 Feb 15.
|
27 |
A small-molecule inhibitor targeting the AURKC-IB interaction decreases transformed growth of MDA-MB-231 breast cancer cells.Oncotarget. 2017 Jun 29;8(41):69691-69708. doi: 10.18632/oncotarget.18883. eCollection 2017 Sep 19.
|
28 |
Serum butyrylcholinesterase and zinc in breast cancer.J Cancer Res Ther. 2017 Apr-Jun;13(2):367-370. doi: 10.4103/0973-1482.165869.
|
29 |
ATP/pH Dual Responsive Nanoparticle with d-[des-Arg(10) ]Kallidin Mediated Efficient In Vivo Targeting Drug Delivery.Small. 2017 Jan;13(3). doi: 10.1002/smll.201602494. Epub 2016 Oct 24.
|
30 |
A comparative study for surface dose evaluation in conventional treatment of carcinoma breast patients irradiated with Co-60 and 6 MV radiation beam.J Cancer Res Ther. 2019 Jul-Sep;15(5):1035-1041. doi: 10.4103/jcrt.JCRT_789_17.
|
31 |
Effect of biphenyl hydrolase-like (BPHL) gene disruption on the intestinal stability, permeability and absorption of valacyclovir in wildtype and Bphl knockout mice.Biochem Pharmacol. 2018 Oct;156:147-156. doi: 10.1016/j.bcp.2018.08.018. Epub 2018 Aug 17.
|
32 |
A strategy to apply quantitative epistasis analysis on developmental traits.BMC Genet. 2017 May 15;18(1):42. doi: 10.1186/s12863-017-0508-4.
|
33 |
B49, a BST-2-based peptide, inhibits adhesion and growth of breast cancer cells.Sci Rep. 2018 Mar 9;8(1):4305. doi: 10.1038/s41598-018-22364-z.
|
34 |
L-Canavanine Potentiates Cytotoxicity of Chemotherapeutic Drugs in Human Breast Cancer Cells.Anticancer Agents Med Chem. 2017;17(2):206-211. doi: 10.2174/1871520616666160223111551.
|
35 |
Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.PLoS One. 2015 Jul 6;10(7):e0125766. doi: 10.1371/journal.pone.0125766. eCollection 2015.
|
36 |
Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.Antioxid Redox Signal. 2017 Jan 10;26(2):70-83. doi: 10.1089/ars.2015.6457. Epub 2016 Aug 5.
|
37 |
Attenuation of Antioxidant Capacity in Human Breast Cancer Cells by Carbon Monoxide through Inhibition of Cystathionine -Synthase Activity: Implications in Chemotherapeutic Drug Sensitivity.J Med Chem. 2017 Oct 12;60(19):8000-8010. doi: 10.1021/acs.jmedchem.7b00476. Epub 2017 Sep 20.
|
38 |
Prognostic values of distinct CBX family members in breast cancer.Oncotarget. 2017 Sep 28;8(54):92375-92387. doi: 10.18632/oncotarget.21325. eCollection 2017 Nov 3.
|
39 |
The Anti-tumoral Effect of -D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGF1 Gene Expression in Pre-surgical Breast Cancer Patients.Iran J Allergy Asthma Immunol. 2019 Feb;18(1):80-90.
|
40 |
NEK5 promotes breast cancer cell proliferation through up-regulation of Cyclin A2.Mol Carcinog. 2019 Jun;58(6):933-943. doi: 10.1002/mc.22982. Epub 2019 Feb 22.
|
41 |
High expression of CCL2 in tumor cells and abundant infiltration with CD14 positive macrophages predict early relapse in breast cancer.Virchows Arch. 2019 Jan;474(1):3-12. doi: 10.1007/s00428-018-2461-7. Epub 2018 Oct 27.
|
42 |
CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1.Cancer Immunol Immunother. 2020 Jan;69(1):103-114. doi: 10.1007/s00262-019-02444-3. Epub 2019 Dec 6.
|
43 |
Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index.Clin Cancer Res. 2019 Sep 15;25(18):5441-5448. doi: 10.1158/1078-0432.CCR-19-0272. Epub 2019 Apr 12.
|
44 |
Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells.Int Immunol. 2018 Nov 14;30(12):559-567. doi: 10.1093/intimm/dxy050.
|
45 |
Cadherin 11 Inhibition Downregulates -catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.J Clin Med. 2019 Jan 27;8(2):148. doi: 10.3390/jcm8020148.
|
46 |
Methylation of C/EBP by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.Cancer Res. 2019 Jun 1;79(11):2865-2877. doi: 10.1158/0008-5472.CAN-18-3211. Epub 2019 Apr 23.
|
47 |
Chemogenetic evaluation of the mitotic kinesin CENP-E reveals a critical role in triple-negative breast cancer.Mol Cancer Ther. 2014 Aug;13(8):2104-15. doi: 10.1158/1535-7163.MCT-14-0083-T. Epub 2014 Jun 13.
|
48 |
CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3.Oncogene. 2019 Jun;38(23):4560-4573. doi: 10.1038/s41388-019-0739-0. Epub 2019 Feb 12.
|
49 |
Chitotriosidase, a marker of innate immunity, is elevated in patients with primary breast cancer.Cancer Biomark. 2017 Jul 4;19(4):383-391. doi: 10.3233/CBM-160101.
|
50 |
Guanine nucleotide binding protein 1: a novel transduction protein with a possible role in human breast cancer.Cancer Genomics Proteomics. 2013 Mar-Apr;10(2):69-73.
|
51 |
Yoga has a solid effect on cancer-related fatigue in patients with breast cancer: a meta-analysis.Breast Cancer Res Treat. 2019 Aug;177(1):5-16. doi: 10.1007/s10549-019-05278-w. Epub 2019 May 24.
|
52 |
Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.BMC Med. 2018 Feb 19;16(1):20. doi: 10.1186/s12916-018-1010-1.
|
53 |
CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway.J Cancer. 2018 Sep 8;9(19):3603-3612. doi: 10.7150/jca.26497. eCollection 2018.
|
54 |
The Role of CXCL13 and CXCL9 in Early Breast Cancer.Clin Breast Cancer. 2020 Feb;20(1):e36-e53. doi: 10.1016/j.clbc.2019.08.008. Epub 2019 Sep 5.
|
55 |
Structure of human cortisol-producing cytochrome P450 11B1 bound to the breast cancer drug fadrozole provides insights for drug design.J Biol Chem. 2019 Jan 11;294(2):453-460. doi: 10.1074/jbc.RA118.006214. Epub 2018 Nov 13.
|
56 |
Therapeutically Active RIG-I Agonist Induces Immunogenic Tumor Cell Killing in Breast Cancers.Cancer Res. 2018 Nov 1;78(21):6183-6195. doi: 10.1158/0008-5472.CAN-18-0730. Epub 2018 Sep 17.
|
57 |
Diacylglycerol kinase promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src.Oncotarget. 2014 Oct 30;5(20):9710-26. doi: 10.18632/oncotarget.2344.
|
58 |
Prognostic value of DKK2 from the Dickkopf family in human breast cancer. Int J Oncol. 2018 Dec;53(6):2555-2565.
|
59 |
Network analysis of EMT and MET micro-RNA regulation in breast cancer.Sci Rep. 2017 Oct 19;7(1):13534. doi: 10.1038/s41598-017-13903-1.
|
60 |
Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis.Cancer Res. 2019 Feb 15;79(4):735-746. doi: 10.1158/0008-5472.CAN-18-0620. Epub 2018 Dec 24.
|
61 |
Collapsin response mediator protein 2 is involved in regulating breast cancer progression.Breast Cancer. 2014 Nov;21(6):715-23. doi: 10.1007/s12282-013-0447-5. Epub 2013 Feb 5.
|
62 |
Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer.Asian Pac J Cancer Prev. 2014;15(23):10339-43. doi: 10.7314/apjcp.2014.15.23.10339.
|
63 |
Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments.Oncotarget. 2017 Jul 4;8(27):43866-43877. doi: 10.18632/oncotarget.16704.
|
64 |
Modelling the role of dual specificity phosphatases in herceptin resistant breast cancer cell lines.Comput Biol Chem. 2019 Jun;80:138-146. doi: 10.1016/j.compbiolchem.2019.03.018. Epub 2019 Mar 25.
|
65 |
miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.Breast Cancer. 2020 Jan;27(1):147-158. doi: 10.1007/s12282-019-01002-0. Epub 2019 Aug 13.
|
66 |
Upregulated EBI3 Correlates with Poor Outcome and Tumor Progression in Breast Cancer.Oncol Res Treat. 2018;41(3):111-115. doi: 10.1159/000484935. Epub 2018 Feb 27.
|
67 |
EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.Oncogene. 2019 Mar;38(12):2123-2134. doi: 10.1038/s41388-018-0565-9. Epub 2018 Nov 19.
|
68 |
Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.Int J Oncol. 2013 Apr;42(4):1367-75. doi: 10.3892/ijo.2013.1820. Epub 2013 Feb 8.
|
69 |
Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.J Biol Chem. 2017 Jun 16;292(24):10295-10305. doi: 10.1074/jbc.M116.773051. Epub 2017 May 3.
|
70 |
Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors.Haematologica. 2020 Jan;105(1):218-225. doi: 10.3324/haematol.2019.217083. Epub 2019 May 2.
|
71 |
Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer.Mol Cancer Ther. 2020 Jan;19(1):63-74. doi: 10.1158/1535-7163.MCT-19-0386. Epub 2019 Sep 23.
|
72 |
GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3.Int J Biol Sci. 2019 Sep 7;15(12):2522-2537. doi: 10.7150/ijbs.35563. eCollection 2019.
|
73 |
Estrogen-related receptors alpha, beta and gamma expression and function is associated with transcriptional repressor EZH2 in breast carcinoma.BMC Cancer. 2018 Jun 26;18(1):690. doi: 10.1186/s12885-018-4586-0.
|
74 |
EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival.Front Oncol. 2019 Jan 29;9:26. doi: 10.3389/fonc.2019.00026. eCollection 2019.
|
75 |
Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.Oncotarget. 2017 Jun 13;8(24):38731-38742. doi: 10.18632/oncotarget.16317.
|
76 |
4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5.Drug Des Devel Ther. 2018 Apr 27;12:997-1008. doi: 10.2147/DDDT.S151029. eCollection 2018.
|
77 |
Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.Oncogene. 2014 Jun 19;33(25):3298-306. doi: 10.1038/onc.2013.293. Epub 2013 Aug 5.
|
78 |
Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-.Acta Pharmacol Sin. 2018 Mar;39(3):415-424. doi: 10.1038/aps.2017.121. Epub 2017 Nov 9.
|
79 |
Endogenously Synthesized n-3 Polyunsaturated Fatty Acids in Pregnant fat-1 Mice Decreases Mammary Cancer Risk of Female Offspring by Regulating Expression of Long Noncoding RNAs.Mol Nutr Food Res. 2019 Mar;63(6):e1801150. doi: 10.1002/mnfr.201801150. Epub 2019 Jan 27.
|
80 |
Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer.J Exp Clin Cancer Res. 2019 Feb 22;38(1):100. doi: 10.1186/s13046-019-1040-3.
|
81 |
Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.Gen Physiol Biophys. 2017 Dec;36(5):565-572. doi: 10.4149/gpb_2017033.
|
82 |
FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.Mol Carcinog. 2018 Nov;57(11):1616-1625. doi: 10.1002/mc.22884. Epub 2018 Aug 22.
|
83 |
MicroRNA-937 inhibits the malignant phenotypes of breast cancer by directly targeting and downregulating forkhead box Q1.Onco Targets Ther. 2019 Jun 20;12:4813-4824. doi: 10.2147/OTT.S207593. eCollection 2019.
|
84 |
Ampelopsins A and C Induce Apoptosis and Metastasis through Downregulating AxL, TYRO3, and FYN Expressions in MDA-MB-231 Breast Cancer Cells.J Agric Food Chem. 2019 Mar 13;67(10):2818-2830. doi: 10.1021/acs.jafc.8b06444. Epub 2019 Mar 4.
|
85 |
Role of the renin-angiotensin-aldosterone system and the glutathione S-transferase Mu, Pi and Theta gene polymorphisms in cardiotoxicity after anthracycline chemotherapy for breast carcinoma.Int J Biol Markers. 2013 Dec 17;28(4):e336-47. doi: 10.5301/jbm.5000041.
|
86 |
Allelic loss at chromosome 11q13 alters FGF3 gene expression in a human breast cancer progression model.Oncol Rep. 2014 Dec;32(6):2445-52. doi: 10.3892/or.2014.3502. Epub 2014 Sep 19.
|
87 |
Prognostic significance of the expression of GFR1, GFR3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma.BMC Cancer. 2013 Jan 26;13:34. doi: 10.1186/1471-2407-13-34.
|
88 |
The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.Int J Oncol. 2019 Dec;55(6):1223-1236. doi: 10.3892/ijo.2019.4891. Epub 2019 Oct 4.
|
89 |
Follow-up of patients with localized breast cancer and first indicators of advanced breast cancer recurrence: A retrospective study.Breast. 2017 Aug;34:53-57. doi: 10.1016/j.breast.2017.05.005. Epub 2017 May 12.
|
90 |
Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis.PLoS One. 2014 Nov 10;9(11):e112541. doi: 10.1371/journal.pone.0112541. eCollection 2014.
|
91 |
Purification and characterization of -galactosidase from newly isolated Aspergillus terreus (KUBCF1306) and evaluating its efficacy on breast cancer cell line (MCF-7).Bioorg Chem. 2020 Jan;94:103442. doi: 10.1016/j.bioorg.2019.103442. Epub 2019 Nov 15.
|
92 |
Correlation Between Doppler Ultrasound Blood Flow Parameters and Angiogenesis and Proliferation Activity in Breast Cancer.Med Sci Monit. 2019 Sep 19;25:7035-7041. doi: 10.12659/MSM.914395.
|
93 |
Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-B Activation.Endocrinology. 2017 Dec 1;158(12):4218-4232. doi: 10.1210/en.2017-00461.
|
94 |
Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial-mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling.Mol Carcinog. 2019 Jul;58(7):1314-1323. doi: 10.1002/mc.23014. Epub 2019 Apr 11.
|
95 |
Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells.Mol Biol Rep. 2019 Jun;46(3):3129-3140. doi: 10.1007/s11033-019-04767-x. Epub 2019 Apr 1.
|
96 |
The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival.Cancer Res. 2014 Feb 15;74(4):1166-78. doi: 10.1158/0008-5472.CAN-13-1451. Epub 2013 Dec 26.
|
97 |
LncRNA SNHG3 promotes cell proliferation and invasion through the miR-384/hepatoma-derived growth factor axis in breast cancer.Hum Cell. 2020 Jan;33(1):232-242. doi: 10.1007/s13577-019-00287-9. Epub 2019 Oct 4.
|
98 |
HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.J Steroid Biochem Mol Biol. 2017 Apr;168:91-101. doi: 10.1016/j.jsbmb.2017.02.008. Epub 2017 Feb 14.
|
99 |
HMG CoA reductase expression as a prognostic factor in Korean patients with breast cancer: A retrospective study.Medicine (Baltimore). 2019 Mar;98(13):e14968. doi: 10.1097/MD.0000000000014968.
|
100 |
Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.Tumour Biol. 2017 Mar;39(3):1010428317694318. doi: 10.1177/1010428317694318.
|
101 |
Cathepsin D enhances breast cancer invasion and metastasis through promoting hepsin ubiquitin-proteasome degradation.Cancer Lett. 2018 Dec 1;438:105-115. doi: 10.1016/j.canlet.2018.09.021. Epub 2018 Sep 15.
|
102 |
Associations of polymorphisms in histidine decarboxylase, histamine N-methyltransferase and histamine receptor H3 genes with breast cancer.PLoS One. 2014 May 16;9(5):e97728. doi: 10.1371/journal.pone.0097728. eCollection 2014.
|
103 |
Steroid enzyme and receptor expression and regulations in breast tumor samples - A statistical evaluation of public data.J Steroid Biochem Mol Biol. 2020 Feb;196:105494. doi: 10.1016/j.jsbmb.2019.105494. Epub 2019 Oct 11.
|
104 |
Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.OMICS. 2014 Dec;18(12):778-91. doi: 10.1089/omi.2014.0075.
|
105 |
Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.Cell Physiol Biochem. 2018;50(1):41-51. doi: 10.1159/000493956. Epub 2018 Oct 2.
|
106 |
TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-B pathway.J Cancer. 2018 Apr 5;9(8):1349-1356. doi: 10.7150/jca.22390. eCollection 2018.
|
107 |
Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.Int J Cancer. 2014 Mar 15;134(6):1408-21. doi: 10.1002/ijc.28458. Epub 2013 Oct 8.
|
108 |
Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers.Carcinogenesis. 2014 Dec;35(12):2698-705. doi: 10.1093/carcin/bgu203. Epub 2014 Sep 19.
|
109 |
Integration of genomic data enables selective discovery of breast cancer drivers.Cell. 2014 Dec 4;159(6):1461-75. doi: 10.1016/j.cell.2014.10.048. Epub 2014 Nov 26.
|
110 |
Regulation of cellular processes by interleukin-16 in homeostasis and cancer.J Cell Physiol. 2014 Feb;229(2):139-47. doi: 10.1002/jcp.24441.
|
111 |
Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.Croat Med J. 2014 Dec;55(6):638-46. doi: 10.3325/cmj.2014.55.638.
|
112 |
Interleukin-22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer.Mol Oncol. 2020 Jan;14(1):211-224. doi: 10.1002/1878-0261.12598. Epub 2019 Dec 4.
|
113 |
Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin 3-p38 MAPK signalling.Cancer Lett. 2019 Feb 1;442:320-332. doi: 10.1016/j.canlet.2018.10.015. Epub 2018 Oct 27.
|
114 |
Interleukin-33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development.Int J Cancer. 2020 Mar 1;146(5):1421-1434. doi: 10.1002/ijc.32779. Epub 2019 Dec 5.
|
115 |
Blocking Interleukin-4 Receptor Using Polyethylene Glycol Functionalized Superparamagnetic Iron Oxide Nanocarriers to Inhibit Breast Cancer Cell Proliferation.Cancer Res Treat. 2017 Apr;49(2):322-329. doi: 10.4143/crt.2016.091. Epub 2016 Jul 12.
|
116 |
The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy.Onco Targets Ther. 2019 Mar 25;12:2171-2180. doi: 10.2147/OTT.S185662. eCollection 2019.
|
117 |
Interplay between interferon-stimulated gene 15/ISGylation and interferon gamma signaling in breast cancer cells.Cell Signal. 2019 Feb;54:91-101. doi: 10.1016/j.cellsig.2018.11.021. Epub 2018 Nov 27.
|
118 |
Calendula arvensis L. as an anti-cancer agent against breast cancer cell lines.Mol Biol Rep. 2019 Apr;46(2):2187-2196. doi: 10.1007/s11033-019-04672-3. Epub 2019 Feb 11.
|
119 |
Identification of MYST3 as a novel epigenetic activator of ER frequently amplified in breast cancer.Oncogene. 2017 May 18;36(20):2910-2918. doi: 10.1038/onc.2016.433. Epub 2016 Nov 28.
|
120 |
Can unknown predisposition in familial breast cancer be family-specific?.Breast J. 2013 Sep-Oct;19(5):520-8. doi: 10.1111/tbj.12145. Epub 2013 Jun 26.
|
121 |
Caveolin-1 facilitated KCNA5 expression, promoting breast cancer viability.Oncol Lett. 2018 Oct;16(4):4829-4838. doi: 10.3892/ol.2018.9261. Epub 2018 Aug 3.
|
122 |
Inducing Polyclonal Eag1-Specific Antibodies by Vaccination with a Linear Epitope Immunogen and Its Relation to Breast Tumorigenesis.Pathol Oncol Res. 2017 Oct;23(4):761-767. doi: 10.1007/s12253-016-0158-2. Epub 2017 Jan 9.
|
123 |
hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer.Cancer Cell Int. 2018 Jul 5;18:93. doi: 10.1186/s12935-018-0592-1. eCollection 2018.
|
124 |
The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.Tumour Biol. 2016 May;37(5):6275-83. doi: 10.1007/s13277-015-4509-5. Epub 2015 Nov 30.
|
125 |
Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression.Oncotarget. 2017 Jul 19;8(47):81737-81753. doi: 10.18632/oncotarget.19387. eCollection 2017 Oct 10.
|
126 |
SF-KDM2A binds to ribosomal RNA gene promoter, reduces H4K20me3 level, and elevates ribosomal RNA transcription in breast cancer cells.Int J Oncol. 2017 Apr;50(4):1372-1382. doi: 10.3892/ijo.2017.3908. Epub 2017 Mar 10.
|
127 |
Histone demethylase JARID1C promotes breast cancer metastasis cells via down regulating BRMS1 expression.Biochem Biophys Res Commun. 2015 Aug 21;464(2):659-66. doi: 10.1016/j.bbrc.2015.07.049. Epub 2015 Jul 13.
|
128 |
KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast Cancer.Mol Cancer Ther. 2018 Sep;17(9):1973-1983. doi: 10.1158/1535-7163.MCT-17-0802. Epub 2018 Jun 20.
|
129 |
Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer.J Cell Physiol. 2020 Feb;235(2):932-943. doi: 10.1002/jcp.29008. Epub 2019 Jun 24.
|
130 |
Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.Immunogenetics. 2017 Feb;69(2):69-76. doi: 10.1007/s00251-016-0950-x. Epub 2016 Sep 15.
|
131 |
Downregulation of klotho is associated with invasive ductal carcinoma progression.Oncol Lett. 2017 Dec;14(6):7443-7448. doi: 10.3892/ol.2017.7110. Epub 2017 Sep 29.
|
132 |
Co-inhibitory T cell receptor KLRG1: human cancer expression and efficacy of neutralization in murine cancer models.Oncotarget. 2019 Feb 15;10(14):1399-1406. doi: 10.18632/oncotarget.26659. eCollection 2019 Feb 15.
|
133 |
Lipopolysaccharide-Binding Protein Is an Early Biomarker of Cardiac Function After Radiation Therapy for Breast Cancer.Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1074-1083. doi: 10.1016/j.ijrobp.2019.04.002. Epub 2019 Apr 13.
|
134 |
USP17 Suppresses Tumorigenesis and Tumor Growth through Deubiquitinating AEP.Int J Biol Sci. 2019 Jan 29;15(4):738-748. doi: 10.7150/ijbs.30106. eCollection 2019.
|
135 |
A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ER-positive breast cancer cells.Oncogene. 2019 Feb;38(6):808-821. doi: 10.1038/s41388-018-0456-0. Epub 2018 Sep 3.
|
136 |
Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10.Diagn Pathol. 2014 Apr 24;9:85. doi: 10.1186/1746-1596-9-85.
|
137 |
Wogonin suppresses the LPSenhanced invasiveness of MDAMB?31 breast cancer cells by inhibiting the 5LO/BLT2 cascade.Int J Mol Med. 2018 Oct;42(4):1899-1908. doi: 10.3892/ijmm.2018.3776. Epub 2018 Jul 12.
|
138 |
Transgenic overexpression of human LY6K in mice suppresses mature T cell development in the thymus.Oncol Lett. 2019 Jan;17(1):379-387. doi: 10.3892/ol.2018.9548. Epub 2018 Oct 4.
|
139 |
The CARMA3-Bcl10-MALT1 Signalosome Drives NFB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.Cancer Res. 2018 Mar 1;78(5):1225-1240. doi: 10.1158/0008-5472.CAN-17-1089. Epub 2017 Dec 19.
|
140 |
Mixed lineage kinase ZAK promotes epithelial-mesenchymal transition in cancer progression.Cell Death Dis. 2018 Feb 2;9(2):143. doi: 10.1038/s41419-017-0161-x.
|
141 |
Topological alternate centrality measure capturing drug targets in the network of MAPK pathways.IET Syst Biol. 2018 Oct;12(5):226-232. doi: 10.1049/iet-syb.2017.0058.
|
142 |
Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.Breast Cancer Res Treat. 2017 Jul;164(1):27-40. doi: 10.1007/s10549-017-4223-7. Epub 2017 Mar 31.
|
143 |
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.Breast Cancer Res Treat. 2019 May;175(1):39-50. doi: 10.1007/s10549-019-05146-7. Epub 2019 Feb 2.
|
144 |
Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.J Biol Chem. 2014 Sep 12;289(37):25737-49. doi: 10.1074/jbc.M114.570838. Epub 2014 Jul 29.
|
145 |
Proteins with Evolutionarily Hypervariable Domains are Associated with Immune Response and Better Survival of Basal-like Breast Cancer Patients.Comput Struct Biotechnol J. 2019 Mar 19;17:430-440. doi: 10.1016/j.csbj.2019.03.008. eCollection 2019.
|
146 |
Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.Glycobiology. 2013 Dec;23(12):1477-90. doi: 10.1093/glycob/cwt075. Epub 2013 Sep 13.
|
147 |
Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism.Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):377-397. doi: 10.21873/cgp.20143.
|
148 |
LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2838-2846. doi: 10.26355/eurrev_201904_17561.
|
149 |
Human G protein-coupled receptor 30 is N-glycosylated and N-terminal domain asparagine 44 is required for receptor structure and activity.Biosci Rep. 2019 Feb 26;39(2):BSR20182436. doi: 10.1042/BSR20182436. Print 2019 Feb 28.
|
150 |
Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.Breast Cancer Res. 2014 Nov 8;16(6):470. doi: 10.1186/s13058-014-0470-2.
|
151 |
Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients.Cancer Biol Ther. 2020;21(2):189-196. doi: 10.1080/15384047.2019.1680057. Epub 2019 Nov 4.
|
152 |
NLRX1 regulates TNF--induced mitochondria-lysosomal crosstalk to maintain the invasive and metastatic potential of breast cancer cells.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1460-1476. doi: 10.1016/j.bbadis.2019.02.018. Epub 2019 Feb 23.
|
153 |
Two minor NQO1 and NQO2 alleles predict poor response of breast cancer patients to adjuvant doxorubicin and cyclophosphamide therapy.Pharmacogenet Genomics. 2011 Dec;21(12):808-19. doi: 10.1097/FPC.0b013e32834b6918.
|
154 |
MiRNA-106a promotes breast cancer progression by regulating DAX-1.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1574-1583. doi: 10.26355/eurrev_201902_17116.
|
155 |
Variability in DNA Repair Capacity Levels among Molecular Breast Cancer Subtypes: Triple Negative Breast Cancer Shows Lowest Repair.Int J Mol Sci. 2017 Jul 12;18(7):1505. doi: 10.3390/ijms18071505.
|
156 |
Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level.PLoS Comput Biol. 2019 Dec 11;15(12):e1007485. doi: 10.1371/journal.pcbi.1007485. eCollection 2019 Dec.
|
157 |
Dichotomous roles for the orphan nuclear receptor NURR1 in breast cancer.BMC Cancer. 2013 Mar 21;13:139. doi: 10.1186/1471-2407-13-139.
|
158 |
Learning common and specific patterns from data of multiple interrelated biological scenarios with matrix factorization.Nucleic Acids Res. 2019 Jul 26;47(13):6606-6617. doi: 10.1093/nar/gkz488.
|
159 |
Preventive effects of oxytocin and oxytocin receptor in breast cancer pathogenesis.Per Med. 2019 Jan;16(1):25-34. doi: 10.2217/pme-2018-0009. Epub 2018 Nov 19.
|
160 |
Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.Clin Exp Metastasis. 2018 Feb;35(1-2):25-35. doi: 10.1007/s10585-018-9874-1. Epub 2018 Jan 11.
|
161 |
P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMT-related genes Snail and E-cadherin.Oncol Rep. 2018 Jan;39(1):138-150. doi: 10.3892/or.2017.6081. Epub 2017 Nov 7.
|
162 |
Prolyl-4-hydroxylase subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.BMC Cancer. 2014 Jan 2;14:1. doi: 10.1186/1471-2407-14-1.
|
163 |
MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2469-2475. doi: 10.26355/eurrev_201903_17394.
|
164 |
TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-1/Smad signaling.Biochem Biophys Res Commun. 2020 Jan 29;522(1):270-277. doi: 10.1016/j.bbrc.2019.11.104. Epub 2019 Nov 20.
|
165 |
BAF180: Its Roles in DNA Repair and Consequences in Cancer.ACS Chem Biol. 2017 Oct 20;12(10):2482-2490. doi: 10.1021/acschembio.7b00541. Epub 2017 Sep 28.
|
166 |
Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth.Oncogene. 2019 Feb;38(7):1106-1120. doi: 10.1038/s41388-018-0499-2. Epub 2018 Sep 12.
|
167 |
The oncoprotein HBXIP upregulates PDGFB via activating transcription factor Sp1 to promote the proliferation of breast cancer cells.Biochem Biophys Res Commun. 2013 May 3;434(2):305-10. doi: 10.1016/j.bbrc.2013.02.123. Epub 2013 Mar 26.
|
168 |
Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors.Oncol Rep. 2016 Mar;35(3):1318-28. doi: 10.3892/or.2015.4525. Epub 2015 Dec 28.
|
169 |
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.Breast Cancer Res Treat. 2018 Jun;169(2):231-241. doi: 10.1007/s10549-018-4664-7. Epub 2018 Jan 29.
|
170 |
Epigenetic repression of phosphatidylethanolamine N-methyltransferase (PEMT) in BRCA1-mutated breast cancer.Oncotarget. 2014 Mar 15;5(5):1315-25. doi: 10.18632/oncotarget.1800.
|
171 |
Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4.Oncogene. 2018 Mar;37(13):1685-1698. doi: 10.1038/s41388-017-0072-4. Epub 2018 Jan 16.
|
172 |
Histone demethylase PHF8 promotes epithelial to mesenchymal transition and breast tumorigenesis.Nucleic Acids Res. 2017 Feb 28;45(4):1687-1702. doi: 10.1093/nar/gkw1093.
|
173 |
The PIKfyve-ArPIKfyve-Sac3 triad in human breast cancer: Functional link between elevated Sac3 phosphatase and enhanced proliferation of triple negative cell lines.Biochem Biophys Res Commun. 2013 Oct 18;440(2):342-7. doi: 10.1016/j.bbrc.2013.09.080. Epub 2013 Sep 23.
|
174 |
Correction: PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.Oncogene. 2020 Jan;39(3):720-721. doi: 10.1038/s41388-019-0982-4.
|
175 |
Gene expression correlation for cancer diagnosis: a pilot study.Biomed Res Int. 2014;2014:253804. doi: 10.1155/2014/253804. Epub 2014 Apr 9.
|
176 |
The role of PIP5K1/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1 inhibitor.Oncogene. 2019 Jan;38(3):375-389. doi: 10.1038/s41388-018-0438-2. Epub 2018 Aug 13.
|
177 |
The NQO1/PKLR axis promotes lymph node metastasis and breast cancer progression by modulating glycolytic reprogramming.Cancer Lett. 2019 Jul 1;453:170-183. doi: 10.1016/j.canlet.2019.03.054. Epub 2019 Apr 4.
|
178 |
Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis.Cell Prolif. 2020 Feb;53(2):e12741. doi: 10.1111/cpr.12741. Epub 2019 Dec 14.
|
179 |
The interaction of p130Cas with PKN3 promotes malignant growth.Mol Oncol. 2019 Feb;13(2):264-289. doi: 10.1002/1878-0261.12401. Epub 2018 Dec 3.
|
180 |
Expression of phospholipase C isozymes in human breast cancer and their clinical significance.Oncol Rep. 2017 Mar;37(3):1707-1715. doi: 10.3892/or.2017.5394. Epub 2017 Jan 20.
|
181 |
MiR-422a weakened breast cancer stem cells properties by targeting PLP2. Cancer Biol Ther. 2018 May 4;19(5):436-444.
|
182 |
miRNA-192-5p impacts the sensitivity of breast cancer cells to doxorubicin via targeting peptidylprolyl isomerase A.Kaohsiung J Med Sci. 2019 Jan;35(1):17-23. doi: 10.1002/kjm2.12004.
|
183 |
Ribonucleotide reductase subunit M2B deficiency leads to mitochondrial permeability transition pore opening and is associated with aggressive clinicopathologic manifestations of breast cancer.Am J Transl Res. 2018 Nov 15;10(11):3635-3649. eCollection 2018.
|
184 |
Dephosphorylation of Girdin by PP2A inhibits breast cancer metastasis.Biochem Biophys Res Commun. 2019 May 21;513(1):28-34. doi: 10.1016/j.bbrc.2019.03.167. Epub 2019 Mar 29.
|
185 |
The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.Breast Cancer. 2017 Sep;24(5):658-666. doi: 10.1007/s12282-017-0752-5. Epub 2017 Jan 9.
|
186 |
Interleukin-32 inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer.Cell Commun Signal. 2019 May 24;17(1):53. doi: 10.1186/s12964-019-0374-y.
|
187 |
Transcriptional regulation of oncogenic protein kinase C (PKC) by STAT1 and Sp1 proteins.J Biol Chem. 2014 Jul 11;289(28):19823-38. doi: 10.1074/jbc.M114.548446. Epub 2014 May 13.
|
188 |
The p52 isoform of SHC1 is a key driver of breast cancer initiation.Breast Cancer Res. 2019 Jun 15;21(1):74. doi: 10.1186/s13058-019-1155-7.
|
189 |
Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers.Cancer Res Treat. 2019 Jan;51(1):80-89. doi: 10.4143/crt.2017.500. Epub 2018 Feb 26.
|
190 |
Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.Biomaterials. 2017 Dec;147:86-98. doi: 10.1016/j.biomaterials.2017.09.010. Epub 2017 Sep 8.
|
191 |
The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells.Breast Cancer Res. 2019 Apr 24;21(1):53. doi: 10.1186/s13058-019-1131-2.
|
192 |
PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases.Int J Endocrinol. 2018 Jul 29;2018:7120979. doi: 10.1155/2018/7120979. eCollection 2018.
|
193 |
PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.PLoS One. 2014 Jan 7;9(1):e84472. doi: 10.1371/journal.pone.0084472. eCollection 2014.
|
194 |
Pleiotrophin as a potential biomarker in breast cancer patients.Clin Chim Acta. 2017 Mar;466:6-12. doi: 10.1016/j.cca.2016.12.030. Epub 2016 Dec 29.
|
195 |
Inhibition of PRL-2CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.J Biol Chem. 2016 May 13;291(20):10716-25. doi: 10.1074/jbc.M115.705863. Epub 2016 Mar 11.
|
196 |
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.Cell Death Dis. 2018 Feb 27;9(3):326. doi: 10.1038/s41419-018-0347-x.
|
197 |
The overexpression of Rab9 promotes tumor progression regulated by XBP1 in breast cancer.Onco Targets Ther. 2019 Mar 4;12:1815-1824. doi: 10.2147/OTT.S183748. eCollection 2019.
|
198 |
2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.Oncotarget. 2018 Apr 6;9(26):18053-18068. doi: 10.18632/oncotarget.24720. eCollection 2018 Apr 6.
|
199 |
Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis.Mol Cell Biochem. 2017 Jun;430(1-2):115-125. doi: 10.1007/s11010-017-2959-3. Epub 2017 Feb 16.
|
200 |
Standing in the GAP : To formulate a novel radioimmunotherapy regime to improve the long-term outcome in breast cancer.Immunotherapy. 2018 Feb 1;10(4):255-263. doi: 10.2217/imt-2017-0080.
|
201 |
Replication of breast cancer susceptibility loci in whites and African Americans using a Bayesian approach.Am J Epidemiol. 2014 Feb 1;179(3):382-94. doi: 10.1093/aje/kwt258. Epub 2013 Nov 10.
|
202 |
Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).Biomed Res Int. 2019 Mar 18;2019:3235021. doi: 10.1155/2019/3235021. eCollection 2019.
|
203 |
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.Sci Transl Med. 2017 Apr 12;9(385):eaak9679. doi: 10.1126/scitranslmed.aak9679.
|
204 |
ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).Anticancer Res. 2019 Mar;39(3):1267-1273. doi: 10.21873/anticanres.13237.
|
205 |
Effects of RSF-1 on proliferation and apoptosis of breast cancer cells.Oncol Lett. 2018 Oct;16(4):4279-4284. doi: 10.3892/ol.2018.9172. Epub 2018 Jul 18.
|
206 |
Clinical value of R-spondins in triple-negative and metaplastic breast cancers.Br J Cancer. 2017 Jun 6;116(12):1595-1603. doi: 10.1038/bjc.2017.131. Epub 2017 May 4.
|
207 |
S1PR1 regulates the switch of two angiogenic modes by VE-cadherin phosphorylation in breast cancer.Cell Death Dis. 2019 Feb 27;10(3):200. doi: 10.1038/s41419-019-1411-x.
|
208 |
Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.Cell Signal. 2014 May;26(5):1040-7. doi: 10.1016/j.cellsig.2014.01.023. Epub 2014 Jan 29.
|
209 |
SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis.Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):115-125. doi: 10.1016/j.bbadis.2018.10.026. Epub 2018 Oct 28.
|
210 |
Long noncoding RNA HOXA-AS2 regulates the expression of SCN3A by sponging miR-106a in breast cancer.J Cell Biochem. 2019 Sep;120(9):14465-14475. doi: 10.1002/jcb.28706. Epub 2019 Apr 16.
|
211 |
Stem-like tumor cells involved in heterogeneous vasculogenesis in breast cancer.Endocr Relat Cancer. 2020 Jan;27(1):23-39. doi: 10.1530/ERC-19-0054.
|
212 |
Mutational landscape of RNA-binding proteins in human cancers.RNA Biol. 2018 Jan 2;15(1):115-129. doi: 10.1080/15476286.2017.1391436. Epub 2017 Nov 14.
|
213 |
Serum- and Glucocorticoid-inducible Kinase 1 is Essential for Osteoclastogenesis and Promotes Breast Cancer Bone Metastasis.Mol Cancer Ther. 2020 Feb;19(2):650-660. doi: 10.1158/1535-7163.MCT-18-0783. Epub 2019 Nov 6.
|
214 |
Molecular expression and functional activity of vitamin C specific transport system (SVCT2) in human breast cancer cells.Int J Pharm. 2014 Oct 20;474(1-2):14-24. doi: 10.1016/j.ijpharm.2014.07.056. Epub 2014 Aug 4.
|
215 |
SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation.Endocr J. 2020 Jan 28;67(1):99-106. doi: 10.1507/endocrj.EJ19-0428. Epub 2019 Nov 27.
|
216 |
Biotin uptake by T47D breast cancer cells: functional and molecular evidence of sodium-dependent multivitamin transporter (SMVT).Int J Pharm. 2013 Jan 30;441(1-2):535-43. doi: 10.1016/j.ijpharm.2012.10.047. Epub 2012 Nov 8.
|
217 |
Calcium signaling affects migration and proliferation differently in individual cancer cells due to nifedipine treatment.Biochem Pharmacol. 2020 Jan;171:113695. doi: 10.1016/j.bcp.2019.113695. Epub 2019 Nov 9.
|
218 |
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.Oncotarget. 2017 Jan 24;8(4):6540-6554. doi: 10.18632/oncotarget.14145.
|
219 |
Suppressor of cytokine signaling (SOCS) genes are downregulated in breast cancer.World J Surg Oncol. 2018 Nov 19;16(1):226. doi: 10.1186/s12957-018-1529-9.
|
220 |
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.Cancer Lett. 2019 May 1;449:196-206. doi: 10.1016/j.canlet.2019.02.019. Epub 2019 Feb 13.
|
221 |
STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.Cancer Biol Ther. 2020;21(3):278-291. doi: 10.1080/15384047.2019.1685290. Epub 2019 Nov 7.
|
222 |
Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7457-7468. doi: 10.26355/eurrev_201909_18855.
|
223 |
MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.Cell Prolif. 2019 Jan;52(1):e12527. doi: 10.1111/cpr.12527. Epub 2018 Oct 17.
|
224 |
Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3 Pathway.Mol Cancer Ther. 2019 Dec;18(12):2457-2468. doi: 10.1158/1535-7163.MCT-19-0261. Epub 2019 Sep 5.
|
225 |
Transducin ()-like 1 X-linked receptor 1 promotes proliferation and tumorigenicity in human breast cancer via activation of beta-catenin signaling.Breast Cancer Res. 2014 Oct 24;16(5):465. doi: 10.1186/s13058-014-0465-z.
|
226 |
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.Nat Med. 2017 Jan;23(1):120-127. doi: 10.1038/nm.4232. Epub 2016 Nov 21.
|
227 |
A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.Clin Cancer Res. 2013 Apr 15;19(8):2061-70. doi: 10.1158/1078-0432.CCR-13-0082. Epub 2013 Mar 11.
|
228 |
HVEM gene polymorphisms are associated with sporadic breast cancer in Chinese women.PLoS One. 2013 Aug 16;8(8):e71040. doi: 10.1371/journal.pone.0071040. eCollection 2013.
|
229 |
Expression of death receptor-3 in human breast cancer and its functional effects on breast cancer cells in vitro.Oncol Rep. 2013 Apr;29(4):1356-64. doi: 10.3892/or.2013.2259. Epub 2013 Jan 30.
|
230 |
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb. J Cancer Res Clin Oncol. 2013 Feb;139(2):315-25.
|
231 |
BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness.Front Oncol. 2018 Aug 7;8:301. doi: 10.3389/fonc.2018.00301. eCollection 2018.
|
232 |
Vascular endothelial growth inhibitor affects the invasion, apoptosis and vascularisation in breast cancer cell line MDA-MB-231.Chin Med J (Engl). 2014;127(10):1947-53.
|
233 |
Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing.BMC Genomics. 2013 Mar 12;14:165. doi: 10.1186/1471-2164-14-165.
|
234 |
Association between the c.*229C>T polymorphism of the topoisomerase II binding protein 1 (TopBP1) gene and breast cancer.Mol Biol Rep. 2013 May;40(5):3493-502. doi: 10.1007/s11033-012-2424-z. Epub 2013 Jan 1.
|
235 |
Differences in transcriptional effects of 1,25 dihydroxyvitamin D3 on fibroblasts associated to breast carcinomas and from paired normal breast tissues.J Steroid Biochem Mol Biol. 2013 Jan;133:12-24. doi: 10.1016/j.jsbmb.2012.08.002. Epub 2012 Aug 23.
|
236 |
TYRO3 as a potential therapeutic target in breast cancer.Anticancer Res. 2014 Jul;34(7):3337-45.
|
237 |
Identification of differentially expressed genes and typical fusion genes associated with three subtypes of breast cancer.Breast Cancer. 2019 May;26(3):305-316. doi: 10.1007/s12282-018-0924-y. Epub 2018 Nov 16.
|
238 |
CyclinB1 deubiquitination by USP14 regulates cell cycle progression in breast cancer.Pathol Res Pract. 2019 Oct;215(10):152592. doi: 10.1016/j.prp.2019.152592. Epub 2019 Aug 17.
|
239 |
Mst1-Hippo pathway triggers breast cancer apoptosis via inducing mitochondrial fragmentation in a manner dependent on JNK-Drp1 axis.Onco Targets Ther. 2019 Feb 11;12:1147-1159. doi: 10.2147/OTT.S193787. eCollection 2019.
|
240 |
Tumor suppressive effects of WEE1 gene silencing could not enhance immunopotentiation effects of CD80 and 4-1BBL co-stimulation in human T cells.J Cancer Res Ther. 2015 Oct-Dec;11(4):708-16. doi: 10.4103/0973-1482.147746.
|
241 |
Analysis of DNA Repair Genes Polymorphisms in Breast Cancer.Pathol Oncol Res. 2017 Jan;23(1):117-123. doi: 10.1007/s12253-016-0110-5. Epub 2016 Aug 29.
|
242 |
Targeting AU-rich element-mediated mRNA decay with a truncated active form of the zinc-finger protein TIS11b/BRF1 impairs major hallmarks of mammary tumorigenesis.Oncogene. 2019 Jun;38(26):5174-5190. doi: 10.1038/s41388-019-0784-8. Epub 2019 Mar 26.
|
243 |
Male secretory breast cancer: case in a 6-year-old boy with a peculiar gene duplication and review of the literature.Breast Cancer Res Treat. 2018 Aug;170(3):445-454. doi: 10.1007/s10549-018-4772-4. Epub 2018 Apr 3.
|
244 |
miR-125a-3p inhibits ER transactivation and overrides tamoxifen resistance by targeting CDK3 in estrogen receptor-positive breast cancer.FASEB J. 2018 Feb;32(2):588-600. doi: 10.1096/fj.201700461RR. Epub 2018 Jan 4.
|
245 |
RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells.J Dermatol Sci. 2015 Jul;79(1):57-63. doi: 10.1016/j.jdermsci.2015.03.020. Epub 2015 Apr 9.
|
246 |
Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer.Cell Death Dis. 2018 Apr 1;9(4):416. doi: 10.1038/s41419-018-0448-6.
|
247 |
Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.Biomaterials. 2018 Jan;152:47-62. doi: 10.1016/j.biomaterials.2017.10.035. Epub 2017 Oct 21.
|
248 |
AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.J Cell Physiol. 2007 Sep;212(3):655-65. doi: 10.1002/jcp.21059.
|
249 |
Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.PLoS Genet. 2013 Apr;9(4):e1003464. doi: 10.1371/journal.pgen.1003464. Epub 2013 Apr 25.
|
250 |
Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the -Ketoglutarate Signaling Pathway.Cancer Res. 2018 Jun 1;78(11):2799-2812. doi: 10.1158/0008-5472.CAN-17-2906. Epub 2018 Mar 29.
|
251 |
Body mass index, diet, and exercise: testing possible linkages to breast cancer risk via DNA methylation.Breast Cancer Res Treat. 2018 Feb;168(1):241-248. doi: 10.1007/s10549-017-4573-1. Epub 2017 Nov 10.
|
252 |
Enhanced cytotoxicity in triple-negative and estrogen receptorpositive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel.Oncol Rep. 2015 Sep;34(3):1589-98. doi: 10.3892/or.2015.4131. Epub 2015 Jul 14.
|
253 |
Expression of LXR? ABCA1 and ABCG1 in human triplenegative breast cancer tissues.Oncol Rep. 2019 Nov;42(5):1869-1877. doi: 10.3892/or.2019.7279. Epub 2019 Aug 14.
|
254 |
Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.Oncotarget. 2015 Sep 22;6(28):26519-27. doi: 10.18632/oncotarget.4470.
|
255 |
Quantitative real-time RT-PCR of ITGA7, SVEP1, TNS1, LPHN3, SEMA3G, KLB and MMP13 mRNA expression in breast cancer.Asian Pac J Cancer Prev. 2012;13(11):5879-82. doi: 10.7314/apjcp.2012.13.11.5879.
|
256 |
Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer.Tumour Biol. 2015 Jul;36(7):5627-34. doi: 10.1007/s13277-015-3235-3. Epub 2015 Feb 15.
|
257 |
Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers.J Cancer Res Clin Oncol. 2012 May;138(5):867-75. doi: 10.1007/s00432-012-1161-y. Epub 2012 Feb 7.
|
258 |
Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.BMC Med. 2017 Dec 19;15(1):218. doi: 10.1186/s12916-017-0976-4.
|
259 |
Human Aquaporin-5 Facilitates Hydrogen Peroxide Permeation Affecting Adaption to Oxidative Stress and Cancer Cell Migration.Cancers (Basel). 2019 Jul 3;11(7):932. doi: 10.3390/cancers11070932.
|
260 |
Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1. Oncotarget. 2016 Sep 6;7(36):58111-58120.
|
261 |
-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1354-63. eCollection 2015.
|
262 |
Derlin-1 functions as a growth promoter in breast cancer.Biol Chem. 2020 Feb 25;401(3):377-387. doi: 10.1515/hsz-2018-0442.
|
263 |
Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation ofp53-miR34a axis.Mol Oncol. 2016 Aug;10(7):1118-32. doi: 10.1016/j.molonc.2016.04.003. Epub 2016 May 20.
|
264 |
ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.Cancer Lett. 2019 Dec 28;467:19-28. doi: 10.1016/j.canlet.2019.09.012. Epub 2019 Sep 26.
|
265 |
The alcohol dehydrogenase 1C(rs698) genotype and breast cancer: a meta-analysis.Asia Pac J Public Health. 2015 Mar;27(2):NP36-46. doi: 10.1177/1010539512446962. Epub 2012 May 31.
|
266 |
Exosome secretome and mediated signaling in breast cancer patients with nontuberculous mycobacterial disease.Oncotarget. 2017 Mar 14;8(11):18070-18081. doi: 10.18632/oncotarget.14964.
|
267 |
AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis.Cancer Res. 2015 Sep 1;75(17):3492-504. doi: 10.1158/0008-5472.CAN-15-0088. Epub 2015 Jul 2.
|
268 |
An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014 Jul;24(7):809-19. doi: 10.1038/cr.2014.71. Epub 2014 May 30.
|
269 |
SUN2: A potential therapeutic target in cancer.Oncol Lett. 2019 Feb;17(2):1401-1408. doi: 10.3892/ol.2018.9764. Epub 2018 Nov 27.
|
270 |
Baihe Zhimu formula attenuates the efficacy of tamoxifen against breast cancer in mice through modulation of CYP450 enzymes.BMC Complement Altern Med. 2019 Sep 4;19(1):240. doi: 10.1186/s12906-019-2651-0.
|
271 |
Voltage-gated calcium channels: Novel targets for cancer therapy.Oncol Lett. 2017 Aug;14(2):2059-2074. doi: 10.3892/ol.2017.6457. Epub 2017 Jun 22.
|
272 |
Methylation of the calcium channel regulatory subunit 2-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas.Br J Cancer. 2012 Jul 10;107(2):375-81. doi: 10.1038/bjc.2012.231. Epub 2012 May 29.
|
273 |
Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province.Breast Cancer Res Treat. 2012 Jun;133(3):1105-13. doi: 10.1007/s10549-012-1987-7. Epub 2012 Mar 8.
|
274 |
ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression.Mol Cell. 2012 Mar 30;45(6):764-76. doi: 10.1016/j.molcel.2012.01.029.
|
275 |
Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control.Genes (Basel). 2019 Feb 28;10(3):186. doi: 10.3390/genes10030186.
|
276 |
CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/ -catenin Signaling.Curr Cancer Drug Targets. 2020;20(2):156-165. doi: 10.2174/1568009619666191118113220.
|
277 |
Long noncoding RNA CASC2 promotes paclitaxel resistance in breast cancer through regulation of miR-18a-5p/CDK19.Histochem Cell Biol. 2019 Oct;152(4):281-291. doi: 10.1007/s00418-019-01794-4. Epub 2019 Jul 27.
|
278 |
Identifying Cancers Impacted by CDK8/19.Cells. 2019 Aug 3;8(8):821. doi: 10.3390/cells8080821.
|
279 |
The anticancer effect of the TLR4 inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer.J Cell Biochem. 2020 Feb;121(2):1623-1634. doi: 10.1002/jcb.29397. Epub 2019 Sep 18.
|
280 |
Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells.Clin Exp Metastasis. 2019 Oct;36(5):423-432. doi: 10.1007/s10585-019-09981-2. Epub 2019 Jun 20.
|
281 |
A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.Cancer Genet. 2019 Nov;239:54-61. doi: 10.1016/j.cancergen.2019.09.005. Epub 2019 Sep 18.
|
282 |
Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.Clin Transl Oncol. 2019 Jul;21(7):910-923. doi: 10.1007/s12094-018-02003-9. Epub 2018 Dec 18.
|
283 |
Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression.J Cell Physiol. 2019 May;234(5):6611-6623. doi: 10.1002/jcp.27402. Epub 2018 Sep 19.
|
284 |
A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells.Cell Death Dis. 2015 Mar 12;6(3):e1686. doi: 10.1038/cddis.2015.25.
|
285 |
Development of dual casein kinase 1/1 (CK1/) inhibitors for treatment of breast cancer.Bioorg Med Chem. 2018 Feb 1;26(3):590-602. doi: 10.1016/j.bmc.2017.12.020. Epub 2017 Dec 15.
|
286 |
The Small C-terminal Domain Phosphatase 1 Inhibits Cancer Cell Migration and Invasion by Dephosphorylating Ser(P)68-Twist1 to Accelerate Twist1 Protein Degradation.J Biol Chem. 2016 May 27;291(22):11518-28. doi: 10.1074/jbc.M116.721795. Epub 2016 Mar 14.
|
287 |
A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer.J Oncol. 2019 Jun 27;2019:3980273. doi: 10.1155/2019/3980273. eCollection 2019.
|
288 |
Potentially functional polymorphisms in aminoacyl-tRNA synthetases genes are associated with breast cancer risk in a Chinese population.Mol Carcinog. 2015 Jul;54(7):577-83. doi: 10.1002/mc.22128. Epub 2014 Feb 9.
|
289 |
siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells.Cell Oncol (Dordr). 2013 Dec;36(6):515-26. doi: 10.1007/s13402-013-0157-1. Epub 2013 Nov 26.
|
290 |
Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China.Genet Mol Res. 2012 Dec 17;11(4):4330-41. doi: 10.4238/2012.September.26.1.
|
291 |
NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.Breast Cancer Res Treat. 2018 Nov;172(2):469-485. doi: 10.1007/s10549-018-4905-9. Epub 2018 Aug 20.
|
292 |
PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ.PLoS One. 2012;7(12):e51239. doi: 10.1371/journal.pone.0051239. Epub 2012 Dec 10.
|
293 |
Design, synthesis and structure-activity relationship of a focused library of -phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.Eur J Med Chem. 2018 Jan 1;143:402-418. doi: 10.1016/j.ejmech.2017.11.065. Epub 2017 Dec 1.
|
294 |
Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells.Oncogene. 2019 Sep;38(36):6382-6398. doi: 10.1038/s41388-019-0890-7. Epub 2019 Jul 16.
|
295 |
Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.Expert Rev Mol Diagn. 2012 Jul;12(6):593-602. doi: 10.1586/erm.12.59.
|
296 |
Tumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.Cancer Discov. 2016 May;6(5):516-31. doi: 10.1158/2159-8290.CD-15-1183. Epub 2016 Jan 25.
|
297 |
ENSA expression correlates with attenuated tumor propagation in liver cancer.Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):56-61. doi: 10.1016/j.bbrc.2013.10.165. Epub 2013 Nov 8.
|
298 |
EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.FASEB J. 2019 Apr;33(4):4851-4865. doi: 10.1096/fj.201701561RRRR. Epub 2019 Jan 8.
|
299 |
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.J Clin Invest. 2018 Apr 2;128(4):1283-1299. doi: 10.1172/JCI95873. Epub 2018 Feb 26.
|
300 |
MicroRNA-765 alleviates the malignant progression of breast cancer via interacting with EZH1.Am J Transl Res. 2019 Jul 15;11(7):4500-4507. eCollection 2019.
|
301 |
PAR-4 overcomes chemo-resistance in breast cancer cells by antagonizing cIAP1.Sci Rep. 2019 Jun 19;9(1):8755. doi: 10.1038/s41598-019-45209-9.
|
302 |
Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study.J Thromb Haemost. 2018 Jul;16(7):1347-1356. doi: 10.1111/jth.14151. Epub 2018 Jun 12.
|
303 |
Coagulation factor VII is regulated by androgen receptor in breast cancer.Exp Cell Res. 2015 Feb 1;331(1):239-250. doi: 10.1016/j.yexcr.2014.10.002. Epub 2014 Oct 14.
|
304 |
Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer cell lines.J Surg Res. 2000 Sep;93(1):108-19. doi: 10.1006/jsre.2000.5957.
|
305 |
Prognostic significance of FAM83D gene expression across human cancer types.Oncotarget. 2016 Jan 19;7(3):3332-40. doi: 10.18632/oncotarget.6620.
|
306 |
A rare FANCA gene variation as a breast cancer susceptibility allele in an Iranian population.Mol Med Rep. 2017 Jun;15(6):3983-3988. doi: 10.3892/mmr.2017.6489. Epub 2017 Apr 20.
|
307 |
MicroRNA Let-7g Directly Targets Forkhead Box C2 (FOXC2) to Modulate Bone Metastasis in Breast Cancer.Open Med (Wars). 2017 Sep 6;12:157-162. doi: 10.1515/med-2017-0023. eCollection 2017.
|
308 |
Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery.J Exp Clin Cancer Res. 2015 Feb 5;34(1):12. doi: 10.1186/s13046-015-0128-7.
|
309 |
Restoration of GATA4 expression impedes breast cancer progression by transcriptional repression of ReLA and inhibition of NF-B signaling.J Cell Biochem. 2019 Jan;120(1):917-927. doi: 10.1002/jcb.27455. Epub 2018 Sep 6.
|
310 |
GDF5 regulates TGF-dependent angiogenesis in breast carcinoma MCF-7 cells: in vitro and in vivo control by anti-TGF peptides.PLoS One. 2012;7(11):e50342. doi: 10.1371/journal.pone.0050342. Epub 2012 Nov 30.
|
311 |
Gap junction ? expression is negatively associated with the estrogen receptor status in breast cancer tissues and is a regulator of breast tumorigenesis.Oncol Rep. 2018 Dec;40(6):3645-3653. doi: 10.3892/or.2018.6764. Epub 2018 Oct 3.
|
312 |
Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.Clin Cancer Res. 2012 Apr 15;18(8):2382-90. doi: 10.1158/1078-0432.CCR-11-2303. Epub 2012 Feb 20.
|
313 |
Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells.Asian Pac J Cancer Prev. 2013;14(10):5805-10. doi: 10.7314/apjcp.2013.14.10.5805.
|
314 |
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.Breast Cancer Res. 2019 Sep 18;21(1):109. doi: 10.1186/s13058-019-1194-0.
|
315 |
G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.EBioMedicine. 2016 Nov;13:132-145. doi: 10.1016/j.ebiom.2016.09.030. Epub 2016 Oct 1.
|
316 |
Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.BMC Cancer. 2019 Sep 6;19(1):891. doi: 10.1186/s12885-019-6068-4.
|
317 |
Differential expression of alternative transcripts of soluble guanylyl cyclase, GYCY1a3 and GUCY1b3 genes, in the malignant and benign breast tumors.Nitric Oxide. 2019 Feb 1;83:65-71. doi: 10.1016/j.niox.2018.12.009. Epub 2018 Dec 28.
|
318 |
Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.Oncogene. 2018 Jul;37(29):4013-4032. doi: 10.1038/s41388-018-0243-y. Epub 2018 Apr 26.
|
319 |
Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism.Oncotarget. 2015 Aug 14;6(23):19706-20. doi: 10.18632/oncotarget.3565.
|
320 |
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes.Nat Commun. 2019 Sep 13;10(1):4192. doi: 10.1038/s41467-019-12222-5.
|
321 |
Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.Breast Cancer Res. 2018 Aug 2;20(1):83. doi: 10.1186/s13058-018-1018-7.
|
322 |
miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.Oncotarget. 2015 Jan 1;6(1):494-509. doi: 10.18632/oncotarget.2674.
|
323 |
HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer.Br J Cancer. 2019 Dec;121(12):1039-1049. doi: 10.1038/s41416-019-0625-0. Epub 2019 Nov 6.
|
324 |
miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.J Cell Physiol. 2020 Mar;235(3):2631-2642. doi: 10.1002/jcp.29167. Epub 2019 Sep 11.
|
325 |
Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.Br J Cancer. 2020 Feb;122(3):348-360. doi: 10.1038/s41416-019-0636-x. Epub 2019 Nov 21.
|
326 |
Ketone bodies and two-compartment tumor metabolism: stromal ketone production fuels mitochondrial biogenesis in epithelial cancer cells.Cell Cycle. 2012 Nov 1;11(21):3956-63. doi: 10.4161/cc.22136. Epub 2012 Sep 19.
|
327 |
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.Oncotarget. 2015 Feb 10;6(4):2466-82. doi: 10.18632/oncotarget.2967.
|
328 |
Estrogen and androgen-converting enzymes 17-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.Oncotarget. 2017 May 2;8(18):30552-30562. doi: 10.18632/oncotarget.15547.
|
329 |
The regulation of hydroxysteroid 17-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.Oncotarget. 2017 Jul 10;8(37):62183-62194. doi: 10.18632/oncotarget.19136. eCollection 2017 Sep 22.
|
330 |
Iduronate-2-Sulfatase-Regulated Dermatan Sulfate Levels Potentiate the Invasion of Breast Cancer Epithelia through Collagen Matrix.J Clin Med. 2019 Sep 30;8(10):1562. doi: 10.3390/jcm8101562.
|
331 |
Molecular mechanism of point mutation-induced Monopolar spindle 1 (Mps1/TTK) inhibitor resistance revealed by a comprehensive molecular modeling study.PeerJ. 2019 Jan 21;7:e6299. doi: 10.7717/peerj.6299. eCollection 2019.
|
332 |
Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.Oncogene. 2019 Apr;38(15):2814-2829. doi: 10.1038/s41388-018-0624-2. Epub 2018 Dec 13.
|
333 |
Association analysis of IL-17A and IL-17F polymorphisms in Chinese Han women with breast cancer.PLoS One. 2012;7(3):e34400. doi: 10.1371/journal.pone.0034400. Epub 2012 Mar 26.
|
334 |
Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment.Clin Cancer Res. 2019 May 1;25(9):2769-2782. doi: 10.1158/1078-0432.CCR-18-2202. Epub 2019 Jan 22.
|
335 |
Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile.Clin Exp Med. 2019 Aug;19(3):385-391. doi: 10.1007/s10238-019-00559-6. Epub 2019 May 18.
|
336 |
IRF-1 inhibits NF-B activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.Cancer Biol Ther. 2015;16(7):1029-41. doi: 10.1080/15384047.2015.1046646.
|
337 |
Negative correlation of ITCH E3 ubiquitin ligase and miRNA-106b dictates metastatic progression in pancreatic cancer.Oncotarget. 2016 Jan 12;7(2):1477-85. doi: 10.18632/oncotarget.6395.
|
338 |
C-reactive protein binds to integrin 2 and Fc receptor I, leading to breast cell adhesion and breast cancer progression.Oncogene. 2018 Jan 4;37(1):28-38. doi: 10.1038/onc.2017.298. Epub 2017 Aug 28.
|
339 |
Heart toxicity from breast cancer radiotherapy : Current findings, assessment, and prevention.Strahlenther Onkol. 2019 Jan;195(1):1-12. doi: 10.1007/s00066-018-1378-z. Epub 2018 Oct 11.
|
340 |
High expression of integrin 6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.Cancer Med. 2016 Aug;5(8):2000-11. doi: 10.1002/cam4.756. Epub 2016 May 17.
|
341 |
Potassium channel KCNA1 modulates oncogene-induced senescence and transformation.Cancer Res. 2013 Aug 15;73(16):5253-65. doi: 10.1158/0008-5472.CAN-12-3690. Epub 2013 Jun 17.
|
342 |
GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.Sci Rep. 2019 Dec 17;9(1):19277. doi: 10.1038/s41598-019-55683-w.
|
343 |
Kdm4c is Recruited to Mitotic Chromosomes and Is Relevant for Chromosomal Stability, Cell Migration and Invasion of Triple Negative Breast Cancer Cells.Breast Cancer (Auckl). 2018 Jul 27;12:1178223418773075. doi: 10.1177/1178223418773075. eCollection 2018.
|
344 |
Prominent Oncogenic Roles of EVI1 in Breast Carcinoma.Cancer Res. 2017 Apr 15;77(8):2148-2160. doi: 10.1158/0008-5472.CAN-16-0593. Epub 2017 Feb 16.
|
345 |
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction.J Pathol. 2012 Feb;226(3):482-94. doi: 10.1002/path.2998. Epub 2011 Oct 19.
|
346 |
Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions.Pathobiology. 2015 Sep;82(3-4):166-71. doi: 10.1159/000375127. Epub 2015 Aug 31.
|
347 |
Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer.Eur J Pharm Biopharm. 2012 May;81(1):24-32. doi: 10.1016/j.ejpb.2012.02.005. Epub 2012 Feb 18.
|
348 |
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.
|
349 |
Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines.Molecules. 2017 Sep 29;22(10):1641. doi: 10.3390/molecules22101641.
|
350 |
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.Oncogene. 2018 Aug;37(31):4197-4213. doi: 10.1038/s41388-018-0270-8. Epub 2018 May 1.
|
351 |
Upregulation of MLK4 promotes migratory and invasive potential of breast cancer cells.Oncogene. 2019 Apr;38(15):2860-2875. doi: 10.1038/s41388-018-0618-0. Epub 2018 Dec 14.
|
352 |
Expression of apoptosis signal-regulating kinase 1 is associated with tight junction protein claudin-6 in cervical carcinoma.Int J Clin Exp Pathol. 2015 May 1;8(5):5535-41. eCollection 2015.
|
353 |
Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.Carcinogenesis. 2014 Jun;35(6):1352-61. doi: 10.1093/carcin/bgu044. Epub 2014 Feb 11.
|
354 |
MAPK genes interact with diet and lifestyle factors to alter risk of breast cancer: the Breast Cancer Health Disparities Study.Nutr Cancer. 2015;67(2):292-304. doi: 10.1080/01635581.2015.990568. Epub 2015 Jan 28.
|
355 |
Alternative promotion and suppression of metastasis by JNK2 governed by its phosphorylation.Oncotarget. 2017 Apr 28;8(34):56569-56581. doi: 10.18632/oncotarget.17507. eCollection 2017 Aug 22.
|
356 |
Characterization of a P-Rex1 gene signature in breast cancer cells.Oncotarget. 2016 Aug 9;7(32):51335-51348. doi: 10.18632/oncotarget.10285.
|
357 |
MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases.Int J Mol Sci. 2019 Jan 16;20(2):354. doi: 10.3390/ijms20020354.
|
358 |
Clinicopathological correlation of PD-L1 expression in primary and metastatic breast cancer and infiltrating immune cells.Hum Pathol. 2018 Oct;80:170-178. doi: 10.1016/j.humpath.2018.06.008. Epub 2018 Jun 22.
|
359 |
Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.Oncogene. 2019 May;38(22):4427-4428. doi: 10.1038/s41388-019-0721-x.
|
360 |
Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth.Oncoimmunology. 2018 Jul 11;7(9):e1480286. doi: 10.1080/2162402X.2018.1480286. eCollection 2018.
|
361 |
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.PLoS One. 2016 Jan 11;11(1):e0145647. doi: 10.1371/journal.pone.0145647. eCollection 2016.
|
362 |
Non-Muscle Myosin II Isoforms Have Different Functions in Matrix Rearrangement by MDA-MB-231 Cells.PLoS One. 2015 Jul 2;10(7):e0131920. doi: 10.1371/journal.pone.0131920. eCollection 2015.
|
363 |
Additive effects of eukaryotic coexpression plasmid carrying GRIM?9 and LKB1 genes on breast cancer in vitro and in vivo.Mol Med Rep. 2015 Nov;12(5):7665-72. doi: 10.3892/mmr.2015.4393. Epub 2015 Sep 30.
|
364 |
NEDD4 Family of E3 Ubiquitin Ligases in Breast Cancer: Spotlight on SMURFs, WWPs and NEDD4.Adv Exp Med Biol. 2019;1152:365-375. doi: 10.1007/978-3-030-20301-6_19.
|
365 |
Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer.Carcinogenesis. 2018 Sep 21;39(9):1165-1175. doi: 10.1093/carcin/bgy078.
|
366 |
Natriuretic peptide receptor a promotes breast cancer development by upregulating MMP9.Am J Cancer Res. 2019 Jul 1;9(7):1415-1428. eCollection 2019.
|
367 |
ARK5 is associated with the invasive and metastatic potential of human breast cancer cells.J Cancer Res Clin Oncol. 2012 Feb;138(2):247-54. doi: 10.1007/s00432-011-1102-1. Epub 2011 Nov 22.
|
368 |
Oncostatin M suppresses oestrogen receptor- expression and is associated with poor outcome in human breast cancer.Endocr Relat Cancer. 2012 Apr 10;19(2):181-95. doi: 10.1530/ERC-11-0326. Print 2012 Apr.
|
369 |
Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3/p53 activation.Cancer Manag Res. 2019 Jan 10;11:625-636. doi: 10.2147/CMAR.S191353. eCollection 2019.
|
370 |
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.BMC Cancer. 2015 Dec 16;15:978. doi: 10.1186/s12885-015-1957-7.
|
371 |
Proprotein convertase subtilisin/kexin type 6 activates the extracellular signal-regulated kinase 1/2 and Wnt family member 3A pathways and promotes in vitro proliferation, migration and invasion of breast cancer MDA-MB-231 cells.Oncol Lett. 2018 Jul;16(1):145-150. doi: 10.3892/ol.2018.8654. Epub 2018 May 7.
|
372 |
Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.Eur J Pharm Sci. 2016 Sep 20;92:39-48. doi: 10.1016/j.ejps.2016.06.020. Epub 2016 Jun 26.
|
373 |
Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management.J Mol Diagn. 2019 Mar;21(2):307-317. doi: 10.1016/j.jmoldx.2018.10.006. Epub 2018 Dec 18.
|
374 |
PlGF signaling and macrophage repolarization contribute to the anti-neoplastic effect of metformin.Eur J Pharmacol. 2019 Nov 15;863:172696. doi: 10.1016/j.ejphar.2019.172696. Epub 2019 Sep 25.
|
375 |
Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.Oncol Rep. 2017 Jul;38(1):109-119. doi: 10.3892/or.2017.5696. Epub 2017 Jun 2.
|
376 |
Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.BMC Cancer. 2015 Dec 16;15:971. doi: 10.1186/s12885-015-1937-y.
|
377 |
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.BMC Cancer. 2019 Jul 30;19(1):747. doi: 10.1186/s12885-019-5949-x.
|
378 |
Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.PLoS One. 2013 Oct 3;8(10):e76403. doi: 10.1371/journal.pone.0076403. eCollection 2013.
|
379 |
DNA polymerase deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts.Mol Oncol. 2014 May;8(3):520-32. doi: 10.1016/j.molonc.2014.01.001. Epub 2014 Jan 10.
|
380 |
Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?.Breast. 2018 Dec;42:68-73. doi: 10.1016/j.breast.2018.08.106. Epub 2018 Aug 29.
|
381 |
Differential effects of protein kinase C-eta on apoptosis versus senescence.Cell Signal. 2019 Mar;55:1-7. doi: 10.1016/j.cellsig.2018.12.003. Epub 2018 Dec 15.
|
382 |
Strong expression association between matriptase and its substrate prostasin in breast cancer.J Cell Physiol. 2012 Apr;227(4):1604-9. doi: 10.1002/jcp.22877.
|
383 |
Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.J Steroid Biochem Mol Biol. 2012 Nov;132(3-5):331-8. doi: 10.1016/j.jsbmb.2012.07.007. Epub 2012 Aug 19.
|
384 |
Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer.J Cell Biochem. 2017 Oct;118(10):3391-3400. doi: 10.1002/jcb.25995. Epub 2017 May 3.
|
385 |
Loss of CSL Unlocks a Hypoxic Response and Enhanced Tumor Growth Potential in Breast Cancer Cells.Stem Cell Reports. 2016 May 10;6(5):643-651. doi: 10.1016/j.stemcr.2016.03.004. Epub 2016 Apr 7.
|
386 |
Night-shift work, circadian and melatonin pathway related genes and their interaction on breast cancer risk: evidence from a case-control study in Korean women.Sci Rep. 2019 Jul 29;9(1):10982. doi: 10.1038/s41598-019-47480-2.
|
387 |
A fatty acid-binding protein 7/RXR pathway enhances survival and proliferation in triple-negative breast cancer. J Pathol. 2012 Nov;228(3):310-21. doi: 10.1002/path.4001. Epub 2012 Apr 18.
|
388 |
Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.Exp Cell Res. 2018 Sep 15;370(2):444-453. doi: 10.1016/j.yexcr.2018.07.008. Epub 2018 Jul 5.
|
389 |
Upregulated tumor sirtuin 2 expression correlates with reduced TNM stage and better overall survival in surgical breast cancer patients.Ir J Med Sci. 2020 Feb;189(1):83-89. doi: 10.1007/s11845-019-02071-y. Epub 2019 Aug 15.
|
390 |
MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.Asian Pac J Cancer Prev. 2012;13(2):591-8. doi: 10.7314/apjcp.2012.13.2.591.
|
391 |
Iodide transport and breast cancer.J Endocrinol. 2015 Oct;227(1):R1-R12. doi: 10.1530/JOE-15-0234. Epub 2015 Aug 18.
|
392 |
Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer.Br J Cancer. 2020 Jan;122(1):94-101. doi: 10.1038/s41416-019-0626-z. Epub 2019 Dec 10.
|
393 |
Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.Breast Cancer Res Treat. 2012 Jan;131(2):653-61. doi: 10.1007/s10549-011-1772-z. Epub 2011 Sep 23.
|
394 |
SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.Cell Death Differ. 2019 May;26(5):843-859. doi: 10.1038/s41418-018-0158-8. Epub 2018 Jul 9.
|
395 |
Enhanced expression of polysialic acid correlates with malignant phenotype in breast cancer cell lines and clinical tissue samples.Int J Mol Med. 2016 Jan;37(1):197-206. doi: 10.3892/ijmm.2015.2395. Epub 2015 Oct 27.
|
396 |
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.Genes Chromosomes Cancer. 2013 Jul;52(7):595-609. doi: 10.1002/gcc.22056. Epub 2013 Apr 30.
|
397 |
The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THR1) Antagonism.Sci Rep. 2018 Nov 8;8(1):16562. doi: 10.1038/s41598-018-34348-0.
|
398 |
Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.Breast Cancer. 2019 May;26(3):282-289. doi: 10.1007/s12282-018-0920-2. Epub 2018 Oct 13.
|
399 |
Expression profile of Tolllike receptors in human breast cancer.Mol Med Rep. 2020 Feb;21(2):786-794. doi: 10.3892/mmr.2019.10853. Epub 2019 Nov 26.
|
400 |
SNP-SNP interaction analysis of NF-B signaling pathway on breast cancer survival.Oncotarget. 2015 Nov 10;6(35):37979-94. doi: 10.18632/oncotarget.4991.
|
401 |
Amyloidosis of the Breast: Three Different and Unusual Presentations of a Rare Entity.Pathobiology. 2015;82(6):264-8. doi: 10.1159/000440866. Epub 2015 Oct 30.
|
402 |
Deubiquitylation and stabilization of PTEN by USP13.Nat Cell Biol. 2013 Dec;15(12):1486-1494. doi: 10.1038/ncb2874. Epub 2013 Nov 24.
|
403 |
USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.Tumour Biol. 2015 Jul;36(7):5415-23. doi: 10.1007/s13277-015-3207-7. Epub 2015 Feb 17.
|
404 |
The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer.Tumour Biol. 2015 Jun;36(6):4427-32. doi: 10.1007/s13277-015-3082-2. Epub 2015 Jan 22.
|
405 |
Homozygous T172T and Heterozygous G135C Variants of Homologous Recombination Repairing Protein RAD51 are Related to Sporadic Breast Cancer Susceptibility.Biochem Genet. 2016 Feb;54(1):83-94. doi: 10.1007/s10528-015-9703-z. Epub 2015 Dec 9.
|
406 |
A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression.Oncogene. 2012 Aug 9;31(32):3696-708. doi: 10.1038/onc.2011.528. Epub 2011 Dec 19.
|
407 |
High expression of valosin-containing protein predicts poor prognosis in patients with breast carcinoma.Tumour Biol. 2015 Dec;36(12):9919-27. doi: 10.1007/s13277-015-3748-9. Epub 2015 Jul 14.
|
408 |
VDAC1 is regulated by BRD4 and contributes to JQ1 resistance in breast cancer.Oncol Lett. 2019 Sep;18(3):2340-2347. doi: 10.3892/ol.2019.10534. Epub 2019 Jun 27.
|
409 |
The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans.Breast Cancer Res Treat. 2011 Oct;129(3):993-9. doi: 10.1007/s10549-011-1613-0. Epub 2011 Jun 8.
|
410 |
Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro. Cancer Chemother Pharmacol. 2018 Aug;82(2):199-210.
|
411 |
The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.Eur J Nutr. 2019 Feb;58(1):139-150. doi: 10.1007/s00394-017-1578-9. Epub 2017 Nov 3.
|
412 |
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.PLoS One. 2016 May 12;11(5):e0155013. doi: 10.1371/journal.pone.0155013. eCollection 2016.
|
413 |
Dual-Targeting of miR-124-3p and ABCC4 Promotes Sensitivity to Adriamycin in Breast Cancer Cells.Genet Test Mol Biomarkers. 2019 Mar;23(3):156-165. doi: 10.1089/gtmb.2018.0259. Epub 2019 Feb 26.
|
414 |
Whole exome sequencing analysis of ABCC8 and ABCD2 genes associating with clinical course of breast carcinoma.Physiol Res. 2015;64(Suppl 4):S549-57. doi: 10.33549/physiolres.933212.
|
415 |
Combined inhibition of EGFR and c-ABL suppresses the growth of fulvestrant-resistant breast cancer cells through miR-375-autophagy axis.Biochem Biophys Res Commun. 2018 Apr 6;498(3):559-565. doi: 10.1016/j.bbrc.2018.03.019. Epub 2018 Mar 6.
|
416 |
Association analysis identifies 65 new breast cancer risk loci.Nature. 2017 Nov 2;551(7678):92-94. doi: 10.1038/nature24284. Epub 2017 Oct 23.
|
417 |
Breast Cancer Screening in Women atHigher-Than-Average Risk: Recommendations From the ACR.J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. doi: 10.1016/j.jacr.2017.11.034. Epub 2018 Jan 19.
|
418 |
Association of vitamin D receptor gene polymorphisms with breast cancer risk in an Egyptian population.Tumour Biol. 2017 Oct;39(10):1010428317727738. doi: 10.1177/1010428317727738.
|
419 |
Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.J Cell Physiol. 2004 Jan;198(1):31-9. doi: 10.1002/jcp.10375.
|
420 |
A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.Breast Cancer Res Treat. 2007 Jun;103(2):239-46. doi: 10.1007/s10549-006-9362-1. Epub 2006 Sep 21.
|
421 |
Urtica dioica inhibits cell growth and induces apoptosis by targeting Ornithine decarboxylase and Adenosine deaminase as key regulatory enzymes in adenosine and polyamines homeostasis in human breast cancer cell lines.Cell Mol Biol (Noisy-le-grand). 2018 Feb 28;64(3):97-102. doi: 10.14715/cmb/2018.64.3.16.
|
422 |
miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.J BUON. 2019 Sep-Oct;24(5):1905-1912.
|
423 |
The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.J Cell Physiol. 2018 Mar;233(3):2247-2256. doi: 10.1002/jcp.26097. Epub 2017 Aug 25.
|
424 |
Breast cancer is associated with methylation and expression of the a disintegrin and metalloproteinase domain33 (ADAM33) gene affected by endocrinedisrupting chemicals.Oncol Rep. 2018 Nov;40(5):2766-2777. doi: 10.3892/or.2018.6675. Epub 2018 Aug 30.
|
425 |
ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells.Int J Cancer. 2018 Feb 15;142(4):779-791. doi: 10.1002/ijc.31090. Epub 2017 Oct 31.
|
426 |
MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells.Oncol Lett. 2017 Dec;14(6):6969-6975. doi: 10.3892/ol.2017.7021. Epub 2017 Sep 21.
|
427 |
ADAMTS1 Promotes Adhesion to Extracellular Matrix Proteins and Predicts Prognosis in Early Stage Breast Cancer Patients.Cell Physiol Biochem. 2019;52(6):1553-1568. doi: 10.33594/000000108.
|
428 |
Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.Oncotarget. 2017 Feb 21;8(8):13716-13729. doi: 10.18632/oncotarget.14627.
|
429 |
Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation.J Mol Neurosci. 2004;22(1-2):83-92. doi: 10.1385/JMN:22:1-2:83.
|
430 |
A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype.Cancer Lett. 2018 Apr 1;418:239-249. doi: 10.1016/j.canlet.2018.01.016. Epub 2018 Jan 11.
|
431 |
Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.Oncogene. 2010 Feb 25;29(8):1114-22. doi: 10.1038/onc.2009.409. Epub 2009 Nov 23.
|
432 |
Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.Gene Ther. 2002 Jul;9(13):867-78. doi: 10.1038/sj.gt.3301703.
|
433 |
Prognostic significance of - and 2-adrenoceptor gene expression in breast cancer patients.Br J Clin Pharmacol. 2019 Sep;85(9):2143-2154. doi: 10.1111/bcp.14030. Epub 2019 Jul 31.
|
434 |
Single nucleotide polymorphisms of let-7-related genes increase susceptibility to breast cancer.Am J Transl Res. 2019 Mar 15;11(3):1748-1759. eCollection 2019.
|
435 |
Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk. Adv Exp Med Biol. 2008;617:477-84. doi: 10.1007/978-0-387-69080-3_47.
|
436 |
miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2.J Exp Clin Cancer Res. 2019 Jan 21;38(1):26. doi: 10.1186/s13046-019-1024-3.
|
437 |
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.J Hematol Oncol. 2019 Jul 24;12(1):81. doi: 10.1186/s13045-019-0747-0.
|
438 |
Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.Am J Pathol. 2010 Nov;177(5):2635-44. doi: 10.2353/ajpath.2010.100177. Epub 2010 Sep 16.
|
439 |
Effects of AIF-1 inflammatory factors on the regulation of proliferation of breast cancer cells.J Biol Regul Homeost Agents. 2019 Jul-Aug;33(4):1085-1095.
|
440 |
Distinct functions of AKT isoforms in breast cancer: a comprehensive review.Cell Commun Signal. 2019 Nov 21;17(1):154. doi: 10.1186/s12964-019-0450-3.
|
441 |
Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis inpatients with breast cancer.Cancer Sci. 2017 Apr;108(4):604-611. doi: 10.1111/cas.13180. Epub 2017 Apr 12.
|
442 |
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth.Biochim Biophys Acta Mol Cell Res. 2019 Aug;1866(8):1338-1352. doi: 10.1016/j.bbamcr.2019.03.010. Epub 2019 Mar 21.
|
443 |
ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis.Biochem Biophys Res Commun. 2019 Jun 18;514(1):24-30. doi: 10.1016/j.bbrc.2019.04.101. Epub 2019 Apr 20.
|
444 |
Progesterone induced expression of alkaline phosphatase is associated with a secretory phenotype in T47D breast cancer cells.Biochem Biophys Res Commun. 1993 May 14;192(3):1066-72. doi: 10.1006/bbrc.1993.1525.
|
445 |
Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.Int J Cancer. 2015 Oct 15;137(8):1842-54. doi: 10.1002/ijc.29565. Epub 2015 Apr 29.
|
446 |
The Effect of Counseling on Breast Cancer Awareness in Rural Iranian Women: a Randomized Controlled Clinical Trial.J Cancer Educ. 2019 Dec;34(6):1083-1091. doi: 10.1007/s13187-018-1411-z.
|
447 |
Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in cocultures of human endothelial and breast cancer cells.Oncol Rep. 2018 Jan;39(1):433-441. doi: 10.3892/or.2017.6070. Epub 2017 Nov 2.
|
448 |
A mutual activation loop between the Ca(2+)-activated chloride channel TMEM16A and EGFR/STAT3 signaling promotes breast cancer tumorigenesis.Cancer Lett. 2019 Jul 28;455:48-59. doi: 10.1016/j.canlet.2019.04.027. Epub 2019 Apr 28.
|
449 |
Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.PLoS One. 2015 Mar 24;10(3):e0119383. doi: 10.1371/journal.pone.0119383. eCollection 2015.
|
450 |
ANXA2 expression in African American triple-negative breast cancer patients.Breast Cancer Res Treat. 2019 Feb;174(1):113-120. doi: 10.1007/s10549-018-5030-5. Epub 2018 Nov 26.
|
451 |
ABP 980: A Trastuzumab Biosimilar.BioDrugs. 2018 Oct;32(5):511-514. doi: 10.1007/s40259-018-0305-2.
|
452 |
Vascular adhesion protein-1 as indicator of breast cancer tumor aggressiveness and invasiveness.APMIS. 2018 Sep;126(9):755-761. doi: 10.1111/apm.12885.
|
453 |
Panobinostat (LBH589) inhibits Wnt/-catenin signaling pathway via upregulating APCL expression in breast cancer.Cell Signal. 2019 Jul;59:62-75. doi: 10.1016/j.cellsig.2019.03.014. Epub 2019 Mar 14.
|
454 |
What is normal? Apelin and VEGFA, drivers of tumor vessel abnormality.EMBO Mol Med. 2019 Aug;11(8):e10892. doi: 10.15252/emmm.201910892. Epub 2019 Jul 18.
|
455 |
HDL and LDL: Potential New Players in Breast Cancer Development.J Clin Med. 2019 Jun 14;8(6):853. doi: 10.3390/jcm8060853.
|
456 |
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.Br J Cancer. 1999 May;80(5-6):879-82. doi: 10.1038/sj.bjc.6690435.
|
457 |
Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway.Int J Mol Med. 2020 Jan;45(1):162-174. doi: 10.3892/ijmm.2019.4404. Epub 2019 Nov 13.
|
458 |
Decreased miR-320 expression is associated with breast cancer progression, cell migration, and invasiveness via targeting Aquaporin 1.Acta Biochim Biophys Sin (Shanghai). 2018 May 1;50(5):473-480. doi: 10.1093/abbs/gmy023.
|
459 |
The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line. Cancer Biol Ther. 2002 May-Jun;1(3):256-62. doi: 10.4161/cbt.77.
|
460 |
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice.Breast Cancer Res Treat. 2020 Feb;179(3):653-660. doi: 10.1007/s10549-019-05507-2. Epub 2019 Dec 14.
|
461 |
Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line.Cell Cycle. 2008 Oct;7(19):3074-82. doi: 10.4161/cc.7.19.6777. Epub 2008 Oct 12.
|
462 |
miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.Cancer Lett. 2019 Jul 10;454:224-233. doi: 10.1016/j.canlet.2019.04.006. Epub 2019 Apr 17.
|
463 |
ErbB4 receptor polymorphism 2368A>C and risk of breast cancer.Breast. 2018 Dec;42:157-163. doi: 10.1016/j.breast.2018.10.002. Epub 2018 Oct 9.
|
464 |
ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.Mol Cancer. 2019 Nov 7;18(1):156. doi: 10.1186/s12943-019-1077-0.
|
465 |
Stimulation of ATF3 interaction with Smad4 via TGF-1 for matrix metalloproteinase 13 gene activation in human breast cancer cells.Int J Biol Macromol. 2019 Aug 1;134:954-961. doi: 10.1016/j.ijbiomac.2019.05.062. Epub 2019 May 10.
|
466 |
Autophagy-related 7 modulates tumor progression in triple-negative breast cancer.Lab Invest. 2019 Sep;99(9):1266-1274. doi: 10.1038/s41374-019-0249-2. Epub 2019 Apr 15.
|
467 |
PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.Invest New Drugs. 2018 Oct;36(5):763-772. doi: 10.1007/s10637-018-0563-3. Epub 2018 Mar 5.
|
468 |
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.Jpn J Cancer Res. 2002 Jan;93(1):70-7. doi: 10.1111/j.1349-7006.2002.tb01202.x.
|
469 |
Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin.Mol Carcinog. 2019 Nov;58(11):2139-2148. doi: 10.1002/mc.23104. Epub 2019 Aug 22.
|
470 |
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10.1158/0008-5472.CAN-15-2980. Epub 2016 Apr 20.
|
471 |
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.Cell Rep. 2018 May 1;23(5):1476-1490. doi: 10.1016/j.celrep.2018.04.019.
|
472 |
2-microglobulin has a different regulatory molecular mechanism between ER(+) and ER(-) breast cancer with HER2().BMC Cancer. 2019 Mar 12;19(1):223. doi: 10.1186/s12885-019-5410-1.
|
473 |
Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.Nature. 2019 Apr;568(7751):254-258. doi: 10.1038/s41586-019-1005-x. Epub 2019 Mar 6.
|
474 |
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer.Sci Transl Med. 2017 Aug 2;9(401):eaam7049. doi: 10.1126/scitranslmed.aam7049.
|
475 |
BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.PLoS One. 2019 Feb 4;14(2):e0211507. doi: 10.1371/journal.pone.0211507. eCollection 2019.
|
476 |
In vitro and in silico anticancer activity of amygdalin on the SK-BR-3 human breast cancer cell line.Mol Biol Rep. 2019 Dec;46(6):6361-6370. doi: 10.1007/s11033-019-05080-3. Epub 2019 Oct 3.
|
477 |
Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.J Clin Invest. 2018 Jan 2;128(1):531-544. doi: 10.1172/JCI93707. Epub 2017 Dec 11.
|
478 |
Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.Biochem Biophys Res Commun. 2017 Apr 29;486(2):224-231. doi: 10.1016/j.bbrc.2017.02.101. Epub 2017 Feb 22.
|
479 |
Transcriptional hallmarks of cancer cell lines reveal an emerging role of branched chain amino acid catabolism.Sci Rep. 2017 Aug 10;7(1):7820. doi: 10.1038/s41598-017-08329-8.
|
480 |
BCL11A enhances stemness and promotes progression by activating Wnt/-catenin signaling in breast cancer.Cancer Manag Res. 2019 Apr 11;11:2997-3007. doi: 10.2147/CMAR.S199368. eCollection 2019.
|
481 |
Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.PLoS One. 2010 Jan 6;5(1):e8604. doi: 10.1371/journal.pone.0008604.
|
482 |
Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma.Oncotarget. 2018 Apr 27;9(32):22727-22740. doi: 10.18632/oncotarget.25220. eCollection 2018 Apr 27.
|
483 |
Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.Mol Neurobiol. 2019 Jul;56(7):4741-4750. doi: 10.1007/s12035-018-1410-4. Epub 2018 Oct 31.
|
484 |
Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients' Outcome.Curr Cancer Drug Targets. 2019;19(3):210-221. doi: 10.2174/1568009618666180706165845.
|
485 |
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.Breast Cancer Res Treat. 2016 Oct;159(3):499-511. doi: 10.1007/s10549-016-3961-2. Epub 2016 Sep 3.
|
486 |
Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.Anticancer Res. 2013 May;33(5):1917-25.
|
487 |
Microcalcification and BMP-2 in breast cancer: correlation with clinicopathological features and outcomes.Onco Targets Ther. 2019 Mar 15;12:2023-2033. doi: 10.2147/OTT.S187835. eCollection 2019.
|
488 |
Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.Int J Oncol. 2018 Sep;53(3):1354-1362. doi: 10.3892/ijo.2018.4469. Epub 2018 Jul 4.
|
489 |
BMPR2 loss in fibroblasts promotes mammary carcinoma metastasis via increased inflammation.Mol Oncol. 2015 Jan;9(1):179-91. doi: 10.1016/j.molonc.2014.08.004. Epub 2014 Aug 23.
|
490 |
BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.Clin Breast Cancer. 2020 Feb;20(1):41-50.e8. doi: 10.1016/j.clbc.2019.08.005. Epub 2019 Aug 29.
|
491 |
Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.J Assist Reprod Genet. 2018 Jan;35(1):91-97. doi: 10.1007/s10815-017-1059-3. Epub 2017 Oct 6.
|
492 |
Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail.Cell Death Differ. 2020 Jan;27(1):255-268. doi: 10.1038/s41418-019-0353-2. Epub 2019 May 21.
|
493 |
Bromodomaincontaining protein7 sensitizes breast cancer cells to paclitaxel by activating Bcl2antagonist/killer protein.Oncol Rep. 2019 Mar;41(3):1487-1496. doi: 10.3892/or.2018.6951. Epub 2018 Dec 21.
|
494 |
Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma.Anticancer Res. 2019 Oct;39(10):5361-5367. doi: 10.21873/anticanres.13729.
|
495 |
Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.Mol Cancer Ther. 2016 Sep;15(9):2198-208. doi: 10.1158/1535-7163.MCT-15-0813. Epub 2016 Jun 2.
|
496 |
C1QBP Promotes Homologous Recombination by Stabilizing MRE11 and Controlling the Assembly and Activation of MRE11/RAD50/NBS1 Complex.Mol Cell. 2019 Sep 19;75(6):1299-1314.e6. doi: 10.1016/j.molcel.2019.06.023. Epub 2019 Jul 25.
|
497 |
The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1.J Immunol. 2017 Apr 1;198(7):2989-2999. doi: 10.4049/jimmunol.1602057. Epub 2017 Feb 22.
|
498 |
TFAP2C regulates carbonic anhydrase XII in human breast cancer.Oncogene. 2020 Feb;39(6):1290-1301. doi: 10.1038/s41388-019-1062-5. Epub 2019 Oct 21.
|
499 |
Comparison of Framingham risk score and chest-CT identified coronary artery calcification in breast cancer patients to predict cardiovascular events.Int J Cardiol. 2019 Aug 15;289:138-143. doi: 10.1016/j.ijcard.2019.01.056. Epub 2019 Jan 23.
|
500 |
Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.Oncol Rep. 2019 Apr;41(4):2585-2594. doi: 10.3892/or.2019.7001. Epub 2019 Feb 5.
|
501 |
Assessing the value of CAN-gene mutations using MALDI-TOF MS.J Cancer Res Clin Oncol. 2011 Aug;137(8):1239-44. doi: 10.1007/s00432-011-0990-4. Epub 2011 Jun 21.
|
502 |
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.Nat Commun. 2019 Jun 4;10(1):2450. doi: 10.1038/s41467-019-10424-5.
|
503 |
LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer.Gene. 2019 Feb 5;684:139-148. doi: 10.1016/j.gene.2018.10.063. Epub 2018 Oct 23.
|
504 |
Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib.Oncotarget. 2018 Sep 7;9(70):33382-33395. doi: 10.18632/oncotarget.26078. eCollection 2018 Sep 7.
|
505 |
Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.Diagn Pathol. 2018 May 30;13(1):36. doi: 10.1186/s13000-018-0715-y.
|
506 |
Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.EMBO Rep. 2020 Feb 5;21(2):e48597. doi: 10.15252/embr.201948597. Epub 2019 Dec 12.
|
507 |
Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progression.Future Oncol. 2013 Mar;9(3):427-38. doi: 10.2217/fon.12.200.
|
508 |
Mutational analysis of caspase 1, 4, and 5 genes in common human cancers.Hum Pathol. 2008 Jun;39(6):895-900. doi: 10.1016/j.humpath.2007.10.015. Epub 2008 Apr 21.
|
509 |
A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.Anticancer Res. 2004 Jan-Feb;24(1):123-31.
|
510 |
Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines.J Biol Chem. 2011 Jun 24;286(25):22291-9. doi: 10.1074/jbc.M111.236596. Epub 2011 May 9.
|
511 |
ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.Biosci Rep. 2019 May 10;39(5):BSR20190087. doi: 10.1042/BSR20190087. Print 2019 May 31.
|
512 |
miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.BMC Cancer. 2016 Nov 15;16(1):826. doi: 10.1186/s12885-016-2862-4.
|
513 |
Low serum gastrin associated with ER(+) breast cancer development via inactivation of CCKBR/ERK/P65 signaling.BMC Cancer. 2018 Aug 16;18(1):824. doi: 10.1186/s12885-018-4717-7.
|
514 |
Down-regulation of CCL17 in cancer-associated fibroblasts inhibits cell migration and invasion of breast cancer through ERK1/2 pathway.Cancer Manag Res. 2019 Aug 7;11:7439-7453. doi: 10.2147/CMAR.S211651. eCollection 2019.
|
515 |
Effects of Notch signalling on the expression of SEMA3C, HMGA2, CXCL14, CXCR7, and CCL20 in breast cancer.Turk J Biol. 2019 Feb 7;43(1):70-76. doi: 10.3906/biy-1808-58. eCollection 2019.
|
516 |
Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.Cancer Sci. 2020 Jan;111(1):209-218. doi: 10.1111/cas.14234. Epub 2019 Dec 16.
|
517 |
Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion.Front Oncol. 2019 Oct 23;9:1074. doi: 10.3389/fonc.2019.01074. eCollection 2019.
|
518 |
In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.J Mammary Gland Biol Neoplasia. 2017 Sep;22(3):203-214. doi: 10.1007/s10911-017-9384-9. Epub 2017 Aug 18.
|
519 |
Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.Cancer Med. 2019 Jun;8(6):2717-2729. doi: 10.1002/cam4.2152. Epub 2019 Apr 5.
|
520 |
Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer.J Cancer. 2019 Oct 21;10(26):6618-6634. doi: 10.7150/jca.33433. eCollection 2019.
|
521 |
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.Mol Cancer Res. 2019 Feb;17(2):604-617. doi: 10.1158/1541-7786.MCR-18-0750. Epub 2018 Nov 16.
|
522 |
Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease.Oncotarget. 2016 May 10;7(19):28570-8. doi: 10.18632/oncotarget.8680.
|
523 |
HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk.J Clin Invest. 2018 Dec 3;128(12):5235-5250. doi: 10.1172/JCI99974. Epub 2018 Oct 22.
|
524 |
Association analysis and allelic distribution of deletion in CC chemokine receptor 5 gene (CCR532) among breast cancer patients of Pakistan.Mol Biol Rep. 2019 Apr;46(2):2387-2394. doi: 10.1007/s11033-019-04699-6. Epub 2019 Mar 8.
|
525 |
MiR-21 controls in situ expansion of CCR6?regulatory T cells through PTEN/AKT pathway in breast cancer.Immunol Cell Biol. 2015 Sep;93(8):753-64. doi: 10.1038/icb.2015.37. Epub 2015 Mar 4.
|
526 |
EVI? acts as an oncogene and positively regulates calreticulin in breast cancer.Mol Med Rep. 2019 Mar;19(3):1645-1653. doi: 10.3892/mmr.2018.9796. Epub 2018 Dec 24.
|
527 |
4T1 Mammary Carcinoma Colonization of Metastatic Niches Is Accelerated by Obesity.Front Oncol. 2019 Sep 20;9:685. doi: 10.3389/fonc.2019.00685. eCollection 2019.
|
528 |
Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.J Immunother Cancer. 2017 May 30;5:48. doi: 10.1186/s40425-017-0248-z. eCollection 2017.
|
529 |
CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.Histopathology. 2008 Jan;52(2):203-12. doi: 10.1111/j.1365-2559.2007.02919.x.
|
530 |
Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation.Oncogene. 2019 Jan;38(1):88-102. doi: 10.1038/s41388-018-0407-9. Epub 2018 Aug 6.
|
531 |
Expression of ICOSL is associated with decreased survival in invasive breast cancer.PeerJ. 2019 May 16;7:e6903. doi: 10.7717/peerj.6903. eCollection 2019.
|
532 |
(89)Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging.ACS Omega. 2017 Oct 31;2(10):6314-6320. doi: 10.1021/acsomega.7b01180. Epub 2017 Oct 2.
|
533 |
Immunohistochemical Expression of Microfibrillar-associated Protein 5 (MFAP5) in Invasive Breast Carcinoma of No Special Type.Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):649-657. doi: 10.1097/PAI.0000000000000686.
|
534 |
Endocytosis of very low-density lipoproteins: an unexpected mechanism for lipid acquisition by breast cancer cells.J Lipid Res. 2020 Feb;61(2):205-218. doi: 10.1194/jlr.RA119000327. Epub 2019 Dec 5.
|
535 |
BRCA2-positive spinal intramedullary ovarian metastatic disease: case report.Spine J. 2016 Mar;16(3):e201-7. doi: 10.1016/j.spinee.2015.10.053. Epub 2015 Nov 10.
|
536 |
Computer-Aided Discovery of Small Molecule Inhibitors of Transcriptional Activity of TLX (NR2E1) Nuclear Receptor.Molecules. 2018 Nov 14;23(11):2967. doi: 10.3390/molecules23112967.
|
537 |
Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients.Cancer Cell Int. 2019 Sep 11;19:238. doi: 10.1186/s12935-019-0957-0. eCollection 2019.
|
538 |
CD55 and CD59 expression protects HER2-overexpressing breast cancer cells from trastuzumab-induced complement-dependent cytotoxicity.Oncol Lett. 2017 Sep;14(3):2961-2969. doi: 10.3892/ol.2017.6555. Epub 2017 Jul 8.
|
539 |
Breast cancer stem cells characterized by CD70 expression preferentially metastasize to the lungs.Breast Cancer. 2018 Nov;25(6):706-716. doi: 10.1007/s12282-018-0880-6. Epub 2018 Jun 14.
|
540 |
The Overexpression of CD80 and ISG15 Are Associated with the Progression and Metastasis of Breast Cancer by a Meta-Analysis Integrating Three Microarray Datasets.Pathol Oncol Res. 2020 Jan;26(1):443-452. doi: 10.1007/s12253-018-0478-5. Epub 2018 Nov 9.
|
541 |
Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.Cancer Res. 2010 Aug 1;70(15):6150-60. doi: 10.1158/0008-5472.CAN-09-2758. Epub 2010 Jul 14.
|
542 |
Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer.Cancer Res. 2015 Apr 1;75(7):1504-15. doi: 10.1158/0008-5472.CAN-14-2341. Epub 2015 Feb 2.
|
543 |
CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell-cycle regulation.J Cell Biochem. 2019 Mar;120(3):2919-2928. doi: 10.1002/jcb.26838. Epub 2018 Nov 15.
|
544 |
6,7-di-O-acetylsinococuline (FK-3000) induces G2/M phase arrest in breast carcinomas through p38 MAPK phosphorylation and CDC25B dephosphorylation.Int J Oncol. 2015 Feb;46(2):578-86. doi: 10.3892/ijo.2014.2739. Epub 2014 Nov 7.
|
545 |
Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation.Med Oncol. 2019 Nov 16;37(1):6. doi: 10.1007/s12032-019-1330-9.
|
546 |
CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells.Gene. 2019 Jun 30;703:1-6. doi: 10.1016/j.gene.2019.04.006. Epub 2019 Apr 3.
|
547 |
Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1651-1665. doi: 10.1016/j.bbadis.2019.04.002. Epub 2019 Apr 4.
|
548 |
Cadherins: The Superfamily Critically Involved in Breast Cancer.Curr Pharm Des. 2016;22(5):616-38. doi: 10.2174/138161282205160127095338.
|
549 |
Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.Oncotarget. 2016 Sep 27;7(39):63537-63548. doi: 10.18632/oncotarget.11535.
|
550 |
The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.Histochem Cell Biol. 2018 Jan;149(1):15-30. doi: 10.1007/s00418-017-1619-8. Epub 2017 Nov 15.
|
551 |
Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.Breast Cancer Res. 2015;17:19. doi: 10.1186/s13058-015-0524-0. Epub 2015 Feb 11.
|
552 |
The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response.Oncotarget. 2018 Jun 29;9(50):29508-29524. doi: 10.18632/oncotarget.25686. eCollection 2018 Jun 29.
|
553 |
Loss of Cdk5 in breast cancer cells promotes ROS-mediated cell death through dysregulation of the mitochondrial permeability transition pore.Oncogene. 2018 Mar;37(13):1788-1804. doi: 10.1038/s41388-017-0103-1. Epub 2018 Jan 19.
|
554 |
Identification of stage-specific breast markers using quantitative proteomics.J Proteome Res. 2013 Dec 6;12(12):5696-708. doi: 10.1021/pr400662k. Epub 2013 Oct 29.
|
555 |
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers.Oncogene. 2020 Jan;39(1):50-63. doi: 10.1038/s41388-019-0953-9. Epub 2019 Aug 28.
|
556 |
The adaptor SASH1 acts through NOTCH1 and its inhibitor DLK1 in a 3D model of lumenogenesis involving CEACAM1.Exp Cell Res. 2017 Oct 15;359(2):384-393. doi: 10.1016/j.yexcr.2017.08.022. Epub 2017 Aug 18.
|
557 |
The association of five preoperative serum tumor markers and pathological features in patients with breast cancer.J Clin Lab Anal. 2019 Jun;33(5):e22875. doi: 10.1002/jcla.22875. Epub 2019 Mar 6.
|
558 |
A novel PAK4-CEBPB-CLDN4 axis involving in breast cancer cell migration and invasion.Biochem Biophys Res Commun. 2019 Apr 2;511(2):404-408. doi: 10.1016/j.bbrc.2019.02.070. Epub 2019 Feb 23.
|
559 |
Ceramide kinase promotes tumor cell survival and mammary tumor recurrence.Cancer Res. 2014 Nov 1;74(21):6352-63. doi: 10.1158/0008-5472.CAN-14-1292. Epub 2014 Aug 27.
|
560 |
A Mendelian randomization study of the effects of blood lipids on breast cancer risk.Nat Commun. 2018 Sep 27;9(1):3957. doi: 10.1038/s41467-018-06467-9.
|
561 |
Intense dose-dense epirubicin, paclitaxel, cyclophosphamideversus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial.Eur J Cancer. 2019 Jan;106:181-192. doi: 10.1016/j.ejca.2018.10.015. Epub 2018 Dec 5.
|
562 |
lncRNA CASC9 positively regulates CHK1 to promote breast cancer cell proliferation and survival through sponging the miR?95/497 cluster.Int J Oncol. 2019 May;54(5):1665-1675. doi: 10.3892/ijo.2019.4734. Epub 2019 Feb 28.
|
563 |
Efficacy and safety of compound Kushen injection combined with chemotherapy on postoperative Patients with breast cancer: A meta-analysis of randomized controlled trials.Medicine (Baltimore). 2019 Jan;98(3):e14024. doi: 10.1097/MD.0000000000014024.
|
564 |
In silico design, synthesis and activity of potential drug-like chrysin scaffold-derived selective EGFR inhibitors as anticancer agents.Comput Biol Chem. 2019 Dec;83:107156. doi: 10.1016/j.compbiolchem.2019.107156. Epub 2019 Nov 1.
|
565 |
Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer.PLoS One. 2018 Dec 13;13(12):e0208982. doi: 10.1371/journal.pone.0208982. eCollection 2018.
|
566 |
Long noncoding RNA HOTAIR promotes invasion of breast cancer cells through chondroitin sulfotransferase CHST15.Int J Cancer. 2019 Nov 1;145(9):2478-2487. doi: 10.1002/ijc.32319. Epub 2019 Apr 26.
|
567 |
High IKK expression is associated with reduced time to recurrence and cancer specific survival in oestrogen receptor (ER)-positive breast cancer.Int J Cancer. 2017 Apr 1;140(7):1633-1644. doi: 10.1002/ijc.30578. Epub 2017 Jan 6.
|
568 |
Expression of the Ca2+-activated chloride channel genes CLCA1 and CLCA2 is downregulated in human colorectal cancer.DNA Cell Biol. 2001 Jun;20(6):331-8. doi: 10.1089/10445490152122442.
|
569 |
Dichotomous roles of claudins as tumor promoters or suppressors: lessons from knockout mice.Cell Mol Life Sci. 2019 Dec;76(23):4663-4672. doi: 10.1007/s00018-019-03238-7. Epub 2019 Jul 23.
|
570 |
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.Cell Cycle. 2010 Jun 15;9(12):2412-22. doi: 10.4161/cc.9.12.11989. Epub 2010 Jun 15.
|
571 |
CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer.Cancer Res. 2015 Apr 1;75(7):1516-26. doi: 10.1158/0008-5472.CAN-14-2443. Epub 2015 Feb 10.
|
572 |
Aberrant fucosylation enables breast cancer clusterin to interact with dendritic cell-specific ICAM-grabbing non-integrin (DC-SIGN).Oncoimmunology. 2019 Jun 24;8(9):e1629257. doi: 10.1080/2162402X.2019.1629257. eCollection 2019.
|
573 |
Interfering cellular lactate homeostasis overcomes Taxol resistance of breast cancer cells through the microRNA-124-mediated lactate transporter (MCT1) inhibition.Cancer Cell Int. 2019 Jul 24;19:193. doi: 10.1186/s12935-019-0904-0. eCollection 2019.
|
574 |
CMKLR1-targeting peptide tracers for PET/MR imaging of breast cancer.Theranostics. 2019 Sep 19;9(22):6719-6733. doi: 10.7150/thno.34857. eCollection 2019.
|
575 |
Cationic Polymeric Nanoparticle Delivering CCR2 siRNA to Inflammatory Monocytes for Tumor Microenvironment Modification and Cancer Therapy.Mol Pharm. 2018 Sep 4;15(9):3642-3653. doi: 10.1021/acs.molpharmaceut.7b00997. Epub 2018 Jan 26.
|
576 |
Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.Oncotarget. 2017 May 2;8(18):29668-29678. doi: 10.18632/oncotarget.9408.
|
577 |
Overexpression of Contactin 1 promotes growth, migration and invasion in Hs578T breast cancer cells.BMC Cell Biol. 2018 Apr 19;19(1):5. doi: 10.1186/s12860-018-0154-3.
|
578 |
A randomized Phase III trial of neoadjuvant recombinant human endostatin, docetaxel and epirubicin as first-line therapy for patients with breast cancer (CBCRT01).Int J Cancer. 2018 May 15;142(10):2130-2138. doi: 10.1002/ijc.31217. Epub 2017 Dec 23.
|
579 |
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.PLoS Med. 2008 May 27;5(5):e114. doi: 10.1371/journal.pmed.0050114.
|
580 |
Inhibition of estrogen-induced mammary tumor formation in MMTV-aromatase transgenic mice by 4-chlorophenylacetate.Cancer Lett. 2007 Jun 28;251(2):302-10. doi: 10.1016/j.canlet.2006.11.031. Epub 2007 Jan 9.
|
581 |
Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor B (NF-B) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast Cancer.Mol Cell Proteomics. 2015 Jul;14(7):1814-30. doi: 10.1074/mcp.M114.041335. Epub 2015 Apr 22.
|
582 |
IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.Curr Probl Cancer. 2018 Mar-Apr;42(2):215-230. doi: 10.1016/j.currproblcancer.2018.01.009. Epub 2018 Jan 10.
|
583 |
Inhibition of CX(3)CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells.Biochem Biophys Res Commun. 2018 Jan 15;495(3):2264-2269. doi: 10.1016/j.bbrc.2017.12.116. Epub 2017 Dec 21.
|
584 |
CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines.J Cell Biochem. 2011 Apr;112(4):1084-92. doi: 10.1002/jcb.23022.
|
585 |
Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis.J Cell Mol Med. 2019 Feb;23(2):1224-1234. doi: 10.1111/jcmm.14024. Epub 2018 Nov 20.
|
586 |
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Nat Genet. 2018 Jul;50(7):968-978. doi: 10.1038/s41588-018-0132-x. Epub 2018 Jun 18.
|
587 |
Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women.Cancer Res. 2009 Jul 1;69(13):5392-9. doi: 10.1158/0008-5472.CAN-09-0108. Epub 2009 Jun 9.
|
588 |
Prognostic value of biomarkers EpCAM and B-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis.BMC Cancer. 2019 Aug 23;19(1):831. doi: 10.1186/s12885-019-6016-3.
|
589 |
Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors.Med Oncol. 2019 May 29;36(7):61. doi: 10.1007/s12032-019-1281-1.
|
590 |
A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment.Sci Rep. 2019 Jun 19;9(1):8726. doi: 10.1038/s41598-019-45278-w.
|
591 |
Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy.Sci Rep. 2019 Jan 29;9(1):857. doi: 10.1038/s41598-018-37408-7.
|
592 |
The Relationship Between Cytokine Production, CSF2RA, and IL1R2 Expression in Mammary Adenocarcinoma, Tumor Histopathological Parameters, and Lymph Node Metastasis.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819883626. doi: 10.1177/1533033819883626.
|
593 |
A high-risk luminal A dominant breast cancer subtype with increased mobility.Breast Cancer Res Treat. 2019 Jun;175(2):459-472. doi: 10.1007/s10549-019-05135-w. Epub 2019 Feb 19.
|
594 |
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):7869-7878. doi: 10.1073/pnas.1722617115. Epub 2018 Jul 9.
|
595 |
CK2/CSNK2A1 Phosphorylates SIRT6 and Is Involved in the Progression of Breast Carcinoma and Predicts Shorter Survival of Diagnosed Patients.Am J Pathol. 2016 Dec;186(12):3297-3315. doi: 10.1016/j.ajpath.2016.08.007. Epub 2016 Oct 13.
|
596 |
Protein kinase CK2 in mammary gland tumorigenesis.Oncogene. 2001 May 31;20(25):3247-57. doi: 10.1038/sj.onc.1204411.
|
597 |
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.PLoS One. 2019 Jan 9;14(1):e0210608. doi: 10.1371/journal.pone.0210608. eCollection 2019.
|
598 |
Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of Mexican population.J BUON. 2019 Sep-Oct;24(5):1927-1933.
|
599 |
MAGEA1 inhibits the expression of BORIS via increased promoter methylation.J Cell Sci. 2019 Jan 2;132(1):jcs218628. doi: 10.1242/jcs.218628.
|
600 |
I157172, a novel inhibitor of cystathionine -lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.Oncol Rep. 2019 Jan;41(1):427-436. doi: 10.3892/or.2018.6798. Epub 2018 Oct 16.
|
601 |
Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin?.Cancer. 2019 Mar 15;125(6):838-842. doi: 10.1002/cncr.31963. Epub 2019 Jan 9.
|
602 |
Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-mediated degradation of BRCA1.J Cell Mol Med. 2019 Mar;23(3):1798-1812. doi: 10.1111/jcmm.14077. Epub 2018 Dec 18.
|
603 |
Insulin-like growth factor-1 signaling is responsible for cathepsin G-induced aggregation of breast cancer MCF-7 cells.Cancer Sci. 2017 Aug;108(8):1574-1583. doi: 10.1111/cas.13286. Epub 2017 Jun 21.
|
604 |
A novel derivative of artemisinin inhibits cell proliferation and metastasis via down-regulation of cathepsin K in breast cancer.Eur J Pharmacol. 2019 Sep 5;858:172382. doi: 10.1016/j.ejphar.2019.05.011. Epub 2019 May 18.
|
605 |
CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).PLoS One. 2019 Apr 9;14(4):e0214844. doi: 10.1371/journal.pone.0214844. eCollection 2019.
|
606 |
XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway.Front Pharmacol. 2019 Nov 15;10:1371. doi: 10.3389/fphar.2019.01371. eCollection 2019.
|
607 |
Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.Med Sci Monit. 2019 Sep 23;25:7149-7157. doi: 10.12659/MSM.917562.
|
608 |
ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
|
609 |
The evaluation of the distribution of CD133, CXCR1 and the tumor associated macrophages in different molecular subtypes of breast cancer.Histol Histopathol. 2020 Jan;35(1):83-96. doi: 10.14670/HH-18-139. Epub 2019 Jun 28.
|
610 |
IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.Am J Pathol. 2020 Jan;190(1):222-233. doi: 10.1016/j.ajpath.2019.09.016. Epub 2019 Oct 22.
|
611 |
The role of CXC chemokine ligand 4/CXC chemokine receptor 3-B in breast cancer progression.Biotech Histochem. 2019 Jan;94(1):53-59. doi: 10.1080/10520295.2018.1497201. Epub 2018 Sep 28.
|
612 |
Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.Oncoimmunology. 2018 Jul 30;7(10):e1490854. doi: 10.1080/2162402X.2018.1490854. eCollection 2018.
|
613 |
Interaction between dietary acrylamide intake and genetic variants for estrogen receptor-positive breast cancer risk.Eur J Nutr. 2019 Apr;58(3):1033-1045. doi: 10.1007/s00394-018-1619-z. Epub 2018 Feb 14.
|
614 |
The retinoic acid-metabolizing enzyme CYP26A1 upregulates fascin and promotes the malignant behavior of breast carcinoma cells.Oncol Rep. 2015 Aug;34(2):850-8. doi: 10.3892/or.2015.4042. Epub 2015 Jun 8.
|
615 |
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer. Breast Cancer Res Treat. 2018 Nov;172(2):371-379.
|
616 |
Severe and prolonged cyclophosphamide-induced hepatotoxicity in a breast cancer patient carrying a CYP2B6*7 variant.Pharmacogenomics. 2019 Nov;20(16):1119-1124. doi: 10.2217/pgs-2019-0093. Epub 2019 Nov 5.
|
617 |
Association of cytochrome P450 genetic polymorphisms with neoadjuvant chemotherapy efficacy in breast cancer patients.BMC Med Genet. 2012 Jun 15;13:45. doi: 10.1186/1471-2350-13-45.
|
618 |
Role of CYP2E1 polymorphisms in breast cancer: a systematic review and meta-analysis.Cancer Cell Int. 2017 Jan 7;17:11. doi: 10.1186/s12935-016-0371-9. eCollection 2017.
|
619 |
Activation of the pro-migratory bone morphogenetic protein receptor 1B gene in human MDA-MB-468 triple-negative breast cancer cells that over-express CYP2J2.Int J Biochem Cell Biol. 2016 Nov;80:173-178. doi: 10.1016/j.biocel.2016.10.004. Epub 2016 Oct 5.
|
620 |
Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.Int J Cancer. 2011 Jul 1;129(1):9-22. doi: 10.1002/ijc.25648. Epub 2010 Nov 9.
|
621 |
Nuclear translocation of beta-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucins.Traffic. 2008 Dec;9(12):2063-72. doi: 10.1111/j.1600-0854.2008.00822.x. Epub 2008 Sep 18.
|
622 |
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs.Breast Cancer Res Treat. 2012 Feb;131(3):809-18. doi: 10.1007/s10549-011-1477-3. Epub 2011 Apr 5.
|
623 |
DCLK1 promotes malignant progression of breast cancer by regulating Wnt/-Catenin signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9489-9498. doi: 10.26355/eurrev_201911_19443.
|
624 |
Carbidopa Alters Tryptophan Metabolism in Breast Cancer and Melanoma Cells Leading to the Formation of Indole-3-Acetonitrile, a Pro-Proliferative Metabolite.Biomolecules. 2019 Aug 24;9(9):409. doi: 10.3390/biom9090409.
|
625 |
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.Endocr Relat Cancer. 2019 Jan 1;26(1):197-214. doi: 10.1530/ERC-18-0310.
|
626 |
Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7786-E7794. doi: 10.1073/pnas.1805020115. Epub 2018 Jul 30.
|
627 |
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.Oncogene. 2019 Jul;38(28):5725-5738. doi: 10.1038/s41388-019-0824-4. Epub 2019 Apr 23.
|
628 |
Optical Redox Imaging Detects the Effects of DEK Oncogene Knockdown on the Redox State of MDA-MB-231 Breast Cancer Cells.Mol Imaging Biol. 2019 Jun;21(3):410-416. doi: 10.1007/s11307-019-01321-w.
|
629 |
High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer.Front Oncol. 2019 Apr 12;9:262. doi: 10.3389/fonc.2019.00262. eCollection 2019.
|
630 |
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.Eur Radiol. 2020 Feb;30(2):756-766. doi: 10.1007/s00330-019-06392-5. Epub 2019 Aug 29.
|
631 |
Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk.PLoS Genet. 2017 Mar 31;13(3):e1006690. doi: 10.1371/journal.pgen.1006690. eCollection 2017 Mar.
|
632 |
Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.Med Oncol. 2012 Dec;29(4):2535-42. doi: 10.1007/s12032-011-0129-0. Epub 2011 Dec 8.
|
633 |
miR-559 polymorphism rs58450758 is linked to breast cancer.Br J Biomed Sci. 2020 Jan;77(1):29-34. doi: 10.1080/09674845.2019.1683309. Epub 2019 Nov 18.
|
634 |
Correlations of DKK1 with incidence and prognosis of breast cancer.J BUON. 2019 Jan-Feb;24(1):26-32.
|
635 |
The clinicopathological and prognostic significances of Dkk3 expression in cancers: A bioinformatics analysis.Cancer Biomark. 2018;23(3):323-331. doi: 10.3233/CBM-181245.
|
636 |
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.Oncogene. 2019 Mar;38(12):2092-2107. doi: 10.1038/s41388-018-0562-z. Epub 2018 Nov 15.
|
637 |
Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism.Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3799-804. doi: 10.1073/pnas.0600065103. Epub 2006 Feb 24.
|
638 |
The bispecific antibody HB-32, blockade of both VEGF and DLL4 shows potent anti-angiogenic activity in vitro and anti-tumor activity in breast cancer xenograft models.Exp Cell Res. 2019 Jul 15;380(2):141-148. doi: 10.1016/j.yexcr.2019.04.025. Epub 2019 Apr 26.
|
639 |
JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status.Int J Mol Med. 2006 Feb;17(2):363-7.
|
640 |
Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer.Nat Commun. 2017 Sep 5;8(1):436. doi: 10.1038/s41467-017-00100-x.
|
641 |
Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy.J Drug Target. 2017 Feb;25(2):140-148. doi: 10.1080/1061186X.2016.1207649. Epub 2016 Jul 12.
|
642 |
Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.J Clin Invest. 2018 Dec 3;128(12):5307-5321. doi: 10.1172/JCI87191. Epub 2018 Oct 29.
|
643 |
Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3A positive feedback loop.J Exp Clin Cancer Res. 2019 Oct 28;38(1):429. doi: 10.1186/s13046-019-1400-z.
|
644 |
A PAK5-DNPEP-USP4 axis dictates breast cancer growth and metastasis.Int J Cancer. 2020 Feb 15;146(4):1139-1151. doi: 10.1002/ijc.32523. Epub 2019 Jun 20.
|
645 |
Inhibition of histone methyltransferase DOT1L silences ER gene and blocks proliferation of antiestrogen-resistant breast cancer cells.Sci Adv. 2019 Feb 6;5(2):eaav5590. doi: 10.1126/sciadv.aav5590. eCollection 2019 Feb.
|
646 |
Comparison of diagnostic precision for bone metastasis of primary breast cancer between BONENAVI version 1 and BONENAVI version 2.Nucl Med Commun. 2019 Nov;40(11):1148-1153. doi: 10.1097/MNM.0000000000001081.
|
647 |
Expression profiling of dipeptidyl peptidase 8 and 9 in breast and ovarian carcinoma cell lines.Int J Oncol. 2012 Sep;41(3):919-32. doi: 10.3892/ijo.2012.1522. Epub 2012 Jun 19.
|
648 |
Effect of dihydropyrimidine dehydrogenase single nucleotide polymorphisms on prognosis of breast cancer patients with chemotherapy.Oncotarget. 2017 Dec 8;8(67):112060-112075. doi: 10.18632/oncotarget.23033. eCollection 2017 Dec 19.
|
649 |
Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women.Breast Cancer Res Treat. 2010 Oct;123(3):885-93. doi: 10.1007/s10549-010-0804-4. Epub 2010 Feb 24.
|
650 |
The effects of spiritual intervention and changes in dopamine receptor gene expression in breast cancer patients.Breast Cancer. 2016 Nov;23(6):893-900. doi: 10.1007/s12282-015-0658-z. Epub 2015 Nov 23.
|
651 |
Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.Sci Rep. 2017 May 19;7(1):2143. doi: 10.1038/s41598-017-02134-z.
|
652 |
Puerarin promotes DUSP1 expression by regulating miR?33a?p in breast cancer.Mol Med Rep. 2019 Jan;19(1):205-212. doi: 10.3892/mmr.2018.9682. Epub 2018 Nov 21.
|
653 |
Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas.Oncol Rep. 2012 Sep;28(3):931-6. doi: 10.3892/or.2012.1862. Epub 2012 Jun 12.
|
654 |
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.Cancer Res. 2018 Aug 1;78(15):4191-4202. doi: 10.1158/0008-5472.CAN-18-0270. Epub 2018 Jun 7.
|
655 |
Immuno-Affinity Mass Spectrometry: A Novel Approaches with Biomedical Relevance.Adv Exp Med Biol. 2019;1140:377-388. doi: 10.1007/978-3-030-15950-4_21.
|
656 |
Dyrk1B overexpression is associated with breast cancer growth and a poor prognosis.Hum Pathol. 2017 Aug;66:48-58. doi: 10.1016/j.humpath.2017.02.033. Epub 2017 May 26.
|
657 |
Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.Oncogene. 2017 Mar 30;36(13):1862-1872. doi: 10.1038/onc.2016.349. Epub 2016 Oct 10.
|
658 |
E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration.Sci Rep. 2019 Jul 24;9(1):10718. doi: 10.1038/s41598-019-47218-0.
|
659 |
The CCAAT/enhancer-binding protein beta-2 isoform (CEBP-2) upregulates galectin-7 expression in human breast cancer cells.PLoS One. 2014 May 2;9(5):e95087. doi: 10.1371/journal.pone.0095087. eCollection 2014.
|
660 |
On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.Breast Cancer Res Treat. 2007 Dec;106(3):361-9. doi: 10.1007/s10549-007-9516-9. Epub 2007 Feb 13.
|
661 |
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55-Mediated Manner.Cell Rep. 2017 Mar 21;18(12):2836-2844. doi: 10.1016/j.celrep.2017.02.081.
|
662 |
Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer.Asian Pac J Cancer Prev. 2018 Apr 25;19(4):923-926. doi: 10.22034/APJCP.2018.19.4.923.
|
663 |
Expression and prognostic analyses of early growth response proteins (EGRs) in human breast carcinoma based on database analysis.PeerJ. 2019 Dec 9;7:e8183. doi: 10.7717/peerj.8183. eCollection 2019.
|
664 |
The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.Int J Oncol. 2019 Jan;54(1):65-76. doi: 10.3892/ijo.2018.4608. Epub 2018 Oct 26.
|
665 |
PERK-Phosphorylated eIF2 Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.Cancer Biother Radiopharm. 2017 Oct;32(8):282-287. doi: 10.1089/cbr.2017.2237.
|
666 |
Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Oncogene. 2018 Feb 1;37(5):651-662. doi: 10.1038/onc.2017.372. Epub 2017 Oct 9.
|
667 |
Feedback Activation of SGK3 and AKT Contributes to Rapamycin Resistance by Reactivating mTORC1/4EBP1 Axis via TSC2 in Breast Cancer.Int J Biol Sci. 2019 Mar 9;15(5):929-941. doi: 10.7150/ijbs.32489. eCollection 2019.
|
668 |
EIF5A2 is a novel chemoresistance gene in breast cancer.Breast Cancer. 2015 Nov;22(6):602-7. doi: 10.1007/s12282-014-0526-2. Epub 2014 Mar 18.
|
669 |
Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.Cancer Med. 2019 Feb;8(2):729-741. doi: 10.1002/cam4.1938. Epub 2019 Jan 16.
|
670 |
ITIH5 induces a shift in TGF- superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.Mol Carcinog. 2018 Feb;57(2):167-181. doi: 10.1002/mc.22742. Epub 2017 Oct 30.
|
671 |
Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.Nat Commun. 2015 Jun 12;6:7318. doi: 10.1038/ncomms8318.
|
672 |
Antitumoral potential of microvesicles extracted from human adipose-derived mesenchymal stem cells on human breast cancer cells.J Cancer Res Ther. 2019 Jul-Sep;15(5):1114-1119. doi: 10.4103/jcrt.JCRT_147_18.
|
673 |
HER2 regulates HIF-2 and drives an increased hypoxic response in breast cancer.Breast Cancer Res. 2019 Jan 22;21(1):10. doi: 10.1186/s13058-019-1097-0.
|
674 |
Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3.Curr Cancer Drug Targets. 2020;20(1):76-83. doi: 10.2174/1568009619666190718124541.
|
675 |
MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.Mol Cell Biochem. 2018 Feb;439(1-2):95-104. doi: 10.1007/s11010-017-3139-1. Epub 2017 Aug 9.
|
676 |
Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.Oncol Lett. 2018 Apr;15(4):5257-5263. doi: 10.3892/ol.2018.7919. Epub 2018 Feb 1.
|
677 |
EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.Cancer Genomics Proteomics. 2016 09-10;13(5):359-68.
|
678 |
Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.J Nat Prod. 2019 Apr 26;82(4):878-885. doi: 10.1021/acs.jnatprod.8b00964. Epub 2019 Feb 27.
|
679 |
Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients.Oncol Lett. 2019 Jul;18(1):742-750. doi: 10.3892/ol.2019.10363. Epub 2019 May 17.
|
680 |
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.Int J Oncol. 2017 Apr;50(4):1191-1200. doi: 10.3892/ijo.2017.3883. Epub 2017 Feb 20.
|
681 |
NRG-1 Stimulates Serum DJ-1 Increase in Breast Cancers.Pathol Oncol Res. 2019 Jan;25(1):71-79. doi: 10.1007/s12253-017-0326-z. Epub 2017 Sep 30.
|
682 |
Downregulation of miroRNA-141 mediates acquired resistance to trastuzumab and is associated with poor outcome in breast cancer by upregulating the expression of ERBB4.J Cell Biochem. 2019 Jul;120(7):11390-11400. doi: 10.1002/jcb.28416. Epub 2019 Feb 11.
|
683 |
The orphan nuclear receptor estrogen-related receptor beta (ERR) in triple-negative breast cancer.Breast Cancer Res Treat. 2020 Feb;179(3):585-604. doi: 10.1007/s10549-019-05485-5. Epub 2019 Nov 19.
|
684 |
Differential expression of Ets-1 in breast cancer among North Indian population.J Cell Biochem. 2019 Sep;120(9):14552-14561. doi: 10.1002/jcb.28716. Epub 2019 Apr 23.
|
685 |
Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer.PLoS One. 2013 Aug 16;8(8):e71533. doi: 10.1371/journal.pone.0071533. eCollection 2013.
|
686 |
Ezrin promotes breast cancer progression by modulating AKT signals.Br J Cancer. 2019 Apr;120(7):703-713. doi: 10.1038/s41416-019-0383-z. Epub 2019 Feb 26.
|
687 |
The direct oral anticoagulants rivaroxaban and dabigatran do not inhibit orthotopic growth and metastasis of human breast cancer in mice.J Thromb Haemost. 2019 Jun;17(6):951-963. doi: 10.1111/jth.14443. Epub 2019 Apr 29.
|
688 |
Differential contribution of tissue factor and FactorXII to thrombin generation triggered by breast and pancreatic cancer cells.Int J Oncol. 2017 Dec;51(6):1747-1756. doi: 10.3892/ijo.2017.4172. Epub 2017 Oct 20.
|
689 |
Functional inhibition of F11 receptor (F11R/junctional adhesion molecule-A/JAM-A) activity by a F11R-derived peptide in breast cancer and its microenvironment.Breast Cancer Res Treat. 2020 Jan;179(2):325-335. doi: 10.1007/s10549-019-05471-x. Epub 2019 Oct 24.
|
690 |
Protease-activated receptor 2 promotes actomyosin dependent transforming microvesicles generation from human breast cancer.Mol Carcinog. 2018 Dec;57(12):1707-1722. doi: 10.1002/mc.22891. Epub 2018 Sep 5.
|
691 |
Novel Hydrophilic Copolymer-Based Nanoparticle Enhances the Therapeutic Efficiency of Doxorubicin in Cultured MCF-7 Cells.ACS Omega. 2019 Oct 11;4(17):17083-17089. doi: 10.1021/acsomega.8b02894. eCollection 2019 Oct 22.
|
692 |
Expression of human delta-6-desaturase is associated with aggressiveness of human breast cancer.Int J Mol Med. 2003 Aug;12(2):253-7.
|
693 |
FAF1 phosphorylation by AKT accumulates TGF- type II receptor and drives breast cancer metastasis.Nat Commun. 2017 Apr 26;8:15021. doi: 10.1038/ncomms15021.
|
694 |
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response.Cell Death Dis. 2019 Sep 11;10(9):666. doi: 10.1038/s41419-019-1871-z.
|
695 |
Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.Tumour Biol. 2014 Apr;35(4):3035-9. doi: 10.1007/s13277-013-1392-9. Epub 2013 Nov 19.
|
696 |
MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.Oncogene. 2016 Jan 28;35(4):448-58. doi: 10.1038/onc.2015.96. Epub 2015 Apr 13.
|
697 |
Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.JCI Insight. 2019 Feb 21;4(4):e125138. doi: 10.1172/jci.insight.125138. eCollection 2019 Feb 21.
|
698 |
Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.Clin Breast Cancer. 2018 Oct;18(5):e863-e868. doi: 10.1016/j.clbc.2018.01.009. Epub 2018 Jan 31.
|
699 |
Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fc receptor engagement.Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10966-71. doi: 10.1073/pnas.1208698109. Epub 2012 Jun 20.
|
700 |
Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.Photochem Photobiol. 2019 Jul;95(4):1052-1059. doi: 10.1111/php.13091. Epub 2019 Mar 15.
|
701 |
The feasibility of (18)F-FES and (18)F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ER in ER+ breast cancer.Ann Nucl Med. 2018 May;32(4):272-280. doi: 10.1007/s12149-018-1245-0. Epub 2018 Feb 24.
|
702 |
Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells.Mol Cell Endocrinol. 2008 Nov 6;294(1-2):81-91. doi: 10.1016/j.mce.2008.08.003. Epub 2008 Aug 15.
|
703 |
Humanization of fibroblast growth factor 1 single-chain antibody and validation for its antitumorigenic efficacy in breast cancer and glioma cells.J Cell Mol Med. 2018 Jun;22(6):3259-3263. doi: 10.1111/jcmm.13547. Epub 2018 Mar 24.
|
704 |
FGF18 Enhances Migration and the Epithelial-Mesenchymal Transition in Breast Cancer by Regulating Akt/GSK3/-Catenin Signaling.Cell Physiol Biochem. 2018;49(3):1019-1032. doi: 10.1159/000493286. Epub 2018 Sep 7.
|
705 |
FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ER and PRB4 isoform to MYC regulatory sequences.Int J Cancer. 2019 Oct 1;145(7):1874-1888. doi: 10.1002/ijc.32252. Epub 2019 Mar 28.
|
706 |
The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.Cancer Biomark. 2017;18(4):441-449. doi: 10.3233/CBM-161507.
|
707 |
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase. J Med Chem. 2011 Oct 27;54(20):7066-83. doi: 10.1021/jm2006222. Epub 2011 Sep 21.
|
708 |
Long noncoding RNA Linc00460 promotes breast cancer progression by regulating the miR-489-5p/FGF7/AKT axis.Cancer Manag Res. 2019 Jul 1;11:5983-6001. doi: 10.2147/CMAR.S207084. eCollection 2019.
|
709 |
The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF.Carcinogenesis. 2014 May;35(5):1144-53. doi: 10.1093/carcin/bgu021. Epub 2014 Jan 24.
|
710 |
Krppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.Oncogene. 2009 Oct 22;28(42):3702-13. doi: 10.1038/onc.2009.235. Epub 2009 Aug 10.
|
711 |
Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.J BUON. 2019 Jan-Feb;24(1):40-47.
|
712 |
Four-and-a-half-LIM protein 1 down-regulates estrogen receptor activity through repression of AKT phosphorylation in human breast cancer cell.Int J Biochem Cell Biol. 2012 Feb;44(2):320-6. doi: 10.1016/j.biocel.2011.11.002. Epub 2011 Nov 10.
|
713 |
FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer.Cancer Chemother Pharmacol. 2019 Oct;84(4):861-872. doi: 10.1007/s00280-019-03923-1. Epub 2019 Aug 19.
|
714 |
FKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancer.Theranostics. 2019 Sep 21;9(23):7003-7015. doi: 10.7150/thno.35561. eCollection 2019.
|
715 |
FLNa negatively regulated proliferation and metastasis in lung adenocarcinoma A549 cells via suppression of EGFR.Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):164-170. doi: 10.1093/abbs/gmx135.
|
716 |
Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [(18)F]FLT and [(18)F]ISO-1 PET/CT.Clin Cancer Res. 2019 May 15;25(10):3063-3073. doi: 10.1158/1078-0432.CCR-18-2769. Epub 2019 Jan 28.
|
717 |
-Lipoic acid stabilized DTX/IR780 micelles for photoacoustic/fluorescence imaging guided photothermal therapy/chemotherapy of breast cancer.Biomater Sci. 2018 May 1;6(5):1201-1216. doi: 10.1039/c8bm00096d.
|
718 |
Extra domain A-containing fibronectin expression in Spin90-deficient fibroblasts mediates cancer-stroma interaction and promotes breast cancer progression.J Cell Physiol. 2020 May;235(5):4494-4507. doi: 10.1002/jcp.29326. Epub 2019 Oct 21.
|
719 |
18F-PSMA 1007 Uptake in Brain Metastases From Breast Cancer.Clin Nucl Med. 2020 Feb;45(2):e77-e79. doi: 10.1097/RLU.0000000000002821.
|
720 |
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous... Hum Pathol. 2009 Oct;40(10):1453-60.
|
721 |
Elucidating feed-forward apoptosis signatures in breast cancer datasets: Higher FOS expression associated with a better outcome.Oncol Lett. 2018 Aug;16(2):2757-2763. doi: 10.3892/ol.2018.8957. Epub 2018 Jun 12.
|
722 |
Expression and function of FRA1 protein in tumors.Mol Biol Rep. 2020 Jan;47(1):737-752. doi: 10.1007/s11033-019-05123-9. Epub 2019 Oct 14.
|
723 |
The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells.Eur J Cancer. 2010 Jun;46(9):1650-60. doi: 10.1016/j.ejca.2010.02.008. Epub 2010 Mar 11.
|
724 |
Research progress on the forkhead box C1.Oncotarget. 2017 Nov 20;9(15):12471-12478. doi: 10.18632/oncotarget.22527. eCollection 2018 Feb 23.
|
725 |
Overexpression of forkhead box J2 can decrease the migration of breast cancer cells. J Cell Biochem. 2012 Aug;113(8):2729-37.
|
726 |
Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.Cell Death Differ. 2020 Mar;27(3):966-983. doi: 10.1038/s41418-019-0389-3. Epub 2019 Jul 11.
|
727 |
Inhibition of the AnxA1/FPR1 autocrine axis reduces MDA-MB-231 breast cancer cell growth and aggressiveness in vitro and in vivo.Biochim Biophys Acta Mol Cell Res. 2018 Sep;1865(9):1368-1382. doi: 10.1016/j.bbamcr.2018.06.010. Epub 2018 Jun 20.
|
728 |
Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2/9 expression.J Cell Biochem. 2019 Mar;120(3):3611-3620. doi: 10.1002/jcb.27638. Epub 2018 Nov 11.
|
729 |
Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast.Breast. 2018 Feb;37:134-141. doi: 10.1016/j.breast.2017.11.010. Epub 2017 Nov 20.
|
730 |
Serum Levels of Activins, Follistatins, and Growth Factors in Neoplasms of the Breast: A Case-Control Study.J Clin Endocrinol Metab. 2019 Feb 1;104(2):349-358. doi: 10.1210/jc.2018-01581.
|
731 |
A Self-Targeting, Dual ROS/pH-Responsive Apoferritin Nanocage for Spatiotemporally Controlled Drug Delivery to Breast Cancer.Biomacromolecules. 2018 Mar 12;19(3):1026-1036. doi: 10.1021/acs.biomac.8b00012. Epub 2018 Feb 23.
|
732 |
Fut3 role in breast invasive ductal carcinoma: Investigating its gene promoter and protein expression.Exp Mol Pathol. 2015 Dec;99(3):409-15. doi: 10.1016/j.yexmp.2015.08.015. Epub 2015 Aug 29.
|
733 |
Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4.Pathol Res Pract. 2020 Feb;216(2):152772. doi: 10.1016/j.prp.2019.152772. Epub 2019 Nov 28.
|
734 |
LncRNA AWPPH promotes the growth of triple-negative breast cancer by up-regulating frizzled homolog 7 (FZD7).Biosci Rep. 2018 Nov 28;38(6):BSR20181223. doi: 10.1042/BSR20181223. Print 2018 Dec 21.
|
735 |
The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
|
736 |
Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.PLoS One. 2019 Jun 27;14(6):e0218917. doi: 10.1371/journal.pone.0218917. eCollection 2019.
|
737 |
The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis.Nat Commun. 2016 Feb 12;7:10715. doi: 10.1038/ncomms10715.
|
738 |
Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.Int J Cancer. 2006 Mar 15;118(6):1453-9. doi: 10.1002/ijc.21517.
|
739 |
Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in the intestinal type of gastric cancer.Genes Chromosomes Cancer. 1999 Jan;24(1):24-9. doi: 10.1002/(sici)1098-2264(199901)24:1<24::aid-gcc4>3.0.co;2-h.
|
740 |
Shortening of apparent transverse relaxation time of inorganic phosphate as a breast cancer biomarker.NMR Biomed. 2019 Oct;32(10):e4011. doi: 10.1002/nbm.4011. Epub 2018 Oct 12.
|
741 |
Growth arrest-specific gene 6 expression in human breast cancer.Br J Cancer. 2008 Mar 25;98(6):1141-6. doi: 10.1038/sj.bjc.6604260. Epub 2008 Feb 19.
|
742 |
Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).Int J Mol Sci. 2019 Jan 4;20(1):163. doi: 10.3390/ijms20010163.
|
743 |
BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.J Exp Clin Cancer Res. 2018 Aug 30;37(1):209. doi: 10.1186/s13046-018-0885-1.
|
744 |
Breast Cancer Cell Apoptosis is Synergistically Induced by Curcumin, Trastuzumab, and Glutathione Peroxidase-1 but Robustly Inhibited by Glial Cell Line-Derived Neurotrophic Factor.Nutr Cancer. 2018 Feb-Mar;70(2):288-296. doi: 10.1080/01635581.2018.1412486. Epub 2018 Jan 3.
|
745 |
High levels of -glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.
|
746 |
Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy.Cancer Chemother Pharmacol. 2020 Jan;85(1):105-111. doi: 10.1007/s00280-019-03981-5. Epub 2019 Nov 21.
|
747 |
Differential immunostaining of various types of breast carcinomas for growth hormone-releasing hormone receptor - Apocrine epithelium and carcinomas emerging as uniformly positive.APMIS. 2014 Sep;122(9):824-31. doi: 10.1111/apm.12224. Epub 2014 Jan 31.
|
748 |
Metabolic hormones and breast cancer risk among Mexican American Women in the Mano a Mano Cohort Study.Sci Rep. 2019 Jul 10;9(1):9989. doi: 10.1038/s41598-019-46429-9.
|
749 |
Spatial Arrangements of Connexin43 in Cancer Related Cells and Re-Arrangements under Treatment Conditions: Investigations on the Nano-Scale by Super-Resolution Localization Light Microscopy.Cancers (Basel). 2019 Mar 4;11(3):301. doi: 10.3390/cancers11030301.
|
750 |
Functional Proteomics of Breast Cancer Metabolism Identifies GLUL as Responder during Hypoxic Adaptation.J Proteome Res. 2019 Mar 1;18(3):1352-1362. doi: 10.1021/acs.jproteome.8b00944. Epub 2019 Jan 18.
|
751 |
Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes.Cancer Sci. 2016 Jun;107(6):828-35. doi: 10.1111/cas.12935. Epub 2016 Apr 27.
|
752 |
Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer.Oncogene. 2019 Jun;38(24):4886. doi: 10.1038/s41388-019-0753-2.
|
753 |
Novel therapeutic strategies and targets in advanced uveal melanoma.Curr Opin Oncol. 2018 Mar;30(2):134-141. doi: 10.1097/CCO.0000000000000425.
|
754 |
Molecular basis of a novel oncogenic mutation in GNAO1.Oncogene. 2011 Jun 9;30(23):2691-6. doi: 10.1038/onc.2010.645. Epub 2011 Feb 14.
|
755 |
Human breast carcinoma cells synthesize a protein immunorelated to platelet glycoprotein-Ib alpha with different functional properties.J Lab Clin Med. 1997 Mar;129(3):337-46. doi: 10.1016/s0022-2143(97)90182-7.
|
756 |
Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer.Cancers (Basel). 2019 Aug 27;11(9):1255. doi: 10.3390/cancers11091255.
|
757 |
Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway.J Cancer Res Clin Oncol. 2018 Dec;144(12):2399-2418. doi: 10.1007/s00432-018-2751-0. Epub 2018 Sep 28.
|
758 |
HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells.Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1679-1690. doi: 10.1016/j.bbamcr.2017.06.015. Epub 2017 Jun 23.
|
759 |
GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and -catenin activity.Oncogene. 2019 Jun;38(26):5294-5307. doi: 10.1038/s41388-019-0793-7. Epub 2019 Mar 26.
|
760 |
GPR119 agonist enhances gefitinib responsiveness through lactate-mediated inhibition of autophagy.J Exp Clin Cancer Res. 2018 Nov 29;37(1):295. doi: 10.1186/s13046-018-0949-2.
|
761 |
Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis.Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):580-585. doi: 10.1073/pnas.1614035114. Epub 2017 Jan 3.
|
762 |
Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.Am J Hum Genet. 1989 Oct;45(4):521-9.
|
763 |
Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.Breast Cancer Res Treat. 2007 Jan;101(1):27-36. doi: 10.1007/s10549-006-9275-z.
|
764 |
The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.Acta Pharmacol Sin. 2018 Mar;39(3):459-471. doi: 10.1038/aps.2017.157. Epub 2017 Nov 30.
|
765 |
Membrane androgen receptors (OXER1, GPRC6A AND ZIP9) in prostate and breast cancer: A comparative study of their expression.Steroids. 2019 Feb;142:100-108. doi: 10.1016/j.steroids.2019.01.006. Epub 2019 Jan 29.
|
766 |
miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells.Cell Death Dis. 2018 Feb 7;9(2):188. doi: 10.1038/s41419-017-0211-4.
|
767 |
The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.Cell Rep. 2019 Oct 22;29(4):889-903.e10. doi: 10.1016/j.celrep.2019.09.032.
|
768 |
Identification of recurrent fusion genes across multiple cancer types.Sci Rep. 2019 Jan 31;9(1):1074. doi: 10.1038/s41598-019-38550-6.
|
769 |
Breast cancer expresses functional NMDA receptors.Breast Cancer Res Treat. 2010 Jul;122(2):307-14. doi: 10.1007/s10549-009-0556-1. Epub 2009 Sep 26.
|
770 |
G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.PLoS One. 2016 Apr 6;11(4):e0152856. doi: 10.1371/journal.pone.0152856. eCollection 2016.
|
771 |
Downregulation of GRK5 hampers the migration of breast cancer cells.Sci Rep. 2019 Oct 29;9(1):15548. doi: 10.1038/s41598-019-51923-1.
|
772 |
Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.Oncotarget. 2017 Jul 4;8(27):44639-44653. doi: 10.18632/oncotarget.17961.
|
773 |
B Cell-Attracting Chemokine-1 and Progranulin in Bronchoalveolar Lavage Fluid of Patients with Advanced Non-small Cell Lung Cancer: New Prognostic Factors.Adv Exp Med Biol. 2019;1150:11-16. doi: 10.1007/5584_2018_285.
|
774 |
Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.PLoS One. 2019 Jan 15;14(1):e0210905. doi: 10.1371/journal.pone.0210905. eCollection 2019.
|
775 |
Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3-modulated mitochondrial binding of HKII.Free Radic Biol Med. 2020 Jan;146:119-129. doi: 10.1016/j.freeradbiomed.2019.10.413. Epub 2019 Oct 24.
|
776 |
Comparative two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) of human milk to identify dysregulated proteins in breast cancer.Electrophoresis. 2018 May 13. doi: 10.1002/elps.201800025. Online ahead of print.
|
777 |
Elevation of glutathione, glutathione-reductase and nucleic acids in both normal tissues and tumour of breast cancer patients.Cancer Lett. 1993 Aug 16;72(1-2):11-5. doi: 10.1016/0304-3835(93)90004-s.
|
778 |
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness.Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):958-974. doi: 10.1016/j.bbabio.2018.04.002. Epub 2018 Apr 13.
|
779 |
Chemopreventive efficacy of oral curcumin: a prodrug hypothesis.FASEB J. 2019 Aug;33(8):9453-9465. doi: 10.1096/fj.201900166R. Epub 2019 May 28.
|
780 |
HAX1 impact on collective cell migration, cell adhesion, and cell shape is linked to the regulation of actomyosin contractility.Mol Biol Cell. 2019 Dec 1;30(25):3024-3036. doi: 10.1091/mbc.E19-05-0304. Epub 2019 Oct 23.
|
781 |
Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis.Hum Mol Genet. 1995 Oct;4(10):1889-94. doi: 10.1093/hmg/4.10.1889.
|
782 |
Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.Oncogene. 2014 Jul 17;33(29):3784-93. doi: 10.1038/onc.2013.363. Epub 2013 Sep 9.
|
783 |
G-protein-coupled receptor 81 promotes a malignant phenotype in breast cancer through angiogenic factor secretion.Oncotarget. 2016 Oct 25;7(43):70898-70911. doi: 10.18632/oncotarget.12286.
|
784 |
Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Oncotarget. 2017 Mar 28;8(13):20925-20938. doi: 10.18632/oncotarget.14995.
|
785 |
Endocrine resistant breast cancer cells with loss of ER expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.Cell Oncol (Dordr). 2020 Feb;43(1):65-80. doi: 10.1007/s13402-019-00439-x. Epub 2019 Nov 7.
|
786 |
Correction: Deacetylation of HSPA5 by HDAC6 leads to GP78-mediated HSPA5 ubiquitination at K447 and suppresses metastasis of breast cancer.Oncogene. 2020 Jan;39(4):946-949. doi: 10.1038/s41388-019-0981-5.
|
787 |
Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy.Bioorg Chem. 2019 Jun;87:200-208. doi: 10.1016/j.bioorg.2019.03.027. Epub 2019 Mar 19.
|
788 |
Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells.Mol Cancer. 2015 Apr 1;14:72. doi: 10.1186/s12943-015-0345-x.
|
789 |
HIPK2 downregulates vimentin and inhibits breast cancer cell invasion.Cancer Biol Ther. 2012 Feb 15;13(4):198-205. doi: 10.4161/cbt.13.4.18694. Epub 2012 Feb 15.
|
790 |
PGC1 Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression.Front Oncol. 2019 Apr 17;9:290. doi: 10.3389/fonc.2019.00290. eCollection 2019.
|
791 |
The Impact of HLA-G 3'UTR Polymorphisms in Breast Cancer in a Tunisian Population.Immunol Invest. 2019 Jul;48(5):521-532. doi: 10.1080/08820139.2019.1569043. Epub 2019 Apr 4.
|
792 |
DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.J Natl Cancer Inst. 2010 Jan 6;102(1):54-68. doi: 10.1093/jnci/djp441. Epub 2009 Dec 14.
|
793 |
High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.Breast Cancer Res Treat. 2020 Jan;179(1):25-35. doi: 10.1007/s10549-019-05419-1. Epub 2019 Sep 17.
|
794 |
HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer.Cell Commun Signal. 2018 Feb 20;16(1):8. doi: 10.1186/s12964-018-0219-0.
|
795 |
Heme Oxygenase-1 Inhibits Tumor Metastasis Mediated by Notch1 Pathway in Murine Mammary Carcinoma.Oncol Res. 2019 Jun 21;27(6):643-651. doi: 10.3727/096504018X15415906335771. Epub 2019 Feb 14.
|
796 |
Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/-Catenin/Notch Signaling in Breast and Colon Cancers.Cancers (Basel). 2019 Jan 15;11(1):99. doi: 10.3390/cancers11010099.
|
797 |
PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.J Cell Biochem. 2019 Apr;120(4):6542-6554. doi: 10.1002/jcb.27947. Epub 2018 Oct 28.
|
798 |
Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha.Biochem Biophys Res Commun. 2013 Nov 1;440(4):652-7. doi: 10.1016/j.bbrc.2013.09.121. Epub 2013 Oct 4.
|
799 |
Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.Int J Pharm. 2017 Aug 7;528(1-2):33-46. doi: 10.1016/j.ijpharm.2017.05.063. Epub 2017 May 31.
|
800 |
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer.Cancer Lett. 2018 Jun 28;424:70-83. doi: 10.1016/j.canlet.2018.03.014. Epub 2018 Mar 14.
|
801 |
Immunomodulatory role of histamine H4 receptor in breast cancer.Br J Cancer. 2019 Jan;120(1):128-138. doi: 10.1038/s41416-018-0173-z. Epub 2018 Jul 10.
|
802 |
Predictive value of genetic analysis for pathological complete response to preoperative treatment in HER2 positive, HR negative early breast cancer (PASSION trial).Jpn J Clin Oncol. 2018 Apr 1;48(4):388-391. doi: 10.1093/jjco/hyy024.
|
803 |
FAM3C-YY1 axis is essential for TGF-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.J Cell Mol Med. 2019 May;23(5):3464-3475. doi: 10.1111/jcmm.14243. Epub 2019 Mar 19.
|
804 |
HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.Naunyn Schmiedebergs Arch Pharmacol. 2020 Feb;393(2):253-262. doi: 10.1007/s00210-019-01725-z. Epub 2019 Sep 14.
|
805 |
USP22-dependent HSP90AB1 expression promotes resistance to HSP90 inhibition in mammary and colorectal cancer.Cell Death Dis. 2019 Dec 4;10(12):911. doi: 10.1038/s41419-019-2141-9.
|
806 |
GRP94 promotes brain metastasis by engaging pro-survival autophagy.Neuro Oncol. 2020 May 15;22(5):652-664. doi: 10.1093/neuonc/noz198.
|
807 |
SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.Oncotarget. 2019 Sep 10;10(52):5419-5438. doi: 10.18632/oncotarget.27138. eCollection 2019 Sep 10.
|
808 |
Simultaneous quantification of Cyt c interactions with HSP27 and Bcl-xL using molecularly imprinted polymers (MIPs) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based targeted proteomics.J Proteomics. 2019 Feb 10;192:188-195. doi: 10.1016/j.jprot.2018.09.001. Epub 2018 Sep 17.
|
809 |
The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8.Acta Pharmacol Sin. 2018 Aug;39(8):1338-1346. doi: 10.1038/aps.2017.181. Epub 2018 Jan 18.
|
810 |
Serotonin Analogues as Inhibitors of Breast Cancer Cell Growth.ACS Med Chem Lett. 2017 Sep 14;8(10):1072-1076. doi: 10.1021/acsmedchemlett.7b00282. eCollection 2017 Oct 12.
|
811 |
Serotonergic and BDNF genes associated with depression 1 week and 1 year after mastectomy for breast cancer.Psychosom Med. 2012 Jan;74(1):8-15. doi: 10.1097/PSY.0b013e318241530c. Epub 2011 Dec 30.
|
812 |
Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer.PLoS One. 2013 Apr 8;8(4):e60359. doi: 10.1371/journal.pone.0060359. Print 2013.
|
813 |
CAG repeat size in Huntingtin alleles is associated with cancer prognosis.Eur J Hum Genet. 2016 Aug;24(9):1310-5. doi: 10.1038/ejhg.2016.13. Epub 2016 Mar 16.
|
814 |
Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer.Transl Oncol. 2018 Oct;11(5):1259-1270. doi: 10.1016/j.tranon.2018.07.015. Epub 2018 Aug 14.
|
815 |
Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1.Cancer Res. 2019 Jan 1;79(1):171-182. doi: 10.1158/0008-5472.CAN-18-1106. Epub 2018 Nov 9.
|
816 |
Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial.Nutrients. 2019 Jun 4;11(6):1264. doi: 10.3390/nu11061264.
|
817 |
Interferon- regulates cell malignant growth via the c-Abl/HDAC2 signaling pathway in mammary epithelial cells.J Zhejiang Univ Sci B. 2019 Jan.;20(1):39-48. doi: 10.1631/jzus.B1800211.
|
818 |
Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.Breast Cancer. 2019 May;26(3):272-281. doi: 10.1007/s12282-018-0922-0. Epub 2018 Oct 16.
|
819 |
The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.Growth Horm IGF Res. 2019 Feb;44:33-42. doi: 10.1016/j.ghir.2018.12.003. Epub 2018 Dec 20.
|
820 |
Comparison of telomere length and insulin-like growth factor-binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women.J Clin Lab Anal. 2017 Sep;31(5):e22083. doi: 10.1002/jcla.22083. Epub 2016 Oct 24.
|
821 |
Piperlongumine Induces Cell Cycle Arrest via Reactive Oxygen Species Accumulation and IKK Suppression in Human Breast Cancer Cells.Antioxidants (Basel). 2019 Nov 14;8(11):553. doi: 10.3390/antiox8110553.
|
822 |
HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.Br J Cancer. 2006 Dec 18;95(12):1689-95. doi: 10.1038/sj.bjc.6603473. Epub 2006 Nov 21.
|
823 |
IL-11 is essential in promoting osteolysis in breast cancer bone metastasis via RANKL-independent activation of osteoclastogenesis.Cell Death Dis. 2019 Apr 30;10(5):353. doi: 10.1038/s41419-019-1594-1.
|
824 |
Interleukin-13 receptor alpha 2 expression in tumor cells is associated with reduced disease-free survival in patients with luminal subtype invasive breast cancer.Tumour Biol. 2018 Jun;40(6):1010428318783657. doi: 10.1177/1010428318783657.
|
825 |
Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus.Biosci Rep. 2019 Jul 23;39(7):BSR20190384. doi: 10.1042/BSR20190384. Print 2019 Jul 31.
|
826 |
A four-gene signature for prognosis in breast cancer patients with hypermethylated IL15RA.Oncol Lett. 2019 May;17(5):4245-4254. doi: 10.3892/ol.2019.10137. Epub 2019 Mar 12.
|
827 |
High Serum Levels of Interleukin-18 Are Associated With Worse Outcomes in Patients With Breast Cancer.Anticancer Res. 2019 Sep;39(9):5009-5018. doi: 10.21873/anticanres.13691.
|
828 |
The association between interleukin-1 gene rs1143634 polymorphism and the risk of breast cancer.Cytokine. 2019 Jan;113:475-476. doi: 10.1016/j.cyto.2018.07.030. Epub 2018 Jul 31.
|
829 |
A transcriptional complex composed of ER(), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.Oncotarget. 2017 Jun 27;8(26):42752-42760. doi: 10.18632/oncotarget.17459.
|
830 |
Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary Carcinoma.Int J Mol Sci. 2017 Jan 29;18(2):270. doi: 10.3390/ijms18020270.
|
831 |
Aberrant expression of IL-23/IL-23R in patients with breast cancer and its clinical significance.Mol Med Rep. 2018 Mar;17(3):4639-4644. doi: 10.3892/mmr.2018.8427. Epub 2018 Jan 12.
|
832 |
IL-24 Promotes Apoptosis through cAMP-Dependent PKA Pathways in Human Breast Cancer Cells.Int J Mol Sci. 2018 Nov 12;19(11):3561. doi: 10.3390/ijms19113561.
|
833 |
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer.Sci Signal. 2018 Jan 2;11(511):eaan0790. doi: 10.1126/scisignal.aan0790.
|
834 |
Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.Breast Cancer Res Treat. 2004 Jan;83(2):119-28. doi: 10.1023/B:BREA.0000010704.17479.8a.
|
835 |
IL-9-producing CD8(+) T cells represent a distinctive subset with different transcriptional characteristics from conventional CD8(+) T cells, and partially infiltrate breast tumors.Int J Biochem Cell Biol. 2019 Oct;115:105576. doi: 10.1016/j.biocel.2019.105576. Epub 2019 Jul 27.
|
836 |
ILK promotes cell proliferation in breast cancer cells by activating the PI3K/Akt pathway.Mol Med Rep. 2017 Oct;16(4):5036-5042. doi: 10.3892/mmr.2017.7180. Epub 2017 Aug 7.
|
837 |
IMP3 promotes TNBC stem cell property through miRNA-34a regulation.Eur Rev Med Pharmacol Sci. 2018 May;22(9):2688-2696. doi: 10.26355/eurrev_201805_14965.
|
838 |
RETRACTED ARTICLE: IMPDH2 is highly expressed in breast cancer and predicts unfavorable prognosis.Biomarkers. 2021 Feb;26(1):i-vi. doi: 10.1080/1354750X.2018.1496360. Epub 2020 Sep 1.
|
839 |
PTEN and SHIP: Impact on lymphatic metastasis in breast cancer.J Cancer Res Ther. 2018 Dec;14(Supplement):S937-S941. doi: 10.4103/0973-1482.193894.
|
840 |
Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project.Mol Carcinog. 2019 Mar;58(3):436-446. doi: 10.1002/mc.22940. Epub 2018 Dec 11.
|
841 |
Proanthocyanidins attenuate breast cancer-induced bone metastasis by inhibiting Irf-3/c-jun activation.Anticancer Drugs. 2019 Nov;30(10):998-1005. doi: 10.1097/CAD.0000000000000852.
|
842 |
MicroRNA-664 Targets Insulin Receptor Substrate 1 to Suppress Cell Proliferation and Invasion in Breast Cancer.Oncol Res. 2019 Mar 29;27(4):459-467. doi: 10.3727/096504018X15193500663936. Epub 2018 Mar 1.
|
843 |
Hypoxia Selectively Enhances Integrin (5)(1) Receptor Expression in Breast Cancer to Promote Metastasis.Mol Cancer Res. 2017 Jun;15(6):723-734. doi: 10.1158/1541-7786.MCR-16-0338. Epub 2017 Feb 17.
|
844 |
Stromal integrin 11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors.BMC Cancer. 2019 Mar 15;19(1):234. doi: 10.1186/s12885-019-5449-z.
|
845 |
Aberrant DNA methylation of integrin 4 in human breast cancer.Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24.
|
846 |
P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.Mod Pathol. 2017 May;30(5):698-709. doi: 10.1038/modpathol.2016.232. Epub 2017 Jan 13.
|
847 |
LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.Breast Cancer Res Treat. 2011 May;127(1):265-71. doi: 10.1007/s10549-010-1203-6. Epub 2010 Oct 17.
|
848 |
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer.Oncotarget. 2014 Nov 30;5(22):11345-53. doi: 10.18632/oncotarget.2489.
|
849 |
microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.PLoS One. 2015 Dec 10;10(12):e0143993. doi: 10.1371/journal.pone.0143993. eCollection 2015.
|
850 |
1 Integrin is essential for fascin-mediated breast cancer stem cell function and disease progression.Int J Cancer. 2019 Aug 1;145(3):830-841. doi: 10.1002/ijc.32183. Epub 2019 Feb 18.
|
851 |
EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy.J Immunother Cancer. 2019 Jan 8;7(1):5. doi: 10.1186/s40425-018-0470-3.
|
852 |
Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.Cancer Res. 2018 Mar 15;78(6):1404-1417. doi: 10.1158/0008-5472.CAN-17-0846. Epub 2018 Jan 12.
|
853 |
Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells.Oncogene. 2011 Sep 29;30(39):4075-86. doi: 10.1038/onc.2011.122. Epub 2011 Apr 18.
|
854 |
Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.J Mol Biol. 2013 Feb 22;425(4):755-66. doi: 10.1016/j.jmb.2012.11.035. Epub 2012 Dec 10.
|
855 |
Chemical genomics reveals inhibition of breast cancer lung metastasis by Ponatinib via c-Jun.Protein Cell. 2019 Mar;10(3):161-177. doi: 10.1007/s13238-018-0533-8. Epub 2018 Apr 17.
|
856 |
Combined Analysis of ChIP Sequencing and Gene Expression Dataset in Breast Cancer.Pathol Oncol Res. 2017 Apr;23(2):361-368. doi: 10.1007/s12253-016-0116-z. Epub 2016 Sep 21.
|
857 |
TASK-3 Downregulation Triggers Cellular Senescence and Growth Inhibition in Breast Cancer Cell Lines.Int J Mol Sci. 2018 Mar 29;19(4):1033. doi: 10.3390/ijms19041033.
|
858 |
The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic.Mar Drugs. 2018 May 11;16(5):157. doi: 10.3390/md16050157.
|
859 |
LSD1 suppresses invasion, migration and metastasis of luminal breast cancer cells via activation of GATA3 and repression of TRIM37 expression.Oncogene. 2019 Oct;38(44):7017-7034. doi: 10.1038/s41388-019-0923-2. Epub 2019 Aug 13.
|
860 |
JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.Breast Cancer Res. 2014 May 30;16(3):R56. doi: 10.1186/bcr3667.
|
861 |
Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines.Cancers (Basel). 2019 Jan 15;11(1):92. doi: 10.3390/cancers11010092.
|
862 |
KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming.Exp Cell Res. 2019 Jun 15;379(2):182-190. doi: 10.1016/j.yexcr.2019.04.006. Epub 2019 Apr 10.
|
863 |
Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer - contradictory effects and future perspectives.Biomed Pharmacother. 2020 Jan;121:109635. doi: 10.1016/j.biopha.2019.109635. Epub 2019 Nov 15.
|
864 |
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.Cancer Res Treat. 2019 Jul;51(3):1207-1221. doi: 10.4143/crt.2018.460. Epub 2018 Dec 27.
|
865 |
KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation.J Cell Physiol. 2019 Sep;234(9):16517-16525. doi: 10.1002/jcp.28322. Epub 2019 Feb 25.
|
866 |
KIF26B promotes cell proliferation and migration through the FGF2/ERK signaling pathway in breast cancer.Biomed Pharmacother. 2018 Dec;108:766-773. doi: 10.1016/j.biopha.2018.09.036. Epub 2018 Sep 22.
|
867 |
Overexpression of kinesins mediates docetaxel resistance in breast cancer cells.Cancer Res. 2009 Oct 15;69(20):8035-42. doi: 10.1158/0008-5472.CAN-09-1224. Epub 2009 Sep 29.
|
868 |
Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis.Cancer Res. 2008 Jun 15;68(12):4862-74. doi: 10.1158/0008-5472.CAN-08-0074.
|
869 |
C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients.Oncotarget. 2017 Dec 22;9(8):7918-7927. doi: 10.18632/oncotarget.23722. eCollection 2018 Jan 30.
|
870 |
A functional p53 responsive polymorphism in KITLG, rs4590952, does not affect the risk of breast cancer.Sci Rep. 2014 Sep 15;4:6371. doi: 10.1038/srep06371.
|
871 |
Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.Biol Chem. 2018 Sep 25;399(9):937-957. doi: 10.1515/hsz-2018-0111.
|
872 |
Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer.Clin Cancer Res. 2019 Jan 15;25(2):881-891. doi: 10.1158/1078-0432.CCR-18-1521. Epub 2018 Sep 25.
|
873 |
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study.Breast. 2016 Aug;28:191-8. doi: 10.1016/j.breast.2016.06.008. Epub 2016 Jun 20.
|
874 |
The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway.Oncotarget. 2014 May 15;5(9):2390-403. doi: 10.18632/oncotarget.1235.
|
875 |
Biochemical pathways mediated by KLK6 protease in breast cancer.Mol Oncol. 2019 Nov;13(11):2329-2343. doi: 10.1002/1878-0261.12493. Epub 2019 Sep 30.
|
876 |
Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.Cancer Sci. 2009 Apr;100(4):601-7. doi: 10.1111/j.1349-7006.2009.01090.x.
|
877 |
The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.Br J Cancer. 1999 Mar;79(9-10):1594-602. doi: 10.1038/sj.bjc.6690254.
|
878 |
Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC). Cell Physiol Biochem. 2018;50(5):1945-1963. doi: 10.1159/000494874. Epub 2018 Nov 5.
|
879 |
Monomethyltransferase SETD8 regulates breast cancer metabolism via stabilizing hypoxia-inducible factor 1.Cancer Lett. 2017 Apr 1;390:1-10. doi: 10.1016/j.canlet.2016.12.038. Epub 2017 Jan 13.
|
880 |
Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.J Natl Cancer Inst. 2017 Nov 1;109(11):djx058. doi: 10.1093/jnci/djx058.
|
881 |
SUV420H2 suppresses breast cancer cell invasion through down regulation of the SH2 domain-containing focal adhesion protein tensin-3.Exp Cell Res. 2015 May 15;334(1):90-9. doi: 10.1016/j.yexcr.2015.03.010. Epub 2015 Mar 23.
|
882 |
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B?receptor in breast cancer cells.Anticancer Res. 2014 Dec;34(12):6925-38.
|
883 |
Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.Oncogene. 2011 Oct 27;30(43):4399-409. doi: 10.1038/onc.2011.147. Epub 2011 May 2.
|
884 |
Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ER-positive advanced breast cancer.Pharmacogenomics J. 2015 Jun;15(3):235-40. doi: 10.1038/tpj.2014.58. Epub 2014 Oct 7.
|
885 |
A novel role of kynureninase in the growth control of breast cancer cells and its relationships with breast cancer.J Cell Mol Med. 2019 Oct;23(10):6700-6707. doi: 10.1111/jcmm.14547. Epub 2019 Jul 22.
|
886 |
L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.BMC Cancer. 2014 Dec 15;14:958. doi: 10.1186/1471-2407-14-958.
|
887 |
Electrochemical immunoassay for lactalbumin based on the use of ferrocene-modified gold nanoparticles and lysozyme-modified magnetic beads.Mikrochim Acta. 2018 Sep 7;185(10):449. doi: 10.1007/s00604-018-2986-0.
|
888 |
Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.BMC Cancer. 2018 Jun 25;18(1):682. doi: 10.1186/s12885-018-4550-z.
|
889 |
LAMP1 expression is associated with poor prognosis in breast cancer.Oncol Lett. 2017 Oct;14(4):4729-4735. doi: 10.3892/ol.2017.6757. Epub 2017 Aug 16.
|
890 |
Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.J Pathol. 2018 Jan;244(1):71-83. doi: 10.1002/path.4995.
|
891 |
Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer.Breast Cancer Res Treat. 2020 Feb;179(3):557-564. doi: 10.1007/s10549-019-05488-2. Epub 2019 Nov 9.
|
892 |
Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer.Biochim Biophys Acta Mol Cell Res. 2019 Jun;1866(6):1004-1018. doi: 10.1016/j.bbamcr.2019.03.004. Epub 2019 Mar 13.
|
893 |
Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.PLoS One. 2019 Jan 9;14(1):e0209435. doi: 10.1371/journal.pone.0209435. eCollection 2019.
|
894 |
Tuning the surface coating of IONs toward efficient sonochemical tethering and sustained liberation of topoisomerase II poisons.Int J Nanomedicine. 2019 Sep 17;14:7609-7624. doi: 10.2147/IJN.S208810. eCollection 2019.
|
895 |
LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.FASEB J. 2018 May;32(5):2422-2437. doi: 10.1096/fj.201700897R. Epub 2017 Dec 21.
|
896 |
Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients.BMC Cancer. 2019 Feb 15;19(1):155. doi: 10.1186/s12885-019-5327-8.
|
897 |
Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.J Cell Physiol. 2020 Feb;235(2):1405-1416. doi: 10.1002/jcp.29059. Epub 2019 Jul 25.
|
898 |
GPER stabilizes F-actin cytoskeleton and activates TAZ via PLC-PKC and Rho/ROCK-LIMK-Cofilin pathway.Biochem Biophys Res Commun. 2019 Aug 27;516(3):976-982. doi: 10.1016/j.bbrc.2019.06.132. Epub 2019 Jul 2.
|
899 |
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.Oncogene. 2017 Oct 5;36(40):5567-5575. doi: 10.1038/onc.2017.165. Epub 2017 Jun 5.
|
900 |
The Heregulin gene can be included in the 8p12 amplification unit in human breast cancer.Genes Chromosomes Cancer. 1994 Sep;11(1):66-9. doi: 10.1002/gcc.2870110111.
|
901 |
LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer.Int J Cancer. 2019 Aug 15;145(4):901-915. doi: 10.1002/ijc.32138. Epub 2019 Feb 7.
|
902 |
A comprehensive function analysis of LMO2 in different breast cancer subtypes.Oncotarget. 2017 Dec 21;9(10):8911-8926. doi: 10.18632/oncotarget.23542. eCollection 2018 Feb 6.
|
903 |
What to expect from the 2018 ASCO/CAP HER2 guideline in the reflex in situ hybridization test of immunohistochemically equivocal 2+ cases?.Virchows Arch. 2019 Sep;475(3):303-311. doi: 10.1007/s00428-019-02567-z. Epub 2019 Apr 5.
|
904 |
MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells.Tumour Biol. 2014 Nov;35(11):11137-45. doi: 10.1007/s13277-014-2412-0. Epub 2014 Aug 8.
|
905 |
Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.Neoplasia. 2019 Apr;21(4):413-427. doi: 10.1016/j.neo.2019.03.003. Epub 2019 Mar 27.
|
906 |
Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target.Oncotarget. 2018 May 4;9(34):23462-23481. doi: 10.18632/oncotarget.25231. eCollection 2018 May 4.
|
907 |
Expression of AutotaxinLysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma.Int J Mol Sci. 2019 Apr 29;20(9):2102. doi: 10.3390/ijms20092102.
|
908 |
Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer.Mol Diagn Ther. 2019 Feb;23(1):127-138. doi: 10.1007/s40291-019-00384-3.
|
909 |
LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.Clin Cancer Res. 2019 Aug 1;25(15):4832-4845. doi: 10.1158/1078-0432.CCR-18-3557. Epub 2019 Apr 22.
|
910 |
IGHG, IGKC, and FCGR genes and endogenous antibody responses to GARP in patients with breast cancer and matched controls.Hum Immunol. 2018 Aug;79(8):632-637. doi: 10.1016/j.humimm.2018.06.001. Epub 2018 Jun 4.
|
911 |
A sparse regulatory network of copy-number driven gene expression reveals putative breast cancer oncogenes.IEEE/ACM Trans Comput Biol Bioinform. 2012 Jul-Aug;9(4):947-54. doi: 10.1109/TCBB.2011.105.
|
912 |
Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Mllerian serous carcinomas: clinical divergence without immunophenotypic differences.Gynecol Oncol. 2000 Dec;79(3):430-7. doi: 10.1006/gyno.2000.6000.
|
913 |
The lymphotoxin- 252A>G polymorphism and breast cancer: a meta-analysis.Asian Pac J Cancer Prev. 2012;13(5):1949-52. doi: 10.7314/apjcp.2012.13.5.1949.
|
914 |
OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma.Cancer Sci. 2018 Oct;109(10):3350-3359. doi: 10.1111/cas.13770. Epub 2018 Sep 27.
|
915 |
Diagnostic utility of CD205 in breast cancer: Simultaneous detection of myoepithelial cells and dendritic cells in breast tissue by CD205.Histol Histopathol. 2020 May;35(5):481-488. doi: 10.14670/HH-18-164. Epub 2019 Sep 16.
|
916 |
Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.Cell Rep. 2018 Dec 26;25(13):3674-3692.e10. doi: 10.1016/j.celrep.2018.11.103.
|
917 |
The effect of neoadjuvant chemotherapy on the correlation of tumor-associated macrophages with CD31 and LYVE-1.Immunobiology. 2018 Jun-Jul;223(6-7):449-459. doi: 10.1016/j.imbio.2017.10.050. Epub 2017 Oct 31.
|
918 |
An -tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy.Drug Deliv. 2018 Nov;25(1):738-749. doi: 10.1080/10717544.2018.1446476.
|
919 |
Mad1 destabilizes p53 by preventing PML from sequestering MDM2.Nat Commun. 2019 Apr 4;10(1):1540. doi: 10.1038/s41467-019-09471-9.
|
920 |
MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.Cancer Res. 1996 Jan 1;56(1):16-20.
|
921 |
Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.World J Surg Oncol. 2019 Feb 23;17(1):41. doi: 10.1186/s12957-019-1585-9.
|
922 |
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.J Exp Med. 1994 Mar 1;179(3):921-30. doi: 10.1084/jem.179.3.921.
|
923 |
Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.Ann Surg Oncol. 2019 Aug;26(8):2475-2485. doi: 10.1245/s10434-019-07453-1. Epub 2019 May 17.
|
924 |
Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.Breast Cancer Res. 2012 May 8;14(3):R74. doi: 10.1186/bcr3183.
|
925 |
Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells.Cell Mol Biol Lett. 2019 Nov 12;24:59. doi: 10.1186/s11658-019-0183-8. eCollection 2019.
|
926 |
Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.Cancer Causes Control. 2014 Sep;25(9):1211-25. doi: 10.1007/s10552-014-0426-y. Epub 2014 Jul 4.
|
927 |
MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.J Nutrigenet Nutrigenomics. 2014;7(4-6):283-98. doi: 10.1159/000381346. Epub 2015 May 27.
|
928 |
Mixed lineage kinase 3 promotes breast tumorigenesis via phosphorylation and activation of p21-activated kinase 1.Oncogene. 2019 May;38(19):3569-3584. doi: 10.1038/s41388-019-0690-0. Epub 2019 Jan 21.
|
929 |
NF-kappa-inducing kinase regulates stem cell phenotype in breast cancer.Sci Rep. 2016 Nov 23;6:37340. doi: 10.1038/srep37340.
|
930 |
Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.J Pathol. 2014 Jan;232(1):75-86. doi: 10.1002/path.4283.
|
931 |
HER2/HER3 regulates lactate secretion and expression of lactate receptor mRNA through the MAP3K4 associated protein GIT1.Sci Rep. 2019 Jul 25;9(1):10823. doi: 10.1038/s41598-019-46954-7.
|
932 |
Transforming growth factor -activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-/TGFR pathway.Chem Biol Drug Des. 2017 Sep;90(3):450-455. doi: 10.1111/cbdd.12965. Epub 2017 Apr 11.
|
933 |
Function of microRNA?41 in human breast cancer through cytotoxic CD4+ T cells regulated by MAP4K4 expression.Mol Med Rep. 2018 Jun;17(6):7893-7901. doi: 10.3892/mmr.2018.8814. Epub 2018 Mar 28.
|
934 |
MicroRNA-21 promotes progression of breast cancer via inhibition of mitogen-activated protein kinase10 (MAPK10).Biosci Rep. 2019 Aug 2:BSR20181000. doi: 10.1042/BSR20181000. Online ahead of print.
|
935 |
A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration.Cell Adh Migr. 2015;9(6):483-94. doi: 10.1080/19336918.2015.1112485.
|
936 |
Ribosomal protein small subunit 15A (RPS15A) inhibits the apoptosis of breast cancer MDA-MB-231 cells via upregulating phosphorylated ERK1/2, Bad, and Chk1.J Cell Biochem. 2020 Jan;121(1):587-595. doi: 10.1002/jcb.29304. Epub 2019 Sep 18.
|
937 |
MicroRNA-155regulates the proliferation and metastasis of human breast cancers by targeting MAPK7.J BUON. 2019 May-Jun;24(3):1075-1080.
|
938 |
Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.PLoS One. 2019 Mar 11;14(3):e0212527. doi: 10.1371/journal.pone.0212527. eCollection 2019.
|
939 |
A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis.Hum Mol Genet. 2014 Jan 15;23(2):355-67. doi: 10.1093/hmg/ddt426. Epub 2013 Sep 5.
|
940 |
Angiotensin 1-7 formation in breast tissue is attenuated in breast cancer - a study on the metabolism of angiotensinogen in breast cancer cell lines.J Physiol Pharmacol. 2019 Aug;70(4). doi: 10.26402/jpp.2019.4.02. Epub 2019 Oct 19.
|
941 |
Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression.Cancer Lett. 2017 Aug 28;402:142-152. doi: 10.1016/j.canlet.2017.05.020. Epub 2017 May 31.
|
942 |
Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide.Eur J Cancer. 2017 Jan;71:15-24. doi: 10.1016/j.ejca.2016.10.035. Epub 2016 Dec 8.
|
943 |
The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2.Cell Death Dis. 2019 Jul 18;10(8):554. doi: 10.1038/s41419-019-1789-5.
|
944 |
A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance.PLoS One. 2011;6(8):e23302. doi: 10.1371/journal.pone.0023302. Epub 2011 Aug 4.
|
945 |
Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming.Int J Mol Sci. 2018 Jan 31;19(2):420. doi: 10.3390/ijms19020420.
|
946 |
MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.Int J Cancer. 2006 Dec 1;119(11):2597-602. doi: 10.1002/ijc.22210.
|
947 |
A quantitative trait locus influencing estrogen levels maps to a region homologous to human chromosome 20.Physiol Genomics. 2001 Mar 8;5(2):75-80. doi: 10.1152/physiolgenomics.2001.5.2.75.
|
948 |
Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression.Acta Biochim Pol. 2019 Dec 11;66(4):619-625. doi: 10.18388/abp.2019_2907.
|
949 |
MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis.Neoplasia. 2019 Oct;21(10):1015-1035. doi: 10.1016/j.neo.2019.07.011. Epub 2019 Aug 30.
|
950 |
A network-based approach to identify disease-associated gene modules through integrating DNA methylation and gene expression.Biochem Biophys Res Commun. 2015 Sep 25;465(3):437-42. doi: 10.1016/j.bbrc.2015.08.033. Epub 2015 Aug 14.
|
951 |
The clinical and prognostic significance of midkine in breast cancer patients.Tumour Biol. 2015 Dec;36(12):9789-94. doi: 10.1007/s13277-015-3710-x. Epub 2015 Jul 10.
|
952 |
Epigenetic regulation by Z-DNA silencer function controls cancer-associated ADAM-12 expression in breast cancer: cross-talk between MeCP2 and NF1 transcription factor family.Cancer Res. 2013 Jan 15;73(2):736-44. doi: 10.1158/0008-5472.CAN-12-2601. Epub 2012 Nov 7.
|
953 |
Reduction in milk fat globule-EGF factor 8 inhibits triple-negative breast cancer cell viability and migration.Oncol Lett. 2019 Mar;17(3):3457-3465. doi: 10.3892/ol.2019.9968. Epub 2019 Jan 25.
|
954 |
MGMT promoter methylation is a rare epigenetic change in malignant effusions.Cytopathology. 2020 Jan;31(1):12-15. doi: 10.1111/cyt.12782. Epub 2019 Dec 5.
|
955 |
Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.Cancer Res. 2003 Oct 15;63(20):6815-24.
|
956 |
Association of genetic polymorphisms in MIF with breast cancer risk in Chinese women.Clin Exp Med. 2017 Aug;17(3):395-401. doi: 10.1007/s10238-016-0439-9. Epub 2016 Nov 14.
|
957 |
Impact of chemotherapy on the expression of claudins and cadherins in invasive breast cancer.Exp Ther Med. 2019 Oct;18(4):3014-3024. doi: 10.3892/etm.2019.7930. Epub 2019 Aug 20.
|
958 |
Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer.Oncotarget. 2018 Feb 5;9(17):13501-13516. doi: 10.18632/oncotarget.24417. eCollection 2018 Mar 2.
|
959 |
MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines.J Biol Chem. 2007 Feb 16;282(7):4243-4252. doi: 10.1074/jbc.M607368200. Epub 2006 Nov 27.
|
960 |
False-positive cells in sentinel lymph nodes.Semin Diagn Pathol. 2008 May;25(2):116-9. doi: 10.1053/j.semdp.2008.03.001.
|
961 |
MMP11 expression in intratumoral inflammatory cells in breast cancer.Histopathology. 2019 Dec;75(6):916-930. doi: 10.1111/his.13956. Epub 2019 Oct 10.
|
962 |
circRNACER mediates malignant progression of breast cancer through targeting the miR?36/MMP13 axis.Mol Med Rep. 2019 Apr;19(4):3314-3320. doi: 10.3892/mmr.2019.9965. Epub 2019 Feb 18.
|
963 |
SNX27-retromer assembly recycles MT1-MMP to invadopodia and promotes breast cancer metastasis.J Cell Biol. 2020 Jan 6;219(1):e201812098. doi: 10.1083/jcb.201812098.
|
964 |
Investigating the regulation mechanism of baicalin on triple negative breast cancer's biological network by a systematic biological strategy.Biomed Pharmacother. 2019 Oct;118:109253. doi: 10.1016/j.biopha.2019.109253. Epub 2019 Aug 27.
|
965 |
MicroRNA-429 inhibits bone metastasis in breast cancer by regulating CrkL and MMP-9.Bone. 2020 Jan;130:115139. doi: 10.1016/j.bone.2019.115139. Epub 2019 Nov 6.
|
966 |
The RNA-binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth. FASEB J. 2016 Jan;30(1):149-59.
|
967 |
Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types.Oncotarget. 2015 Sep 29;6(29):28164-72. doi: 10.18632/oncotarget.4461.
|
968 |
Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer.Aging (Albany NY). 2019 Dec 4;11(23):10883-10901. doi: 10.18632/aging.102490. Epub 2019 Dec 4.
|
969 |
Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.Nat Commun. 2018 Nov 19;9(1):4848. doi: 10.1038/s41467-018-07058-4.
|
970 |
A case-control study of Metallothionein-1 expression in breast cancer and breast fibroadenoma.Sci Rep. 2019 May 15;9(1):7407. doi: 10.1038/s41598-019-43565-0.
|
971 |
Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study.Chronobiol Int. 2014 Dec;31(10):1115-22. doi: 10.3109/07420528.2014.957301. Epub 2014 Sep 17.
|
972 |
The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA-Mutant Breast Cancer Brain Metastases.Clin Cancer Res. 2019 Jun 1;25(11):3374-3383. doi: 10.1158/1078-0432.CCR-18-3049. Epub 2019 Feb 22.
|
973 |
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.Oncotarget. 2018 Apr 24;9(31):22158-22183. doi: 10.18632/oncotarget.25243. eCollection 2018 Apr 24.
|
974 |
Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.Cancer Res. 1993 Mar 15;53(6):1437-43.
|
975 |
Chemokine C-C motif ligand 18 expression correlates with tumor malignancy in breast cancer.Pathol Biol (Paris). 2015 Sep;63(4-5):199-203. doi: 10.1016/j.patbio.2015.07.001. Epub 2015 Aug 17.
|
976 |
MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells.Oncogene. 2019 Jun;38(26):5239-5249. doi: 10.1038/s41388-019-0789-3. Epub 2019 Apr 10.
|
977 |
MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.Gene. 2019 Jun 5;700:85-95. doi: 10.1016/j.gene.2019.02.066. Epub 2019 Mar 13.
|
978 |
Loss of MLCK leads to disruption of cell-cell adhesion and invasive behavior of breast epithelial cells via increased expression of EGFR and ERK/JNK signaling.Oncogene. 2016 Aug 25;35(34):4495-508. doi: 10.1038/onc.2015.508. Epub 2016 Feb 15.
|
979 |
FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression.Biochem Biophys Res Commun. 2019 Apr 2;511(2):398-403. doi: 10.1016/j.bbrc.2019.02.069. Epub 2019 Feb 21.
|
980 |
CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse.Sci Rep. 2019 Jun 19;9(1):8756. doi: 10.1038/s41598-019-45377-8.
|
981 |
Integration of fluorescence imaging and electrochemical biosensing for both qualitative location and quantitative detection of cancer cells.Biosens Bioelectron. 2019 Apr 1;130:132-138. doi: 10.1016/j.bios.2019.01.024. Epub 2019 Jan 18.
|
982 |
Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene.Carcinogenesis. 2001 Sep;22(9):1521-6. doi: 10.1093/carcin/22.9.1521.
|
983 |
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.Front Med (Lausanne). 2019 Sep 13;6:200. doi: 10.3389/fmed.2019.00200. eCollection 2019.
|
984 |
Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NFkappaB-dependent transcription.Nat Cell Biol. 2006 Oct;8(10):1171-7. doi: 10.1038/ncb1483. Epub 2006 Sep 24.
|
985 |
Vesicular trafficking-related proteins as the potential therapeutic target for breast cancer.Protoplasma. 2020 Mar;257(2):345-352. doi: 10.1007/s00709-019-01462-3. Epub 2019 Dec 11.
|
986 |
Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism.Oncogene. 2015 Mar 5;34(10):1220-30. doi: 10.1038/onc.2014.67. Epub 2014 Mar 24.
|
987 |
Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in Human Breast Cancer.Pathol Res Pract. 2018 Oct;214(10):1648-1654. doi: 10.1016/j.prp.2018.07.030. Epub 2018 Jul 27.
|
988 |
miR-376a inhibits breast cancer cell progression by targeting neuropilin-1 NR.Onco Targets Ther. 2018 Aug 30;11:5293-5302. doi: 10.2147/OTT.S173416. eCollection 2018.
|
989 |
The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).BMC Cancer. 2019 Feb 28;19(1):187. doi: 10.1186/s12885-019-5373-2.
|
990 |
Fabrication and characterization of solid lipid nano-formulation of astraxanthin against DMBA-induced breast cancer via Nrf-2-Keap1 and NF-kB and mTOR/Maf-1/PTEN pathway.Drug Deliv. 2019 Dec;26(1):975-988. doi: 10.1080/10717544.2019.1667454.
|
991 |
Selection of a breast cancer subpopulation-specific antibody using phage display on tissue sections.Immunol Res. 2015 Jul;62(3):263-72. doi: 10.1007/s12026-015-8657-x.
|
992 |
Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.Int J Cancer. 2020 May 1;146(9):2576-2587. doi: 10.1002/ijc.32690. Epub 2019 Oct 31.
|
993 |
Nkx3-1 and LEF-1 function as transcriptional inhibitors of estrogen receptor activity.Cancer Res. 2008 Sep 15;68(18):7380-5. doi: 10.1158/0008-5472.CAN-08-0133.
|
994 |
Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway.Oncotarget. 2017 May 30;8(22):36246-36265. doi: 10.18632/oncotarget.16121.
|
995 |
Transcription Levels of nicotinamide nucleotide transhydrogenase and Its Antisense in Breast Cancer Samples.Cell J. 2019 Oct;21(3):331-336. doi: 10.22074/cellj.2019.6238. Epub 2019 Jun 15.
|
996 |
MNK1/NODAL Signaling Promotes Invasive Progression of Breast Ductal Carcinoma In Situ.Cancer Res. 2019 Apr 1;79(7):1646-1657. doi: 10.1158/0008-5472.CAN-18-1602. Epub 2019 Jan 18.
|
997 |
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of Treatment.Mol Ther Nucleic Acids. 2017 Mar 17;6:249-258. doi: 10.1016/j.omtn.2016.12.010. Epub 2016 Dec 31.
|
998 |
Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer.Cell Death Differ. 2020 Apr;27(4):1341-1354. doi: 10.1038/s41418-019-0419-1. Epub 2019 Sep 17.
|
999 |
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry.Br J Cancer. 2019 Jul;121(2):157-171. doi: 10.1038/s41416-019-0501-y. Epub 2019 Jun 26.
|
1000 |
The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.Exp Cell Res. 2020 Jan 15;386(2):111743. doi: 10.1016/j.yexcr.2019.111743. Epub 2019 Nov 23.
|
1001 |
The PI3K/Akt/GSK-3/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility.Cancer Biol Med. 2019 Feb;16(1):38-54. doi: 10.20892/j.issn.2095-3941.2018.0253.
|
1002 |
BNP as a potential biomarker for cardiac damage of breast cancer after radiotherapy: a meta-analysis.Medicine (Baltimore). 2019 Jul;98(29):e16507. doi: 10.1097/MD.0000000000016507.
|
1003 |
Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.Cancer Res. 2006 Apr 1;66(7):3706-14. doi: 10.1158/0008-5472.CAN-05-2744.
|
1004 |
Identification of breast cancer candidate genes using gene co-expression and protein-protein interaction information.Oncotarget. 2016 Jun 14;7(24):36092-36100. doi: 10.18632/oncotarget.9132.
|
1005 |
Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.Mol Cancer Res. 2010 Apr;8(4):604-14. doi: 10.1158/1541-7786.MCR-09-0301. Epub 2010 Mar 23.
|
1006 |
WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.Br J Pharmacol. 2017 Sep;174(17):2941-2961. doi: 10.1111/bph.13929. Epub 2017 Aug 1.
|
1007 |
High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy.Breast Cancer Res. 2019 Nov 28;21(1):127. doi: 10.1186/s13058-019-1197-x.
|
1008 |
Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells.Cell Oncol (Dordr). 2018 Feb;41(1):13-24. doi: 10.1007/s13402-017-0353-5. Epub 2017 Oct 9.
|
1009 |
LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.Oncogene. 2018 Jun;37(24):3243-3259. doi: 10.1038/s41388-018-0193-4. Epub 2018 Mar 16.
|
1010 |
Mesenchymal stem cells drive paclitaxel resistance in ErbB2/ErbB3-coexpressing breast cancer cells via paracrine of neuregulin 1.Biochem Biophys Res Commun. 2018 Jun 18;501(1):212-219. doi: 10.1016/j.bbrc.2018.04.218. Epub 2018 May 4.
|
1011 |
RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.Biomed Pharmacother. 2019 Jun;114:108772. doi: 10.1016/j.biopha.2019.108772. Epub 2019 Mar 23.
|
1012 |
GLI1 regulates a novel neuropilin-2/61 integrin based autocrine pathway that contributes to breast cancer initiation.EMBO Mol Med. 2013 Apr;5(4):488-508. doi: 10.1002/emmm.201202078. Epub 2013 Feb 21.
|
1013 |
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.Breast Cancer Res Treat. 2017 Nov;166(2):593-601. doi: 10.1007/s10549-017-4428-9. Epub 2017 Aug 4.
|
1014 |
CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.J Clin Invest. 2020 Mar 2;130(3):1185-1198. doi: 10.1172/JCI128895.
|
1015 |
Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.Clin Cancer Res. 2011 Apr 1;17(7):1741-52. doi: 10.1158/1078-0432.CCR-10-1890. Epub 2011 Feb 24.
|
1016 |
Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.Theranostics. 2018 Oct 6;8(18):5126-5142. doi: 10.7150/thno.27221. eCollection 2018.
|
1017 |
Non-secretory breast carcinomas lack NTRK rearrangements and TRK protein expression.Pathol Int. 2019 Feb;69(2):94-96. doi: 10.1111/pin.12766. Epub 2019 Feb 1.
|
1018 |
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.Oncotarget. 2014 Sep 30;5(18):8235-51. doi: 10.18632/oncotarget.1632.
|
1019 |
Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.Int J Mol Med. 2019 Aug;44(2):390-404. doi: 10.3892/ijmm.2019.4239. Epub 2019 Jun 11.
|
1020 |
-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.Cell Death Dis. 2018 Jul 9;9(7):756. doi: 10.1038/s41419-018-0802-8.
|
1021 |
OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach.Proteomics. 2019 Nov;19(21-22):e1800446. doi: 10.1002/pmic.201800446. Epub 2019 Aug 8.
|
1022 |
Pro-oncogenic action of LOX-1 and its splice variant LOX-14 in breast cancer phenotypes.Cell Death Dis. 2019 Jan 18;10(2):53. doi: 10.1038/s41419-018-1279-1.
|
1023 |
-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.Tumour Biol. 2015 Jun;36(6):4655-60. doi: 10.1007/s13277-015-3113-z. Epub 2015 Jan 25.
|
1024 |
ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses.Cancers (Basel). 2019 Feb 11;11(2):208. doi: 10.3390/cancers11020208.
|
1025 |
miR-181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation.J Cell Biochem. 2020 Feb;121(2):1664-1674. doi: 10.1002/jcb.29401. Epub 2019 Nov 3.
|
1026 |
Involvement of the P2X7 receptor in the migration and metastasis of tamoxifen-resistant breast cancer: effects on small extracellular vesicles production.Sci Rep. 2019 Aug 12;9(1):11587. doi: 10.1038/s41598-019-47734-z.
|
1027 |
Altered purinergic receptor-Ca?signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.Mol Oncol. 2016 Jan;10(1):166-78. doi: 10.1016/j.molonc.2015.09.006. Epub 2015 Sep 25.
|
1028 |
An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells. Cancer Sci. 2011 Jul;102(7):1410-7. doi: 10.1111/j.1349-7006.2011.01948.x. Epub 2011 May 5.
|
1029 |
IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk.Breast Cancer Res Treat. 2006 Sep;99(1):1-7. doi: 10.1007/s10549-006-9174-3. Epub 2006 Jun 5.
|
1030 |
MiR-142-3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer.J Cell Physiol. 2020 May;235(5):4928-4940. doi: 10.1002/jcp.29372. Epub 2019 Oct 31.
|
1031 |
Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.BMJ Open. 2019 Jun 20;9(6):e028117. doi: 10.1136/bmjopen-2018-028117.
|
1032 |
Inducible expression of maize polyamine oxidase in the nucleus of MCF-7 human breast cancer cells confers sensitivity to etoposide.Amino Acids. 2008 Apr;34(3):403-12. doi: 10.1007/s00726-007-0558-4. Epub 2007 Jul 4.
|
1033 |
Oncogenic activity of poly (ADP-ribose) glycohydrolase.Oncogene. 2019 Mar;38(12):2177-2191. doi: 10.1038/s41388-018-0568-6. Epub 2018 Nov 20.
|
1034 |
PARP3, a new therapeutic target to alter Rictor/mTORC2 signaling and tumor progression in BRCA1-associated cancers.Cell Death Differ. 2019 Sep;26(9):1615-1630. doi: 10.1038/s41418-018-0233-1. Epub 2018 Nov 15.
|
1035 |
Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation.Anticancer Res. 2018 Sep;38(9):5013-5026. doi: 10.21873/anticanres.12820.
|
1036 |
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.J Cell Sci. 2005 Mar 15;118(Pt 6):1245-53. doi: 10.1242/jcs.01704. Epub 2005 Mar 1.
|
1037 |
Chaperonin Containing TCP-1 Protein Level in Breast Cancer Cells Predicts Therapeutic Application of a Cytotoxic Peptide.Clin Cancer Res. 2016 Sep 1;22(17):4366-79. doi: 10.1158/1078-0432.CCR-15-2502. Epub 2016 Mar 24.
|
1038 |
Combination Immunotherapy with Cytotoxic T-Lymphocyte-Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis.Mol Cancer Ther. 2020 Mar;19(3):802-811. doi: 10.1158/1535-7163.MCT-19-0495. Epub 2019 Dec 3.
|
1039 |
A microarray based expression profiling of paclitaxel and vincristine resistant MCF-7 cells.Eur J Pharmacol. 2011 Apr 25;657(1-3):4-9. doi: 10.1016/j.ejphar.2011.02.001. Epub 2011 Feb 18.
|
1040 |
Phase I and II study of exisulind in combination with capecitabine in patients with metastatic breast cancer.J Clin Oncol. 2003 Sep 15;21(18):3454-61. doi: 10.1200/JCO.2003.02.114.
|
1041 |
Epac1, PDE4, and PKC protein expression and their association with AKAP95, Cx43, and cyclinD2/E1 in breast cancer tissues.Thorac Cancer. 2017 Sep;8(5):495-500. doi: 10.1111/1759-7714.12475. Epub 2017 Jul 29.
|
1042 |
Systematic identification of regulatory variants associated with cancer risk.Genome Biol. 2017 Oct 23;18(1):194. doi: 10.1186/s13059-017-1322-z.
|
1043 |
Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer.Clin Cancer Res. 2018 Apr 15;24(8):1987-2001. doi: 10.1158/1078-0432.CCR-17-2776. Epub 2018 Jan 31.
|
1044 |
Phosphodiesterase 5 (PDE5) Is Highly Expressed in Cancer-Associated Fibroblasts and Enhances Breast Tumor Progression.Cancers (Basel). 2019 Nov 6;11(11):1740. doi: 10.3390/cancers11111740.
|
1045 |
FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.Oncotarget. 2015 May 10;6(13):11281-94. doi: 10.18632/oncotarget.3596.
|
1046 |
Platelet-derived growth factor-D promotes colorectal cancer cell migration, invasion and proliferation by regulating Notch1 and matrix metalloproteinase-9.Oncol Lett. 2018 Feb;15(2):1573-1579. doi: 10.3892/ol.2017.7510. Epub 2017 Dec 5.
|
1047 |
An oncogenic activity of PDGF-C and its splice variant in human breast cancer.Growth Factors. 2019 Aug;37(3-4):131-145. doi: 10.1080/08977194.2019.1662415. Epub 2019 Sep 23.
|
1048 |
Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-B/c-Myc pathway.Biochem Pharmacol. 2019 Mar;161:149-162. doi: 10.1016/j.bcp.2019.01.016. Epub 2019 Jan 24.
|
1049 |
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation.Cancers (Basel). 2019 Oct 31;11(11):1695. doi: 10.3390/cancers11111695.
|
1050 |
Downregulation of pancreatic-duodenal homeobox 1 expression in breast cancer patients: a mechanism of proliferation and apoptosis in cancer.Mol Med Rep. 2012 Nov;6(5):983-8. doi: 10.3892/mmr.2012.1067. Epub 2012 Sep 5.
|
1051 |
A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials.Oncotarget. 2015 Oct 13;6(31):31693-701. doi: 10.18632/oncotarget.5562.
|
1052 |
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.Nat Genet. 2015 Apr;47(4):373-80. doi: 10.1038/ng.3242. Epub 2015 Mar 9.
|
1053 |
RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.Oncotarget. 2015 Nov 17;6(36):39050-61. doi: 10.18632/oncotarget.5176.
|
1054 |
Overall survival in women with breast cancer: the influence of pepsinogen C gene polymorphism.DNA Cell Biol. 2008 Jun;27(6):333-6. doi: 10.1089/dna.2007.0713.
|
1055 |
Inhibiting 6-phosphogluconate dehydrogenase selectively targets breast cancer through AMPK activation.Clin Transl Oncol. 2018 Sep;20(9):1145-1152. doi: 10.1007/s12094-018-1833-4. Epub 2018 Jan 16.
|
1056 |
Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.J Biol Chem. 2003 Aug 8;278(32):29420-34. doi: 10.1074/jbc.M301885200. Epub 2003 May 14.
|
1057 |
Targeting PML in triple negative breast cancer elicits growth suppression and senescence.Cell Death Differ. 2020 Apr;27(4):1186-1199. doi: 10.1038/s41418-019-0407-5. Epub 2019 Oct 1.
|
1058 |
Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer.Oncol Lett. 2018 Apr;15(4):5236-5242. doi: 10.3892/ol.2018.7915. Epub 2018 Jan 31.
|
1059 |
Detection and Differentiation of Breast Cancer Sub-Types using a cPLA2 Activatable Fluorophore.Sci Rep. 2019 Apr 16;9(1):6122. doi: 10.1038/s41598-019-41626-y.
|
1060 |
Prognostic significance of PLA2G4C gene polymorphism in patients with stage II colorectal cancer.Acta Oncol. 2016;55(4):474-9. doi: 10.3109/0284186X.2015.1073350. Epub 2015 Sep 12.
|
1061 |
PLAC1 as a serum biomarker for breast cancer.PLoS One. 2018 Feb 12;13(2):e0192106. doi: 10.1371/journal.pone.0192106. eCollection 2018.
|
1062 |
Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.Gene. 2019 Apr 20;693:61-68. doi: 10.1016/j.gene.2018.12.072. Epub 2019 Jan 11.
|
1063 |
Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.Cancer Res. 2013 Apr 1;73(7):2070-81. doi: 10.1158/0008-5472.CAN-12-3526. Epub 2013 Feb 11.
|
1064 |
Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.Mol Cell. 2018 Oct 18;72(2):328-340.e8. doi: 10.1016/j.molcel.2018.08.038. Epub 2018 Oct 4.
|
1065 |
A feedback mechanism between PLD and deadenylase PARN for the shortening of eukaryotic poly(A) mRNA tails that is deregulated in cancer cells.Biol Open. 2017 Feb 15;6(2):176-186. doi: 10.1242/bio.021261.
|
1066 |
Co-Delivery of Paclitaxel and PLK1-Targeted siRNA Using Aptamer-Functionalized Cationic Liposome for Synergistic Anti-Breast Cancer Effects In Vivo.J Biomed Nanotechnol. 2019 Jun 1;15(6):1135-1148. doi: 10.1166/jbn.2019.2751.
|
1067 |
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.Nat Commun. 2018 Oct 16;9(1):4181. doi: 10.1038/s41467-018-06616-0.
|
1068 |
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defect.Cell Death Dis. 2018 Oct 18;9(11):1066. doi: 10.1038/s41419-018-1071-2.
|
1069 |
DT-13 suppresses breast cancer metastasis by modulating PLOD2 in the adipocytes microenvironment.Phytomedicine. 2019 Jun;59:152778. doi: 10.1016/j.phymed.2018.12.001. Epub 2018 Dec 2.
|
1070 |
Opposing roles of Nfkb2 gene products p100 and p52 in the regulation of breast cancer stem cells. Breast Cancer Res Treat. 2017 Apr;162(3):465-477. doi: 10.1007/s10549-017-4149-0. Epub 2017 Feb 11.
|
1071 |
Evolutionary recombination hotspot around GSDML-GSDM locus is closely linked to the oncogenomic recombination hotspot around the PPP1R1B-ERBB2-GRB7 amplicon.Int J Oncol. 2004 Apr;24(4):757-63.
|
1072 |
A variant in the cytochrome p450 oxidoreductase gene is associated with breast cancer risk in African Americans.Cancer Res. 2007 Apr 15;67(8):3565-8. doi: 10.1158/0008-5472.CAN-06-4801.
|
1073 |
WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor -Mediated Signaling in Human Breast Cancer Cells.Int J Mol Sci. 2019 Nov 25;20(23):5928. doi: 10.3390/ijms20235928.
|
1074 |
Ligand-activated interaction of PPAR with c-Myc governs the tumorigenicity of breast cancer.Int J Cancer. 2018 Dec 1;143(11):2985-2996. doi: 10.1002/ijc.31864. Epub 2018 Oct 4.
|
1075 |
PGC-1 cooperating with FOXA2 inhibits proliferation and migration of breast cancer cells.Cancer Cell Int. 2019 Apr 11;19:93. doi: 10.1186/s12935-019-0810-5. eCollection 2019.
|
1076 |
Single-Cell Transcriptome Analysis Reveals Estrogen Signaling Coordinately Augments One-Carbon, Polyamine, and Purine Synthesis in Breast Cancer.Cell Rep. 2018 Nov 20;25(8):2285-2298.e4. doi: 10.1016/j.celrep.2018.10.093.
|
1077 |
Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells.J Mol Endocrinol. 2010 Jun;44(6):319-29. doi: 10.1677/JME-09-0140. Epub 2010 Mar 17.
|
1078 |
The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.BMC Cancer. 2007 May 19;7:85. doi: 10.1186/1471-2407-7-85.
|
1079 |
Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.Oncotarget. 2017 Jul 25;8(30):48807-48819. doi: 10.18632/oncotarget.16178.
|
1080 |
Knockdown of protein phosphatase 5 (PPP5C) suppresses the growth of leukemic cell line U937.Cell Mol Biol (Noisy-le-grand). 2016 Sep 30;62(11):27-31.
|
1081 |
The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential.Clin Exp Metastasis. 2005;22(8):621-8. doi: 10.1007/s10585-006-9001-6. Epub 2006 Apr 27.
|
1082 |
Inhibition of Thioredoxin Reductase by Targeted Selenopolymeric Nanocarriers Synergizes the Therapeutic Efficacy of Doxorubicin in MCF7 Human Breast Cancer Cells.ACS Appl Mater Interfaces. 2017 Oct 25;9(42):36493-36512. doi: 10.1021/acsami.7b07056. Epub 2017 Oct 10.
|
1083 |
Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.Am J Pathol. 2009 Mar;174(3):746-61. doi: 10.2353/ajpath.2009.080658.
|
1084 |
PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling.Oncogene. 2015 Apr 16;34(16):2061-71. doi: 10.1038/onc.2014.153. Epub 2014 Jun 9.
|
1085 |
High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival.Mol Genet Genomic Med. 2019 Nov;7(11):e908. doi: 10.1002/mgg3.908. Epub 2019 Sep 12.
|
1086 |
Concomitant Expression of Prolactin Receptor and TGF Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome.Int J Mol Sci. 2019 Apr 2;20(7):1640. doi: 10.3390/ijms20071640.
|
1087 |
The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer.Oncogene. 2019 May;38(21):4015-4027. doi: 10.1038/s41388-019-0694-9. Epub 2019 Jan 28.
|
1088 |
Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers.Cancer Med. 2019 May;8(5):2414-2428. doi: 10.1002/cam4.2114. Epub 2019 Apr 8.
|
1089 |
Examining Product Specificity in Protein Arginine Methyltransferase 7 (PRMT7) Using Quantum and Molecular Mechanical Simulations.J Chem Inf Model. 2019 Jun 24;59(6):2913-2923. doi: 10.1021/acs.jcim.9b00137. Epub 2019 May 7.
|
1090 |
Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.JCI Insight. 2019 Feb 26;5(6):e124092. doi: 10.1172/jci.insight.124092.
|
1091 |
Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.Exp Cell Res. 2010 Feb 1;316(3):314-28. doi: 10.1016/j.yexcr.2009.10.024. Epub 2009 Nov 3.
|
1092 |
Seeking for Correlative Genes and Signaling Pathways With Bone Metastasis From Breast Cancer by Integrated Analysis.Front Oncol. 2019 Mar 13;9:138. doi: 10.3389/fonc.2019.00138. eCollection 2019.
|
1093 |
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.Oncotarget. 2017 Apr 29;8(33):54592-54603. doi: 10.18632/oncotarget.17523. eCollection 2017 Aug 15.
|
1094 |
A comparative characterization of estrogens used in hormone therapy via estrogen receptor (ER)- and -.J Steroid Biochem Mol Biol. 2017 Nov;174:27-39. doi: 10.1016/j.jsbmb.2017.07.022. Epub 2017 Jul 22.
|
1095 |
PSMB5 plays a dual role in cancer development and immunosuppression.Am J Cancer Res. 2017 Nov 1;7(11):2103-2120. eCollection 2017.
|
1096 |
PSMB7 is associated with anthracycline resistance and is a prognostic biomarker in breast cancer.Br J Cancer. 2010 Jan 19;102(2):361-8. doi: 10.1038/sj.bjc.6605478. Epub 2009 Dec 15.
|
1097 |
Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets.Funct Integr Genomics. 2019 Jul;19(4):645-658. doi: 10.1007/s10142-019-00670-7. Epub 2019 Mar 12.
|
1098 |
PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.J Cell Physiol. 2018 Nov;233(11):8930-8939. doi: 10.1002/jcp.26823. Epub 2018 Jun 1.
|
1099 |
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.BMC Cancer. 2018 Apr 16;18(1):431. doi: 10.1186/s12885-018-4286-9.
|
1100 |
Cigarette Smoke Regulates Calcium-Independent Phospholipase A(2) Metabolic Pathways in Breast Cancer.Am J Pathol. 2017 Aug;187(8):1855-1866. doi: 10.1016/j.ajpath.2017.04.003. Epub 2017 Jun 12.
|
1101 |
11-Prostaglandin F2, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer.Mol Cell Endocrinol. 2015 Sep 15;413:236-47. doi: 10.1016/j.mce.2015.07.008. Epub 2015 Jul 10.
|
1102 |
The SuprMam1 breast cancer susceptibility locus disrupts the vitamin D/ calcium/ parathyroid hormone pathway and alters bone structure in congenic mice.J Steroid Biochem Mol Biol. 2019 Apr;188:48-58. doi: 10.1016/j.jsbmb.2018.12.004. Epub 2018 Dec 7.
|
1103 |
Fluid flow-induced activation of subcellular AMPK and its interaction with FAK and Src.Arch Biochem Biophys. 2020 Jan 15;679:108208. doi: 10.1016/j.abb.2019.108208. Epub 2019 Nov 21.
|
1104 |
PYK2 promotes HER2-positive breast cancer invasion.J Exp Clin Cancer Res. 2019 May 22;38(1):210. doi: 10.1186/s13046-019-1221-0.
|
1105 |
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells.BMC Cancer. 2019 Jan 16;19(1):78. doi: 10.1186/s12885-018-5186-8.
|
1106 |
miR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer.Biomed Pharmacother. 2016 Apr;79:247-53. doi: 10.1016/j.biopha.2016.02.014. Epub 2016 Mar 11.
|
1107 |
Prospective validation in epithelial tumors of a gene expression predictor of liver metastasis derived from uveal melanoma.Sci Rep. 2019 Nov 20;9(1):17178. doi: 10.1038/s41598-019-52841-y.
|
1108 |
The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.Sci Signal. 2015 Feb 17;8(364):ra18. doi: 10.1126/scisignal.2005547.
|
1109 |
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.J Cancer Res Clin Oncol. 2019 Jul;145(7):1845-1856. doi: 10.1007/s00432-019-02918-y. Epub 2019 Apr 25.
|
1110 |
The presence of Y674/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma.Hum Pathol. 2019 Apr;86:182-192. doi: 10.1016/j.humpath.2018.12.003. Epub 2018 Dec 27.
|
1111 |
Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer.Clin Transl Oncol. 2019 Apr;21(4):433-442. doi: 10.1007/s12094-018-1941-1. Epub 2018 Sep 14.
|
1112 |
Clinical significance of the immune cell landscape in hepatocellular carcinoma patients with different degrees of fibrosis.Ann Transl Med. 2019 Oct;7(20):528. doi: 10.21037/atm.2019.09.122.
|
1113 |
Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.Mod Pathol. 1999 Dec;12(12):1083-9.
|
1114 |
Granular cell tumor in breast: a case report.Breast Cancer (Dove Med Press). 2017 Apr 11;9:245-248. doi: 10.2147/BCTT.S131446. eCollection 2017.
|
1115 |
Regulation of RAB22A by mir-193b inhibits breast cancer growth and metastasis mediated by exosomes.Int J Oncol. 2018 Dec;53(6):2705-2714. doi: 10.3892/ijo.2018.4571. Epub 2018 Sep 25.
|
1116 |
Expression of the RAC1, RHOA and CXCR4 proteins and their interaction as risk factors for infiltration to the nipple areola complex in operable breast carcinoma.Breast Cancer. 2019 Mar;26(2):172-179. doi: 10.1007/s12282-018-0907-z. Epub 2018 Sep 12.
|
1117 |
Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation.J Cell Biol. 2017 Dec 4;216(12):4331-4349. doi: 10.1083/jcb.201704048. Epub 2017 Oct 23.
|
1118 |
RACK1 stabilises the activity of PP2A to regulate the transformed phenotype in mammary epithelial cells.Cell Signal. 2017 Jul;35:290-300. doi: 10.1016/j.cellsig.2016.09.001. Epub 2016 Sep 4.
|
1119 |
Nuclear localized Raf1 isoform alters DNA-dependent protein kinase activity and the DNA damage response.FASEB J. 2019 Jan;33(1):1138-1150. doi: 10.1096/fj.201800336R. Epub 2018 Aug 14.
|
1120 |
Therapeutic potential of Bcl-x(L)/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment.Oncol Lett. 2018 May;15(5):7231-7236. doi: 10.3892/ol.2018.8258. Epub 2018 Mar 14.
|
1121 |
RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.Cancer Res. 2010 Feb 1;70(3):1265-74. doi: 10.1158/0008-5472.CAN-09-2674. Epub 2010 Jan 26.
|
1122 |
miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.Mol Diagn Ther. 2016 Apr;20(2):97-110. doi: 10.1007/s40291-016-0186-3.
|
1123 |
Circulating renin-angiotensin system-regulating specific aminopeptidase activities in pre- and post- menopausal women with breast cancer treated or not with neoadyuvant chemotherapy. A two years follow up study.Breast. 2019 Feb;43:28-30. doi: 10.1016/j.breast.2018.10.010. Epub 2018 Nov 1.
|
1124 |
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.Eur J Cancer. 2016 Dec;69:127-134. doi: 10.1016/j.ejca.2016.10.006. Epub 2016 Nov 4.
|
1125 |
Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer.BMC Cancer. 2019 Jan 8;19(1):41. doi: 10.1186/s12885-018-5262-0.
|
1126 |
Potential prognostic value of repulsive guidance molecules in breast cancer.Anticancer Res. 2011 May;31(5):1703-11.
|
1127 |
Downregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of no special type: Clinicopathological associations and prognostic relevance.Oncol Lett. 2018 Jan;15(1):213-220. doi: 10.3892/ol.2017.7351. Epub 2017 Nov 3.
|
1128 |
Growth inhibition of human breast carcinoma cells by overexpression of regulator of G-protein signaling 4.Oncol Lett. 2017 Jun;13(6):4357-4363. doi: 10.3892/ol.2017.6009. Epub 2017 Apr 7.
|
1129 |
High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):397-407. doi: 10.1158/1055-9965.EPI-10-0514. Epub 2010 Dec 6.
|
1130 |
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.Curr Cancer Drug Targets. 2008 Aug;8(5):404-13. doi: 10.2174/156800908785133141.
|
1131 |
DLC2 operates as a tumor suppressor gene in breast cancer via the RhoGTPase pathway.Oncol Lett. 2019 Feb;17(2):2107-2116. doi: 10.3892/ol.2018.9874. Epub 2018 Dec 28.
|
1132 |
Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha.Oncotarget. 2017 Mar 21;8(12):20103-20112. doi: 10.18632/oncotarget.15384.
|
1133 |
Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells. Open Biol. 2019 Apr 26;9(4):190052.
|
1134 |
MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer.Oncol Res. 2020 Feb 7;28(1):13-19. doi: 10.3727/096504019X15519249902838. Epub 2019 Apr 8.
|
1135 |
ROCK isoforms differentially modulate cancer cell motility by mechanosensing the substrate stiffness.Acta Biomater. 2019 Apr 1;88:86-101. doi: 10.1016/j.actbio.2019.02.015. Epub 2019 Feb 13.
|
1136 |
Immobilization of HIV-1 TAT peptide on gold nanoparticles: A feasible approach for siRNA delivery.J Cell Physiol. 2020 Mar;235(3):2049-2059. doi: 10.1002/jcp.29105. Epub 2019 Jul 31.
|
1137 |
Ror2 Signaling and Its Relevance in Breast Cancer Progression.Front Oncol. 2017 Jun 26;7:135. doi: 10.3389/fonc.2017.00135. eCollection 2017.
|
1138 |
Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.Tumour Biol. 2016 Oct;37(10):13721-13731. doi: 10.1007/s13277-016-5266-9. Epub 2016 Jul 30.
|
1139 |
RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.Int J Mol Sci. 2019 Apr 23;20(8):1994. doi: 10.3390/ijms20081994.
|
1140 |
Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER(+) breast cancer.Nat Cell Biol. 2018 Aug;20(8):990. doi: 10.1038/s41556-018-0052-0.
|
1141 |
RSK4 inhibits breast cancer cell proliferation and invasion invitro, and is correlated with estrogen receptor upregulation in breast cancer.Oncol Rep. 2019 Dec;42(6):2777-2787. doi: 10.3892/or.2019.7328. Epub 2019 Sep 20.
|
1142 |
CircZNF609 promotes breast cancer cell growth, migration, and invasion by elevating p70S6K1 via sponging miR-145-5p.Cancer Manag Res. 2018 Sep 25;10:3881-3890. doi: 10.2147/CMAR.S174778. eCollection 2018.
|
1143 |
Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer.J Cell Physiol. 2020 Apr;235(4):3372-3381. doi: 10.1002/jcp.29225. Epub 2019 Oct 17.
|
1144 |
R-spondin3 Is Associated with Basal-Progenitor Behavior in Normal and Tumor Mammary Cells.Cancer Res. 2018 Aug 15;78(16):4497-4511. doi: 10.1158/0008-5472.CAN-17-2676. Epub 2018 May 10.
|
1145 |
RUNX1-dependent mechanisms in biological control and dysregulation in cancer.J Cell Physiol. 2019 Jun;234(6):8597-8609. doi: 10.1002/jcp.27841. Epub 2018 Dec 4.
|
1146 |
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.Br J Cancer. 2019 Oct;121(9):776-785. doi: 10.1038/s41416-019-0589-0. Epub 2019 Sep 27.
|
1147 |
Comparison of a calcitonin gene-related peptide receptor in a human neuroblastoma cell line (SK-N-MC) and a calcitonin receptor in a human breast carcinoma cell line (T47D).Ann N Y Acad Sci. 1992 Jun 30;657:106-16. doi: 10.1111/j.1749-6632.1992.tb22760.x.
|
1148 |
Effects of Platycodin D on S100A8/A9-induced inflammatory response in murine mammary carcinoma 4T1 cells.Int Immunopharmacol. 2019 Feb;67:239-247. doi: 10.1016/j.intimp.2018.12.008. Epub 2018 Dec 15.
|
1149 |
Promoter hypermethylation of RAR2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2018 Dec;97(51):e13666. doi: 10.1097/MD.0000000000013666.
|
1150 |
S100B expression in breast cancer as a predictive marker for cancer metastasis.Int J Oncol. 2018 Feb;52(2):433-440. doi: 10.3892/ijo.2017.4226. Epub 2017 Dec 12.
|
1151 |
Effects of S1P1 and S1P3 in ER(+) and ER(-) Breast Cancer Cells.Anticancer Res. 2017 Oct;37(10):5469-5475. doi: 10.21873/anticanres.11976.
|
1152 |
Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5.Oncotarget. 2018 May 11;9(36):24364-24380. doi: 10.18632/oncotarget.25273. eCollection 2018 May 11.
|
1153 |
Human mammaglobin in breast cancer: a brief review of its clinical utility.Indian J Med Res. 2014 May;139(5):675-85.
|
1154 |
Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.Anticancer Res. 2008 May-Jun;28(3A):1493-8.
|
1155 |
4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway.Biochem Biophys Res Commun. 2018 Oct 12;504(4):812-819. doi: 10.1016/j.bbrc.2018.08.043. Epub 2018 Sep 11.
|
1156 |
Sodium Channel Na(v)1.5 Controls Epithelial-to-Mesenchymal Transition and Invasiveness in Breast Cancer Cells Through its Regulation by the Salt-Inducible Kinase-1.Sci Rep. 2019 Dec 9;9(1):18652. doi: 10.1038/s41598-019-55197-5.
|
1157 |
Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.Mol Cancer. 2015 Jan 27;14(1):15. doi: 10.1186/s12943-014-0279-8.
|
1158 |
A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer.Biochim Biophys Acta Gen Subj. 2018 Sep;1862(9):2069-2080. doi: 10.1016/j.bbagen.2018.05.013. Epub 2018 May 17.
|
1159 |
Expression of septin 2 and association with clinicopathological parameters in colorectal cancer.Oncol Lett. 2019 Sep;18(3):2376-2383. doi: 10.3892/ol.2019.10528. Epub 2019 Jun 26.
|
1160 |
Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells.Int J Oncol. 2019 Jul;55(1):116-130. doi: 10.3892/ijo.2019.4796. Epub 2019 May 6.
|
1161 |
Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene Network.Cancer Res. 2015 Apr 15;75(8):1580-91. doi: 10.1158/0008-5472.CAN-14-1027. Epub 2015 Mar 5.
|
1162 |
SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.Oncotarget. 2017 Oct 6;8(55):94080-94090. doi: 10.18632/oncotarget.21583. eCollection 2017 Nov 7.
|
1163 |
Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy.Lab Invest. 1999 Apr;79(4):439-47.
|
1164 |
The clinical utility of circulating tumor cells in breast cancer patients: detection by a quantitative assay of h-MAM gene expression.Int J Biol Markers. 2014 Sep 30;29(3):e268-78. doi: 10.5301/jbm.5000065.
|
1165 |
First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells.PLoS One. 2018 May 2;13(5):e0196854. doi: 10.1371/journal.pone.0196854. eCollection 2018.
|
1166 |
SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.Gene. 2016 Aug 1;587(1):91-7. doi: 10.1016/j.gene.2016.04.046. Epub 2016 Apr 26.
|
1167 |
LOC101930370/MiR-1471 Axis Modulates the Hedgehog Signaling Pathway in Breast Cancer.Cell Physiol Biochem. 2018;48(3):1139-1150. doi: 10.1159/000491980. Epub 2018 Jul 24.
|
1168 |
The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca(2+) homeostasis.Oncogene. 2017 Jun 22;36(25):3640-3647. doi: 10.1038/onc.2016.501. Epub 2017 Jan 23.
|
1169 |
Tumor suppression by LKB1: SIK-ness prevents metastasis.Sci Signal. 2009 Sep 1;2(86):pe55. doi: 10.1126/scisignal.286pe55.
|
1170 |
SIK2 attenuates proliferation and survival of breast cancer cells with simultaneous perturbation of MAPK and PI3K/Akt pathways.Oncotarget. 2018 Apr 24;9(31):21876-21892. doi: 10.18632/oncotarget.25082. eCollection 2018 Apr 24.
|
1171 |
Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients.Clin Cancer Res. 2010 Sep 15;16(18):4625-35. doi: 10.1158/1078-0432.CCR-10-0349. Epub 2010 Aug 12.
|
1172 |
Small-Molecule Screen Identifies De Novo Nucleotide Synthesis as a Vulnerability of Cells Lacking SIRT3.Cell Rep. 2018 Feb 20;22(8):1945-1955. doi: 10.1016/j.celrep.2018.01.076.
|
1173 |
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):26625-26632. doi: 10.1073/pnas.1911954116. Epub 2019 Dec 16.
|
1174 |
EP300 and SIRT1/6 Co-Regulate Lapatinib Sensitivity Via Modulating FOXO3-Acetylation and Activity in Breast Cancer.Cancers (Basel). 2019 Jul 28;11(8):1067. doi: 10.3390/cancers11081067.
|
1175 |
SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination.J Exp Clin Cancer Res. 2019 Feb 13;38(1):76. doi: 10.1186/s13046-019-1069-3.
|
1176 |
Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.Anticancer Res. 2010 Mar;30(3):759-65.
|
1177 |
IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.J Cell Physiol. 2007 Mar;210(3):626-36. doi: 10.1002/jcp.20859.
|
1178 |
Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study.Nutr Cancer. 2020;72(4):627-634. doi: 10.1080/01635581.2019.1650942. Epub 2019 Sep 9.
|
1179 |
Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters.Bioconjug Chem. 2003 Mar-Apr;14(2):404-11. doi: 10.1021/bc0340013.
|
1180 |
Hypoxia induced upregulation and function of the thiamine transporter, SLC19A3 in a breast cancer cell line.Cancer Biol Ther. 2010 Dec 1;10(11):1101-11. doi: 10.4161/cbt.10.11.13444. Epub 2010 Dec 1.
|
1181 |
Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways.BMC Cancer. 2018 Jun 26;18(1):689. doi: 10.1186/s12885-018-4599-8.
|
1182 |
ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.Oncogene. 2008 Feb 14;27(8):1045-54. doi: 10.1038/sj.onc.1210727. Epub 2007 Aug 13.
|
1183 |
Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.World J Surg. 2016 Jul;40(7):1600-10. doi: 10.1007/s00268-015-3263-6.
|
1184 |
Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells.Int J Mol Sci. 2018 Nov 1;19(11):3434. doi: 10.3390/ijms19113434.
|
1185 |
GLUT12 and adipose tissue: Expression, regulation and its relation with obesity in mice.Acta Physiol (Oxf). 2019 Aug;226(4):e13283. doi: 10.1111/apha.13283. Epub 2019 May 11.
|
1186 |
Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.PLoS One. 2018 Feb 7;13(2):e0191270. doi: 10.1371/journal.pone.0191270. eCollection 2018.
|
1187 |
17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.Cancer Res. 2000 Oct 1;60(19):5371-5.
|
1188 |
Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer.Mol Med. 2009 May-Jun;15(5-6):160-5. doi: 10.2119/molmed.2008.00136. Epub 2009 Mar 6.
|
1189 |
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.Proc Natl Acad Sci U S A. 2019 Jun 18;116(25):12452-12461. doi: 10.1073/pnas.1818521116. Epub 2019 May 31.
|
1190 |
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.Mol Cancer Res. 2003 Sep;1(11):826-35.
|
1191 |
Zinc Transporters and the Progression of Breast Cancers.Biol Pharm Bull. 2018;41(10):1517-1522. doi: 10.1248/bpb.b18-00086.
|
1192 |
Tumor expression of environmental chemical-responsive genes and breast cancer mortality.Endocr Relat Cancer. 2019 Dec;26(12):843-851. doi: 10.1530/ERC-19-0357.
|
1193 |
SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity.Mol Oncol. 2019 Sep;13(9):1874-1886. doi: 10.1002/1878-0261.12530. Epub 2019 Jun 14.
|
1194 |
Mannose glycosylation is an integral step for NIS localization and function in human breast cancer cells.J Cell Sci. 2019 Oct 23;132(20):jcs232058. doi: 10.1242/jcs.232058.
|
1195 |
SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.J Biol Chem. 2011 Sep 9;286(36):31830-8. doi: 10.1074/jbc.M111.229518. Epub 2011 Jul 19.
|
1196 |
Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene.Br J Anaesth. 2011 Dec;107(6):916-23. doi: 10.1093/bja/aer259. Epub 2011 Aug 19.
|
1197 |
MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.FEBS Lett. 2011 May 6;585(9):1363-7. doi: 10.1016/j.febslet.2011.04.018. Epub 2011 Apr 14.
|
1198 |
LLGL2 rescues nutrient stress by promoting leucine uptake in ER(+) breast cancer.Nature. 2019 May;569(7755):275-279. doi: 10.1038/s41586-019-1126-2. Epub 2019 Apr 17.
|
1199 |
Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo.BMC Cancer. 2019 Mar 8;19(1):211. doi: 10.1186/s12885-019-5397-7.
|
1200 |
Effect of Carbon-Ion Radiation on Drug Transporters Organic Anion Transporting Polypeptides in Breast Cancer Cells.Radiat Res. 2017 Jun;187(6):689-700. doi: 10.1667/RR14603.1. Epub 2017 Apr 7.
|
1201 |
Organic aniontransporting polypeptides contribute to the uptake of curcumin and its main metabolites by human breast cancer cells: Impact on antitumor activity.Oncol Rep. 2019 Apr;41(4):2558-2566. doi: 10.3892/or.2019.7011. Epub 2019 Feb 14.
|
1202 |
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.Cancer Chemother Pharmacol. 2017 Jun;79(6):1179-1186. doi: 10.1007/s00280-017-3314-9. Epub 2017 Apr 26.
|
1203 |
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.Breast Cancer Res Treat. 2011 Jan;125(2):563-9. doi: 10.1007/s10549-010-1046-1. Epub 2010 Jul 16.
|
1204 |
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissue.Cancer Biol Ther. 2011 Mar 15;11(6):584-91. doi: 10.4161/cbt.11.6.14533. Epub 2011 Mar 15.
|
1205 |
Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells.J Pharmacol Exp Ther. 2012 Aug;342(2):510-9. doi: 10.1124/jpet.112.192344. Epub 2012 May 15.
|
1206 |
The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.Oncogene. 2009 Aug 6;28(31):2839-48. doi: 10.1038/onc.2009.146. Epub 2009 Jun 15.
|
1207 |
SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.Nucleic Acids Res. 2019 Feb 20;47(3):1278-1293. doi: 10.1093/nar/gky1221.
|
1208 |
Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model.Sci Rep. 2016 Apr 26;6:24968. doi: 10.1038/srep24968.
|
1209 |
SETDB1 regulates SMAD7 expression for breast cancer metastasis.BMB Rep. 2019 Feb;52(2):139-144. doi: 10.5483/BMBRep.2019.52.2.235.
|
1210 |
Brahma related gene 1 (BRG1) regulates breast cancer cell migration and invasion by activating MUC1 transcription.Biochem Biophys Res Commun. 2019 Apr 9;511(3):536-543. doi: 10.1016/j.bbrc.2019.02.088. Epub 2019 Feb 26.
|
1211 |
Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin. Biochim Biophys Acta. 2009 Nov-Dec;1789(11-12):681-90. doi: 10.1016/j.bbagrm.2009.08.006. Epub 2009 Aug 19.
|
1212 |
Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.Oncol Lett. 2019 Apr;17(4):3851-3861. doi: 10.3892/ol.2019.10054. Epub 2019 Feb 19.
|
1213 |
Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype study.Gene. 2020 Feb 20;728:144281. doi: 10.1016/j.gene.2019.144281. Epub 2019 Dec 10.
|
1214 |
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model.BMC Cancer. 2018 Jun 19;18(1):669. doi: 10.1186/s12885-018-4412-8.
|
1215 |
circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis.Cell Death Dis. 2019 Feb 20;10(3):175. doi: 10.1038/s41419-019-1382-y.
|
1216 |
Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.JCI Insight. 2019 Apr 9;5(9):e125543. doi: 10.1172/jci.insight.125543.
|
1217 |
SOX5 promotes breast cancer proliferation and invasion by transactivation of EZH2.Oncol Lett. 2019 Mar;17(3):2754-2762. doi: 10.3892/ol.2019.9914. Epub 2019 Jan 9.
|
1218 |
A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.Clin Breast Cancer. 2019 Jun;19(3):e415-e421. doi: 10.1016/j.clbc.2018.11.006. Epub 2018 Nov 14.
|
1219 |
Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women.Mol Biol Rep. 2018 Dec;45(6):2313-2324. doi: 10.1007/s11033-018-4394-2. Epub 2018 Sep 27.
|
1220 |
Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer.J Enzyme Inhib Med Chem. 2020 Dec;35(1):172-186. doi: 10.1080/14756366.2019.1692828.
|
1221 |
Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy.Br J Cancer. 2014 Jan 7;110(1):146-55. doi: 10.1038/bjc.2013.526. Epub 2013 Nov 26.
|
1222 |
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.J Hematol Oncol. 2017 Jan 19;10(1):23. doi: 10.1186/s13045-017-0399-x.
|
1223 |
Suppression of Spry1 inhibits triple-negative breast cancer malignancy by decreasing EGF/EGFR mediated mesenchymal phenotype.Sci Rep. 2016 Mar 15;6:23216. doi: 10.1038/srep23216.
|
1224 |
The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation.Oncogene. 2018 Aug;37(34):4750-4768. doi: 10.1038/s41388-018-0281-5. Epub 2018 May 16.
|
1225 |
Optimizing multi-modal cancer treatment under 3D spatio-temporal tumor growth.Math Biosci. 2019 Jan;307:53-69. doi: 10.1016/j.mbs.2018.10.010. Epub 2018 Oct 31.
|
1226 |
Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.Matrix Biol. 2018 Dec;74:35-51. doi: 10.1016/j.matbio.2018.05.011. Epub 2018 May 26.
|
1227 |
The many faces of SRPK1.J Pathol. 2017 Mar;241(4):437-440. doi: 10.1002/path.4846. Epub 2017 Feb 1.
|
1228 |
Prognostic value of histone chaperone FACT subunits expression in breast cancer.Breast Cancer (Dove Med Press). 2017 May 3;9:301-311. doi: 10.2147/BCTT.S126390. eCollection 2017.
|
1229 |
Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes.Can J Physiol Pharmacol. 2020 Mar;98(3):131-138. doi: 10.1139/cjpp-2019-0352. Epub 2019 Sep 23.
|
1230 |
Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.Ann Diagn Pathol. 2019 Feb;38:62-66. doi: 10.1016/j.anndiagpath.2018.11.002. Epub 2018 Nov 20.
|
1231 |
Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.J Exp Clin Cancer Res. 2019 Aug 19;38(1):363. doi: 10.1186/s13046-019-1373-y.
|
1232 |
Overexpression of the steroidogenic acute regulatory protein in breast cancer: Regulation by histone deacetylase inhibition.Biochem Biophys Res Commun. 2019 Feb 5;509(2):476-482. doi: 10.1016/j.bbrc.2018.12.145. Epub 2018 Dec 27.
|
1233 |
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.J Immunol. 2019 May 15;202(10):3076-3086. doi: 10.4049/jimmunol.1801152. Epub 2019 Apr 1.
|
1234 |
STAT6 knockdown using multiple siRNA sequences inhibits proliferation and induces apoptosis of human colorectal and breast cancer cell lines.PLoS One. 2019 May 10;14(5):e0207558. doi: 10.1371/journal.pone.0207558. eCollection 2019.
|
1235 |
Role of stanniocalcin-1 in breast cancer.Oncol Lett. 2019 Oct;18(4):3946-3953. doi: 10.3892/ol.2019.10777. Epub 2019 Aug 22.
|
1236 |
Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.J Cell Physiol. 2019 Aug;234(10):17824-17838. doi: 10.1002/jcp.28409. Epub 2019 Apr 16.
|
1237 |
STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.Clin Breast Cancer. 2019 Feb;19(1):e195-e207. doi: 10.1016/j.clbc.2018.08.010. Epub 2018 Aug 30.
|
1238 |
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome.Breast Cancer Res Treat. 2011 Dec;130(3):905-16. doi: 10.1007/s10549-011-1600-5. Epub 2011 Jun 1.
|
1239 |
Stathmin Is Required for Normal Mouse Mammary Gland Development and 16HER2-Driven Tumorigenesis.Cancer Res. 2019 Jan 15;79(2):397-409. doi: 10.1158/0008-5472.CAN-18-2488. Epub 2018 Nov 26.
|
1240 |
Molecular cloning and characterization of human MAWD, a novel protein containing WD-40 repeats frequently overexpressed in breast cancer.Cancer Res. 2000 Jan 1;60(1):13-7.
|
1241 |
In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics.Br J Cancer. 2018 May;118(9):1208-1216. doi: 10.1038/s41416-018-0034-9. Epub 2018 Mar 22.
|
1242 |
A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment.Mol Biol Rep. 2008 Mar;35(1):23-7. doi: 10.1007/s11033-006-9047-1. Epub 2007 Apr 6.
|
1243 |
Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer.Oncogene. 2013 Mar 14;32(11):1351-62. doi: 10.1038/onc.2012.169. Epub 2012 May 7.
|
1244 |
Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer.Cancer Res. 2019 Apr 15;79(8):1831-1843. doi: 10.1158/0008-5472.CAN-18-2636. Epub 2019 Feb 7.
|
1245 |
HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation.Oncotarget. 2017 Apr 4;8(14):23564-23574. doi: 10.18632/oncotarget.15797.
|
1246 |
Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.Breast Cancer (Dove Med Press). 2019 Feb 19;11:87-97. doi: 10.2147/BCTT.S178721. eCollection 2019.
|
1247 |
IL-13R2 mediates PNR-induced migration and metastasis in ER-negative breast cancer.Oncogene. 2015 Mar 19;34(12):1596-607. doi: 10.1038/onc.2014.53. Epub 2014 Apr 21.
|
1248 |
Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.Biomed Pharmacother. 2018 Dec;108:263-270. doi: 10.1016/j.biopha.2018.09.013. Epub 2018 Sep 14.
|
1249 |
Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.Oncol Rep. 2018 Aug;40(2):759-766. doi: 10.3892/or.2018.6496. Epub 2018 Jun 14.
|
1250 |
Epigenetic Silencing of TAP1 in Aldefluor(+) Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion.Stem Cells. 2018 May;36(5):641-654. doi: 10.1002/stem.2780. Epub 2018 Jan 30.
|
1251 |
Transducin -like protein 1 recruits nuclear factor B to the target gene promoter for transcriptional activation.Mol Cell Biol. 2011 Mar;31(5):924-34. doi: 10.1128/MCB.00576-10. Epub 2010 Dec 28.
|
1252 |
Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs).Oncotarget. 2016 Aug 23;7(34):55458-55472. doi: 10.18632/oncotarget.10969.
|
1253 |
Control of breast cancer growth and initiation by the stem cell-associated transcription factor TCF3.Cancer Res. 2012 Nov 1;72(21):5613-24. doi: 10.1158/0008-5472.CAN-12-0119. Epub 2012 Oct 22.
|
1254 |
Genome-wide analysis reveals a role for TDG in estrogen receptor-mediated enhancer RNA transcription and 3-dimensional reorganization.Epigenetics Chromatin. 2018 Jan 29;11(1):5. doi: 10.1186/s13072-018-0176-2.
|
1255 |
Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells.J Cell Physiol. 2013 Jun;228(6):1174-88. doi: 10.1002/jcp.24271.
|
1256 |
A Role for Tryptophan-2,3-dioxygenase in CD8 T-cell Suppression and Evidence of Tryptophan Catabolism in Breast Cancer Patient Plasma.Mol Cancer Res. 2019 Jan;17(1):131-139. doi: 10.1158/1541-7786.MCR-18-0362. Epub 2018 Aug 24.
|
1257 |
Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.BMC Cancer. 2019 Nov 29;19(1):1158. doi: 10.1186/s12885-019-6371-0.
|
1258 |
Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells.Oncotarget. 2017 Dec 29;9(13):10945-10961. doi: 10.18632/oncotarget.23760. eCollection 2018 Feb 16.
|
1259 |
Association Between Single Nucleotide Polymorphisms in DNA Polymerase Kappa Gene and Breast Cancer Risk in Chinese Han Population: A STROBE-Compliant Observational Study.Medicine (Baltimore). 2016 Jan;95(2):e2466. doi: 10.1097/MD.0000000000002466.
|
1260 |
miR-155 drives telomere fragility in human breast cancer by targeting TRF1.Cancer Res. 2014 Aug 1;74(15):4145-56. doi: 10.1158/0008-5472.CAN-13-2038. Epub 2014 May 29.
|
1261 |
Estrogen regulation of transferrin gene expression in MCF-7 human breast cancer cells.J Mol Endocrinol. 2002 Dec;29(3):305-17. doi: 10.1677/jme.0.0290305.
|
1262 |
Genome-wide Estrogen Receptor- activation is sustained, not cyclical.Elife. 2018 Nov 20;7:e40854. doi: 10.7554/eLife.40854.
|
1263 |
Protein-Polymer Conjugates Synthesized Using Water-Soluble Azlactone-Functionalized Polymers Enable Receptor-Specific Cellular Uptake toward Targeted Drug Delivery.Bioconjug Chem. 2019 Apr 17;30(4):1220-1231. doi: 10.1021/acs.bioconjchem.9b00155. Epub 2019 Apr 5.
|
1264 |
Novel CD44-downstream signaling pathways mediating breast tumor invasion.Int J Biol Sci. 2018 Oct 5;14(13):1782-1790. doi: 10.7150/ijbs.23586. eCollection 2018.
|
1265 |
In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model.EJNMMI Res. 2018 May 25;8(1):39. doi: 10.1186/s13550-018-0388-2.
|
1266 |
Exosomal Thrombospondin-1 Disrupts the Integrity of Endothelial Intercellular Junctions to Facilitate Breast Cancer Cell Metastasis.Cancers (Basel). 2019 Dec 5;11(12):1946. doi: 10.3390/cancers11121946.
|
1267 |
Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice.Blood Adv. 2019 Oct 22;3(20):3080-3091. doi: 10.1182/bloodadvances.2019000250.
|
1268 |
High baseline Tie1 level predicts poor survival in metastatic breast cancer.BMC Cancer. 2019 Jul 24;19(1):732. doi: 10.1186/s12885-019-5959-8.
|
1269 |
TCDD-Inducible Poly-ADP-Ribose Polymerase (TIPARP), A Novel Therapeutic Target Of Breast Cancer.Cancer Manag Res. 2019 Oct 18;11:8991-9004. doi: 10.2147/CMAR.S219289. eCollection 2019.
|
1270 |
Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.FASEB J. 2019 Dec;33(12):13837-13851. doi: 10.1096/fj.201900870RR. Epub 2019 Oct 10.
|
1271 |
Tumor-Associated Disialylated Glycosphingolipid Antigen-Revealing Antibodies Found in Melanoma Patients' Immunoglobulin Repertoire Suggest a Two-Direction Regulation Mechanism Between Immune B Cells and the Tumor.Front Immunol. 2019 Apr 5;10:650. doi: 10.3389/fimmu.2019.00650. eCollection 2019.
|
1272 |
No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations.Onco Targets Ther. 2017 Apr 27;10:2325-2333. doi: 10.2147/OTT.S121618. eCollection 2017.
|
1273 |
Toll-like receptor 3 -926T>A increased the risk of breast cancer through decreased transcriptional activity.Oncoimmunology. 2019 Oct 15;8(12):e1673126. doi: 10.1080/2162402X.2019.1673126. eCollection 2019.
|
1274 |
Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells.Front Oncol. 2019 May 30;9:445. doi: 10.3389/fonc.2019.00445. eCollection 2019.
|
1275 |
Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells.J Pathol. 2006 Feb;208(3):340-9. doi: 10.1002/path.1902.
|
1276 |
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer.J Biol Chem. 2010 Sep 24;285(39):30233-46. doi: 10.1074/jbc.M110.122226. Epub 2010 Mar 30.
|
1277 |
Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.ACS Chem Neurosci. 2019 Mar 20;10(3):1595-1602. doi: 10.1021/acschemneuro.8b00543. Epub 2018 Dec 3.
|
1278 |
Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines.Biochem Pharmacol. 2017 Aug 15;138:163-173. doi: 10.1016/j.bcp.2017.04.015. Epub 2017 Apr 18.
|
1279 |
Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.Int J Cancer. 2013 Nov 15;133(10):2334-40. doi: 10.1002/ijc.28254. Epub 2013 Jun 4.
|
1280 |
Tenascin-C increases lung metastasis by impacting blood vessel invasions.Matrix Biol. 2019 Oct;83:26-47. doi: 10.1016/j.matbio.2019.07.001. Epub 2019 Jul 6.
|
1281 |
Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.Carcinogenesis. 2005 Nov;26(11):1975-7. doi: 10.1093/carcin/bgi164. Epub 2005 Jun 23.
|
1282 |
Polyethyleneimine-polyethylene glycol copolymer targeted by anti-HER2 nanobody for specific delivery of transcriptionally targeted tBid containing construct.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):501-511. doi: 10.1080/21691401.2018.1549063.
|
1283 |
Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis.Crit Rev Oncol Hematol. 2019 May;137:1-8. doi: 10.1016/j.critrevonc.2019.02.004. Epub 2019 Feb 19.
|
1284 |
High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.PLoS One. 2018 Aug 24;13(8):e0202113. doi: 10.1371/journal.pone.0202113. eCollection 2018.
|
1285 |
APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.Carcinogenesis. 2015 May;36(5):574-84. doi: 10.1093/carcin/bgv020. Epub 2015 Mar 6.
|
1286 |
TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes.Immunol Lett. 2019 May;209:36-44. doi: 10.1016/j.imlet.2019.03.013. Epub 2019 Mar 22.
|
1287 |
Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.J Immunol. 2007 Aug 1;179(3):1960-8. doi: 10.4049/jimmunol.179.3.1960.
|
1288 |
Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer.Oncotarget. 2017 Aug 5;8(53):90825-90841. doi: 10.18632/oncotarget.19967. eCollection 2017 Oct 31.
|
1289 |
LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression.Mol Ther Nucleic Acids. 2019 Dec 6;18:871-881. doi: 10.1016/j.omtn.2019.09.033. Epub 2019 Oct 22.
|
1290 |
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.Eur J Cancer. 2009 Nov;45(17):3008-16. doi: 10.1016/j.ejca.2009.08.012. Epub 2009 Sep 18.
|
1291 |
Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.J Pathol. 1997 Aug;182(4):421-8. doi: 10.1002/(SICI)1096-9896(199708)182:4<421::AID-PATH886>3.0.CO;2-U.
|
1292 |
The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair.Nucleic Acids Res. 2019 Apr 8;47(6):2703-2715. doi: 10.1093/nar/gkz138.
|
1293 |
Tryptophan hydroxylase 1 and 5-HT(7) receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling.Mol Cancer. 2016 Nov 21;15(1):75. doi: 10.1186/s12943-016-0559-6.
|
1294 |
Thyroid peroxidase as a dual active site enzyme: Focus on biosynthesis, hormonogenesis and thyroid disorders of autoimmunityand cancer.Biochimie. 2019 May;160:34-45. doi: 10.1016/j.biochi.2019.02.003. Epub 2019 Feb 10.
|
1295 |
Radiosensitivity of Cancer Cells Is Regulated by Translationally Controlled Tumor Protein.Cancers (Basel). 2019 Mar 19;11(3):386. doi: 10.3390/cancers11030386.
|
1296 |
MiR-491 suppresses migration and invasion via directly targeting TPX2 in breast cancer.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9996-10004. doi: 10.26355/eurrev_201911_19566.
|
1297 |
Tumor necrosis factor receptor-associated factor 6 contributes to malignant behavior of human cancers through promoting AKT ubiquitination and phosphorylation.Cancer Sci. 2019 Jun;110(6):1909-1920. doi: 10.1111/cas.14012. Epub 2019 Apr 29.
|
1298 |
The forgotten effects of thyrotropin-releasing hormone: Metabolic functions and medical applications.Front Neuroendocrinol. 2019 Jan;52:29-43. doi: 10.1016/j.yfrne.2018.06.006. Epub 2018 Jun 22.
|
1299 |
TRIM24 links glucose metabolism with transformation of human mammary epithelial cells.Oncogene. 2015 May 28;34(22):2836-45. doi: 10.1038/onc.2014.220. Epub 2014 Jul 28.
|
1300 |
RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.Pathol Res Pract. 2009;205(6):403-8. doi: 10.1016/j.prp.2008.12.014. Epub 2009 Feb 20.
|
1301 |
miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28.Oncol Lett. 2019 Apr;17(4):3835-3841. doi: 10.3892/ol.2019.10038. Epub 2019 Feb 13.
|
1302 |
TRIM59 deficiency curtails breast cancer metastasis through SQSTM1-selective autophagic degradation of PDCD10.Autophagy. 2019 Apr;15(4):747-749. doi: 10.1080/15548627.2019.1569951. Epub 2019 Jan 22.
|
1303 |
CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis.Oncotarget. 2015 Apr 20;6(11):9397-408. doi: 10.18632/oncotarget.3351.
|
1304 |
TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.J Cell Sci. 2017 Jul 15;130(14):2292-2305. doi: 10.1242/jcs.196659. Epub 2017 May 30.
|
1305 |
TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3/RASA4/MAPK Pathway.Cancers (Basel). 2019 Apr 18;11(4):558. doi: 10.3390/cancers11040558.
|
1306 |
Increasing circulating exosomes-carrying TRPC5 predicts chemoresistance in metastatic breast cancer patients.Cancer Sci. 2017 Mar;108(3):448-454. doi: 10.1111/cas.13150.
|
1307 |
Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site.J Immunother. 2000 Jan;23(1):2-10. doi: 10.1097/00002371-200001000-00002.
|
1308 |
TRPM7 residue S1269 mediates cAMP dependence of Ca2+ influx.PLoS One. 2019 Jan 7;14(1):e0209563. doi: 10.1371/journal.pone.0209563. eCollection 2019.
|
1309 |
Assessment of the TRPM8 inhibitor AMTB in breast cancer cells and its identification as an inhibitor of voltage gated sodium channels.Life Sci. 2018 Apr 1;198:128-135. doi: 10.1016/j.lfs.2018.02.030. Epub 2018 Feb 26.
|
1310 |
Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients.Breast Cancer (Dove Med Press). 2018 Oct 15;10:161-168. doi: 10.2147/BCTT.S170208. eCollection 2018.
|
1311 |
TRPV4 plays a role in breast cancer cell migration via Ca(2+)-dependent activation of AKT and downregulation of E-cadherin cell cortex protein.Oncogenesis. 2017 May 22;6(5):e338. doi: 10.1038/oncsis.2017.39.
|
1312 |
Inhibition of Transient Receptor Potential Vanilloid 6 channel, elevated in human ovarian cancers, reduces tumour growth in a xenograft model.J Cancer. 2018 Aug 6;9(17):3196-3207. doi: 10.7150/jca.20639. eCollection 2018.
|
1313 |
Genetic variants in EBV reactivation-related genes and the risk and survival of breast cancer.Tumour Biol. 2016 Jun;37(6):8337-47. doi: 10.1007/s13277-015-4562-0. Epub 2016 Jan 5.
|
1314 |
Review of the possible association between thyroid and breast carcinoma.World J Surg Oncol. 2018 Jul 5;16(1):130. doi: 10.1186/s12957-018-1436-0.
|
1315 |
Optimized Translocator Protein Ligand for Optical Molecular Imaging and Screening.Bioconjug Chem. 2017 Apr 19;28(4):1016-1023. doi: 10.1021/acs.bioconjchem.6b00711. Epub 2017 Feb 13.
|
1316 |
Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.Oncogene. 2001 Sep 27;20(43):6258-62. doi: 10.1038/sj.onc.1204832.
|
1317 |
Downregulation of TXNIP leads to high proliferative activity and estrogen-dependent cell growth in breast cancer.Biochem Biophys Res Commun. 2018 Apr 6;498(3):566-572. doi: 10.1016/j.bbrc.2018.03.020. Epub 2018 Mar 13.
|
1318 |
miR526b and miR655 Induce Oxidative Stress in Breast Cancer.Int J Mol Sci. 2019 Aug 19;20(16):4039. doi: 10.3390/ijms20164039.
|
1319 |
-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):E707-E716. doi: 10.1073/pnas.1610383114. Epub 2017 Jan 17.
|
1320 |
Isolation, characterization, and bioactivities of compounds from Fuscoporia torulosa mushroom.J Food Biochem. 2019 Dec;43(12):e13074. doi: 10.1111/jfbc.13074. Epub 2019 Oct 10.
|
1321 |
Genetic variation in the vitamin D related pathway and breast cancer risk in women of African ancestry in the root consortium.Int J Cancer. 2018 Jan 1;142(1):36-43. doi: 10.1002/ijc.31038. Epub 2017 Sep 23.
|
1322 |
Mining the tissue-tissue gene co-expression network for tumor microenvironment study and biomarker prediction.BMC Genomics. 2013;14 Suppl 5(Suppl 5):S4. doi: 10.1186/1471-2164-14-S5-S4. Epub 2013 Oct 16.
|
1323 |
ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.Exp Biol Med (Maywood). 2012 Jan;237(1):38-49. doi: 10.1258/ebm.2011.011236. Epub 2011 Dec 20.
|
1324 |
Proteomic identification of E6AP as a molecular target of tamoxifen in MCF7 cells.Proteomics. 2012 May;12(9):1363-77. doi: 10.1002/pmic.201100572.
|
1325 |
UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer.J Surg Oncol. 2017 Jun;115(8):932-940. doi: 10.1002/jso.24614. Epub 2017 Mar 23.
|
1326 |
A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.Genes Dev. 2016 Dec 1;30(23):2581-2595. doi: 10.1101/gad.289439.116. Epub 2016 Dec 9.
|
1327 |
Altered methylation of glucosylceramide synthase promoter regulates its expression and associates with acquired multidrug resistance in invasive ductal breast cancer.Oncotarget. 2016 Jun 14;7(24):36755-36766. doi: 10.18632/oncotarget.9337.
|
1328 |
Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer.Mol Med Rep. 2014 Feb;9(2):669-76. doi: 10.3892/mmr.2013.1830. Epub 2013 Nov 26.
|
1329 |
USP1 (ubiquitin specific peptidase 1) targets ULK1 and regulates its cellular compartmentalization and autophagy.Autophagy. 2019 Apr;15(4):613-630. doi: 10.1080/15548627.2018.1535291. Epub 2018 Oct 29.
|
1330 |
Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14530-5. doi: 10.1073/pnas.0801262106. Epub 2009 Aug 12.
|
1331 |
Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.J Exp Clin Cancer Res. 2018 Nov 27;37(1):287. doi: 10.1186/s13046-018-0934-9.
|
1332 |
VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors.Clin Cancer Res. 2019 Jan 15;25(2):533-543. doi: 10.1158/1078-0432.CCR-18-1889. Epub 2018 Nov 2.
|
1333 |
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.Breast Cancer Res. 2012 Nov 12;14(6):R145. doi: 10.1186/bcr3354.
|
1334 |
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.Pathol Oncol Res. 2019 Oct;25(4):1477-1486. doi: 10.1007/s12253-018-0527-0. Epub 2018 Nov 1.
|
1335 |
Association between ER gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis.Medicine (Baltimore). 2018 Apr;97(17):e0317. doi: 10.1097/MD.0000000000010317.
|
1336 |
3D structure prediction of VAPC1 and identification of dual natural inhibitors for VPAC1 and EGFR.J Bioenerg Biomembr. 2019 Apr;51(2):89-102. doi: 10.1007/s10863-019-09790-y. Epub 2019 Feb 27.
|
1337 |
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells.Regul Pept. 2007 Dec 4;144(1-3):101-8. doi: 10.1016/j.regpep.2007.06.006. Epub 2007 Jun 28.
|
1338 |
A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.Clin Cancer Res. 2019 May 1;25(9):2925-2934. doi: 10.1158/1078-0432.CCR-17-3123. Epub 2019 Feb 8.
|
1339 |
Induction of the fatty acid 2-hydroxylase (FA2H) gene by (9)-tetrahydrocannabinol in human breast cancer cells. J Toxicol Sci. 2013;38(2):305-8. doi: 10.2131/jts.38.305.
|
1340 |
Biophysical characterization of the breast cancer-related BIG3-PHB2 interaction: Effect of non-conserved loop region of BIG3 on the structure and the interaction.Biochem Biophys Res Commun. 2019 Oct 8;518(1):183-189. doi: 10.1016/j.bbrc.2019.08.028. Epub 2019 Aug 14.
|
1341 |
Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation.Toxicol In Vitro. 2019 Oct;60:125-133. doi: 10.1016/j.tiv.2019.05.004. Epub 2019 May 8.
|
1342 |
Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.Cancer Manag Res. 2019 Apr 10;11:2803-2815. doi: 10.2147/CMAR.S190999. eCollection 2019.
|
1343 |
Wnt7a Deficiency Could Predict Worse Disease-Free and Overall Survival in Estrogen Receptor-Positive Breast Cancer.J Breast Cancer. 2017 Dec;20(4):361-367. doi: 10.4048/jbc.2017.20.4.361. Epub 2017 Dec 19.
|
1344 |
WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer.Br J Cancer. 2018 Dec;119(12):1508-1517. doi: 10.1038/s41416-018-0317-1. Epub 2018 Oct 30.
|
1345 |
The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.Int J Cancer. 2012 Apr 1;130(7):1504-10. doi: 10.1002/ijc.26122. Epub 2011 May 30.
|
1346 |
Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activity.Oncotarget. 2016 Sep 13;7(37):59220-59235. doi: 10.18632/oncotarget.11042.
|
1347 |
XIAP Regulation by MNK Links MAPK and NFB Signaling to Determine an Aggressive Breast Cancer Phenotype.Cancer Res. 2018 Apr 1;78(7):1726-1738. doi: 10.1158/0008-5472.CAN-17-1667. Epub 2018 Jan 19.
|
1348 |
Association of XPA polymorphism with breast cancer risk: A meta-analysis.Medicine (Baltimore). 2018 Jun;97(26):e11276. doi: 10.1097/MD.0000000000011276.
|
1349 |
CRM1, a novel independent prognostic factor overexpressed in invasive breast carcinoma of poor prognosis.Oncol Lett. 2018 May;15(5):7515-7522. doi: 10.3892/ol.2018.8316. Epub 2018 Mar 22.
|
1350 |
Association between polymorphisms at promoters of XRCC5 and XRCC6 genes and risk of breast cancer.Med Oncol. 2014 Apr;31(4):885. doi: 10.1007/s12032-014-0885-8. Epub 2014 Mar 11.
|
1351 |
Structural Comparison of Gene Relevance Networks for Breast Cancer Tissues in Different Grades.Comb Chem High Throughput Screen. 2016;19(9):714-719. doi: 10.2174/1386207319666160831152801.
|
1352 |
Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway.Biosci Rep. 2019 May 17;39(5):BSR20181919. doi: 10.1042/BSR20181919. Print 2019 May 31.
|
1353 |
The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.J Pathol. 2017 May;242(1):73-89. doi: 10.1002/path.4882. Epub 2017 Mar 27.
|
1354 |
ZNF224, Krppel like zinc finger protein, induces cell growth and apoptosis-resistance by down-regulation of p21 and p53 via miR-663a.Oncotarget. 2016 May 24;7(21):31177-90. doi: 10.18632/oncotarget.8870.
|
1355 |
Centchroman: A safe reversible postcoital contraceptive with curative and prophylactic activity in many disorders.Front Biosci (Elite Ed). 2018 Jan 1;10(1):1-14. doi: 10.2741/e807.
|
1356 |
Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.Eur J Cancer. 2009 Feb;45(3):435-42. doi: 10.1016/j.ejca.2008.10.001. Epub 2008 Nov 12.
|
1357 |
Downregulation of BTLA on NKT Cells Promotes Tumor Immune Control in a Mouse Model of Mammary Carcinoma.Int J Mol Sci. 2018 Mar 7;19(3):752. doi: 10.3390/ijms19030752.
|
1358 |
Carbonic Anhydrase 1-Mediated Calcification Is Associated With Atherosclerosis, and Methazolamide Alleviates Its Pathogenesis.Front Pharmacol. 2019 Jul 10;10:766. doi: 10.3389/fphar.2019.00766. eCollection 2019.
|
1359 |
Ca(2+) and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF.EBioMedicine. 2019 Jun;44:194-208. doi: 10.1016/j.ebiom.2019.05.038. Epub 2019 May 23.
|
1360 |
Applying a new computer-aided detection scheme generated imaging marker to predict short-term breast cancer risk.Phys Med Biol. 2018 May 15;63(10):105005. doi: 10.1088/1361-6560/aabefe.
|
1361 |
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence.Cancer Immunol Immunother. 2015 Apr;64(4):467-78. doi: 10.1007/s00262-015-1658-8. Epub 2015 Jan 25.
|
1362 |
-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to 7-nAChR overexpressed non-small cell lung cancer.Drug Deliv. 2018 Nov;25(1):493-503. doi: 10.1080/10717544.2018.1436097.
|
1363 |
Membrane protein-regulated networks across human cancers.Nat Commun. 2019 Jul 16;10(1):3131. doi: 10.1038/s41467-019-10920-8.
|
1364 |
Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40.Biochem Cell Biol. 2015 Dec;93(6):604-10. doi: 10.1139/bcb-2015-0007. Epub 2015 Sep 15.
|
1365 |
Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.PLoS One. 2019 May 17;14(5):e0217196. doi: 10.1371/journal.pone.0217196. eCollection 2019.
|
1366 |
Glutamine-utilizing transaminases are a metabolic vulnerability of TAZ/YAP-activated cancer cells.EMBO Rep. 2018 Jun;19(6):e43577. doi: 10.15252/embr.201643577. Epub 2018 Apr 16.
|
1367 |
ZnR/GPR39 upregulation of K(+)/Cl(-)-cotransporter 3 in tamoxifen resistant breast cancer cells.Cell Calcium. 2019 Jul;81:12-20. doi: 10.1016/j.ceca.2019.05.005. Epub 2019 May 22.
|
1368 |
HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.Oncogene. 2019 Sep;38(39):6599-6614. doi: 10.1038/s41388-019-0897-0. Epub 2019 Aug 2.
|
1369 |
LncRNA HOTTIP-Mediated HOXA11 Expression Promotes Cell Growth, Migration and Inhibits Cell Apoptosis in Breast Cancer.Int J Mol Sci. 2018 Feb 6;19(2):472. doi: 10.3390/ijms19020472.
|
1370 |
HPD overexpression predicts poor prognosis in breast cancer.Pathol Res Pract. 2019 Sep;215(9):152524. doi: 10.1016/j.prp.2019.152524. Epub 2019 Jun 28.
|
1371 |
A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune system.Oncoimmunology. 2019 Apr 12;8(7):1596005. doi: 10.1080/2162402X.2019.1596005. eCollection 2019.
|
1372 |
The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-1-induced growth inhibition by targeting Smad3 linker region.Oncotarget. 2015 Dec 8;6(39):41650-66. doi: 10.18632/oncotarget.6146.
|
1373 |
Overexpression of MAPT-AS1 is associated with better patient survival in breast cancer.Biochem Cell Biol. 2019 Apr;97(2):158-164. doi: 10.1139/bcb-2018-0039. Epub 2018 Aug 3.
|
1374 |
Down-Regulation of NDUFB9 Promotes Breast Cancer Cell Proliferation, Metastasis by Mediating Mitochondrial Metabolism.PLoS One. 2015 Dec 7;10(12):e0144441. doi: 10.1371/journal.pone.0144441. eCollection 2015.
|
1375 |
Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.J Exp Clin Cancer Res. 2019 May 9;38(1):187. doi: 10.1186/s13046-019-1187-y.
|
1376 |
Effects of immunization against PCSK9 in an experimental model of breast cancer.Arch Med Sci. 2019 May;15(3):570-579. doi: 10.5114/aoms.2019.84734. Epub 2019 Apr 30.
|
1377 |
Inhibition of breast cancer cell migration by activation of cAMP signaling.Breast Cancer Res Treat. 2015 Jul;152(1):17-28. doi: 10.1007/s10549-015-3445-9. Epub 2015 May 29.
|
1378 |
PRDX4 and Its Roles in Various Cancers.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819864313. doi: 10.1177/1533033819864313.
|
1379 |
Analysis of PKC- protein levels in normal and malignant breast tissue subtypes.Oncol Lett. 2019 Feb;17(2):1537-1546. doi: 10.3892/ol.2018.9792. Epub 2018 Dec 4.
|
1380 |
RIP2 enhances cell survival by activation of NF-B in triple negative breast cancer cells.Biochem Biophys Res Commun. 2018 Feb 26;497(1):115-121. doi: 10.1016/j.bbrc.2018.02.034. Epub 2018 Feb 6.
|
1381 |
Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.Mol Nutr Food Res. 2019 Oct;63(19):e1801386. doi: 10.1002/mnfr.201801386. Epub 2019 Jul 31.
|
1382 |
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial.J Natl Cancer Inst. 2018 Aug 1;110(8):871-879. doi: 10.1093/jnci/djx280.
|
1383 |
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/-catenin pathway.J Exp Clin Cancer Res. 2019 Jul 12;38(1):305. doi: 10.1186/s13046-019-1315-8.
|
1384 |
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.Oncologist. 2018 Sep;23(9):1092-1102. doi: 10.1634/theoncologist.2017-0379. Epub 2018 Apr 26.
|
1385 |
The pleiotropic effects of TNF in breast cancer subtypes is regulated by TNFAIP3/A20.Oncogene. 2019 Jan;38(4):469-482. doi: 10.1038/s41388-018-0472-0. Epub 2018 Aug 30.
|
1386 |
CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes/macrophages.Theranostics. 2019 May 9;9(10):2950-2966. doi: 10.7150/thno.29617. eCollection 2019.
|
1387 |
USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.Mol Cancer Ther. 2015 Sep;14(9):2121-31. doi: 10.1158/1535-7163.MCT-15-0114-T. Epub 2015 Jul 31.
|
1388 |
ABCB5-ZEB1 Axis Promotes Invasion and Metastasis in Breast Cancer Cells.Oncol Res. 2017 Mar 13;25(3):305-316. doi: 10.3727/096504016X14734149559061.
|
1389 |
Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response.Br J Cancer. 2014 Aug 12;111(4):696-707. doi: 10.1038/bjc.2014.326. Epub 2014 Jun 17.
|
1390 |
CACNG2 polymorphisms associate with chronic pain after mastectomy.Pain. 2019 Mar;160(3):561-568. doi: 10.1097/j.pain.0000000000001432.
|
1391 |
MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation.Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):433-442. doi: 10.21873/cgp.20147.
|
1392 |
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1.
|
1393 |
Zip1, Zip2, and Zip8 mRNA expressions were associated with growth hormone level during the growth hormone provocation test in children with short stature.Biol Trace Elem Res. 2013 Oct;155(1):11-22. doi: 10.1007/s12011-013-9764-y. Epub 2013 Aug 7.
|
1394 |
The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer.Cancer Manag Res. 2019 Jan 17;11:865-876. doi: 10.2147/CMAR.S190591. eCollection 2019.
|
1395 |
SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).Breast Cancer Res Treat. 2012 Jul;134(1):101-15. doi: 10.1007/s10549-011-1925-0. Epub 2012 Jan 3.
|
1396 |
Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.J Cell Biochem. 2012 Nov;113(11):3363-70. doi: 10.1002/jcb.24212.
|
1397 |
Unraveling FATP1, regulated by ER-, as a targeted breast cancer innovative therapy.Sci Rep. 2019 Oct 1;9(1):14107. doi: 10.1038/s41598-019-50531-3.
|
1398 |
Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3765-3773. doi: 10.1080/21691401.2019.1664559.
|
1399 |
Targeting Taurine Transporter (TauT) for Cancer Immunotherapy of p53 Mutation Mediated Cancers - Molecular Basis and Preclinical Implication.Adv Exp Med Biol. 2019;1155:543-553. doi: 10.1007/978-981-13-8023-5_50.
|
1400 |
Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells.Oncol Rep. 2012 Feb;27(2):311-7. doi: 10.3892/or.2011.1542. Epub 2011 Nov 9.
|
1401 |
Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.Curr Drug Metab. 2019;20(2):124-129. doi: 10.2174/1389200219666181003142036.
|
1402 |
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Breast Cancer (Dove Med Press). 2017 Jul 11;9:495-514. doi: 10.2147/BCTT.S139963. eCollection 2017.
|
1403 |
A functional single nucleotide polymorphism in ABCC11, rs17822931, is associated with the risk of breast cancer in Japanese.Carcinogenesis. 2019 Jun 10;40(4):537-543. doi: 10.1093/carcin/bgz005.
|
1404 |
Expression of plasma membrane calcium pump isoform mRNAs in breast cancer cell lines.Cell Signal. 2002 Dec;14(12):1015-22. doi: 10.1016/s0898-6568(02)00049-9.
|
1405 |
Inhibiting the MNK-eIF4E--catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy.Oncotarget. 2017 Jan 10;8(2):2906-2915. doi: 10.18632/oncotarget.13772.
|
1406 |
Estrone-3-Sulfate Stimulates the Proliferation of T47D Breast Cancer Cells Stably Transfected With the Sodium-Dependent Organic Anion Transporter SOAT (SLC10A6). Front Pharmacol. 2018 Aug 21;9:941. doi: 10.3389/fphar.2018.00941. eCollection 2018.
|
1407 |
Treatment of breast cancer cells with DNA demethylating agents leads to a release of Pol II stalling at genes with DNA-hypermethylated regions upstream of TSS.Nucleic Acids Res. 2011 Dec;39(22):9508-20. doi: 10.1093/nar/gkr611. Epub 2011 Aug 31.
|
1408 |
Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS).Pharmacogenomics J. 2018 Sep;18(5):633-645. doi: 10.1038/s41397-018-0016-6. Epub 2018 Apr 4.
|
1409 |
New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.Anticancer Agents Med Chem. 2018;18(2):295-301. doi: 10.2174/1871520617666171003145533.
|
1410 |
Adipocytes promote malignant growth of breast tumours with monocarboxylate transporter 2 expression via beta-hydroxybutyrate. Nat Commun. 2017 Mar 10;8:14706.
|
1411 |
Mammalian protein homologous to VAT-1 of Torpedo californica: isolation from Ehrlich ascites tumor cells, biochemical characterization, and organization of its gene.J Cell Biochem. 1998 Jun 1;69(3):304-15.
|
1412 |
POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.J Pathol. 2019 Nov;249(3):381-394. doi: 10.1002/path.5324. Epub 2019 Aug 27.
|
1413 |
Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.Cancer Genomics Proteomics. 2019 May-Jun;16(3):147-153. doi: 10.21873/cgp.20120.
|
1414 |
Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.Pathol Res Pract. 2011 Jun 15;207(6):377-82. doi: 10.1016/j.prp.2011.03.007. Epub 2011 May 31.
|
1415 |
Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi.Int J Cancer. 2008 May 1;122(9):1999-2007. doi: 10.1002/ijc.23321.
|
1416 |
Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.Exp Mol Med. 2012 Apr 30;44(4):251-9. doi: 10.3858/emm.2012.44.4.019.
|
1417 |
A systematic study on drug-response associated genes using baseline gene expressions of the Cancer Cell Line Encyclopedia.Sci Rep. 2016 Mar 10;6:22811. doi: 10.1038/srep22811.
|
1418 |
New Insight on Solute Carrier Family 27 Member 6 (SLC27A6) in Tumoral and Non-Tumoral Breast Cells.Int J Med Sci. 2019 Jan 24;16(3):366-375. doi: 10.7150/ijms.29946. eCollection 2019.
|
1419 |
Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.Biochem Pharmacol. 2008 Feb 1;75(3):639-48. doi: 10.1016/j.bcp.2007.10.005. Epub 2007 Oct 13.
|
1420 |
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.Nat Genet. 2014 Oct;46(10):1051-9. doi: 10.1038/ng.3073. Epub 2014 Aug 24.
|
1421 |
Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.FASEB J. 2018 Sep;32(9):5104-5118. doi: 10.1096/fj.201800360R. Epub 2018 Apr 13.
|
1422 |
Glucose Transporter 3 is Essential for the Survival of Breast Cancer Cells in the Brain.Cells. 2019 Dec 4;8(12):1568. doi: 10.3390/cells8121568.
|
1423 |
Sugar Concentration and Arrangement on the Surface of Glycopolymer Micelles Affect the Interaction with Cancer Cells.Biomacromolecules. 2019 Jan 14;20(1):273-284. doi: 10.1021/acs.biomac.8b01406. Epub 2018 Dec 14.
|
1424 |
Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.Cancer Res. 2016 Oct 1;76(19):5881-5893. doi: 10.1158/0008-5472.CAN-15-3372. Epub 2016 Aug 5.
|
1425 |
Expression of the SART-1 tumor rejection antigen in breast cancer.Int J Cancer. 1999 Jan 5;80(1):64-7. doi: 10.1002/(sici)1097-0215(19990105)80:1<64::aid-ijc13>3.0.co;2-7.
|
1426 |
SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma.Asian Pac J Cancer Prev. 2014;15(15):6065-70. doi: 10.7314/apjcp.2014.15.15.6065.
|
1427 |
SLC37A1 gene expression is up-regulated by epidermal growth factor in breast cancer cells.Breast Cancer Res Treat. 2010 Aug;122(3):755-64. doi: 10.1007/s10549-009-0620-x. Epub 2009 Nov 6.
|
1428 |
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.J Hematol Oncol. 2017 Apr 17;10(1):89. doi: 10.1186/s13045-017-0462-7.
|
1429 |
Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells.Cancer Sci. 2007 May;98(5):692-7. doi: 10.1111/j.1349-7006.2007.00446.x. Epub 2007 Mar 14.
|
1430 |
Over-expression of Zip-13 mRNA in kidney and lung during dietary zinc deficiency in Wistar rats.Mol Biol Rep. 2011 Mar;38(3):1869-74. doi: 10.1007/s11033-010-0304-y. Epub 2010 Sep 22.
|
1431 |
Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer.Metallomics. 2019 Sep 1;11(9):1579-1592. doi: 10.1039/c9mt00136k. Epub 2019 Sep 4.
|
1432 |
Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis. Theranostics. 2017 Feb 26;7(4):1036-1046.
|
1433 |
CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India.Asian Pac J Cancer Prev. 2011;12(8):2133-8.
|
1434 |
MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells.Oncotarget. 2016 Mar 22;7(12):13706-16. doi: 10.18632/oncotarget.7333.
|
1435 |
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8703-8. doi: 10.1073/pnas.95.15.8703.
|
1436 |
Protease-activated receptor 2 (PAR2) upregulates granulocyte colony stimulating factor (G-CSF) expression in breast cancer cells.Biochem Biophys Res Commun. 2018 Sep 26;504(1):270-276. doi: 10.1016/j.bbrc.2018.08.169. Epub 2018 Aug 30.
|
1437 |
The plasma membrane transporter SLC5A8 suppresses tumour progression through depletion of survivin without involving its transport function.Biochem J. 2013 Feb 15;450(1):169-78. doi: 10.1042/BJ20121248.
|
1438 |
Modification of ASC1 by UFM1 is crucial for ER transactivation and breast cancer development.Mol Cell. 2014 Oct 23;56(2):261-274. doi: 10.1016/j.molcel.2014.08.007. Epub 2014 Sep 11.
|
1439 |
Targeting Apoptosis Inhibition to Activate Antitumor Immunity.Trends Immunol. 2019 Dec;40(12):1073-1075. doi: 10.1016/j.it.2019.11.002. Epub 2019 Nov 14.
|
1440 |
Na(+),HCO(3)(-)-cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice.Oncogene. 2018 Oct;37(41):5569-5584. doi: 10.1038/s41388-018-0353-6. Epub 2018 Jun 15.
|
1441 |
Breast cancer survivorship: state of the science.Breast Cancer Res Treat. 2018 Apr;168(3):593-600. doi: 10.1007/s10549-017-4650-5. Epub 2018 Jan 13.
|
1442 |
Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.Chem Biol Drug Des. 2014 Nov;84(5):578-84. doi: 10.1111/cbdd.12348. Epub 2014 Jul 12.
|
1443 |
Plasma carotenoid- and retinol-weighted multi-SNP scores and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):927-36. doi: 10.1158/1055-9965.EPI-13-0017. Epub 2013 Mar 20.
|
1444 |
Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.Cancer Causes Control. 2014 Nov;25(11):1513-21. doi: 10.1007/s10552-014-0454-7. Epub 2014 Sep 16.
|
1445 |
Polyunsaturated Fatty Acids Differentially Modulate Cell Proliferation and Endocannabinoid System in Two Human Cancer Lines.Arch Med Res. 2017 Jan;48(1):46-54. doi: 10.1016/j.arcmed.2017.01.009.
|
1446 |
Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells via the FoxO3a-Bmi-1 Axis.Antioxid Redox Signal. 2020 Jun;32(18):1313-1329. doi: 10.1089/ars.2019.7730. Epub 2020 Jan 8.
|
1447 |
Oxidative stress in susceptibility to breast cancer: study in Spanish population.BMC Cancer. 2014 Nov 21;14:861. doi: 10.1186/1471-2407-14-861.
|
1448 |
Diagnostic and prognostic value of the cancer-testis antigen lactate dehydrogenase C4 in breast cancer.Clin Chim Acta. 2020 Apr;503:203-209. doi: 10.1016/j.cca.2019.11.032. Epub 2019 Nov 30.
|
1449 |
Blood and Tissue Enzymatic Activities of GDH and LDH, Index of Glutathione, and Oxidative Stress among Breast Cancer Patients Attending Referral Hospitals of Addis Ababa, Ethiopia: Hospital-Based Comparative Cross-Sectional Study.Oxid Med Cell Longev. 2018 Mar 26;2018:6039453. doi: 10.1155/2018/6039453. eCollection 2018.
|
1450 |
Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.Biochem Pharmacol. 2018 Sep;155:252-263. doi: 10.1016/j.bcp.2018.07.006. Epub 2018 Jul 20.
|
1451 |
Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment.Ther Clin Risk Manag. 2018 Mar 14;14:543-549. doi: 10.2147/TCRM.S156466. eCollection 2018.
|
1452 |
Hormone-related pathways and risk of breast cancer subtypes in African American women.Breast Cancer Res Treat. 2015 Nov;154(1):145-54. doi: 10.1007/s10549-015-3594-x. Epub 2015 Oct 12.
|
1453 |
Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer.PLoS One. 2013 Nov 15;8(11):e78901. doi: 10.1371/journal.pone.0078901. eCollection 2013.
|
1454 |
Human 3-hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations.Cancer Med. 2016 Jul;5(7):1405-15. doi: 10.1002/cam4.708. Epub 2016 May 3.
|
1455 |
NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.Mol Cell Proteomics. 2015 Nov;14(11):2988-99. doi: 10.1074/mcp.M115.050385. Epub 2015 Sep 8.
|
1456 |
Expression of CYP2S1 and CYP2W1 in breast cancer epithelial cells and modulation of their expression by synthetic methoxy stilbenes.Pharmacol Rep. 2019 Dec;71(6):1001-1005. doi: 10.1016/j.pharep.2019.08.005. Epub 2019 Aug 14.
|
1457 |
Salivary Gland Function, Antioxidant Defence and Oxidative Damage in the Saliva of Patients with Breast Cancer: Does the BRCA1 Mutation Disturb the Salivary Redox Profile?.Cancers (Basel). 2019 Oct 8;11(10):1501. doi: 10.3390/cancers11101501.
|
1458 |
Over-expression of EPS15 is a favorable prognostic factor in breast cancer.Mol Biosyst. 2015 Nov;11(11):2978-85. doi: 10.1039/c5mb00219b.
|
1459 |
A splice variant of HER2 corresponding to Herstatin is expressed in the noncancerous breast and in breast carcinomas.Neoplasia. 2008 Jul;10(7):687-96. doi: 10.1593/neo.08314.
|
1460 |
Expression and inducibility of UDP-glucuronosyltransferase 1As in MCF-7 human breast carcinoma cells.Basic Clin Pharmacol Toxicol. 2012 Mar;110(3):253-8. doi: 10.1111/j.1742-7843.2011.00790.x. Epub 2011 Oct 10.
|
1461 |
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China.Clin Breast Cancer. 2019 Apr;19(2):e370-e375. doi: 10.1016/j.clbc.2018.12.009. Epub 2018 Dec 19.
|
1462 |
UDP-glucuronosyltransferase 1A6 overexpression in breast cancer cells resistant to methotrexate. Biochem Pharmacol. 2011 Jan 1;81(1):60-70.
|
1463 |
UGT2B4 previously implicated in the risk of breast cancer is associated with menarche timing in Ukrainian females.Gene. 2016 Sep 15;590(1):85-9. doi: 10.1016/j.gene.2016.06.015. Epub 2016 Jun 7.
|
1464 |
Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.Stem Cell Res. 2012 Mar;8(2):247-58. doi: 10.1016/j.scr.2011.11.006. Epub 2011 Dec 6.
|
1465 |
Blood groups type linked to breast cancer in a Greek cohort of women - a case control study.J BUON. 2019 Sep-Oct;24(5):1884-1888.
|
1466 |
RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.Clin Exp Metastasis. 2007;24(6):439-48. doi: 10.1007/s10585-007-9081-y. Epub 2007 Jun 21.
|
1467 |
ADH3 genotype, alcohol intake and breast cancer risk.Carcinogenesis. 2006 Apr;27(4):840-7. doi: 10.1093/carcin/bgi285. Epub 2005 Dec 12.
|
1468 |
ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming.J Clin Invest. 2018 Jan 2;128(1):323-340. doi: 10.1172/JCI93815. Epub 2017 Nov 27.
|
1469 |
AKR1B10 activates diacylglycerol (DAG) second messenger in breast cancer cells.Mol Carcinog. 2018 Oct;57(10):1300-1310. doi: 10.1002/mc.22844. Epub 2018 Jun 28.
|
1470 |
Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.Am J Epidemiol. 2009 Nov 15;170(10):1241-9. doi: 10.1093/aje/kwp298. Epub 2009 Oct 21.
|
1471 |
Phytosomal-curcumin antagonizes cell growth and migration, induced by thrombin through AMP-Kinase in breast cancer.J Cell Biochem. 2018 Jul;119(7):5996-6007. doi: 10.1002/jcb.26796. Epub 2018 Mar 30.
|
1472 |
Allelic variation of BAT-25 and BAT-26 mononucleotide repeat loci in tumours from a group of young women with breast cancer.Int J Oncol. 2004 Sep;25(3):771-5. doi: 10.3892/ijo.25.3.771.
|
1473 |
Gene characterization, promoter analysis, and chromosomal localization of human bleomycin hydrolase.J Biol Chem. 1997 Dec 26;272(52):33298-304. doi: 10.1074/jbc.272.52.33298.
|
1474 |
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity.Pharmacogenet Genomics. 2008 Jul;18(7):621-31. doi: 10.1097/FPC.0b013e328301a869.
|
1475 |
Carboxylesterase-2-Selective Two-Photon Ratiometric Probe Reveals Decreased Carboxylesterase-2 Activity in Breast Cancer Cells.Anal Chem. 2018 Aug 7;90(15):9465-9471. doi: 10.1021/acs.analchem.8b02101. Epub 2018 Jul 27.
|
1476 |
Breast cancer relapse prediction based on multi-gene RT-PCR algorithm.Med Sci Monit. 2010 Mar;16(3):CR132-136.
|
1477 |
Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells.Artif Cells Nanomed Biotechnol. 2018;46(sup1):896-905. doi: 10.1080/21691401.2018.1439835. Epub 2018 Feb 23.
|
1478 |
Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer.Biomolecules. 2019 Mar 14;9(3):103. doi: 10.3390/biom9030103.
|
1479 |
Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.Breast Cancer Res Treat. 2018 Feb;167(3):797-802. doi: 10.1007/s10549-017-4562-4. Epub 2017 Nov 7.
|
1480 |
The synthesis of 4,6-diaryl-2-pyridones and their bioactivation in CYP1 expressing breast cancer cells.Bioorg Med Chem Lett. 2019 Jun 1;29(11):1403-1406. doi: 10.1016/j.bmcl.2019.03.030. Epub 2019 Mar 22.
|
1481 |
CYP2C and IL-6 expression in breast cancer.Breast. 2004 Feb;13(1):28-34. doi: 10.1016/j.breast.2003.07.002.
|
1482 |
Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.Cancer Res. 1998 Feb 15;58(4):667-71.
|
1483 |
Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.Mol Cancer Res. 2004 Aug;2(8):477-87.
|
1484 |
Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.Am J Epidemiol. 2017 Jan 15;185(2):75-85. doi: 10.1093/aje/kww178. Epub 2016 Dec 17.
|
1485 |
Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer.Am J Cancer Res. 2019 Oct 1;9(10):2194-2208. eCollection 2019.
|
1486 |
A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP.Int J Cancer. 2011 Oct 1;129(7):1689-98. doi: 10.1002/ijc.25786. Epub 2011 Mar 11.
|
1487 |
Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro.Biomed Pharmacother. 2019 Mar;111:602-612. doi: 10.1016/j.biopha.2018.12.117. Epub 2019 Jan 3.
|
1488 |
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1 and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.Breast Cancer Res. 2011 Feb 3;13(1):R16. doi: 10.1186/bcr2825.
|
1489 |
Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo--linolenic acid peroxidation dependent mechanism.BMC Cancer. 2018 Mar 27;18(1):330. doi: 10.1186/s12885-018-4250-8.
|
1490 |
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.Breast Cancer Res. 2004;6(3):R252-63. doi: 10.1186/bcr784. Epub 2004 Mar 26.
|
1491 |
Transforming growth factor beta 1 (TGF1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.J Cancer Res Clin Oncol. 2018 Apr;144(4):645-655. doi: 10.1007/s00432-018-2585-9. Epub 2018 Jan 23.
|
1492 |
Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1.Breast Cancer Res Treat. 2010 Jun;121(2):485-96. doi: 10.1007/s10549-009-0585-9. Epub 2009 Oct 24.
|
1493 |
Expression of glyoxalase I and II in normal and breast cancer tissues.Breast Cancer Res Treat. 2001 Mar;66(1):67-72. doi: 10.1023/a:1010632919129.
|
1494 |
Effect of resveratrol on the radiosensitivity of 5-FU in human breast cancer MCF-7 cells.J Cell Biochem. 2019 Sep;120(9):15671-15677. doi: 10.1002/jcb.28836. Epub 2019 May 8.
|
1495 |
The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1.J Pharmacol Exp Ther. 2017 Jun;361(3):398-407. doi: 10.1124/jpet.116.238212. Epub 2017 Mar 27.
|
1496 |
15-Deoxy-(12,14)-prostaglandin J(2) up-regulates the expression of 15-hydroxyprostaglandin dehydrogenase through DNA methyltransferase 1 inactivation.Free Radic Res. 2019 Mar;53(3):335-347. doi: 10.1080/10715762.2019.1576867. Epub 2019 Mar 1.
|
1497 |
Single nucleotide instability: a wide involvement in human and rat mammary carcinogenesis?.Mutat Res. 2002 Sep 30;506-507:101-11. doi: 10.1016/s0027-5107(02)00156-2.
|
1498 |
Identification of Hydroxysteroid (17) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.Cancer Immunol Immunother. 2011 Jul;60(7):919-29. doi: 10.1007/s00262-011-1001-y. Epub 2011 Mar 16.
|
1499 |
Inhibition of 3-Hydroxysteroid Dehydrogenase Type 1 Suppresses Interleukin-6 in Breast Cancer.J Surg Res. 2019 Sep;241:8-14. doi: 10.1016/j.jss.2019.03.024. Epub 2019 Apr 17.
|
1500 |
Genetic Variants in CD44 and MAT1A Confer Susceptibility to Acute Skin Reaction in Breast Cancer Patients Undergoing Radiation Therapy.Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):118-127. doi: 10.1016/j.ijrobp.2016.09.017. Epub 2016 Sep 20.
|
1501 |
Socioeconomic and demographic disparities in breast cancer stage at presentation and survival: A Swiss population-based study.Int J Cancer. 2017 Oct 15;141(8):1529-1539. doi: 10.1002/ijc.30856. Epub 2017 Jul 7.
|
1502 |
Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.Aging (Albany NY). 2017 Feb 22;9(2):547-555. doi: 10.18632/aging.101177.
|
1503 |
Suppression of mitochondrial complex I influences cell metastatic properties.PLoS One. 2013 Apr 22;8(4):e61677. doi: 10.1371/journal.pone.0061677. Print 2013.
|
1504 |
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study.Lancet Oncol. 2019 Aug;20(8):1124-1135. doi: 10.1016/S1470-2045(19)30328-6. Epub 2019 Jun 27.
|
1505 |
Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.FEBS J. 2011 Sep;278(18):3360-9. doi: 10.1111/j.1742-4658.2011.08260.x. Epub 2011 Aug 16.
|
1506 |
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer.Br J Cancer. 2009 May 19;100(10):1687-96. doi: 10.1038/sj.bjc.6605042.
|
1507 |
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis.Cell Death Dis. 2018 Mar 7;9(3):377. doi: 10.1038/s41419-018-0405-4.
|
1508 |
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.Cancer Res. 2009 Jul 1;69(13):5349-56. doi: 10.1158/0008-5472.CAN-09-0488. Epub 2009 Jun 16.
|
1509 |
Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3.Theranostics. 2019 Aug 14;9(21):6129-6142. doi: 10.7150/thno.37094. eCollection 2019.
|
1510 |
Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.Aging (Albany NY). 2019 Apr 14;11(7):2151-2176. doi: 10.18632/aging.101908.
|
1511 |
Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease.Cancer Detect Prev. 2007;31(2):95-101. doi: 10.1016/j.cdp.2007.02.004. Epub 2007 Apr 10.
|
1512 |
Elevated 80K-H protein in breast cancer: a role for FGF-1 stimulation of 80K-H.Int J Biol Markers. 2003 Apr-Jun;18(2):89-98. doi: 10.1177/172460080301800201.
|
1513 |
Functional Consequences of Intracellular Proline Levels Manipulation Affecting PRODH/POX-Dependent Pro-Apoptotic Pathways in a Novel in Vitro Cell Culture Model.Cell Physiol Biochem. 2017;43(2):670-684. doi: 10.1159/000480653. Epub 2017 Sep 22.
|
1514 |
Auranofin/Vitamin C: A Novel Drug Combination Targeting Triple-Negative Breast Cancer.J Natl Cancer Inst. 2019 Jun 1;111(6):597-608. doi: 10.1093/jnci/djy149.
|
1515 |
The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.Cancer Chemother Pharmacol. 2010 May;65(6):1067-81. doi: 10.1007/s00280-009-1112-8. Epub 2009 Aug 30.
|
1516 |
Altered expression of the hormone- and xenobiotic-metabolizing sulfotransferase enzymes 1A2 and 1C1 in malignant breast tissue.Int J Oncol. 2005 Apr;26(4):1079-85.
|
1517 |
SULT1E1 inhibits cell proliferation and invasion by activating PPAR in breast cancer.J Cancer. 2018 Feb 28;9(6):1078-1087. doi: 10.7150/jca.23596. eCollection 2018.
|
1518 |
Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells.Breast Cancer Res Treat. 2002 Jul;74(2):155-65. doi: 10.1023/a:1016114026769.
|
1519 |
Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis.J Breast Cancer. 2017 Jun;20(2):132-141. doi: 10.4048/jbc.2017.20.2.132. Epub 2017 Jun 26.
|
1520 |
Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues.Steroids. 2008 Jul;73(6):611-20. doi: 10.1016/j.steroids.2008.01.019. Epub 2008 Feb 3.
|
1521 |
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study.Clin Pharmacol Ther. 2019 Aug;106(2):422-431. doi: 10.1002/cpt.1391. Epub 2019 Mar 28.
|
1522 |
Uridine phosphorylase 1 associates to biological and clinical significance in thyroid carcinoma cell lines.J Cell Mol Med. 2019 Nov;23(11):7438-7448. doi: 10.1111/jcmm.14612. Epub 2019 Sep 9.
|
1523 |
Distinct prognostic values of ALDH1 isoenzymes in breast cancer.Tumour Biol. 2015 Apr;36(4):2421-6. doi: 10.1007/s13277-014-2852-6. Epub 2015 Jan 13.
|
1524 |
Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.Breast Cancer Res. 2019 May 17;21(1):64. doi: 10.1186/s13058-019-1150-z.
|
1525 |
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.Pharmacogenomics J. 2020 Feb;20(1):19-26. doi: 10.1038/s41397-019-0087-z. Epub 2019 Apr 10.
|
1526 |
The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.Anticancer Res. 2013 Apr;33(4):1499-509.
|
1527 |
Che-1 gene silencing induces osteosarcoma cell apoptosis by inhibiting mutant p53 expression.Biochem Biophys Res Commun. 2016 Apr 22;473(1):168-173. doi: 10.1016/j.bbrc.2016.03.073. Epub 2016 Mar 21.
|
1528 |
Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.Breast Cancer Res. 2017 Dec 11;19(1):131. doi: 10.1186/s13058-017-0914-6.
|
1529 |
HBXIP up-regulates ACSL1 through activating transcriptional factor Sp1 in breast cancer.Biochem Biophys Res Commun. 2017 Mar 11;484(3):565-571. doi: 10.1016/j.bbrc.2017.01.126. Epub 2017 Jan 26.
|
1530 |
Increased -actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.PLoS One. 2018 May 9;13(5):e0196986. doi: 10.1371/journal.pone.0196986. eCollection 2018.
|
1531 |
miR-449a Suppresses Tamoxifen Resistance in Human Breast Cancer Cells by Targeting ADAM22.Cell Physiol Biochem. 2018;50(1):136-149. doi: 10.1159/000493964. Epub 2018 Oct 2.
|
1532 |
A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18.
|
1533 |
Interaction between the ADAMTS-12 metalloprotease and fibulin-2 induces tumor-suppressive effects in breast cancer cells.Oncotarget. 2014 Mar 15;5(5):1253-64. doi: 10.18632/oncotarget.1690.
|
1534 |
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries.Nucleic Acids Res. 2019 Feb 28;47(4):e22. doi: 10.1093/nar/gky1228.
|
1535 |
Effects of targeted CD97 immune epitopes small interference RNA on cellular biological behaviors in MDA-MB231 malignant breast cancer cell line.Am J Transl Res. 2017 Oct 15;9(10):4640-4651. eCollection 2017.
|
1536 |
High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma.Oncotarget. 2017 Jul 18;8(29):47943-47956. doi: 10.18632/oncotarget.18203.
|
1537 |
Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.World J Surg Oncol. 2014 May 7;12:142. doi: 10.1186/1477-7819-12-142.
|
1538 |
Absence of AIF1L contributes to cell migration and a poor prognosis of breast cancer.Onco Targets Ther. 2018 Sep 5;11:5485-5498. doi: 10.2147/OTT.S165874. eCollection 2018.
|
1539 |
The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.Cancer Biomark. 2017;18(4):413-423. doi: 10.3233/CBM-160308.
|
1540 |
A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.PLoS One. 2013;8(2):e57095. doi: 10.1371/journal.pone.0057095. Epub 2013 Feb 22.
|
1541 |
Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.J Cell Physiol. 2019 Feb;234(2):1904-1912. doi: 10.1002/jcp.27066. Epub 2018 Aug 26.
|
1542 |
MicroRNA-452 contributes to the docetaxel resistance of breast cancer cells.Tumour Biol. 2014 Jul;35(7):6327-34. doi: 10.1007/s13277-014-1834-z. Epub 2014 Mar 20.
|
1543 |
Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer.Breast Cancer Res Treat. 2019 Jul;176(1):63-73. doi: 10.1007/s10549-019-05216-w. Epub 2019 Apr 2.
|
1544 |
Mask is required for the activity of the Hippo pathway effector Yki/YAP.Curr Biol. 2013 Feb 4;23(3):229-35. doi: 10.1016/j.cub.2012.12.033. Epub 2013 Jan 17.
|
1545 |
Prognostic roles of MAGE family members in breast cancer based on KM-Plotter Data.Oncol Lett. 2019 Oct;18(4):3501-3516. doi: 10.3892/ol.2019.10722. Epub 2019 Aug 6.
|
1546 |
Diversin is overexpressed in breast cancer and accelerates cell proliferation and invasion.PLoS One. 2014 May 23;9(5):e98591. doi: 10.1371/journal.pone.0098591. eCollection 2014.
|
1547 |
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.Oncologist. 2019 Nov;24(11):e1014-e1023. doi: 10.1634/theoncologist.2018-0727. Epub 2019 Apr 24.
|
1548 |
Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome.Oncotarget. 2017 Apr 20;8(32):52511-52526. doi: 10.18632/oncotarget.17281. eCollection 2017 Aug 8.
|
1549 |
Receptor-interacting protein kinase 2 promotes triple-negative breast cancer cell migration and invasion via activation of nuclear factor-kappaB and c-Jun N-terminal kinase pathways.Breast Cancer Res. 2014 Mar 19;16(2):R28. doi: 10.1186/bcr3629.
|
1550 |
The Role of Arrestin Domain-Containing 3 in Regulating Endocytic Recycling and Extracellular Vesicle Sorting of Integrin 4 in Breast Cancer.Cancers (Basel). 2018 Dec 11;10(12):507. doi: 10.3390/cancers10120507.
|
1551 |
Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ER.Anticancer Drugs. 2018 Jan;29(1):50-60. doi: 10.1097/CAD.0000000000000566.
|
1552 |
mASH1 is Highly Specific for Neuroendocrine Carcinomas: An Immunohistochemical Evaluation on Normal and Various Neoplastic Tissues.Arch Pathol Lab Med. 2017 Feb;141(2):288-292. doi: 10.5858/arpa.2015-0489-OA. Epub 2016 Sep 15.
|
1553 |
Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor gene through GATA-binding protein 3 (GATA3).J Biol Chem. 2014 Nov 7;289(45):31373-81. doi: 10.1074/jbc.M114.579839. Epub 2014 Sep 25.
|
1554 |
Defining the human copper proteome and analysis of its expression variation in cancers.Metallomics. 2017 Feb 22;9(2):112-123. doi: 10.1039/c6mt00202a.
|
1555 |
Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells.BMC Cancer. 2018 Oct 23;18(1):1029. doi: 10.1186/s12885-018-4945-x.
|
1556 |
Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Oncotarget. 2017 Jul 18;8(29):47675-47690. doi: 10.18632/oncotarget.17544.
|
1557 |
Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.Cell Cycle. 2017 Feb 16;16(4):312-318. doi: 10.1080/15384101.2016.1237325. Epub 2017 Jan 5.
|
1558 |
Novel ADC Solidifies Role in Breast Cancer.Cancer Discov. 2020 Feb;10(2):167. doi: 10.1158/2159-8290.CD-NB2019-139. Epub 2019 Dec 16.
|
1559 |
Involvement of B3GALNT2 overexpression in the cell growth of breast cancer.Int J Oncol. 2014 Feb;44(2):427-34. doi: 10.3892/ijo.2013.2187. Epub 2013 Nov 27.
|
1560 |
The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.Int J Oncol. 2014 Oct;45(4):1658-72. doi: 10.3892/ijo.2014.2565. Epub 2014 Jul 28.
|
1561 |
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer.Oncotarget. 2017 Mar 7;8(10):16642-16649. doi: 10.18632/oncotarget.15120.
|
1562 |
Roles of BCCIP deficiency in mammary tumorigenesis.Breast Cancer Res. 2017 Oct 18;19(1):115. doi: 10.1186/s13058-017-0907-5.
|
1563 |
Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer.Osteoporos Int. 2017 Apr;28(4):1413-1422. doi: 10.1007/s00198-016-3899-6. Epub 2017 Jan 12.
|
1564 |
Knockdown of BRCC3 exerts an antitumor effect on cervical cancer invitro.Mol Med Rep. 2018 Dec;18(6):4886-4894. doi: 10.3892/mmr.2018.9511. Epub 2018 Sep 26.
|
1565 |
Nifedipine promotes the proliferation and migration of breast cancer cells.PLoS One. 2014 Dec 1;9(12):e113649. doi: 10.1371/journal.pone.0113649. eCollection 2014.
|
1566 |
The LIM protein Ajuba recruits DBC1 and CBP/p300 to acetylate ER and enhances ER target gene expression in breast cancer cells.Nucleic Acids Res. 2019 Mar 18;47(5):2322-2335. doi: 10.1093/nar/gky1306.
|
1567 |
LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3.Cell Res. 2019 May;29(5):365-378. doi: 10.1038/s41422-019-0155-6. Epub 2019 Mar 11.
|
1568 |
Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation.Biosci Rep. 2017 Nov 21;37(6):BSR20171039. doi: 10.1042/BSR20171039. Print 2017 Dec 22.
|
1569 |
CAP2 is a Valuable Biomarker for Diagnosis and Prognostic in Patients with Gastric Cancer.Pathol Oncol Res. 2020 Jan;26(1):273-279. doi: 10.1007/s12253-018-0450-4. Epub 2018 Jul 26.
|
1570 |
CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.Theranostics. 2018 Apr 3;8(9):2549-2564. doi: 10.7150/thno.22523. eCollection 2018.
|
1571 |
Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.Biomed Pharmacother. 2013 Sep;67(7):629-36. doi: 10.1016/j.biopha.2013.06.006. Epub 2013 Jul 12.
|
1572 |
Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.Mol Cancer Res. 2020 Feb;18(2):240-252. doi: 10.1158/1541-7786.MCR-19-0722. Epub 2019 Nov 6.
|
1573 |
NIM: a node influence based method for cancer classification.Comput Math Methods Med. 2014;2014:826373. doi: 10.1155/2014/826373. Epub 2014 Aug 11.
|
1574 |
A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma.Br J Cancer. 2019 Apr;120(7):746-753. doi: 10.1038/s41416-019-0387-8. Epub 2019 Mar 1.
|
1575 |
CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.J Exp Clin Cancer Res. 2019 Mar 18;38(1):131. doi: 10.1186/s13046-019-1137-8.
|
1576 |
DDT exposure during pregnancy and DNA methylation alterations in female offspring in the Child Health and Development Study.Reprod Toxicol. 2020 Mar;92:138-147. doi: 10.1016/j.reprotox.2019.02.010. Epub 2019 Feb 26.
|
1577 |
CCL1 is a major regulatory T cell attracting factor in human breast cancer.BMC Cancer. 2018 Dec 20;18(1):1278. doi: 10.1186/s12885-018-5117-8.
|
1578 |
Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.Breast Cancer Res. 2019 Feb 27;21(1):31. doi: 10.1186/s13058-019-1117-0.
|
1579 |
Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.Cell Physiol Biochem. 2017;44(5):1741-1748. doi: 10.1159/000485780. Epub 2017 Dec 6.
|
1580 |
Copper Chaperone for Superoxide Dismutase Promotes Breast Cancer Cell Proliferation and Migration via ROS-Mediated MAPK/ERK Signaling.Front Pharmacol. 2019 Apr 5;10:356. doi: 10.3389/fphar.2019.00356. eCollection 2019.
|
1581 |
Role of TGF- receptor III localization in polarity and breast cancer progression.Mol Biol Cell. 2014 Aug 1;25(15):2291-304. doi: 10.1091/mbc.E14-03-0825. Epub 2014 May 28.
|
1582 |
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.Anticancer Res. 2019 Feb;39(2):549-555. doi: 10.21873/anticanres.13147.
|
1583 |
The prognostic significance of Cdc6 and Cdt1 in breast cancer.Sci Rep. 2017 Apr 20;7(1):985. doi: 10.1038/s41598-017-00998-9.
|
1584 |
The PDGFR/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.BMC Cancer. 2018 May 23;18(1):586. doi: 10.1186/s12885-018-4500-9.
|
1585 |
Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.J Cell Biochem. 2020 Feb;121(2):1307-1316. doi: 10.1002/jcb.29367. Epub 2019 Sep 6.
|
1586 |
CENPI is overexpressed in colorectal cancer and regulates cell migration and invasion.Gene. 2018 Oct 20;674:80-86. doi: 10.1016/j.gene.2018.06.067. Epub 2018 Jun 21.
|
1587 |
CEP135 isoform dysregulation promotes centrosome amplification in breast cancer cells.Mol Biol Cell. 2019 May 1;30(10):1230-1244. doi: 10.1091/mbc.E18-10-0674. Epub 2019 Feb 27.
|
1588 |
Discovery of Centrosomal Protein 70 as an Important Player in the Development and Progression of Breast Cancer.Am J Pathol. 2017 Mar;187(3):679-688. doi: 10.1016/j.ajpath.2016.11.005. Epub 2017 Jan 5.
|
1589 |
Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer.Horm Cancer. 2018 Oct;9(5):338-348. doi: 10.1007/s12672-018-0339-4. Epub 2018 Jun 28.
|
1590 |
A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells.J Transl Med. 2013 Mar 5;11:57. doi: 10.1186/1479-5876-11-57.
|
1591 |
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1.J Comp Eff Res. 2017 Oct;6(7):563-574. doi: 10.2217/cer-2017-0015. Epub 2017 Sep 19.
|
1592 |
Aberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Tumour Biol. 2014 Sep;35(9):9395-404. doi: 10.1007/s13277-014-2235-z. Epub 2014 Jun 22.
|
1593 |
The genetic landscape of breast carcinomas with neuroendocrine differentiation.J Pathol. 2017 Feb;241(3):405-419. doi: 10.1002/path.4837. Epub 2016 Dec 26.
|
1594 |
Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy.Oncoimmunology. 2018 Mar 13;7(6):e1436922. doi: 10.1080/2162402X.2018.1436922. eCollection 2018.
|
1595 |
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.Oncotarget. 2017 Feb 28;8(9):15789-15801. doi: 10.18632/oncotarget.15004.
|
1596 |
Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review.Medicine (Baltimore). 2018 Apr;97(15):e0349. doi: 10.1097/MD.0000000000010349.
|
1597 |
NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14676-81. doi: 10.1073/pnas.1313198110. Epub 2013 Aug 19.
|
1598 |
CITED2 attenuates macrophage recruitment concordant with the downregulation of CCL20 in breast cancer cells.Oncol Lett. 2018 Jan;15(1):871-878. doi: 10.3892/ol.2017.7420. Epub 2017 Nov 15.
|
1599 |
Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.Mol Med Rep. 2019 Jun;19(6):4761-4769. doi: 10.3892/mmr.2019.10134. Epub 2019 Apr 5.
|
1600 |
Association of Cytokeratin 5 and Claudin 3 expression with BRCA1 and BRCA2 germline mutations in women with early breast cancer.BMC Cancer. 2019 Jul 15;19(1):695. doi: 10.1186/s12885-019-5908-6.
|
1601 |
Soy Foods Might Weaken the Sensitivity of Tamoxifen in Premenopausal Patients With Lumina A Subtype of Breast Cancer.Clin Breast Cancer. 2019 Apr;19(2):e337-e342. doi: 10.1016/j.clbc.2018.12.003. Epub 2018 Dec 12.
|
1602 |
CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer.J Cell Sci. 2014 Sep 15;127(Pt 18):3893-901. doi: 10.1242/jcs.135947. Epub 2014 Jul 11.
|
1603 |
CMTM1_v17 is a novel potential therapeutic target in breast cancer.Oncol Rep. 2014 Nov;32(5):1829-36. doi: 10.3892/or.2014.3429. Epub 2014 Aug 20.
|
1604 |
MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.J Pathol. 2013 Nov;231(3):388-99. doi: 10.1002/path.4248.
|
1605 |
Genetic variants of genes in the NER pathway associated with risk of breast cancer: A large-scale analysis of 14 published GWAS datasets in the DRIVE study.Int J Cancer. 2019 Sep 1;145(5):1270-1279. doi: 10.1002/ijc.32371. Epub 2019 May 13.
|
1606 |
miR-26 suppresses renal cell cancer via down-regulating coronin-3.Mol Cell Biochem. 2020 Jan;463(1-2):137-146. doi: 10.1007/s11010-019-03636-2. Epub 2019 Oct 8.
|
1607 |
Detection of mitochondrial DNA mutations by high-throughput sequencing in the blood of breast cancer patients.Int J Mol Med. 2014 Jan;33(1):77-82. doi: 10.3892/ijmm.2013.1559. Epub 2013 Nov 19.
|
1608 |
Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients.Int J Oncol. 2014 Dec;45(6):2549-59. doi: 10.3892/ijo.2014.2676. Epub 2014 Sep 25.
|
1609 |
MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4.Biochem Cell Biol. 2019 Dec;97(6):722-730. doi: 10.1139/bcb-2019-0008. Epub 2019 Apr 10.
|
1610 |
Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.Oncol Rep. 2019 Feb;41(2):801-810. doi: 10.3892/or.2018.6887. Epub 2018 Nov 27.
|
1611 |
The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.Mol Cancer. 2013 Apr 9;12:28. doi: 10.1186/1476-4598-12-28.
|
1612 |
ITIH5 mediates epigenetic reprogramming of breast cancer cells.Mol Cancer. 2017 Feb 23;16(1):44. doi: 10.1186/s12943-017-0610-2.
|
1613 |
Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion.Oncol Rep. 2017 Jul;38(1):283-292. doi: 10.3892/or.2017.5656. Epub 2017 May 22.
|
1614 |
Nuclear CSPP1 expression defined subtypes of basal-like breast cancer.Br J Cancer. 2014 Jul 15;111(2):326-38. doi: 10.1038/bjc.2014.297. Epub 2014 Jun 5.
|
1615 |
Hypoxia promotes breast cancer cell invasion through HIF-1-mediated up-regulation of the invadopodial actin bundling protein CSRP2.Sci Rep. 2018 Jul 5;8(1):10191. doi: 10.1038/s41598-018-28637-x.
|
1616 |
ACE: A Workbench Using Evolutionary Genetic Algorithms for Analyzing Association in TCGA.Cancer Res. 2019 Apr 15;79(8):2072-2075. doi: 10.1158/0008-5472.CAN-18-1976. Epub 2019 Feb 13.
|
1617 |
Detection of KK-LC-1 Protein, a Cancer/Testis Antigen, in Patients with Breast Cancer.Anticancer Res. 2018 Oct;38(10):5923-5928. doi: 10.21873/anticanres.12937.
|
1618 |
Association of CYBA gene (-930 A/G and 242 C/T) polymorphisms with oxidative stress in breast cancer: a case-control study.PeerJ. 2018 Oct 4;6:e5509. doi: 10.7717/peerj.5509. eCollection 2018.
|
1619 |
Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions.Naunyn Schmiedebergs Arch Pharmacol. 2019 Feb;392(2):165-175. doi: 10.1007/s00210-018-1579-0. Epub 2018 Nov 21.
|
1620 |
Disabled-1 is down-regulated in clinical breast cancer and regulates cell apoptosis through NF-B/Bcl-2/caspase-9.J Cell Mol Med. 2019 Feb;23(2):1622-1627. doi: 10.1111/jcmm.14047. Epub 2018 Nov 28.
|
1621 |
miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.IUBMB Life. 2018 Jan;70(1):71-80. doi: 10.1002/iub.1705. Epub 2017 Dec 16.
|
1622 |
DACT1, an antagonist to Wnt/-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer.Breast Cancer Res. 2013 Mar 12;15(2):R23. doi: 10.1186/bcr3399.
|
1623 |
One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?.Eur Radiol. 2018 May;28(5):1938-1948. doi: 10.1007/s00330-017-5167-3. Epub 2017 Dec 11.
|
1624 |
Half-sandwich Ru((6)-p-cymene) complexes featuring pyrazole appended ligands: Synthesis, DNA binding and in vitro cytotoxicity.J Inorg Biochem. 2019 May;194:74-84. doi: 10.1016/j.jinorgbio.2019.02.012. Epub 2019 Feb 23.
|
1625 |
DDT and Breast Cancer: Prospective Study of Induction Time and Susceptibility Windows.J Natl Cancer Inst. 2019 Aug 1;111(8):803-810. doi: 10.1093/jnci/djy198.
|
1626 |
Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.BMC Cancer. 2018 Oct 22;18(1):1016. doi: 10.1186/s12885-018-4950-0.
|
1627 |
The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer.J Cell Physiol. 2019 May;234(5):5478-5487. doi: 10.1002/jcp.26912. Epub 2018 Nov 11.
|
1628 |
IBP regulates epithelial-to-mesenchymal transition and the motility of breast cancer cells via Rac1, RhoA and Cdc42 signaling pathways.Oncogene. 2014 Jun 26;33(26):3374-82. doi: 10.1038/onc.2013.337. Epub 2013 Aug 26.
|
1629 |
Association between polymorphisms in the thymidylate synthase gene and risk of breast cancer in a Mexican population.Genet Mol Res. 2014 Oct 27;13(4):8749-56. doi: 10.4238/2014.October.27.16.
|
1630 |
LncRNA AK023948 is a positive regulator of AKT.Nat Commun. 2017 Feb 8;8:14422. doi: 10.1038/ncomms14422.
|
1631 |
Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanes.Sci Rep. 2015 Jul 16;5:12136. doi: 10.1038/srep12136.
|
1632 |
DIP2C expression in breast cancer and its clinical significance.Pathol Res Pract. 2017 Nov;213(11):1394-1399. doi: 10.1016/j.prp.2017.09.007. Epub 2017 Sep 12.
|
1633 |
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation.Oncotarget. 2015 Sep 8;6(26):22467-79. doi: 10.18632/oncotarget.4164.
|
1634 |
ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells.Neoplasia. 2018 Aug;20(8):857-870. doi: 10.1016/j.neo.2018.06.008. Epub 2018 Jul 17.
|
1635 |
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.J Pathol. 2019 Mar;247(3):381-391. doi: 10.1002/path.5197. Epub 2019 Jan 25.
|
1636 |
The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.Oncol Rep. 2017 May;37(5):2695-2701. doi: 10.3892/or.2017.5538. Epub 2017 Mar 31.
|
1637 |
Exposure to bisphenol A: current levels from food intake are toxic to human cells.Mol Biol Rep. 2019 Apr;46(2):2555-2559. doi: 10.1007/s11033-019-04666-1. Epub 2019 Feb 7.
|
1638 |
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/-catenin signaling in breast cancer.Biochem Biophys Res Commun. 2018 Oct 20;505(1):302-308. doi: 10.1016/j.bbrc.2018.09.103. Epub 2018 Sep 22.
|
1639 |
E2F6 is essential for cell viability in breast cancer cells during replication stress.Turk J Biol. 2019 Oct 14;43(5):293-304. doi: 10.3906/biy-1905-6. eCollection 2019.
|
1640 |
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.Oncol Lett. 2018 Jun;15(6):9216-9230. doi: 10.3892/ol.2018.8514. Epub 2018 Apr 17.
|
1641 |
FBLN-4 and BCRP genes as two prognostic markers are downregulated in breast cancer tissue.Cancer Biomark. 2017;19(1):51-55. doi: 10.3233/CBM-160335.
|
1642 |
CLE-10 from Carpesium abrotanoides L. Suppresses the Growth of Human Breast Cancer Cells (MDA-MB-231) In Vitro by Inducing Apoptosis and Pro-Death Autophagy Via the PI3K/Akt/mTOR Signaling Pathway.Molecules. 2019 Mar 20;24(6):1091. doi: 10.3390/molecules24061091.
|
1643 |
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.Hum Mol Genet. 2014 Nov 15;23(22):6034-46. doi: 10.1093/hmg/ddu300. Epub 2014 Jun 13.
|
1644 |
Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.Biochem Biophys Res Commun. 2013 Sep 6;438(4):635-9. doi: 10.1016/j.bbrc.2013.07.131. Epub 2013 Aug 8.
|
1645 |
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.Breast Cancer Res Treat. 2013 Feb;138(1):37-45. doi: 10.1007/s10549-013-2408-2. Epub 2013 Jan 18.
|
1646 |
Embigin, regulated by HOXC8, plays a suppressive role in breast tumorigenesis.Oncotarget. 2015 Sep 15;6(27):23496-509. doi: 10.18632/oncotarget.4360.
|
1647 |
A novel protein is lower expressed in renal cell carcinoma.Int J Mol Sci. 2014 Apr 29;15(5):7398-408. doi: 10.3390/ijms15057398.
|
1648 |
EPB41L5 Mediates TGF-Induced Metastasis of Gastric Cancer.Clin Cancer Res. 2019 Jun 15;25(12):3617-3629. doi: 10.1158/1078-0432.CCR-18-2959. Epub 2019 Feb 27.
|
1649 |
Development and Evaluation of Antibody Proteomics Technology for Rapid and Comprehensive Identification of Potential Biomarkers and Therapeutic Targets.Biol Pharm Bull. 2018;41(5):663-669. doi: 10.1248/bpb.b17-01041.
|
1650 |
Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling.Tumour Biol. 2017 Feb;39(2):1010428317691010. doi: 10.1177/1010428317691010.
|
1651 |
Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance.Oncogene. 2018 Mar;37(12):1594-1609. doi: 10.1038/s41388-017-0031-0. Epub 2018 Jan 12.
|
1652 |
miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.Exp Ther Med. 2019 Nov;18(5):3525-3533. doi: 10.3892/etm.2019.7962. Epub 2019 Aug 30.
|
1653 |
Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways.EMBO Rep. 2019 Feb;20(2):e46078. doi: 10.15252/embr.201846078. Epub 2019 Jan 21.
|
1654 |
Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.Chromosoma. 2017 Jun;126(3):417-430. doi: 10.1007/s00412-016-0602-9. Epub 2016 Jun 8.
|
1655 |
Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies.Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):622-8. doi: 10.1158/1055-9965.EPI-13-1043. Epub 2014 Jan 27.
|
1656 |
The appearance of breast cancer metastases on dry bone: Implications for forensic anthropology.J Forensic Leg Med. 2019 Feb;61:5-12. doi: 10.1016/j.jflm.2018.10.007. Epub 2018 Oct 25.
|
1657 |
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer.Oncotarget. 2017 Mar 14;8(11):18381-18398. doi: 10.18632/oncotarget.15110.
|
1658 |
Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.Asian Pac J Cancer Prev. 2014 Jan;14(11):6625-9. doi: 10.7314/apjcp.2013.14.11.6625.
|
1659 |
Expression of kindlin-3 in melanoma cells impedes cell migration and metastasis.Cell Adh Migr. 2017 Sep 3;11(5-6):419-433. doi: 10.1080/19336918.2016.1243645. Epub 2016 Nov 2.
|
1660 |
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.Br J Cancer. 2014 Feb 18;110(4):1088-100. doi: 10.1038/bjc.2013.769.
|
1661 |
FHOD1 formin is upregulated in melanomas and modifies proliferation and tumor growth.Exp Cell Res. 2017 Jan 1;350(1):267-278. doi: 10.1016/j.yexcr.2016.12.004. Epub 2016 Dec 2.
|
1662 |
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.BMC Cancer. 2019 Apr 11;19(1):351. doi: 10.1186/s12885-019-5500-0.
|
1663 |
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.Genome Biol. 2018 Dec 11;19(1):218. doi: 10.1186/s13059-018-1594-y.
|
1664 |
Propensity for different vascular distributions and cerebral edema of intraparenchymal brain metastases from different primary cancers.J Neurooncol. 2019 May;143(1):115-122. doi: 10.1007/s11060-019-03142-x. Epub 2019 Mar 5.
|
1665 |
Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.Breast Cancer Res. 2014 Dec 30;16(6):3413. doi: 10.1186/s13058-014-0503-x.
|
1666 |
FOXF2 reprograms breast cancer cells into bone metastasis seeds.Nat Commun. 2019 Jun 20;10(1):2707. doi: 10.1038/s41467-019-10379-7.
|
1667 |
Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.Gene. 2020 Jan 5;722:144057. doi: 10.1016/j.gene.2019.144057. Epub 2019 Aug 17.
|
1668 |
Downregulation of FOXP2 promotes breast cancer migration and invasion through TGF/SMAD signaling pathway.Oncol Lett. 2018 Jun;15(6):8582-8588. doi: 10.3892/ol.2018.8402. Epub 2018 Mar 30.
|
1669 |
FSIP1 is correlated with estrogen receptor status and poor prognosis.Mol Carcinog. 2020 Jan;59(1):126-135. doi: 10.1002/mc.23134. Epub 2019 Nov 12.
|
1670 |
Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin.Int J Oncol. 2013 Nov;43(5):1481-6. doi: 10.3892/ijo.2013.2063. Epub 2013 Aug 20.
|
1671 |
FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis.EBioMedicine. 2019 Mar;41:384-394. doi: 10.1016/j.ebiom.2019.02.032. Epub 2019 Feb 23.
|
1672 |
EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion.Transl Oncol. 2018 Apr;11(2):346-352. doi: 10.1016/j.tranon.2018.01.021. Epub 2018 Feb 8.
|
1673 |
T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression.Acta Neuropathol. 2018 Apr;135(4):581-599. doi: 10.1007/s00401-018-1806-2. Epub 2018 Jan 19.
|
1674 |
Genetic Variants in Group-Specific Component (GC) Gene Are Associated with Breast Cancer Risk among Chinese Women.Biomed Res Int. 2019 Nov 15;2019:3295781. doi: 10.1155/2019/3295781. eCollection 2019.
|
1675 |
Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis.BMC Cancer. 2018 Dec 4;18(1):1211. doi: 10.1186/s12885-018-5113-z.
|
1676 |
Loss of glutaredoxin 3 impedes mammary lobuloalveolar development during pregnancy and lactation.Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E136-E149. doi: 10.1152/ajpendo.00150.2016. Epub 2016 Nov 15.
|
1677 |
NDF, a nucleosome-destabilizing factor that facilitates transcription through nucleosomes.Genes Dev. 2018 May 1;32(9-10):682-694. doi: 10.1101/gad.313973.118. Epub 2018 May 14.
|
1678 |
Lack of expression of the proteins GMPR2 and PPAR are associated with the basal phenotype and patient outcome in breast cancer.Breast Cancer Res Treat. 2013 Jan;137(1):127-37. doi: 10.1007/s10549-012-2302-3. Epub 2012 Dec 4.
|
1679 |
c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells.Molecules. 2017 Apr 10;22(4):612. doi: 10.3390/molecules22040612.
|
1680 |
Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients' outcome: A STROBE-compliant article.Medicine (Baltimore). 2019 Mar;98(9):e14744. doi: 10.1097/MD.0000000000014744.
|
1681 |
Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer.J Transl Med. 2014 May 28;12:149. doi: 10.1186/1479-5876-12-149.
|
1682 |
Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation.Mol Oncol. 2019 Apr;13(4):959-977. doi: 10.1002/1878-0261.12466. Epub 2019 Mar 1.
|
1683 |
Small non-coding RNA landscape is modified by GPAT2 silencing in MDA-MB-231 cells.Oncotarget. 2018 Jun 15;9(46):28141-28154. doi: 10.18632/oncotarget.25582. eCollection 2018 Jun 15.
|
1684 |
AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer.Oncotarget. 2015 Jul 30;6(21):18406-17. doi: 10.18632/oncotarget.4074.
|
1685 |
Her2-Functionalized Gold-Nanoshelled Magnetic Hybrid Nanoparticles: a Theranostic Agent for Dual-Modal Imaging and Photothermal Therapy of Breast Cancer.Nanoscale Res Lett. 2019 Aug 26;14(1):235. doi: 10.1186/s11671-019-3053-4.
|
1686 |
Breast carcinoma progression and tumour vascular markers related to apoptotic mechanisms.Dis Markers. 2014;2014:156034. doi: 10.1155/2014/156034. Epub 2014 Feb 18.
|
1687 |
The Prognosis Of Peroxiredoxin Family In Breast Cancer.Cancer Manag Res. 2019 Nov 14;11:9685-9699. doi: 10.2147/CMAR.S229389. eCollection 2019.
|
1688 |
Gasdermin-B promotes invasion and metastasis in breast cancer cells.PLoS One. 2014 Mar 27;9(3):e90099. doi: 10.1371/journal.pone.0090099. eCollection 2014.
|
1689 |
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.Eur J Hum Genet. 2017 Apr;25(4):432-438. doi: 10.1038/ejhg.2016.203. Epub 2017 Feb 1.
|
1690 |
Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.J Biol Chem. 2017 Feb 10;292(6):2237-2254. doi: 10.1074/jbc.M116.764233. Epub 2016 Dec 29.
|
1691 |
A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer.Horm Cancer. 2015 Dec;6(5-6):214-24. doi: 10.1007/s12672-015-0230-5. Epub 2015 Jun 26.
|
1692 |
Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.Dis Markers. 2018 Feb 25;2018:9369358. doi: 10.1155/2018/9369358. eCollection 2018.
|
1693 |
Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer.PLoS One. 2014 Jun 20;9(6):e100691. doi: 10.1371/journal.pone.0100691. eCollection 2014.
|
1694 |
TIMELESS contributes to the progression of breast cancer through activation of MYC.Breast Cancer Res. 2017 May 2;19(1):53. doi: 10.1186/s13058-017-0838-1.
|
1695 |
MicroRNA related polymorphisms and breast cancer risk.PLoS One. 2014 Nov 12;9(11):e109973. doi: 10.1371/journal.pone.0109973. eCollection 2014.
|
1696 |
A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.Protein Cell. 2019 Aug;10(8):595-605. doi: 10.1007/s13238-019-0607-2. Epub 2019 Feb 1.
|
1697 |
Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/-catenin signaling pathway in colorectal cancer.Oncol Rep. 2018 Sep;40(3):1261-1274. doi: 10.3892/or.2018.6539. Epub 2018 Jul 2.
|
1698 |
Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers.Oncotarget. 2015 Jul 30;6(21):18641-52. doi: 10.18632/oncotarget.4080.
|
1699 |
SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment.Br J Cancer. 2019 Apr;120(7):728-745. doi: 10.1038/s41416-019-0405-x. Epub 2019 Feb 28.
|
1700 |
The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels.Cancer Chemother Pharmacol. 2013 Mar;71(3):593-601. doi: 10.1007/s00280-012-2034-4. Epub 2012 Dec 11.
|
1701 |
High-mobility group boxes mediate cell proliferation and radiosensitivity via retinoblastoma-interaction-dependent and -independent mechanisms.Cancer Biother Radiopharm. 2012 Jun;27(5):329-35. doi: 10.1089/cbr.2012.1199. Epub 2012 Jun 1.
|
1702 |
Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.J Cell Biochem. 2019 Jan;120(1):658-670. doi: 10.1002/jcb.27423. Epub 2018 Sep 11.
|
1703 |
Analysis of HOX gene expression patterns in human breast cancer.Mol Biotechnol. 2014 Jan;56(1):64-71. doi: 10.1007/s12033-013-9682-4.
|
1704 |
Transcriptional activation of EGFR by HOXB5 and its role in breast cancer cell invasion.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2924-2930. doi: 10.1016/j.bbrc.2018.08.071. Epub 2018 Aug 13.
|
1705 |
Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer.Oncol Rep. 2014 Sep;32(3):1078-86. doi: 10.3892/or.2014.3277. Epub 2014 Jun 23.
|
1706 |
Melatonin charge transfer complex with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone: Molecular structure, DFT studies, thermal analyses, evaluation of biological activity and utility for determination of melatonin in pure and dosage forms.Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jul 5;182:143-159. doi: 10.1016/j.saa.2017.03.068. Epub 2017 Apr 4.
|
1707 |
HSP105 recruits protein phosphatase 2A to dephosphorylate -catenin.Mol Cell Biol. 2015 Apr;35(8):1390-400. doi: 10.1128/MCB.01307-14. Epub 2015 Feb 2.
|
1708 |
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer.Breast Cancer Res Treat. 2014 Feb;144(1):123-31. doi: 10.1007/s10549-014-2832-y. Epub 2014 Jan 30.
|
1709 |
Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy.Sci Rep. 2014 Dec 18;4:7548. doi: 10.1038/srep07548.
|
1710 |
Identification of a Novel Invasion-Promoting Region in Insulin Receptor Substrate 2.Mol Cell Biol. 2018 Jun 28;38(14):e00590-17. doi: 10.1128/MCB.00590-17. Print 2018 Jul 15.
|
1711 |
Absence of gamma-interferon-inducible lysosomal thiol reductase (GILT) is associated with poor disease-free survival in breast cancer patients.PLoS One. 2014 Oct 21;9(10):e109449. doi: 10.1371/journal.pone.0109449. eCollection 2014.
|
1712 |
G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS.Br J Cancer. 2018 Jul;119(1):52-64. doi: 10.1038/s41416-018-0137-3. Epub 2018 Jun 14.
|
1713 |
IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer invivo by JAK/STAT-mediated induction of p21.Cancer Lett. 2017 Jul 28;399:29-43. doi: 10.1016/j.canlet.2017.04.005. Epub 2017 Apr 12.
|
1714 |
Recurrent read-through fusion transcripts in breast cancer.Breast Cancer Res Treat. 2014 Jul;146(2):287-97. doi: 10.1007/s10549-014-3019-2. Epub 2014 Jun 15.
|
1715 |
4 is highly expressed in carcinogen-transformed human cells and primary human cancers.Oncogene. 2011 Jun 30;30(26):2943-53. doi: 10.1038/onc.2011.20. Epub 2011 Feb 21.
|
1716 |
mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of 1 integrin function.Mol Cancer Res. 2013 Jun;11(6):593-603. doi: 10.1158/1541-7786.MCR-12-0496. Epub 2013 Mar 6.
|
1717 |
Genetic variants in interleukin genes are associated with breast cancer risk and survival in a genetically admixed population: the Breast Cancer Health Disparities Study.Carcinogenesis. 2014 Aug;35(8):1750-9. doi: 10.1093/carcin/bgu078. Epub 2014 Mar 26.
|
1718 |
The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.Oncotarget. 2017 May 17;8(47):81953-81966. doi: 10.18632/oncotarget.17918. eCollection 2017 Oct 10.
|
1719 |
Expression and prognostic role of SKIP in human breast carcinoma.J Mol Histol. 2014 Apr;45(2):169-80. doi: 10.1007/s10735-013-9546-z. Epub 2013 Oct 23.
|
1720 |
Effects of high fat diet-induced obesity on mammary tumorigenesis in the PyMT/MMTV murine model.Cancer Biol Ther. 2019;20(4):487-496. doi: 10.1080/15384047.2018.1537574. Epub 2018 Nov 2.
|
1721 |
Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer.Nanoscale. 2020 Jan 2;12(2):877-887. doi: 10.1039/c9nr09011h.
|
1722 |
Bio-Field Array: The Influence of Junction Mediating and Regulatory Protein Expression on Cytoskeletal Filament Behavior During Apoptosis in Triple-Negative Breast Cancer.Breast Cancer (Auckl). 2019 Feb 28;13:1178223419830981. doi: 10.1177/1178223419830981. eCollection 2019.
|
1723 |
Histone lysine demethylases in breast cancer.Crit Rev Oncol Hematol. 2013 May;86(2):97-103. doi: 10.1016/j.critrevonc.2012.11.008. Epub 2012 Dec 23.
|
1724 |
Soybean (Glycine max) prevents the progression of breast cancer cells by downregulating the level of histone demethylase JMJD5.J Cancer Res Ther. 2018 Sep;14(Supplement):S609-S615. doi: 10.4103/0973-1482.187292.
|
1725 |
Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.PLoS One. 2013 Jul 29;8(7):e70596. doi: 10.1371/journal.pone.0070596. Print 2013.
|
1726 |
Differential promoter methylation of kinesin family member 1a in plasma is associated with breast cancer and DNA repair capacity.Oncol Rep. 2014 Aug;32(2):505-12. doi: 10.3892/or.2014.3262. Epub 2014 Jun 13.
|
1727 |
Down-regulation of KIF2A inhibits gastric cancer cell invasion via suppressing MT1-MMP.Clin Exp Pharmacol Physiol. 2018 Oct;45(10):1010-1018. doi: 10.1111/1440-1681.12974. Epub 2018 Jun 26.
|
1728 |
An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.Onco Targets Ther. 2018 Aug 10;11:4755-4768. doi: 10.2147/OTT.S164730. eCollection 2018.
|
1729 |
Low doses of Paclitaxel repress breast cancer invasion through DJ-1/KLF17 signalling pathway.Clin Exp Pharmacol Physiol. 2018 Apr 27. doi: 10.1111/1440-1681.12960. Online ahead of print.
|
1730 |
PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.Cell Rep. 2019 Apr 2;27(1):294-306.e5. doi: 10.1016/j.celrep.2019.02.111.
|
1731 |
Weighted gene co-expression network analysis reveals modules and hub genes associated with the development of breast cancer.Medicine (Baltimore). 2019 Feb;98(6):e14345. doi: 10.1097/MD.0000000000014345.
|
1732 |
Integrin 31 can function to promote spontaneous metastasis and lung colonization of invasive breast carcinoma.Mol Cancer Res. 2014 Jan;12(1):143-154. doi: 10.1158/1541-7786.MCR-13-0184. Epub 2013 Sep 3.
|
1733 |
LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis.Elife. 2014 Jul 22;3:e02907. doi: 10.7554/eLife.02907.
|
1734 |
Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.Transl Oncol. 2018 Oct;11(5):1090-1096. doi: 10.1016/j.tranon.2018.06.006. Epub 2018 Jul 11.
|
1735 |
LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.Mol Oncol. 2014 Mar;8(2):401-16. doi: 10.1016/j.molonc.2013.12.009. Epub 2013 Dec 25.
|
1736 |
LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.Eur Rev Med Pharmacol Sci. 2018 May;22(10):3067-3073. doi: 10.26355/eurrev_201805_15066.
|
1737 |
Polymorphisms in homologous recombination repair genes and the risk and survival of breast cancer.J Gene Med. 2017 Sep;19(9-10). doi: 10.1002/jgm.2988. Epub 2017 Oct 10.
|
1738 |
Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.Oncogene. 2016 Mar 3;35(9):1143-52. doi: 10.1038/onc.2015.169. Epub 2015 Jul 6.
|
1739 |
Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling.Front Immunol. 2018 May 8;9:871. doi: 10.3389/fimmu.2018.00871. eCollection 2018.
|
1740 |
A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.J Cell Physiol. 2019 Nov;234(11):20036-20045. doi: 10.1002/jcp.28600. Epub 2019 Apr 4.
|
1741 |
Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients.PLoS One. 2014 Jun 9;9(6):e98930. doi: 10.1371/journal.pone.0098930. eCollection 2014.
|
1742 |
Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.Eur J Surg Oncol. 2019 Feb;45(2):110-117. doi: 10.1016/j.ejso.2018.09.027. Epub 2018 Oct 17.
|
1743 |
MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines.Biochem Biophys Res Commun. 2018 Oct 2;504(2):434-439. doi: 10.1016/j.bbrc.2018.08.187. Epub 2018 Sep 6.
|
1744 |
Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.Mol Med Rep. 2013 Apr;7(4):1215-22. doi: 10.3892/mmr.2013.1308. Epub 2013 Feb 5.
|
1745 |
MAP1S controls breast cancer cell TLR5 signaling pathway and promotes TLR5 signaling-based tumor suppression.PLoS One. 2014 Jan 23;9(1):e86839. doi: 10.1371/journal.pone.0086839. eCollection 2014.
|
1746 |
MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.Cancer Res. 2014 Jan 1;74(1):162-72. doi: 10.1158/0008-5472.CAN-13-1310. Epub 2013 Nov 14.
|
1747 |
MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells.EMBO Rep. 2017 Mar;18(3):420-436. doi: 10.15252/embr.201642455. Epub 2017 Feb 9.
|
1748 |
Myoglobin induces mitochondrial fusion, thereby inhibiting breast cancer cell proliferation.J Biol Chem. 2019 May 3;294(18):7269-7282. doi: 10.1074/jbc.RA118.006673. Epub 2019 Mar 14.
|
1749 |
Methylcrotonoyl-CoA carboxylase 2 overexpression predicts an unfavorable prognosis and promotes cell proliferation in breast cancer.Biomark Med. 2019 Apr;13(6):427-436. doi: 10.2217/bmm-2018-0475. Epub 2019 Mar 21.
|
1750 |
Fluoro-Chromogenic Labelling for Detection of MCM2 to Assess Proliferation Activity in HER2-amplified Breast Carcinomas.Appl Immunohistochem Mol Morphol. 2020 Mar;28(3):175-186. doi: 10.1097/PAI.0000000000000716.
|
1751 |
Mitochondrial calcium uniporter as a target of microRNA-340 and promoter of metastasis via enhancing the Warburg effect.Oncotarget. 2017 Jul 31;8(48):83831-83844. doi: 10.18632/oncotarget.19747. eCollection 2017 Oct 13.
|
1752 |
Med19 is involved in chemoresistance by mediating autophagy through HMGB1 in breast cancer.J Cell Biochem. 2019 Jan;120(1):507-518. doi: 10.1002/jcb.27406. Epub 2018 Aug 30.
|
1753 |
Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER?breast tumors.FASEB J. 2013 Mar;27(3):942-54. doi: 10.1096/fj.12-209346. Epub 2012 Nov 16.
|
1754 |
Integrated analysis of microfibrillar-associated proteins reveals MFAP4 as a novel biomarker in human cancers.Epigenomics. 2019 Jan;11(1):1635-1651. doi: 10.2217/epi-2018-0080. Epub 2018 Aug 9.
|
1755 |
MiR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells.RNA Biol. 2019 Jul;16(7):918-929. doi: 10.1080/15476286.2019.1600999. Epub 2019 Apr 25.
|
1756 |
CRISPR deletion of MIEN1 in breast cancer cells.PLoS One. 2018 Oct 4;13(10):e0204976. doi: 10.1371/journal.pone.0204976. eCollection 2018.
|
1757 |
Abbreviated MRI Protocols for Detecting Breast Cancer in Women with Dense Breasts.Korean J Radiol. 2017 May-Jun;18(3):470-475. doi: 10.3348/kjr.2017.18.3.470. Epub 2017 Apr 3.
|
1758 |
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8838-43. doi: 10.1073/pnas.1320769111. Epub 2014 May 29.
|
1759 |
Recombinant expression and purification of AF1q and its interaction with T-cell Factor 7.Protein Expr Purif. 2020 Jan;165:105499. doi: 10.1016/j.pep.2019.105499. Epub 2019 Sep 18.
|
1760 |
Fresh and ozonized black carbon promoted DNA damage and repair responses in A549 cells.Toxicol Res (Camb). 2018 Nov 30;8(2):180-187. doi: 10.1039/c8tx00281a. eCollection 2019 Mar 1.
|
1761 |
Newly characterized motile sperm domain-containing protein 2 promotes human breast cancer metastasis.Int J Cancer. 2019 Jan 1;144(1):125-135. doi: 10.1002/ijc.31665. Epub 2018 Oct 29.
|
1762 |
MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.Breast Cancer. 2018 Nov;25(6):742-752. doi: 10.1007/s12282-018-0881-5. Epub 2018 Jun 27.
|
1763 |
MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.Mol Cancer Res. 2014 Sep;12(9):1216-24. doi: 10.1158/1541-7786.MCR-14-0069. Epub 2014 May 27.
|
1764 |
Circular RNAMTO1 suppresses breast cancer cell viability and reverses monastrol resistance through regulating the TRAF4/Eg5 axis.Int J Oncol. 2018 Oct;53(4):1752-1762. doi: 10.3892/ijo.2018.4485. Epub 2018 Jul 17.
|
1765 |
Microtubule-associated tumor suppressors as prognostic biomarkers in breast cancer.Breast Cancer Res Treat. 2020 Jan;179(2):267-273. doi: 10.1007/s10549-019-05463-x. Epub 2019 Oct 12.
|
1766 |
Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis.Br J Cancer. 2014 Jul 29;111(3):539-50. doi: 10.1038/bjc.2014.298. Epub 2014 Jun 12.
|
1767 |
TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9.Sci Rep. 2018 Sep 26;8(1):14402. doi: 10.1038/s41598-018-32698-3.
|
1768 |
Myosin Va interacts with the exosomal protein spermine synthase.Biosci Rep. 2019 Mar 1;39(3):BSR20182189. doi: 10.1042/BSR20182189. Print 2019 Mar 29.
|
1769 |
Tumor suppressor p53 induces miR-15a processing to inhibit neuronal apoptosis inhibitory protein (NAIP) in the apoptotic response DNA damage in breast cancer cell.Am J Transl Res. 2017 Feb 15;9(2):683-691. eCollection 2017.
|
1770 |
Long non-coding RNA LINC00673 promotes breast cancer proliferation and metastasis through regulating B7-H6 and epithelial-mesenchymal transition.Am J Cancer Res. 2018 Jul 1;8(7):1273-1287. eCollection 2018.
|
1771 |
NCS-1 expression is higher in basal breast cancers and regulates calcium influx and cytotoxic responses to doxorubicin.Mol Oncol. 2020 Jan;14(1):87-104. doi: 10.1002/1878-0261.12589. Epub 2019 Nov 11.
|
1772 |
Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study.Cancer Chemother Pharmacol. 2019 Jun;83(6):1091-1097. doi: 10.1007/s00280-019-03831-4. Epub 2019 Apr 8.
|
1773 |
Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer.FEBS J. 2014 Oct;281(20):4718-30. doi: 10.1111/febs.13012. Epub 2014 Sep 30.
|
1774 |
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.PLoS Genet. 2014 Apr 3;10(4):e1004256. doi: 10.1371/journal.pgen.1004256. eCollection 2014 Apr.
|
1775 |
Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.Breast Cancer Res. 2018 May 16;20(1):41. doi: 10.1186/s13058-018-0966-2.
|
1776 |
E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells.Cell Oncol (Dordr). 2014 Dec;37(6):409-19. doi: 10.1007/s13402-014-0204-6. Epub 2014 Oct 22.
|
1777 |
Dissecting the 17-estradiol pathways necessary for neuroglobin anti-apoptotic activity in breast cancer.J Cell Physiol. 2018 Jul;233(7):5087-5103. doi: 10.1002/jcp.26378. Epub 2018 Jan 19.
|
1778 |
Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.Genes Dev. 2017 Jul 15;31(14):1439-1455. doi: 10.1101/gad.301937.117. Epub 2017 Aug 21.
|
1779 |
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.Oncotarget. 2015 Sep 8;6(26):22126-38. doi: 10.18632/oncotarget.4244.
|
1780 |
Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells.Sci Rep. 2018 Aug 28;8(1):12969. doi: 10.1038/s41598-018-30447-0.
|
1781 |
Overexpression of NOTCH-regulated ankyrin repeat protein is associated with breast cancer cell proliferation.Anticancer Res. 2014 May;34(5):2165-71.
|
1782 |
Increased expression of mitochondrial transcription factor A and nuclear respiratory factor-1 predicts a poor clinical outcome of breast cancer.Oncol Lett. 2018 Feb;15(2):1449-1458. doi: 10.3892/ol.2017.7487. Epub 2017 Nov 24.
|
1783 |
Downregulation of RIP140 in triple-negative breast cancer inhibits the growth and proliferation of cancer cells.Oncol Lett. 2018 Jun;15(6):8784-8788. doi: 10.3892/ol.2018.8434. Epub 2018 Apr 5.
|
1784 |
Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer.Oncotarget. 2017 Mar 28;8(13):20751-20765. doi: 10.18632/oncotarget.10612.
|
1785 |
Identification of Nucleobindin-2 as a Potential Biomarker for Breast Cancer Metastasis Using iTRAQ-based Quantitative Proteomic Analysis.J Cancer. 2017 Sep 2;8(15):3062-3069. doi: 10.7150/jca.19619. eCollection 2017.
|
1786 |
Effect of NUCKS-1 overexpression on cytokine profiling in obese women with breast cancer.Asian Pac J Cancer Prev. 2014;15(2):837-45. doi: 10.7314/apjcp.2014.15.2.837.
|
1787 |
Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice.Iran J Basic Med Sci. 2018 Jan;21(1):26-32. doi: 10.22038/IJBMS.2017.25686.6335.
|
1788 |
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.Cancer Lett. 2018 Apr 10;419:233-244. doi: 10.1016/j.canlet.2018.01.054. Epub 2018 Feb 2.
|
1789 |
Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative study.Breast Cancer. 2017 Jan;24(1):161-170. doi: 10.1007/s12282-016-0691-6. Epub 2016 Mar 26.
|
1790 |
A rare eicosanoid precursor analogue, sciadonic acid (5Z,11Z,14Z-20:3), detected in vivo in hormone positive breast cancer tissue.Prostaglandins Leukot Essent Fatty Acids. 2018 Jul;134:1-6. doi: 10.1016/j.plefa.2018.05.002. Epub 2018 May 16.
|
1791 |
Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.Stem Cells. 2012 Oct;30(10):2065-75. doi: 10.1002/stem.1139.
|
1792 |
Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer.Exp Cell Res. 2018 Feb 1;363(1):121-128. doi: 10.1016/j.yexcr.2017.12.020. Epub 2017 Dec 23.
|
1793 |
Delivery of Amonafide from Fructose-Coated Nanodiamonds by Oxime Ligation for the Treatment of Human Breast Cancer.Biomacromolecules. 2018 Feb 12;19(2):481-489. doi: 10.1021/acs.biomac.7b01592. Epub 2018 Jan 23.
|
1794 |
-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.Oncogene. 2019 Jun;38(24):4856-4874. doi: 10.1038/s41388-019-0762-1. Epub 2019 Feb 25.
|
1795 |
Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.Oncol Lett. 2017 Jan;13(1):488-496. doi: 10.3892/ol.2016.5438. Epub 2016 Nov 28.
|
1796 |
Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer.Breast Cancer Res. 2018 Jul 13;20(1):76. doi: 10.1186/s13058-018-1008-9.
|
1797 |
PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells.Oncotarget. 2018 Jul 3;9(51):29619-29633. doi: 10.18632/oncotarget.25651. eCollection 2018 Jul 3.
|
1798 |
MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in breast cancer.Oncol Lett. 2018 Jan;15(1):984-990. doi: 10.3892/ol.2017.7358. Epub 2017 Nov 8.
|
1799 |
PDLIM2 Is a Marker of Adhesion and -Catenin Activity in Triple-Negative Breast Cancer.Cancer Res. 2019 May 15;79(10):2619-2633. doi: 10.1158/0008-5472.CAN-18-2787. Epub 2019 Mar 18.
|
1800 |
Methylation of HIN-1, RASSF1A, RIL and CDH13 in breast cancer is associated with clinical characteristics, but only RASSF1A methylation is associated with outcome.BMC Cancer. 2012 Jun 13;12:243. doi: 10.1186/1471-2407-12-243.
|
1801 |
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.Oncotarget. 2018 Apr 3;9(25):17334-17348. doi: 10.18632/oncotarget.24671. eCollection 2018 Apr 3.
|
1802 |
Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.Biomed Pharmacother. 2017 Jun;90:659-664. doi: 10.1016/j.biopha.2017.03.098. Epub 2017 Apr 14.
|
1803 |
Decorin-inducible Peg3 Evokes Beclin 1-mediated Autophagy and Thrombospondin 1-mediated Angiostasis.J Biol Chem. 2017 Mar 24;292(12):5055-5069. doi: 10.1074/jbc.M116.753632. Epub 2017 Feb 7.
|
1804 |
Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells.Oncogene. 2020 Jan;39(4):801-813. doi: 10.1038/s41388-019-1010-4. Epub 2019 Sep 25.
|
1805 |
The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.Oncotarget. 2017 Mar 28;8(13):21001-21014. doi: 10.18632/oncotarget.15471.
|
1806 |
PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription.FEBS Lett. 2013 Oct 11;587(20):3303-8. doi: 10.1016/j.febslet.2013.09.001. Epub 2013 Sep 11.
|
1807 |
Group X secreted phospholipase A(2) induces lipid droplet formation and prolongs breast cancer cell survival.Mol Cancer. 2013 Sep 27;12(1):111. doi: 10.1186/1476-4598-12-111.
|
1808 |
Secreted phospholipases Aare differentially expressed and epigenetically silenced in human breast cancer cells.Biochem Biophys Res Commun. 2014 Feb 28;445(1):230-5. doi: 10.1016/j.bbrc.2014.01.182. Epub 2014 Feb 6.
|
1809 |
PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF-B pathway.J Cell Mol Med. 2019 Oct;23(10):6930-6941. doi: 10.1111/jcmm.14578. Epub 2019 Aug 26.
|
1810 |
Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers.Int J Oncol. 2014 Dec;45(6):2250-66. doi: 10.3892/ijo.2014.2648. Epub 2014 Sep 9.
|
1811 |
Plastin 3 down-regulation augments the sensitivity of MDA-MB-231 cells to paclitaxel via the p38 MAPK signalling pathway.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):685-695. doi: 10.1080/21691401.2019.1576707.
|
1812 |
Utilization of adipocyte-derived lipids and enhanced intracellular trafficking of fatty acids contribute to breast cancer progression.Cell Commun Signal. 2018 Jun 18;16(1):32. doi: 10.1186/s12964-018-0221-6.
|
1813 |
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project.BMC Cancer. 2018 Sep 27;18(1):932. doi: 10.1186/s12885-018-4843-2.
|
1814 |
CXCL7 promotes proliferation and invasion of cholangiocarcinoma cells.Oncol Rep. 2017 Feb;37(2):1114-1122. doi: 10.3892/or.2016.5312. Epub 2016 Dec 12.
|
1815 |
The anti-apoptotic proteins NAF-1 and iASPP interact to drive apoptosis in cancer cells.Chem Sci. 2018 Nov 20;10(3):665-673. doi: 10.1039/c8sc03390k. eCollection 2019 Jan 21.
|
1816 |
Protein phosphatase 1, regulatory subunit 15B is a survival factor for ER-positive breast cancer.Int J Cancer. 2013 Jun 1;132(11):2714-9. doi: 10.1002/ijc.27945. Epub 2012 Dec 27.
|
1817 |
Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms.Nat Commun. 2018 Aug 23;9(1):3377. doi: 10.1038/s41467-018-05728-x.
|
1818 |
Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography/nanoelectrospray ionization-mass spectrometry.Proteomics Clin Appl. 2016 May;10(5):605-13. doi: 10.1002/prca.201500016. Epub 2016 Apr 26.
|
1819 |
P-Rex1 and P-Rex2 RacGEFs and cancer.Biochem Soc Trans. 2017 Aug 15;45(4):963-77. doi: 10.1042/BST20160269. Epub 2017 Jul 14.
|
1820 |
DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpoint.Int J Cancer. 2019 Feb 1;144(3):615-630. doi: 10.1002/ijc.31788. Epub 2018 Nov 21.
|
1821 |
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells.J Biol Chem. 2019 Mar 8;294(10):3670-3682. doi: 10.1074/jbc.RA118.004671. Epub 2019 Jan 2.
|
1822 |
Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.Int J Cancer. 2013 May 1;132(9):2044-55. doi: 10.1002/ijc.27884. Epub 2012 Oct 25.
|
1823 |
The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.Oncotarget. 2017 Nov 18;8(68):112245-112257. doi: 10.18632/oncotarget.22496. eCollection 2017 Dec 22.
|
1824 |
PTPN12 Affects Nasopharyngeal Carcinoma Cell Proliferation and Migration Through Regulating EGFR.Cancer Biother Radiopharm. 2018 Mar;33(2):60-64. doi: 10.1089/cbr.2017.2254.
|
1825 |
Suppression of protein tyrosine phosphatase N23 predisposes to breast tumorigenesis via activation of FYN kinase.Genes Dev. 2017 Oct 1;31(19):1939-1957. doi: 10.1101/gad.304261.117. Epub 2017 Oct 24.
|
1826 |
Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer.J Cancer Res Clin Oncol. 2013 Jul;139(7):1129-39. doi: 10.1007/s00432-013-1421-5. Epub 2013 Apr 4.
|
1827 |
PTTG1-interacting protein (PTTG1IP/PBF) predicts breast cancer survival.BMC Cancer. 2017 Oct 27;17(1):705. doi: 10.1186/s12885-017-3694-6.
|
1828 |
PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression.Cancer Manag Res. 2019 Jan 17;11:821-830. doi: 10.2147/CMAR.S180242. eCollection 2019.
|
1829 |
The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: An in vitro and in vivo study.Tumour Biol. 2017 May;39(5):1010428317701649. doi: 10.1177/1010428317701649.
|
1830 |
MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration.Breast Cancer Res. 2014 Nov 14;16(6):473. doi: 10.1186/s13058-014-0473-z.
|
1831 |
Integrative functional genomics identifies regulatory genetic variant modulating RAB31 expression and altering susceptibility to breast cancer.Mol Carcinog. 2018 Dec;57(12):1845-1854. doi: 10.1002/mc.22902. Epub 2018 Sep 19.
|
1832 |
Suppression of RAD21 Induces Senescence of MDA-MB-231 Human Breast Cancer Cells Through RB1 Pathway Activation Via c-Myc Downregulation.J Cell Biochem. 2016 Jun;117(6):1359-69. doi: 10.1002/jcb.25426. Epub 2015 Nov 20.
|
1833 |
Replication Stress Response Links RAD52 to Protecting Common Fragile Sites.Cancers (Basel). 2019 Sep 29;11(10):1467. doi: 10.3390/cancers11101467.
|
1834 |
Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.Clin Epigenetics. 2018 May 23;10:69. doi: 10.1186/s13148-018-0501-4. eCollection 2018.
|
1835 |
RanBPM inhibits BLT2-mediated IL-8 production and invasiveness in aggressive breast cancer cells.Biochem Biophys Res Commun. 2017 Jan 29;483(1):305-311. doi: 10.1016/j.bbrc.2016.12.147. Epub 2016 Dec 25.
|
1836 |
Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis.Tumour Biol. 2012 Oct;33(5):1581-7. doi: 10.1007/s13277-012-0412-5. Epub 2012 May 30.
|
1837 |
Function of RasGRP3 in the formation and progression of human breast cancer.Mol Cancer. 2014 Apr 29;13:96. doi: 10.1186/1476-4598-13-96.
|
1838 |
Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.J Neurooncol. 2018 Nov;140(2):237-248. doi: 10.1007/s11060-018-2959-5. Epub 2018 Aug 9.
|
1839 |
RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case report.Cancer Genet. 2019 Feb;231-232:41-45. doi: 10.1016/j.cancergen.2019.01.001. Epub 2019 Jan 9.
|
1840 |
The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.J Exp Clin Cancer Res. 2019 Feb 28;38(1):105. doi: 10.1186/s13046-019-1111-5.
|
1841 |
TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.Oncogene. 2018 Sep;37(39):5281-5291. doi: 10.1038/s41388-018-0312-2. Epub 2018 Jun 12.
|
1842 |
Production and characterization of monoclonal antibodies against the DNA binding domain of the RE1-silencing transcription factor.J Biochem. 2019 Nov 1;166(5):393-402. doi: 10.1093/jb/mvz046.
|
1843 |
PGC-1 alpha interacts with microRNA-217 to functionally regulate breast cancer cell proliferation.Biomed Pharmacother. 2017 Jan;85:541-548. doi: 10.1016/j.biopha.2016.11.062.
|
1844 |
Expression of regulatory factor X1 can predict the prognosis of breast cancer.Oncol Lett. 2017 Jun;13(6):4334-4340. doi: 10.3892/ol.2017.6005. Epub 2017 Apr 7.
|
1845 |
Estrogen receptor dependent regulation of estrogen related receptor and its role in cell cycle in breast cancer.BMC Cancer. 2018 May 30;18(1):607. doi: 10.1186/s12885-018-4528-x.
|
1846 |
Magnetic Resonance Imaging-Guided Drug Delivery to Breast Cancer Stem-Like Cells.Adv Healthc Mater. 2018 Nov;7(21):e1800266. doi: 10.1002/adhm.201800266. Epub 2018 Aug 26.
|
1847 |
The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells.Int J Oncol. 2014 Mar;44(3):896-904. doi: 10.3892/ijo.2014.2245. Epub 2014 Jan 7.
|
1848 |
Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.Cancer Sci. 2019 Apr;110(4):1268-1278. doi: 10.1111/cas.13953. Epub 2019 Feb 21.
|
1849 |
Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer.Front Oncol. 2019 Oct 23;9:1114. doi: 10.3389/fonc.2019.01114. eCollection 2019.
|
1850 |
Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility.PLoS One. 2013 Jun 3;8(6):e64896. doi: 10.1371/journal.pone.0064896. Print 2014.
|
1851 |
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.Oncotarget. 2017 Feb 28;8(9):14462-14478. doi: 10.18632/oncotarget.14895.
|
1852 |
MiR-454-3p-Mediated Wnt/-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.Theranostics. 2019 Jan 1;9(2):449-465. doi: 10.7150/thno.29055. eCollection 2019.
|
1853 |
Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation.Onco Targets Ther. 2019 Jul 22;12:5907-5916. doi: 10.2147/OTT.S208988. eCollection 2019.
|
1854 |
HSPC111 governs breast cancer growth by regulating ribosomal biogenesis.Mol Cancer Res. 2014 Apr;12(4):583-94. doi: 10.1158/1541-7786.MCR-13-0168. Epub 2014 Jan 14.
|
1855 |
Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7434-9. doi: 10.1073/pnas.1213050110. Epub 2013 Apr 16.
|
1856 |
SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin.J Cell Physiol. 2020 Feb;235(2):1543-1555. doi: 10.1002/jcp.29073. Epub 2019 Jul 17.
|
1857 |
Tissue factor-specific ultra-bright SERRS nanostars for Raman detection of pulmonary micrometastases.Nanoscale. 2017 Jan 19;9(3):1110-1119. doi: 10.1039/c6nr08217c.
|
1858 |
Correlation of SASH1 expression and ultrasonographic features in breast cancer.Onco Targets Ther. 2017 Jan 10;10:271-276. doi: 10.2147/OTT.S119244. eCollection 2017.
|
1859 |
The sodium channel 1 subunit mediates outgrowth of neurite-like processes on breast cancer cells and promotes tumour growth and metastasis.Int J Cancer. 2014 Nov 15;135(10):2338-51. doi: 10.1002/ijc.28890. Epub 2014 Apr 26.
|
1860 |
Repression of miR-135b-5p promotes metastasis of early-stage breast cancer by regulating downstream target SDCBP.Lab Invest. 2019 Sep;99(9):1296-1308. doi: 10.1038/s41374-019-0258-1. Epub 2019 Apr 25.
|
1861 |
Identification of 3q oncogene SEC62 as a marker for distant metastasis and poor clinical outcome in invasive ductal breast cancer.Arch Gynecol Obstet. 2019 May;299(5):1405-1413. doi: 10.1007/s00404-019-05081-4. Epub 2019 Feb 12.
|
1862 |
Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.Cancer Res. 2018 Nov 15;78(22):6473-6485. doi: 10.1158/0008-5472.CAN-18-1642. Epub 2018 Sep 25.
|
1863 |
Association of SENPs single-nucleotide polymorphism and breast cancer in Chinese population.Medicine (Baltimore). 2019 Feb;98(6):e14168. doi: 10.1097/MD.0000000000014168.
|
1864 |
Lysines 207 and 325 methylation of WDR5 catalyzed by SETD6 promotes breast cancer cell proliferation and migration.Oncol Rep. 2018 Nov;40(5):3069-3077. doi: 10.3892/or.2018.6669. Epub 2018 Aug 23.
|
1865 |
SETDB1 induces epithelialmesenchymal transition in breast carcinoma by directly binding with Snail promoter.Oncol Rep. 2019 Feb;41(2):1284-1292. doi: 10.3892/or.2018.6871. Epub 2018 Nov 19.
|
1866 |
Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader.ACS Chem Biol. 2019 Sep 20;14(9):2024-2034. doi: 10.1021/acschembio.9b00505. Epub 2019 Sep 5.
|
1867 |
Sphingomyelin synthase 2 promotes an aggressive breast cancer phenotype by disrupting the homoeostasis of ceramide and sphingomyelin.Cell Death Dis. 2019 Feb 15;10(3):157. doi: 10.1038/s41419-019-1303-0.
|
1868 |
Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.J Mol Histol. 2014 Dec;45(6):665-77. doi: 10.1007/s10735-014-9586-z. Epub 2014 Jul 16.
|
1869 |
Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins.Cancer Res. 2016 Jul 15;76(14):4068-80. doi: 10.1158/0008-5472.CAN-15-3110. Epub 2016 May 17.
|
1870 |
Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression.Biomed Pharmacother. 2019 Nov;119:109414. doi: 10.1016/j.biopha.2019.109414. Epub 2019 Sep 10.
|
1871 |
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.Breast Cancer Res. 2017 Oct 11;19(1):112. doi: 10.1186/s13058-017-0905-7.
|
1872 |
Deciphering Macrophage and Monocyte Code to Stratify Human Breast Cancer Patients.Cancer Cell. 2019 Apr 15;35(4):538-539. doi: 10.1016/j.ccell.2019.03.010.
|
1873 |
Involvement of an Orphan Transporter, SLC22A18, in Cell Growth and Drug Resistance of Human Breast Cancer MCF7 Cells.J Pharm Sci. 2018 Dec;107(12):3163-3170. doi: 10.1016/j.xphs.2018.08.011. Epub 2018 Aug 23.
|
1874 |
P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer.Oncotarget. 2018 Jun 19;9(47):28612-28624. doi: 10.18632/oncotarget.25584. eCollection 2018 Jun 19.
|
1875 |
SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3/-catenin pathway.Cell Signal. 2019 Jul;59:1-12. doi: 10.1016/j.cellsig.2019.03.004. Epub 2019 Mar 4.
|
1876 |
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity.Int J Cancer. 2018 Feb 15;142(4):757-768. doi: 10.1002/ijc.31105. Epub 2017 Oct 30.
|
1877 |
SMARCAD1 in Breast Cancer Progression.Cell Physiol Biochem. 2018;50(2):489-500. doi: 10.1159/000494163. Epub 2018 Oct 11.
|
1878 |
CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis.Cancer Cell. 2014 Jan 13;25(1):21-36. doi: 10.1016/j.ccr.2013.12.007.
|
1879 |
Low power blue LED exposure increases effects of doxorubicin on MDA-MB-231 breast cancer cells.Photodiagnosis Photodyn Ther. 2018 Dec;24:250-255. doi: 10.1016/j.pdpdt.2018.07.016. Epub 2018 Jul 29.
|
1880 |
PRL-3 promotes breast cancer progression by downregulating p14(ARF)-mediated p53 expression.Oncol Lett. 2018 Mar;15(3):2795-2800. doi: 10.3892/ol.2017.7639. Epub 2017 Dec 19.
|
1881 |
SND1 expression in breast cancer tumors is associated with poor prognosis.Ann N Y Acad Sci. 2018 Dec;1433(1):53-60. doi: 10.1111/nyas.13970. Epub 2018 Sep 14.
|
1882 |
In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor.Biomed Res Int. 2014;2014:648040. doi: 10.1155/2014/648040. Epub 2014 Aug 4.
|
1883 |
Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/-catenin signaling pathway.Mol Carcinog. 2019 Jun;58(6):1008-1018. doi: 10.1002/mc.22989. Epub 2019 Mar 5.
|
1884 |
SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.Carcinogenesis. 2019 Oct 16;40(10):1278-1287. doi: 10.1093/carcin/bgz034.
|
1885 |
Clinicopathological significance of reduced SPARCL1 expression in human breast cancer.Asian Pac J Cancer Prev. 2013;14(1):195-200. doi: 10.7314/apjcp.2013.14.1.195.
|
1886 |
Comprehensive genome-wide transcription factor analysis reveals that a combination of high affinity and low affinity DNA binding is needed for human gene regulation.BMC Genomics. 2015;16 Suppl 7(Suppl 7):S12. doi: 10.1186/1471-2164-16-S7-S12. Epub 2015 Jun 11.
|
1887 |
Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo.Breast Cancer Res Treat. 2014 Jan;143(2):287-99. doi: 10.1007/s10549-013-2809-2. Epub 2013 Dec 15.
|
1888 |
Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.Cancer Chemother Pharmacol. 2019 Nov;84(5):1133-1143. doi: 10.1007/s00280-019-03945-9. Epub 2019 Sep 12.
|
1889 |
circFBXL5 promotes breast cancer progression by sponging miR-660.J Cell Mol Med. 2020 Jan;24(1):356-361. doi: 10.1111/jcmm.14737. Epub 2019 Nov 15.
|
1890 |
Modification of 2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.Int J Cancer. 2018 Nov 1;143(9):2319-2330. doi: 10.1002/ijc.31737. Epub 2018 Sep 7.
|
1891 |
Suppression of the proliferation and invasion of breast cancer cells by ST7L occurs through inhibition of activation of Wnt/GSK-3/-catenin signalling.Clin Exp Pharmacol Physiol. 2020 Jan;47(1):119-126. doi: 10.1111/1440-1681.13166. Epub 2019 Sep 9.
|
1892 |
Correction: Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents.Oncotarget. 2019 Jun 25;10(41):4249-4251. doi: 10.18632/oncotarget.27042. eCollection 2019 Jun 25.
|
1893 |
Transcriptional positive cofactor 4 promotes breast cancer proliferation and metastasis through c-Myc mediated Warburg effect.Cell Commun Signal. 2019 Apr 16;17(1):36. doi: 10.1186/s12964-019-0348-0.
|
1894 |
Genome-wide expression analysis reveals six contravened targets of EZH2 associated with breast cancer patient survival.Sci Rep. 2019 Feb 13;9(1):1974. doi: 10.1038/s41598-019-39122-4.
|
1895 |
Differential expression and molecular interactions of chromosome region maintenance 1 and calreticulin exportins in breast cancer cells.J Steroid Biochem Mol Biol. 2019 Jan;185:7-16. doi: 10.1016/j.jsbmb.2018.07.003. Epub 2018 Jul 5.
|
1896 |
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.Oncotarget. 2017 Sep 19;8(52):89692-89706. doi: 10.18632/oncotarget.21058. eCollection 2017 Oct 27.
|
1897 |
Cancer/Testis OIP5 and TAF7L Genes are Up-Regulated in Breast Cancer.Asian Pac J Cancer Prev. 2015;16(11):4623-8. doi: 10.7314/apjcp.2015.16.11.4623.
|
1898 |
A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.Carcinogenesis. 2014 Mar;35(3):670-82. doi: 10.1093/carcin/bgt351. Epub 2013 Oct 22.
|
1899 |
Downregulation of TAP1 and TAP2 in early stage breast cancer.PLoS One. 2017 Nov 1;12(11):e0187323. doi: 10.1371/journal.pone.0187323. eCollection 2017.
|
1900 |
High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGF pathways as fundamental Notch regulators in breast cancer.Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1714-9. doi: 10.1073/pnas.1214014110. Epub 2013 Jan 14.
|
1901 |
Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.Carcinogenesis. 2020 Jul 10;41(5):551-560. doi: 10.1093/carcin/bgz142.
|
1902 |
Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.BMC Cancer. 2019 Mar 12;19(1):219. doi: 10.1186/s12885-019-5403-0.
|
1903 |
Enriched variations in TEKT4 and breast cancer resistance to paclitaxel.Nat Commun. 2014 May 13;5:3802. doi: 10.1038/ncomms4802.
|
1904 |
Expression of teneurins is associated with tumor differentiation and patient survival in ovarian cancer.PLoS One. 2017 May 4;12(5):e0177244. doi: 10.1371/journal.pone.0177244. eCollection 2017.
|
1905 |
Reduced Expression of TET1, TET2, TET3 and TDG mRNAs Are Associated with Poor Prognosis of Patients with Early Breast Cancer.PLoS One. 2015 Jul 24;10(7):e0133896. doi: 10.1371/journal.pone.0133896. eCollection 2015.
|
1906 |
TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.PLoS One. 2018 Sep 20;13(9):e0203833. doi: 10.1371/journal.pone.0203833. eCollection 2018.
|
1907 |
TPC2 mediates autophagy progression and extracellular vesicle secretion in cancer cells.Exp Cell Res. 2018 Sep 15;370(2):478-489. doi: 10.1016/j.yexcr.2018.07.013. Epub 2018 Jul 7.
|
1908 |
Network analysis of icb-1 gene function in human breast cancer cells.J Cell Biochem. 2012 Sep;113(9):2979-88. doi: 10.1002/jcb.24175.
|
1909 |
4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.Anticancer Res. 2018 Aug;38(8):4403-4416. doi: 10.21873/anticanres.12742.
|
1910 |
Improvement of implantation potential in mouse blastocysts derived from IVF by combined treatment with prolactin, epidermal growth factor and 4-hydroxyestradiol.Mol Hum Reprod. 2017 Aug 1;23(8):557-570. doi: 10.1093/molehr/gax035.
|
1911 |
Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short report.Cell Oncol (Dordr). 2014 Aug;37(4):297-303. doi: 10.1007/s13402-014-0189-1. Epub 2014 Aug 16.
|
1912 |
TMED3 promotes cell proliferation and motility in breast cancer and is negatively modulated by miR-188-3p.Cancer Cell Int. 2019 Mar 29;19:75. doi: 10.1186/s12935-019-0791-4. eCollection 2019.
|
1913 |
Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling.Cancer Lett. 2019 Jan;440-441:189-201. doi: 10.1016/j.canlet.2018.10.018. Epub 2018 Oct 26.
|
1914 |
Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case-control study in Japanese women.Br J Cancer. 2014 May 27;110(11):2765-71. doi: 10.1038/bjc.2014.223. Epub 2014 May 1.
|
1915 |
Negative regulation of ER by a novel protein CAC1 through association with histone demethylase LSD1.FEBS Lett. 2013 Jan 4;587(1):17-22. doi: 10.1016/j.febslet.2012.10.054. Epub 2012 Nov 20.
|
1916 |
Type II transmembrane serine protease gene variants associate with breast cancer.PLoS One. 2014 Jul 16;9(7):e102519. doi: 10.1371/journal.pone.0102519. eCollection 2014.
|
1917 |
Estrogen receptor alpha (ERS1) SNPs c454-397T>C (PvuII) and c454-351A>G (XbaI) are risk biomarkers for breast cancer development.Mol Biol Rep. 2014 Aug;41(8):5459-66. doi: 10.1007/s11033-014-3419-8. Epub 2014 Jun 14.
|
1918 |
SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.J Cell Physiol. 2014 Sep;229(9):1160-9. doi: 10.1002/jcp.24545.
|
1919 |
Gene delivery of TIPE2 inhibits breast cancer development and metastasis via CD8(+) T and NK cell-mediated antitumor responses.Mol Immunol. 2017 May;85:230-237. doi: 10.1016/j.molimm.2017.03.007. Epub 2017 Mar 15.
|
1920 |
Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer.Nat Commun. 2018 Oct 12;9(1):4236. doi: 10.1038/s41467-018-06529-y.
|
1921 |
RIP-Chip analysis supports different roles for AGO2 and GW182 proteins in recruiting and processing microRNA targets.BMC Bioinformatics. 2019 Apr 18;20(Suppl 4):120. doi: 10.1186/s12859-019-2683-y.
|
1922 |
TP53I11 suppresses epithelial-mesenchymal transition and metastasis of breast cancer cells.BMB Rep. 2019 Jun;52(6):379-384. doi: 10.5483/BMBRep.2019.52.6.173.
|
1923 |
TP53INP1 inhibits hypoxia-induced vasculogenic mimicry formation via the ROS/snail signalling axis in breast cancer.J Cell Mol Med. 2018 Jul;22(7):3475-3488. doi: 10.1111/jcmm.13625. Epub 2018 Apr 14.
|
1924 |
Correction to: Retraction of: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer Cells; 10.10.89/cbr.2014.1723Cancer Biother Radiopharm 2017;32(10):387. DOI: 10.1089/cbr.2014.1723.retract.Cancer Biother Radiopharm. 2018 Oct 1;33(8):361. doi: 10.1089/cbr.2014.1723.retract.correx. Epub 2018 Oct 18.
|
1925 |
Integrative "omic" analysis for tamoxifen sensitivity through cell based models.PLoS One. 2014 Apr 3;9(4):e93420. doi: 10.1371/journal.pone.0093420. eCollection 2014.
|
1926 |
Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer.Oncol Rep. 2013 Jan;29(1):283-7. doi: 10.3892/or.2012.2121. Epub 2012 Nov 1.
|
1927 |
Prognostic role of Tif1 expression and circulating tumor cells in patients with breast cancer.Mol Med Rep. 2019 May;19(5):3685-3695. doi: 10.3892/mmr.2019.10033. Epub 2019 Mar 14.
|
1928 |
Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56.Oncogenesis. 2019 Apr 18;8(5):30. doi: 10.1038/s41389-019-0139-x.
|
1929 |
Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer.J Pathol. 2014 Sep;234(1):108-19. doi: 10.1002/path.4385. Epub 2014 Jul 16.
|
1930 |
Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.Clin Breast Cancer. 2018 Jun;18(3):e329-e333. doi: 10.1016/j.clbc.2017.09.003. Epub 2017 Sep 19.
|
1931 |
The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer.J Cell Mol Med. 2018 Feb;22(2):1257-1271. doi: 10.1111/jcmm.13404. Epub 2017 Nov 29.
|
1932 |
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2.Lab Invest. 2018 Jan;98(1):117-129. doi: 10.1038/labinvest.2017.106. Epub 2017 Oct 16.
|
1933 |
PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.Carcinogenesis. 2015 Oct;36(10):1094-102. doi: 10.1093/carcin/bgv105. Epub 2015 Jul 25.
|
1934 |
CdGAP/ARHGAP31 is regulated by RSK phosphorylation and binding to 14-3-3 adaptor protein.Oncotarget. 2018 Jan 10;9(14):11646-11664. doi: 10.18632/oncotarget.24126. eCollection 2018 Feb 20.
|
1935 |
Cross-cancer profiling of molecular alterations within the human autophagy interaction network.Autophagy. 2015;11(9):1668-87. doi: 10.1080/15548627.2015.1067362.
|
1936 |
Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.J Neurooncol. 2018 Jan;136(2):395-401. doi: 10.1007/s11060-017-2666-7. Epub 2017 Nov 20.
|
1937 |
Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.Mol Cancer. 2015 May 14;14:102. doi: 10.1186/s12943-015-0370-9.
|
1938 |
Rational design for heterologous production of aurovertin-type compounds in Aspergillus nidulans.Appl Microbiol Biotechnol. 2018 Jan;102(1):297-304. doi: 10.1007/s00253-017-8606-9. Epub 2017 Nov 2.
|
1939 |
The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.Cell Death Dis. 2015 Jan 22;6(1):e1603. doi: 10.1038/cddis.2014.542.
|
1940 |
The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells.Cell Death Dis. 2017 Nov 16;8(11):e3169. doi: 10.1038/cddis.2017.521.
|
1941 |
Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor .Int J Oncol. 2015 Jul;47(1):106-14. doi: 10.3892/ijo.2015.2988. Epub 2015 May 6.
|
1942 |
Drivers of advanced stage at breast cancer diagnosis in the multicountry African breast cancer - disparities in outcomes (ABC-DO) study.Int J Cancer. 2018 Apr 15;142(8):1568-1579. doi: 10.1002/ijc.31187. Epub 2017 Dec 23.
|
1943 |
Aberrant high expression level of MORC2 is a common character in multiple cancers.Hum Pathol. 2018 Jun;76:58-67. doi: 10.1016/j.humpath.2018.03.011. Epub 2018 Mar 16.
|
1944 |
Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer.Epigenetics. 2015;10(7):622-32. doi: 10.1080/15592294.2015.1050173.
|
1945 |
NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/-catenin pathway.Oncotarget. 2015 Sep 22;6(28):25701-14. doi: 10.18632/oncotarget.4573.
|
1946 |
O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.Horm Cancer. 2018 Feb;9(1):12-21. doi: 10.1007/s12672-017-0310-9. Epub 2017 Sep 19.
|
1947 |
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer.Clin Cancer Res. 2016 Dec 1;22(23):5929-5938. doi: 10.1158/1078-0432.CCR-15-1104. Epub 2016 Jun 14.
|
1948 |
The effect of the Progesterone-Induced Blocking Factor (PIBF) on E-cadherin expression, cell motility and invasion of primary tumour cell lines.J Reprod Immunol. 2018 Feb;125:8-15. doi: 10.1016/j.jri.2017.10.047. Epub 2017 Nov 2.
|
1949 |
PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.Cancer Res. 2018 Jan 15;78(2):387-398. doi: 10.1158/0008-5472.CAN-17-0883. Epub 2017 Nov 29.
|
1950 |
Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.Mol Carcinog. 2013 Nov;52 Suppl 1:E52-9. doi: 10.1002/mc.21979. Epub 2012 Nov 9.
|
1951 |
Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3.Cancer Manag Res. 2018 Mar 19;10:535-544. doi: 10.2147/CMAR.S155923. eCollection 2018.
|
1952 |
ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.Breast Cancer Res. 2016 Nov 16;18(1):113. doi: 10.1186/s13058-016-0770-9.
|
1953 |
New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.J Cell Physiol. 2018 Jan;233(1):79-87. doi: 10.1002/jcp.25853. Epub 2017 Apr 27.
|
1954 |
Focal adhesion kinase regulates the phosphorylation protein tyrosine phosphatase- at Tyr789 in breast cancer cells.Mol Med Rep. 2015 Jun;11(6):4303-8. doi: 10.3892/mmr.2015.3262. Epub 2015 Jan 27.
|
1955 |
Metabolic Studies of Tumor Cells Using [1-(13) C] Pyruvate Hyperpolarized by Means of PHIP-Side Arm Hydrogenation.Chemphyschem. 2019 Jan 21;20(2):318-325. doi: 10.1002/cphc.201800652. Epub 2018 Oct 24.
|
1956 |
High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.Mol Med Rep. 2019 Feb;19(2):877-884. doi: 10.3892/mmr.2018.9716. Epub 2018 Dec 3.
|
1957 |
Actinin-4 as a Diagnostic Biomarker in Serum of Breast Cancer Patients.Med Sci Monit. 2019 May 4;25:3298-3302. doi: 10.12659/MSM.912404.
|
1958 |
Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.Breast Cancer Res. 2012 Jan 31;14(1):R20. doi: 10.1186/bcr3105.
|
1959 |
Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases.Epigenomics. 2019 Nov;11(14):1561-1579. doi: 10.2217/epi-2019-0207. Epub 2019 Oct 4.
|
1960 |
Afadin cooperates with Claudin-2 to promote breast cancer metastasis.Genes Dev. 2019 Feb 1;33(3-4):180-193. doi: 10.1101/gad.319194.118. Epub 2019 Jan 28.
|
1961 |
Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines.Cell Biol Int. 2012 Apr 1;36(4):339-44. doi: 10.1042/CBI20110394.
|
1962 |
AKAP3 correlates with triple negative status and disease free survival in breast cancer.BMC Cancer. 2015 Oct 12;15:681. doi: 10.1186/s12885-015-1668-0.
|
1963 |
Interactome-transcriptome integration for predicting distant metastasis in breast cancer.Bioinformatics. 2012 Mar 1;28(5):672-8. doi: 10.1093/bioinformatics/bts025. Epub 2012 Jan 11.
|
1964 |
AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53.Breast Cancer Res Treat. 2013 Oct;141(3):397-408. doi: 10.1007/s10549-013-2702-z. Epub 2013 Oct 5.
|
1965 |
Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.EMBO Rep. 2020 Jan 7;21(1):e48741. doi: 10.15252/embr.201948741. Epub 2019 Dec 2.
|
1966 |
Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.Eur J Cancer. 2019 Jan;107:68-78. doi: 10.1016/j.ejca.2018.10.022. Epub 2018 Dec 11.
|
1967 |
miR-937 regulates the proliferation and apoptosis via targeting APAF1 in breast cancer.Onco Targets Ther. 2019 Jul 17;12:5687-5699. doi: 10.2147/OTT.S207091. eCollection 2019.
|
1968 |
Fe65 Suppresses Breast Cancer Cell Migration and Invasion through Tip60 Mediated Cortactin Acetylation.Sci Rep. 2015 Jul 13;5:11529. doi: 10.1038/srep11529.
|
1969 |
Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration.Cancer Lett. 2012 Jan 28;314(2):185-97. doi: 10.1016/j.canlet.2011.09.028. Epub 2011 Sep 29.
|
1970 |
MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer.Oncotarget. 2017 Dec 15;9(3):3446-3458. doi: 10.18632/oncotarget.23316. eCollection 2018 Jan 9.
|
1971 |
ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.J Clin Pathol. 2017 Feb;70(2):162-167. doi: 10.1136/jclinpath-2016-203804. Epub 2016 Jul 22.
|
1972 |
Arl13b Regulates Breast Cancer Cell Migration and Invasion by Controlling Integrin-Mediated Signaling.Cancers (Basel). 2019 Sep 29;11(10):1461. doi: 10.3390/cancers11101461.
|
1973 |
Expression of HIF-1 and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future Therapy.PLoS One. 2015 Jun 5;10(6):e0129356. doi: 10.1371/journal.pone.0129356. eCollection 2015.
|
1974 |
Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells.Cancer Res. 2012 Nov 15;72(22):6036-50. doi: 10.1158/0008-5472.CAN-12-1507. Epub 2012 Sep 26.
|
1975 |
RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation.Carcinogenesis. 2013 Nov;34(11):2498-504. doi: 10.1093/carcin/bgt247. Epub 2013 Jul 10.
|
1976 |
Optimism outweighs neuroticism and anxiety sensitivity to predict insomnia symptoms in women after surgery for breast cancer.Support Care Cancer. 2019 Aug;27(8):2903-2909. doi: 10.1007/s00520-018-4610-6. Epub 2018 Dec 17.
|
1977 |
Functional and cancer genomics of ASXL family members.Br J Cancer. 2013 Jul 23;109(2):299-306. doi: 10.1038/bjc.2013.281. Epub 2013 Jun 4.
|
1978 |
Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer.PLoS Comput Biol. 2013;9(6):e1003100. doi: 10.1371/journal.pcbi.1003100. Epub 2013 Jun 20.
|
1979 |
Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.Oncotarget. 2012 Dec;3(12):1600-14. doi: 10.18632/oncotarget.742.
|
1980 |
A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype.Breast Cancer Res. 2013 Nov 14;15(6):R109. doi: 10.1186/bcr3576.
|
1981 |
Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.Mol Cell Endocrinol. 2012 May 15;355(1):15-24. doi: 10.1016/j.mce.2011.12.020. Epub 2012 Jan 18.
|
1982 |
Resveratrol up-regulates ATP2A3 gene expression in breast cancer cell lines through epigenetic mechanisms.Int J Biochem Cell Biol. 2019 Aug;113:37-47. doi: 10.1016/j.biocel.2019.05.020. Epub 2019 Jun 4.
|
1983 |
Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population.Breast Cancer. 2016 Jul;23(4):607-16. doi: 10.1007/s12282-015-0611-1. Epub 2015 Apr 21.
|
1984 |
Estrogen induced -1,4-galactosyltransferase 1 expression regulates proliferation of human breast cancer MCF-7 cells.Biochem Biophys Res Commun. 2012 Oct 5;426(4):620-5. doi: 10.1016/j.bbrc.2012.08.140. Epub 2012 Sep 6.
|
1985 |
A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer.Cancer Chemother Pharmacol. 2019 Oct;84(4):759-770. doi: 10.1007/s00280-019-03908-0. Epub 2019 Jul 31.
|
1986 |
Epithelial-to-mesenchymal transition induced by TGF-1 is mediated by Blimp-1-dependent repression of BMP-5.Cancer Res. 2012 Dec 1;72(23):6268-78. doi: 10.1158/0008-5472.CAN-12-2270. Epub 2012 Oct 10.
|
1987 |
Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach.Mol Biosyst. 2016 Mar;12(3):963-72. doi: 10.1039/c5mb00655d.
|
1988 |
Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers.Exp Mol Med. 2012 Jan 31;44(1):36-44. doi: 10.3858/emm.2012.44.1.003.
|
1989 |
Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res. 2005 Jun 15;65(12):5408-16. doi: 10.1158/0008-5472.CAN-05-0271.
|
1990 |
Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells.Sci Rep. 2016 Sep 8;6:33132. doi: 10.1038/srep33132.
|
1991 |
Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response.Int J Cancer. 2012 Nov 15;131(10):2420-32. doi: 10.1002/ijc.27510. Epub 2012 Mar 28.
|
1992 |
SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):638-43. doi: 10.1073/pnas.1514663113. Epub 2016 Jan 6.
|
1993 |
Clinical relevance of loss of 11p15 in primary and metastatic breast cancer: association with loss of PRKCDBP expression in brain metastases.PLoS One. 2012;7(10):e47537. doi: 10.1371/journal.pone.0047537. Epub 2012 Oct 31.
|
1994 |
Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer.Oncol Lett. 2017 Mar;13(3):1149-1156. doi: 10.3892/ol.2016.5529. Epub 2016 Dec 23.
|
1995 |
CBX6 is negatively regulated by EZH2 and plays a potential tumor suppressor role in breast cancer.Sci Rep. 2019 Jan 17;9(1):197. doi: 10.1038/s41598-018-36560-4.
|
1996 |
STAT3 protein up-regulates G-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis.J Biol Chem. 2012 Dec 7;287(50):41667-83. doi: 10.1074/jbc.M112.390781. Epub 2012 Oct 12.
|
1997 |
CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model.Cancer Gene Ther. 2016 Jun;23(6):162-7. doi: 10.1038/cgt.2016.9. Epub 2016 Apr 8.
|
1998 |
Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer.J Cell Physiol. 2020 Jan;235(1):394-407. doi: 10.1002/jcp.28980. Epub 2019 Jun 21.
|
1999 |
Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer.Medicine (Baltimore). 2019 Nov;98(44):e17854. doi: 10.1097/MD.0000000000017854.
|
2000 |
miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-, CCNJ, and MEGF9.PLoS One. 2013 Oct 3;8(10):e76247. doi: 10.1371/journal.pone.0076247. eCollection 2013.
|
2001 |
Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}.Bioorg Chem. 2020 Jan;94:103427. doi: 10.1016/j.bioorg.2019.103427. Epub 2019 Nov 9.
|
2002 |
Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling.Breast Cancer Res Treat. 2013 Nov;142(2):271-82. doi: 10.1007/s10549-013-2735-3. Epub 2013 Oct 29.
|
2003 |
Cadherin-23 mediates heterotypic cell-cell adhesion between breast cancer epithelial cells and fibroblasts.PLoS One. 2012;7(3):e33289. doi: 10.1371/journal.pone.0033289. Epub 2012 Mar 7.
|
2004 |
H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis.Biomed Pharmacother. 2020 Mar;123:109728. doi: 10.1016/j.biopha.2019.109728. Epub 2019 Dec 14.
|
2005 |
Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.Int J Cancer. 2016 Aug 15;139(4):899-907. doi: 10.1002/ijc.30133. Epub 2016 Apr 21.
|
2006 |
Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.Cancer Med. 2020 Jan;9(1):278-289. doi: 10.1002/cam4.2675. Epub 2019 Nov 8.
|
2007 |
The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.Biochem Biophys Res Commun. 2012 Oct 19;427(2):336-42. doi: 10.1016/j.bbrc.2012.09.057. Epub 2012 Sep 18.
|
2008 |
Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.Bioorg Chem. 2019 Dec;93:103317. doi: 10.1016/j.bioorg.2019.103317. Epub 2019 Sep 26.
|
2009 |
CHST11 gene expression and DNA methylation in breast cancer.Int J Oncol. 2015 Mar;46(3):1243-51. doi: 10.3892/ijo.2015.2828. Epub 2015 Jan 9.
|
2010 |
CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.PLoS One. 2017 Aug 3;12(8):e0182107. doi: 10.1371/journal.pone.0182107. eCollection 2017.
|
2011 |
Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells.PLoS One. 2013 Dec 26;8(12):e83943. doi: 10.1371/journal.pone.0083943. eCollection 2013.
|
2012 |
Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry.Breast Cancer Res Treat. 2012 Feb;132(1):341-5. doi: 10.1007/s10549-011-1890-7. Epub 2011 Nov 29.
|
2013 |
Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population.Breast Cancer Res Treat. 2012 Nov;136(1):241-51. doi: 10.1007/s10549-012-2244-9. Epub 2012 Sep 23.
|
2014 |
Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.J Exp Clin Cancer Res. 2017 Jul 12;36(1):92. doi: 10.1186/s13046-017-0564-7.
|
2015 |
Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.Biochim Biophys Acta. 2016 Sep;1862(9):1472-84. doi: 10.1016/j.bbadis.2016.05.009. Epub 2016 May 18.
|
2016 |
Systematic identification of Ctr9 regulome in ER-positive breast cancer.BMC Genomics. 2016 Nov 9;17(1):902. doi: 10.1186/s12864-016-3248-3.
|
2017 |
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ER-positive breast cancer through regulation of BRCA1.PLoS Genet. 2017 Oct 2;13(10):e1007031. doi: 10.1371/journal.pgen.1007031. eCollection 2017 Oct.
|
2018 |
Anti-breast Cancer Activity of SPG-56 from Sweet Potato in MCF-7 Bearing Mice in Situ through Promoting Apoptosis and Inhibiting Metastasis.Sci Rep. 2019 Jan 16;9(1):146. doi: 10.1038/s41598-018-29099-x.
|
2019 |
Overexpressed DAAM1 correlates with metastasis and predicts poor prognosis in breast cancer.Pathol Res Pract. 2020 Mar;216(3):152736. doi: 10.1016/j.prp.2019.152736. Epub 2019 Nov 11.
|
2020 |
Identification of androgen-responsive microRNAs and androgen-related genes in breast cancer.Anticancer Res. 2013 Nov;33(11):4811-9.
|
2021 |
Simvastatin downregulates HER2 via upregulation of PEA3 to induce cell death in HER2-positive breast cancer cells.Oncol Res. 2012;20(5-6):187-95. doi: 10.3727/096504013x13589503482699.
|
2022 |
DLC-1 expression levels in breast cancer assessed by qRT- PCR are negatively associated with malignancy.Asian Pac J Cancer Prev. 2012;13(4):1231-3. doi: 10.7314/apjcp.2012.13.4.1231.
|
2023 |
Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells.Oncol Rep. 2015 Mar;33(3):1450-8. doi: 10.3892/or.2014.3686. Epub 2014 Dec 22.
|
2024 |
Calpain-dependent clearance of the autophagy protein p62/SQSTM1 is a contributor to PK oncolytic activity in melanoma.Gene Ther. 2014 Apr;21(4):371-8. doi: 10.1038/gt.2014.6. Epub 2014 Feb 20.
|
2025 |
Distinct Roles for BET Family Members in Estrogen Receptor Enhancer Function and Gene Regulation in Breast Cancer Cells.Mol Cancer Res. 2019 Dec;17(12):2356-2368. doi: 10.1158/1541-7786.MCR-19-0393. Epub 2019 Sep 24.
|
2026 |
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.Cancer Med. 2019 Oct;8(14):6393-6402. doi: 10.1002/cam4.2540. Epub 2019 Sep 4.
|
2027 |
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.Mol Oncol. 2016 Aug;10(7):1008-29. doi: 10.1016/j.molonc.2016.04.001. Epub 2016 Apr 12.
|
2028 |
Genetic variants in microRNA and microRNA biogenesis pathway genes and breast cancer risk among women of African ancestry.Hum Genet. 2016 Oct;135(10):1145-59. doi: 10.1007/s00439-016-1707-1. Epub 2016 Jul 5.
|
2029 |
Development of a novel approach, the epigenome-based outlier approach, to identify tumor-suppressor genes silenced by aberrant DNA methylation.Cancer Lett. 2012 Sep 28;322(2):204-12. doi: 10.1016/j.canlet.2012.03.016. Epub 2012 Mar 17.
|
2030 |
MiR-548-3p functions as an anti-oncogenic regulator in breast cancer.Biomed Pharmacother. 2015 Oct;75:111-6. doi: 10.1016/j.biopha.2015.07.027. Epub 2015 Aug 18.
|
2031 |
Hypoxia-inducible factor-1 (HIF-1) promotes cap-dependent translation of selective mRNAs through up-regulating initiation factor eIF4E1 in breast cancer cells under hypoxia conditions.J Biol Chem. 2013 Jun 28;288(26):18732-42. doi: 10.1074/jbc.M113.471466. Epub 2013 May 10.
|
2032 |
Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.Oncol Rep. 2012 Dec;28(6):2255-63. doi: 10.3892/or.2012.2018. Epub 2012 Sep 5.
|
2033 |
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.Cancer Discov. 2016 Nov;6(11):1267-1275. doi: 10.1158/2159-8290.CD-16-0487. Epub 2016 Sep 21.
|
2034 |
HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer. Breast Cancer Res Treat. 2014 Jul;146(1):85-97.
|
2035 |
Estrogen receptor- regulation of microRNA-590 targets FAM171A1-a modifier of breast cancer invasiveness.Oncogenesis. 2019 Jan 9;8(1):5. doi: 10.1038/s41389-018-0113-z.
|
2036 |
FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice.J Clin Invest. 2012 Sep;122(9):3211-20. doi: 10.1172/JCI60498. Epub 2012 Aug 13.
|
2037 |
Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.Clin Genet. 2016 Oct;90(4):324-33. doi: 10.1111/cge.12748. Epub 2016 Mar 4.
|
2038 |
Fibulin-2 is required for basement membrane integrity of mammary epithelium.Sci Rep. 2018 Sep 20;8(1):14139. doi: 10.1038/s41598-018-32507-x.
|
2039 |
FBP1 modulates cell metabolism of breast cancer cells by inhibiting the expression of HIF-1.Neoplasma. 2017;64(4):535-542. doi: 10.4149/neo_2017_407.
|
2040 |
A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR.Artif Cells Nanomed Biotechnol. 2016;44(2):695-703. doi: 10.3109/21691401.2014.981270. Epub 2014 Dec 1.
|
2041 |
Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation.Cell Mol Life Sci. 2020 Jul;77(13):2605-2620. doi: 10.1007/s00018-019-03306-y. Epub 2019 Sep 27.
|
2042 |
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42. doi: 10.1073/pnas.1007863107. Epub 2010 Nov 22.
|
2043 |
Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells.Biochem Biophys Res Commun. 2012 May 11;421(3):532-7. doi: 10.1016/j.bbrc.2012.04.039. Epub 2012 Apr 13.
|
2044 |
Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.Mol Endocrinol. 2013 Jul;27(7):1113-27. doi: 10.1210/me.2012-1353. Epub 2013 May 9.
|
2045 |
FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial- mesenchymal transition through regulation of SLUG.Cancer Manag Res. 2019 Jan 4;11:525-535. doi: 10.2147/CMAR.S176938. eCollection 2019.
|
2046 |
Transcription Factors in Breast Cancer-Lessons From Recent Genomic Analyses and Therapeutic Implications.Adv Protein Chem Struct Biol. 2017;107:223-273. doi: 10.1016/bs.apcsb.2016.10.003. Epub 2016 Dec 12.
|
2047 |
The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models.BMC Cancer. 2015 Oct 17;15:729. doi: 10.1186/s12885-015-1761-4.
|
2048 |
GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via -catenin/MUC1-C Signaling Pathway.Int J Biol Sci. 2019 Jan 1;15(1):169-182. doi: 10.7150/ijbs.29048. eCollection 2019.
|
2049 |
Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription.Cell Discov. 2018 May 29;4:26. doi: 10.1038/s41421-018-0024-3. eCollection 2018.
|
2050 |
Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.NMR Biomed. 2012 Sep;25(9):1033-42. doi: 10.1002/nbm.2766. Epub 2012 Jan 26.
|
2051 |
Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.Int J Cancer. 2013 Nov;133(9):2216-24. doi: 10.1002/ijc.28237. Epub 2013 Jul 11.
|
2052 |
GINS2 regulates cell proliferation and apoptosis in human epithelial ovarian cancer.Oncol Lett. 2018 Aug;16(2):2591-2598. doi: 10.3892/ol.2018.8944. Epub 2018 Jun 11.
|
2053 |
GLS2 is protumorigenic in breast cancers.Oncogene. 2020 Jan;39(3):690-702. doi: 10.1038/s41388-019-1007-z. Epub 2019 Sep 20.
|
2054 |
Loss of GM130 in breast cancer cells and its effects on cell migration, invasion and polarity.Cell Cycle. 2015;14(8):1139-47. doi: 10.1080/15384101.2015.1007771.
|
2055 |
Gpn3 Is Essential for Cell Proliferation of Breast Cancer Cells Independent of Their Malignancy Degree.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819870823. doi: 10.1177/1533033819870823.
|
2056 |
GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway.Oncol Rep. 2016 Nov;36(5):2983-2990. doi: 10.3892/or.2016.5062. Epub 2016 Sep 2.
|
2057 |
Oxygen sensor FIH inhibits HACE1-dependent ubiquitination of Rac1 to enhance metastatic potential in breast cancer cells.Oncogene. 2019 May;38(19):3651-3666. doi: 10.1038/s41388-019-0676-y. Epub 2019 Jan 18.
|
2058 |
HAP1 gene expression is associated with radiosensitivity in breast cancer cells.Biochem Biophys Res Commun. 2015 Jan 2;456(1):162-6. doi: 10.1016/j.bbrc.2014.11.052. Epub 2014 Nov 22.
|
2059 |
DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer.Nat Commun. 2018 Jan 16;9(1):248. doi: 10.1038/s41467-017-02630-w.
|
2060 |
CTLA-4 polymorphisms associate with breast cancer susceptibility in Asians: a meta-analysis.PeerJ. 2017 Jan 10;5:e2815. doi: 10.7717/peerj.2815. eCollection 2017.
|
2061 |
Heterogenous ribonucleoprotein A18 (hnRNP A18) promotes tumor growth by increasing protein translation of selected transcripts in cancer cells.Oncotarget. 2016 Mar 1;7(9):10578-93. doi: 10.18632/oncotarget.7020.
|
2062 |
A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients.Clin Epigenetics. 2017 Jul 24;9:73. doi: 10.1186/s13148-017-0373-z. eCollection 2017.
|
2063 |
Targeting the HOX/PBX dimer in breast cancer.Breast Cancer Res Treat. 2012 Nov;136(2):389-98. doi: 10.1007/s10549-012-2259-2. Epub 2012 Sep 30.
|
2064 |
Bisphenol-A induces expression of HOXC6, an estrogen-regulated homeobox-containing gene associated with breast cancer.Biochim Biophys Acta. 2015 Jun;1849(6):697-708. doi: 10.1016/j.bbagrm.2015.02.003. Epub 2015 Feb 25.
|
2065 |
Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen.Epigenetics. 2012 Jul;7(7):701-9. doi: 10.4161/epi.20445. Epub 2012 Jul 1.
|
2066 |
RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.Cell Death Differ. 2020 Mar;27(3):1105-1118. doi: 10.1038/s41418-019-0400-z. Epub 2019 Aug 13.
|
2067 |
HtrA4 Protease Promotes Chemotherapeutic-Dependent Cancer Cell Death.Cells. 2019 Sep 20;8(10):1112. doi: 10.3390/cells8101112.
|
2068 |
Clinicopathological and biological significance of human voltage-gated proton channel Hv1 protein overexpression in breast cancer.J Biol Chem. 2012 Apr 20;287(17):13877-88. doi: 10.1074/jbc.M112.345280. Epub 2012 Feb 24.
|
2069 |
Validation of the European Health Literacy Survey Questionnaire in Women With Breast Cancer.Cancer Nurs. 2018 Mar/Apr;41(2):E40-E48. doi: 10.1097/NCC.0000000000000475.
|
2070 |
2-Hydroxyglutarate in Cancer Cells.Antioxid Redox Signal. 2020 Nov 1;33(13):903-926. doi: 10.1089/ars.2019.7902. Epub 2020 Jan 22.
|
2071 |
The Arabian camel, Camelus dromedarius interferon epsilon: Functional expression, in vitro refolding, purification and cytotoxicity on breast cancer cell lines.PLoS One. 2019 Sep 6;14(9):e0213880. doi: 10.1371/journal.pone.0213880. eCollection 2019.
|
2072 |
Modulation of IFN- receptor 1 expression by AP-2 influences IFN- sensitivity of cancer cells.Am J Pathol. 2012 Feb;180(2):661-71. doi: 10.1016/j.ajpath.2011.10.040. Epub 2011 Dec 16.
|
2073 |
Upregulation of SHIP2 participates in the development of breast cancer via promoting Wnt/-catenin signaling.Onco Targets Ther. 2019 Aug 30;12:7067-7077. doi: 10.2147/OTT.S223422. eCollection 2019.
|
2074 |
Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.Endocr Pathol. 2019 Mar;30(1):35-42. doi: 10.1007/s12022-018-9559-y.
|
2075 |
A Novel Strategy to Investigate Tissue-Secreted Tumor Microenvironmental Proteins in Serum toward Development of Breast Cancer Early Diagnosis Biomarker Signature.Proteomics Clin Appl. 2019 May;13(3):e1700119. doi: 10.1002/prca.201700119. Epub 2018 Oct 18.
|
2076 |
EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.Int J Oncol. 2015 Aug;47(2):481-9. doi: 10.3892/ijo.2015.3051. Epub 2015 Jun 16.
|
2077 |
Integral membrane protein 2A inhibits cell growth in human breast cancer via enhancing autophagy induction.Cell Commun Signal. 2019 Aug 22;17(1):105. doi: 10.1186/s12964-019-0422-7.
|
2078 |
Intersectin 1 (ITSN1) identified by comprehensive bioinformatic analysis and experimental validation as a key candidate biological target in breast cancer.Onco Targets Ther. 2019 Aug 30;12:7079-7093. doi: 10.2147/OTT.S216286. eCollection 2019.
|
2079 |
Quantifying Tip60 (Kat5) stratifies breast cancer.Sci Rep. 2019 Mar 7;9(1):3819. doi: 10.1038/s41598-019-40221-5.
|
2080 |
Characterization of Kelch domain-containing protein 7B in breast tumours and breast cancer cell lines.Oncol Lett. 2019 Sep;18(3):2853-2860. doi: 10.3892/ol.2019.10672. Epub 2019 Jul 26.
|
2081 |
JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.Int J Cancer. 2015 Mar 1;136(5):E272-81. doi: 10.1002/ijc.29240. Epub 2014 Oct 10.
|
2082 |
Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.Mol Biol Rep. 2012 Feb;39(2):1895-901. doi: 10.1007/s11033-011-0935-7. Epub 2011 Jun 5.
|
2083 |
KLP-PI: a new prognostic index for luminal B HER-2-negative breast cancer.Hum Cell. 2019 Apr;32(2):172-184. doi: 10.1007/s13577-018-00229-x. Epub 2018 Dec 17.
|
2084 |
Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.Medicine (Baltimore). 2019 Oct;98(40):e17346. doi: 10.1097/MD.0000000000017346.
|
2085 |
Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.Oncotarget. 2016 Dec 20;7(51):84645-84657. doi: 10.18632/oncotarget.13175.
|
2086 |
Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.Clin Cancer Res. 2012 Feb 15;18(4):993-1003. doi: 10.1158/1078-0432.CCR-11-2100. Epub 2012 Jan 6.
|
2087 |
Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.Breast Cancer Res Treat. 2012 May;133(1):127-35. doi: 10.1007/s10549-011-1716-7. Epub 2011 Aug 12.
|
2088 |
Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.J Immunol. 2015 Aug 15;195(4):1858-67. doi: 10.4049/jimmunol.1500365. Epub 2015 Jul 1.
|
2089 |
PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis.Oncogene. 2020 Mar;39(10):2069-2087. doi: 10.1038/s41388-019-1135-5. Epub 2019 Dec 4.
|
2090 |
The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer.Cell Mol Biol Lett. 2013 Dec;18(4):595-611. doi: 10.2478/s11658-013-0109-9. Epub 2013 Nov 30.
|
2091 |
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.Hum Mol Genet. 2012 Apr 1;21(7):1665-72. doi: 10.1093/hmg/ddr597. Epub 2011 Dec 16.
|
2092 |
Nuclear localization of LDL receptor-related protein 1B in mammary gland carcinogenesis.J Mol Med (Berl). 2019 Feb;97(2):257-268. doi: 10.1007/s00109-018-01732-2. Epub 2019 Jan 3.
|
2093 |
CAPC negatively regulates NF-B activation and suppresses tumor growth and metastasis.Oncogene. 2012 Mar 29;31(13):1673-82. doi: 10.1038/onc.2011.355. Epub 2011 Aug 8.
|
2094 |
Versican G1 and G3 domains are upregulated and latent transforming growth factor- binding protein-4 is downregulated in breast cancer stroma.Breast Cancer. 2012 Jan;19(1):46-53. doi: 10.1007/s12282-011-0264-7. Epub 2011 Apr 20.
|
2095 |
Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation.Cell Commun Signal. 2019 Jan 14;17(1):4. doi: 10.1186/s12964-019-0318-6.
|
2096 |
Knockdown of REV7 Inhibits Breast Cancer Cell Migration and Invasion.Oncol Res. 2016;24(5):315-325. doi: 10.3727/096504016X14666990347590.
|
2097 |
MAML1 regulates EMT markers expression through NOTCH-independent pathway in breast cancer cell line MCF7.Biochem Biophys Res Commun. 2019 Mar 12;510(3):376-382. doi: 10.1016/j.bbrc.2019.01.101. Epub 2019 Feb 4.
|
2098 |
The role of Runx2 in facilitating autophagy in metastatic breast cancer cells.J Cell Physiol. 2018 Jan;233(1):559-571. doi: 10.1002/jcp.25916. Epub 2017 May 19.
|
2099 |
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer.PLoS Genet. 2012;8(2):e1002532. doi: 10.1371/journal.pgen.1002532. Epub 2012 Feb 23.
|
2100 |
MARCH5 overexpression contributes to tumor growth and metastasis and associates with poor survival in breast cancer.Cancer Manag Res. 2018 Dec 24;11:201-215. doi: 10.2147/CMAR.S190694. eCollection 2019.
|
2101 |
Targeted expression of miR-34a using the T-VISA system suppresses breast cancer cell growth and invasion.Mol Ther. 2012 Dec;20(12):2326-34. doi: 10.1038/mt.2012.201. Epub 2012 Oct 2.
|
2102 |
Impact of germinal center-associated nuclear protein polymorphisms on breast cancer risk and prognosis in a Japanese population.Breast Cancer. 2019 Sep;26(5):562-572. doi: 10.1007/s12282-019-00956-5. Epub 2019 Feb 27.
|
2103 |
Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):625-630. doi: 10.1073/pnas.1806851116. Epub 2018 Dec 26.
|
2104 |
HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.J Immunol. 2012 Mar 1;188(5):2136-45. doi: 10.4049/jimmunol.1102237. Epub 2012 Feb 1.
|
2105 |
Is calcitonin an active hormone in the onset and prevention of hypocalcemia in dairy cattle?.J Dairy Sci. 2016 Apr;99(4):3023-3030. doi: 10.3168/jds.2015-10229. Epub 2016 Feb 3.
|
2106 |
MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.J Cell Biochem. 2019 Mar;120(3):4634-4643. doi: 10.1002/jcb.27751. Epub 2018 Oct 15.
|
2107 |
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics.Cell Res. 2015 Jun;25(6):707-25. doi: 10.1038/cr.2015.56. Epub 2015 May 8.
|
2108 |
Assessment of changes in expression and presentation of NKG2D under influence of MICA serum factor in different stages of breast cancer.Tumour Biol. 2016 May;37(5):6953-62. doi: 10.1007/s13277-015-4584-7. Epub 2015 Dec 11.
|
2109 |
BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner.Oncotarget. 2015 Apr 10;6(10):7608-18. doi: 10.18632/oncotarget.3263.
|
2110 |
Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.Breast Cancer Res Treat. 2019 Jan;173(2):289-299. doi: 10.1007/s10549-018-4989-2. Epub 2018 Oct 13.
|
2111 |
Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.Oncogene. 2018 Jan 11;37(2):197-207. doi: 10.1038/onc.2017.327. Epub 2017 Sep 11.
|
2112 |
The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.J Surg Res. 2020 Feb;246:442-449. doi: 10.1016/j.jss.2019.09.018. Epub 2019 Oct 18.
|
2113 |
Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.Oncotarget. 2016 Mar 15;7(11):12267-85. doi: 10.18632/oncotarget.7860.
|
2114 |
MYO1D binds with kinase domain of the EGFR family to anchor them to plasma membrane before their activation and contributes carcinogenesis.Oncogene. 2019 Dec;38(49):7416-7432. doi: 10.1038/s41388-019-0954-8. Epub 2019 Aug 16.
|
2115 |
Myocardin inhibits estrogen receptor alpha-mediated proliferation of human breast cancer MCF-7 cells via regulating MicroRNA expression.IUBMB Life. 2016 Jun;68(6):477-87. doi: 10.1002/iub.1507. Epub 2016 May 9.
|
2116 |
Repression of ESR1 transcription by MYOD potentiates letrozole-resistance in ER-positive breast cancer cells.Biochem Biophys Res Commun. 2017 Oct 21;492(3):425-433. doi: 10.1016/j.bbrc.2017.08.082. Epub 2017 Aug 24.
|
2117 |
VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-B and -catenin.Cancer Lett. 2016 Apr 1;373(1):1-11. doi: 10.1016/j.canlet.2016.01.010. Epub 2016 Jan 19.
|
2118 |
Association between mitochondrial genetic variation and breast cancer risk: The Multiethnic Cohort.PLoS One. 2019 Oct 2;14(10):e0222284. doi: 10.1371/journal.pone.0222284. eCollection 2019.
|
2119 |
Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.Oncotarget. 2015 Oct 13;6(31):31557-68. doi: 10.18632/oncotarget.5230.
|
2120 |
The expression of the Nectin complex in human breast cancer and the role of Nectin-3 in the control of tight junctions during metastasis.PLoS One. 2013 Dec 26;8(12):e82696. doi: 10.1371/journal.pone.0082696. eCollection 2013.
|
2121 |
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients.Oncoimmunology. 2019 Sep 30;8(12):e1663107. doi: 10.1080/2162402X.2019.1663107. eCollection 2019.
|
2122 |
Overexpression of neogenin inhibits cell proliferation and induces apoptosis in human MDA-MB-231 breast carcinoma cells.Oncol Rep. 2015 Jul;34(1):258-64. doi: 10.3892/or.2015.4004. Epub 2015 May 22.
|
2123 |
miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.PLoS One. 2016 Dec 8;11(12):e0168171. doi: 10.1371/journal.pone.0168171. eCollection 2016.
|
2124 |
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.Breast Cancer Res. 2012 Oct 26;14(5):R138. doi: 10.1186/bcr3343.
|
2125 |
Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on nidogen-1 and nidogen-2.Int J Cancer. 2013 Nov 15;133(10):2315-24. doi: 10.1002/ijc.28271. Epub 2013 Jun 13.
|
2126 |
Effects of the ninein-like protein centrosomal protein on breast cancer cell invasion and migration.Mol Med Rep. 2015 Aug;12(2):1659-64. doi: 10.3892/mmr.2015.3650. Epub 2015 Apr 20.
|
2127 |
NKD1 down-regulation is associated with poor prognosis in breast invasive ductal carcinoma.Int J Clin Exp Pathol. 2015 Apr 1;8(4):4015-21. eCollection 2015.
|
2128 |
Nemo-like kinase associated with proliferation and apoptosis by c-Myb degradation in breast cancer.PLoS One. 2013 Jul 23;8(7):e69148. doi: 10.1371/journal.pone.0069148. Print 2013.
|
2129 |
siRNA mediated silencing of NIN1/RPN12 binding protein 1 homolog inhibits proliferation and growth of breast cancer cells.Asian Pac J Cancer Prev. 2012;13(5):1823-7. doi: 10.7314/apjcp.2012.13.5.1823.
|
2130 |
Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110201. doi: 10.1016/j.msec.2019.110201. Epub 2019 Sep 13.
|
2131 |
RNA-binding protein NONO promotes breast cancer proliferation by post-transcriptional regulation of SKP2 and E2F8.Cancer Sci. 2020 Jan;111(1):148-159. doi: 10.1111/cas.14240. Epub 2019 Dec 11.
|
2132 |
Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs.Neoplasia. 2018 Apr;20(4):387-400. doi: 10.1016/j.neo.2018.02.008. Epub 2018 Mar 11.
|
2133 |
Breast cancer and synchronous multiple myeloma as a diagnostic challenge: Case report and review of literature.Curr Probl Cancer. 2018 Mar-Apr;42(2):231-234. doi: 10.1016/j.currproblcancer.2017.11.001. Epub 2017 Nov 22.
|
2134 |
Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk.Mol Biol Rep. 2012 Mar;39(3):2915-9. doi: 10.1007/s11033-011-1053-2. Epub 2011 Jun 19.
|
2135 |
Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.Breast Cancer Res Treat. 2017 Jul;164(2):349-358. doi: 10.1007/s10549-017-4258-9. Epub 2017 May 8.
|
2136 |
Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.Biochim Biophys Acta. 2012 Dec;1820(12):1893-900. doi: 10.1016/j.bbagen.2012.08.002. Epub 2012 Aug 10.
|
2137 |
ODAM inhibits RhoA-dependent invasion in breast cancer.Cell Biochem Funct. 2015 Oct;33(7):451-61. doi: 10.1002/cbf.3132. Epub 2015 Sep 10.
|
2138 |
Gene expression of O-GlcNAc cycling enzymes in human breast cancers.Clin Exp Med. 2012 Mar;12(1):61-5. doi: 10.1007/s10238-011-0138-5. Epub 2011 May 13.
|
2139 |
Effective Antiemetic Therapy Is Important With Adjuvant Anthracycline-based Chemotherapy in Breast Cancer.Anticancer Res. 2019 Jan;39(1):279-283. doi: 10.21873/anticanres.13108.
|
2140 |
Identifying genes with tri-modal association with survival and tumor grade in cancer patients.BMC Bioinformatics. 2019 Jan 8;20(1):13. doi: 10.1186/s12859-018-2582-7.
|
2141 |
Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.Oncol Rep. 2012 May;27(5):1681-8. doi: 10.3892/or.2012.1691. Epub 2012 Feb 17.
|
2142 |
Suppression of mitochondrial respiration with local anesthetic ropivacaine targets breast cancer cells.J Thorac Dis. 2018 May;10(5):2804-2812. doi: 10.21037/jtd.2018.05.21.
|
2143 |
Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.J Exp Clin Cancer Res. 2019 Oct 10;38(1):414. doi: 10.1186/s13046-019-1404-8.
|
2144 |
The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.Oncol Rep. 2016 Sep;36(3):1612-8. doi: 10.3892/or.2016.4951. Epub 2016 Jul 19.
|
2145 |
Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.Mol Med Rep. 2018 May;17(5):6211-6226. doi: 10.3892/mmr.2018.8704. Epub 2018 Mar 7.
|
2146 |
circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer.Oncogene. 2019 Oct;38(42):6850-6866. doi: 10.1038/s41388-019-0926-z. Epub 2019 Aug 12.
|
2147 |
Protocadherin-7 induces bone metastasis of breast cancer.Biochem Biophys Res Commun. 2013 Jul 5;436(3):486-90. doi: 10.1016/j.bbrc.2013.05.131. Epub 2013 Jun 7.
|
2148 |
KIAA0101 inhibition suppresses cell proliferation and cell cycle progression by promoting the interaction between p53 and Sp1 in breast cancer.Biochem Biophys Res Commun. 2018 Sep 5;503(2):600-606. doi: 10.1016/j.bbrc.2018.06.046. Epub 2018 Jun 15.
|
2149 |
The influence of socio-cultural factors on breast cancer screening behaviors in Lagos, Nigeria.Ethn Health. 2019 Jul;24(5):544-559. doi: 10.1080/13557858.2017.1348489. Epub 2017 Jul 5.
|
2150 |
Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo.Biochem Cell Biol. 2013 Dec;91(6):526-31. doi: 10.1139/bcb-2013-0052. Epub 2013 Sep 13.
|
2151 |
Autoantibodies against TYMS and PDLIM1 proteins detected as circulatory signatures in Indian breast cancer patients.Proteomics Clin Appl. 2016 May;10(5):564-73. doi: 10.1002/prca.201500138.
|
2152 |
Detection of early breast cancer beyond mammographic screening: a promising biomarker panel.Biomark Med. 2019 Sep;13(13):1107-1117. doi: 10.2217/bmm-2019-0085. Epub 2019 Aug 30.
|
2153 |
Candidate tumor suppressor gene IRF6 is involved in human breast cancer pathogenesis via modulating PI3K-regulatory subunit PIK3R2 expression.Cancer Manag Res. 2019 Jun 21;11:5557-5572. doi: 10.2147/CMAR.S203060. eCollection 2019.
|
2154 |
PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1.Cell Cycle. 2019 Nov;18(21):2914-2927. doi: 10.1080/15384101.2019.1662259. Epub 2019 Sep 10.
|
2155 |
CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.BMC Cancer. 2019 Jan 16;19(1):76. doi: 10.1186/s12885-018-5221-9.
|
2156 |
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.Breast Cancer Res. 2015 Aug 16;17(1):110. doi: 10.1186/s13058-015-0625-9.
|
2157 |
Novel inhibitors induce large conformational changes of GAB1 pleckstrin homology domain and kill breast cancer cells.PLoS Comput Biol. 2015 Jan 8;11(1):e1004021. doi: 10.1371/journal.pcbi.1004021. eCollection 2015 Jan.
|
2158 |
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers.Cancers (Basel). 2019 May 28;11(6):738. doi: 10.3390/cancers11060738.
|
2159 |
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.Endocr Relat Cancer. 2013 Nov 4;20(6):875-87. doi: 10.1530/ERC-13-0349. Print 2013 Dec.
|
2160 |
Proliferation-associated POU4F2/Brn-3b transcription factor expression is regulated by oestrogen through ER and growth factors via MAPK pathway.Breast Cancer Res. 2011 Jan 17;13(1):R5. doi: 10.1186/bcr2809.
|
2161 |
Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.Tumour Biol. 2016 Oct;37(10):13111-13119. doi: 10.1007/s13277-016-5190-z. Epub 2016 Jul 23.
|
2162 |
Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.Biomed Pharmacother. 2017 Feb;86:595-604. doi: 10.1016/j.biopha.2016.12.041. Epub 2016 Dec 24.
|
2163 |
A Novel lncRNA HOXC-AS3 Acts as a miR-3922-5p Sponge to Promote Breast Cancer Metastasis.Cancer Invest. 2020 Jan;38(1):1-12. doi: 10.1080/07357907.2019.1695816. Epub 2019 Dec 4.
|
2164 |
Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway.Neoplasia. 2019 Jan;21(1):30-40. doi: 10.1016/j.neo.2018.10.009. Epub 2018 Nov 27.
|
2165 |
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer.BMC Cancer. 2015 Apr 15;15:285. doi: 10.1186/s12885-015-1266-1.
|
2166 |
High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.Mol Cancer. 2015 Apr 28;14:95. doi: 10.1186/s12943-015-0356-7.
|
2167 |
Silencing PRDM14 via Oligonucleotide Therapeutics Suppresses Tumorigenicity and Metastasis of Breast Cancer.Methods Mol Biol. 2019;1974:233-243. doi: 10.1007/978-1-4939-9220-1_18.
|
2168 |
Protein arginine N-methyltransferase2 reverses tamoxifen resistance in breast cancer cells through suppression of ER-36.Oncol Rep. 2018 Jun;39(6):2604-2612. doi: 10.3892/or.2018.6350. Epub 2018 Apr 2.
|
2169 |
Integrative transcriptome data mining for identification of core lncRNAs in breast cancer.PeerJ. 2019 Oct 7;7:e7821. doi: 10.7717/peerj.7821. eCollection 2019.
|
2170 |
PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway.Mol Cell Probes. 2019 Oct;47:101440. doi: 10.1016/j.mcp.2019.101440. Epub 2019 Aug 22.
|
2171 |
Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition.Cell Physiol Biochem. 2017;42(5):1847-1856. doi: 10.1159/000479542. Epub 2017 Jul 27.
|
2172 |
Serine protease PRSS23 is upregulated by estrogen receptor and associated with proliferation of breast cancer cells.PLoS One. 2012;7(1):e30397. doi: 10.1371/journal.pone.0030397. Epub 2012 Jan 23.
|
2173 |
Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumors.Cancer Med. 2016 Dec;5(12):3426-3436. doi: 10.1002/cam4.950. Epub 2016 Oct 24.
|
2174 |
Knockdown of PSMC3IP suppresses the proliferation and xenografted tumorigenesis of hepatocellular carcinoma cell.J Cell Biochem. 2019 Apr;120(4):5449-5458. doi: 10.1002/jcb.27824. Epub 2018 Oct 25.
|
2175 |
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.Cancer Res. 2013 Jul 15;73(14):4521-32. doi: 10.1158/0008-5472.CAN-12-4178. Epub 2013 May 21.
|
2176 |
Protein tyrosine phosphatase (PTP or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.PLoS One. 2012;7(11):e50183. doi: 10.1371/journal.pone.0050183. Epub 2012 Nov 20.
|
2177 |
PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.Oncogene. 2017 Jan 19;36(3):410-422. doi: 10.1038/onc.2016.213. Epub 2016 Jun 27.
|
2178 |
Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.Cancer Biol Ther. 2019;20(6):760-773. doi: 10.1080/15384047.2018.1564563. Epub 2019 Feb 27.
|
2179 |
Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes.PLoS One. 2019 Sep 19;14(9):e0220973. doi: 10.1371/journal.pone.0220973. eCollection 2019.
|
2180 |
The emerging role of QSOX1 in cancer.Antioxid Redox Signal. 2014 Jul 20;21(3):485-96. doi: 10.1089/ars.2013.5572. Epub 2014 Feb 19.
|
2181 |
Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-/SMAD signaling.Oncotarget. 2015 Jun 30;6(18):16352-65. doi: 10.18632/oncotarget.3877.
|
2182 |
MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.Thorac Cancer. 2018 Apr;9(4):472-479. doi: 10.1111/1759-7714.12612. Epub 2018 Mar 10.
|
2183 |
RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.EMBO Rep. 2016 Jul;17(7):1061-80. doi: 10.15252/embr.201642032. Epub 2016 Jun 2.
|
2184 |
Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1.Oncotarget. 2016 Jul 12;7(28):44096-44112. doi: 10.18632/oncotarget.9858.
|
2185 |
A novel role for an RCAN3-derived peptide as a tumor suppressor in breast cancer.Carcinogenesis. 2015 Jul;36(7):792-9. doi: 10.1093/carcin/bgv056. Epub 2015 Apr 26.
|
2186 |
RECQL4 helicase has oncogenic potential in sporadic breast cancers.J Pathol. 2016 Mar;238(4):495-501. doi: 10.1002/path.4681. Epub 2016 Feb 2.
|
2187 |
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.Carcinogenesis. 2016 Jan;37(1):63-71. doi: 10.1093/carcin/bgv163. Epub 2015 Nov 19.
|
2188 |
Human REV3 DNA Polymerase Zeta Localizes to Mitochondria and Protects the Mitochondrial Genome.PLoS One. 2015 Oct 13;10(10):e0140409. doi: 10.1371/journal.pone.0140409. eCollection 2015.
|
2189 |
Mitogen-inducible Gene-2 (MIG2) and migfilin expression is reduced in samples of human breast cancer.Anticancer Res. 2013 May;33(5):1977-81.
|
2190 |
Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.J Control Release. 2018 Nov 10;289:79-93. doi: 10.1016/j.jconrel.2018.07.042. Epub 2018 Aug 24.
|
2191 |
shRNA mediated RHOXF1 silencing influences expression of BCL2 but not CASP8 in MCF-7 and MDA-MB-231 cell lines.Asian Pac J Cancer Prev. 2012;13(11):5865-9. doi: 10.7314/apjcp.2012.13.11.5865.
|
2192 |
RILPL2 regulates breast cancer proliferation, metastasis, and chemoresistance via the TUBB3/PTEN pathway.Am J Cancer Res. 2019 Aug 1;9(8):1583-1606. eCollection 2019.
|
2193 |
Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin.PLoS One. 2019 May 10;14(5):e0216642. doi: 10.1371/journal.pone.0216642. eCollection 2019.
|
2194 |
Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.Int J Cancer. 2019 Jul 1;145(1):49-57. doi: 10.1002/ijc.32073. Epub 2019 Jan 5.
|
2195 |
DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.Oncotarget. 2016 Sep 27;7(39):64191-64202. doi: 10.18632/oncotarget.11640.
|
2196 |
Effect of RRS1 gene knockdown on BT549 cell line proliferation and apoptosis in breast cancer.Neoplasma. 2019 Jan 15;66(1):28-32. doi: 10.4149/neo_2018_171229N853. Epub 2018 Aug 9.
|
2197 |
Long noncoding RNA RUSC1ASN promotes cell proliferation and metastasis through Wnt/catenin signaling in human breast cancer.Mol Med Rep. 2019 Feb;19(2):861-868. doi: 10.3892/mmr.2018.9763. Epub 2018 Dec 14.
|
2198 |
Prognostic and clinicopathological significance of S100A14 expression in cancer patients: A meta-analysis.Medicine (Baltimore). 2019 Jul;98(28):e16356. doi: 10.1097/MD.0000000000016356.
|
2199 |
Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.BMC Cancer. 2015 Feb 13;15:53. doi: 10.1186/s12885-015-1059-6.
|
2200 |
Differential expression of neurogenes among breast cancer subtypes identifies high risk patients.Oncotarget. 2016 Feb 2;7(5):5313-26. doi: 10.18632/oncotarget.6543.
|
2201 |
Knockdown of sal-like 4 expression by small interfering RNA induces apoptosis in breast cancer cells.J Cell Biochem. 2019 Jun;120(6):9392-9399. doi: 10.1002/jcb.28214. Epub 2018 Dec 5.
|
2202 |
SATB2 suppresses non-small cell lung cancer invasiveness by G9a.Clin Exp Med. 2018 Feb;18(1):37-44. doi: 10.1007/s10238-017-0464-3. Epub 2017 Jun 30.
|
2203 |
Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.Cell Rep. 2017 Jul 11;20(2):297-307. doi: 10.1016/j.celrep.2017.06.056.
|
2204 |
A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGF-mediated breast cancer cell migration and invasion.Breast Cancer Res. 2012 Sep 20;14(5):R127. doi: 10.1186/bcr3322.
|
2205 |
Breast carcinoma cells modulate the chemoattractive activity of human bone marrow-derived mesenchymal stromal cells by interfering with CXCL12.Int J Cancer. 2015 Jan 1;136(1):44-54. doi: 10.1002/ijc.28960. Epub 2014 May 20.
|
2206 |
The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.Tumour Biol. 2016 Jan;37(1):1009-15. doi: 10.1007/s13277-015-3847-7. Epub 2015 Aug 12.
|
2207 |
SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities study.PLoS One. 2013 Nov 20;8(11):e80554. doi: 10.1371/journal.pone.0080554. eCollection 2013.
|
2208 |
Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform.Biochim Biophys Acta. 2013 Oct;1830(10):4543-53. doi: 10.1016/j.bbagen.2013.05.003. Epub 2013 May 9.
|
2209 |
The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.Int J Mol Sci. 2016 Apr 21;17(4):606. doi: 10.3390/ijms17040606.
|
2210 |
DNA homologous recombination factor SFR1 physically and functionally interacts with estrogen receptor alpha.PLoS One. 2013 Jul 9;8(7):e68075. doi: 10.1371/journal.pone.0068075. Print 2013.
|
2211 |
Mitochondrial Reprogramming Regulates Breast Cancer Progression.Clin Cancer Res. 2016 Jul 1;22(13):3348-60. doi: 10.1158/1078-0432.CCR-15-2456. Epub 2016 Feb 17.
|
2212 |
A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ER expression.Sci Rep. 2018 Oct 30;8(1):16000. doi: 10.1038/s41598-018-34290-1.
|
2213 |
Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.J Biol Chem. 2016 Apr 1;291(14):7313-24. doi: 10.1074/jbc.M115.701227. Epub 2016 Feb 3.
|
2214 |
SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells.J Cell Physiol. 2018 Sep;233(9):6767-6778. doi: 10.1002/jcp.26398. Epub 2018 Mar 25.
|
2215 |
Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.J Cell Biochem. 2019 Jun;120(6):9522-9531. doi: 10.1002/jcb.28228. Epub 2018 Dec 3.
|
2216 |
BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1.Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1210-9. doi: 10.1073/pnas.1418335112. Epub 2015 Mar 2.
|
2217 |
Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.Tumour Biol. 2015 Mar;36(3):1895-902. doi: 10.1007/s13277-014-2791-2. Epub 2014 Nov 7.
|
2218 |
TP53 upregulates smooth muscle actin expression in tamoxifenresistant breast cancer cells.Oncol Rep. 2019 Feb;41(2):1075-1082. doi: 10.3892/or.2018.6910. Epub 2018 Dec 6.
|
2219 |
USF2 inhibits the transcriptional activity of Smurf1 and Smurf2 to promote breast cancer tumorigenesis.Cell Signal. 2019 Jan;53:49-58. doi: 10.1016/j.cellsig.2018.09.013. Epub 2018 Sep 21.
|
2220 |
miR-1307-3p Stimulates Breast Cancer Development and Progression by Targeting SMYD4.J Cancer. 2019 Jan 1;10(2):441-448. doi: 10.7150/jca.30041. eCollection 2019.
|
2221 |
Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells.Cancer Med. 2015 Feb;4(2):268-77. doi: 10.1002/cam4.366. Epub 2014 Dec 1.
|
2222 |
Long noncoding RNA HAND2-AS1 restrains proliferation and metastasis of breast cancer cells through sponging miR-1275 and promoting SOX7.Cancer Biomark. 2020;27(1):85-94. doi: 10.3233/CBM-190530.
|
2223 |
MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions.Hum Pathol. 2013 Dec;44(12):2837-44. doi: 10.1016/j.humpath.2013.08.001. Epub 2013 Oct 18.
|
2224 |
Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells.Tumour Biol. 2016 Oct;37(10):13101-13110. doi: 10.1007/s13277-016-5240-6. Epub 2016 Jul 23.
|
2225 |
Up-regulation of SPC25 promotes breast cancer.Aging (Albany NY). 2019 Aug 10;11(15):5689-5704. doi: 10.18632/aging.102153. Epub 2019 Aug 10.
|
2226 |
SPZ1 is critical for chemoresistance and aggressiveness in drug-resistant breast cancer cells.Biochem Pharmacol. 2018 Oct;156:43-51. doi: 10.1016/j.bcp.2018.07.046. Epub 2018 Aug 1.
|
2227 |
SRSF1-Regulated Alternative Splicing in Breast Cancer.Mol Cell. 2015 Oct 1;60(1):105-17. doi: 10.1016/j.molcel.2015.09.005.
|
2228 |
Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.Cancer Res. 2012 Nov 1;72(21):5537-46. doi: 10.1158/0008-5472.CAN-12-1474. Epub 2012 Sep 10.
|
2229 |
Sialylation of vasorin by ST3Gal1 facilitates TGF-1-mediated tumor angiogenesis and progression.Int J Cancer. 2019 Apr 15;144(8):1996-2007. doi: 10.1002/ijc.31891. Epub 2019 Jan 3.
|
2230 |
TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.PLoS One. 2018 Apr 26;13(4):e0196369. doi: 10.1371/journal.pone.0196369. eCollection 2018.
|
2231 |
Post-translational modification of OCT4 in breast cancer tumorigenesis.Cell Death Differ. 2018 Nov;25(10):1781-1795. doi: 10.1038/s41418-018-0079-6. Epub 2018 Mar 6.
|
2232 |
Genomic profiling of histological special types of breast cancer.Breast Cancer Res Treat. 2013 Nov;142(2):257-69. doi: 10.1007/s10549-013-2740-6. Epub 2013 Oct 27.
|
2233 |
Heparan sulfate mediates trastuzumab effect in breast cancer cells.BMC Cancer. 2013 Oct 1;13:444. doi: 10.1186/1471-2407-13-444.
|
2234 |
Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin in RhoA stabilization.EMBO J. 2012 Feb 15;31(4):1028-40. doi: 10.1038/emboj.2011.464. Epub 2011 Dec 13.
|
2235 |
Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.Oncol Rep. 2013 Apr;29(4):1517-23. doi: 10.3892/or.2013.2253. Epub 2013 Jan 24.
|
2236 |
Ranked retrieval of segmented nuclei for objective assessment of cancer gene repositioning.BMC Bioinformatics. 2012 Sep 12;13:232. doi: 10.1186/1471-2105-13-232.
|
2237 |
Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.Sci Rep. 2017 Jul 7;7(1):4846. doi: 10.1038/s41598-017-05129-y.
|
2238 |
Bisphenol S induced epigenetic and transcriptional changes in human breast cancer cell line MCF-7.Environ Pollut. 2019 Mar;246:697-703. doi: 10.1016/j.envpol.2018.12.084. Epub 2018 Dec 31.
|
2239 |
Expression of THSD7A in neoplasm tissues and its relationship with proteinuria.BMC Nephrol. 2019 Aug 23;20(1):332. doi: 10.1186/s12882-019-1489-5.
|
2240 |
TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells.Mol Cancer Res. 2012 Nov;10(11):1482-95. doi: 10.1158/1541-7786.MCR-12-0144. Epub 2012 Sep 4.
|
2241 |
TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells.BMC Cancer. 2012 Sep 6;12:391. doi: 10.1186/1471-2407-12-391.
|
2242 |
A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis.Breast Cancer Res. 2013 Dec 13;15(6):R116. doi: 10.1186/bcr3585.
|
2243 |
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.Clin Cancer Res. 2008 Aug 15;14(16):5050-60. doi: 10.1158/1078-0432.CCR-07-4994.
|
2244 |
TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis.Oncol Res. 2019 Mar 29;27(4):439-447. doi: 10.3727/096504018X15214994641786. Epub 2018 Mar 21.
|
2245 |
High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.Cancer Lett. 2016 May 1;374(2):315-23. doi: 10.1016/j.canlet.2016.02.021. Epub 2016 Feb 20.
|
2246 |
Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated induction.Biochem Biophys Res Commun. 2013 Nov 22;441(3):600-6. doi: 10.1016/j.bbrc.2013.10.110. Epub 2013 Oct 29.
|
2247 |
A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/-catenin signaling pathway in breast cancer.Pathol Res Pract. 2019 Oct;215(10):152573. doi: 10.1016/j.prp.2019.152573. Epub 2019 Jul 31.
|
2248 |
Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.J Exp Clin Cancer Res. 2019 Jun 11;38(1):248. doi: 10.1186/s13046-019-1200-5.
|
2249 |
Bcl-2 has differing effects on the sensitivity of breast cancer cells depending on the antineoplastic drug used.Eur J Cancer. 2002 Dec;38(18):2455-62. doi: 10.1016/s0959-8049(02)00391-x.
|
2250 |
Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment.PLoS One. 2011;6(11):e27355. doi: 10.1371/journal.pone.0027355. Epub 2011 Nov 4.
|
2251 |
The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers.J Clin Lab Anal. 2020 Jan;34(1):e23049. doi: 10.1002/jcla.23049. Epub 2019 Sep 25.
|
2252 |
MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer.Proc Natl Acad Sci U S A. 2002 May 14;99(10):6997-7002. doi: 10.1073/pnas.102187299.
|
2253 |
Dual inhibition of ABCE1 and LCP1 by microRNA-96 results in an additive effect in breast cancer mouse model.Oncotarget. 2019 Mar 12;10(21):2086-2094. doi: 10.18632/oncotarget.26747. eCollection 2019 Mar 12.
|
2254 |
Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.Breast Cancer Res Treat. 2011 Sep;129(2):373-86. doi: 10.1007/s10549-010-1241-0. Epub 2010 Nov 3.
|
2255 |
Functionalization of nanotextured substrates for enhanced identification of metastatic breast cancer cells.Nanotechnology. 2017 Sep 20;28(38):385101. doi: 10.1088/1361-6528/aa7f84. Epub 2017 Jul 13.
|
2256 |
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.Dig Liver Dis. 2006 Jan;38(1):18-23. doi: 10.1016/j.dld.2005.07.006. Epub 2005 Sep 19.
|
2257 |
Caspase-1 cleaves PPAR for potentiating the pro-tumor action of TAMs.Nat Commun. 2017 Oct 3;8(1):766. doi: 10.1038/s41467-017-00523-6.
|
2258 |
Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women.Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2313-6. doi: 10.1158/1055-9965.EPI-11-0704. Epub 2011 Aug 9.
|
2259 |
Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2.Cell Oncol (Dordr). 2017 Dec;40(6):537-547. doi: 10.1007/s13402-017-0342-8. Epub 2017 Aug 2.
|
2260 |
Overexpressed ACBD3 has prognostic value in human breast cancer and promotes the self-renewal potential of breast cancer cells by activating the Wnt/beta-catenin signaling pathway.Exp Cell Res. 2018 Feb 1;363(1):39-47. doi: 10.1016/j.yexcr.2018.01.003. Epub 2018 Jan 4.
|
2261 |
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.Clin Cancer Res. 2019 Jun 15;25(12):3702-3717. doi: 10.1158/1078-0432.CCR-18-1294. Epub 2019 Mar 8.
|
2262 |
Effect of functional genetic variants in chemokine decoy receptors on the recurrence risk of breast cancer.Cancer Med. 2018 Nov;7(11):5497-5504. doi: 10.1002/cam4.1823. Epub 2018 Oct 24.
|
2263 |
In vivo efficacy of folate-targeted lipid-protamine-DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma.Cancer Gene Ther. 2004 Feb;11(2):128-34. doi: 10.1038/sj.cgt.7700662.
|
2264 |
Association of long-chain acyl-coenzyme A synthetase5 expression in human breast cancer by estrogen receptor status and its clinical significance.Oncol Rep. 2017 Jun;37(6):3253-3260. doi: 10.3892/or.2017.5610. Epub 2017 Apr 28.
|
2265 |
High ASMA(+) Fibroblasts and Low Cytoplasmic HMGB1(+) Breast Cancer Cells Predict PoorPrognosis.Clin Breast Cancer. 2017 Oct;17(6):441-452.e2. doi: 10.1016/j.clbc.2017.04.007. Epub 2017 Apr 21.
|
2266 |
Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.EMBO Mol Med. 2014 Dec;6(12):1542-60. doi: 10.15252/emmm.201404402.
|
2267 |
Involvement of Actin Cytoskeletal Components in Breast Cancer Cell Fusion with Human Mesenchymal Stroma/Stem-Like Cells.Int J Mol Sci. 2019 Feb 18;20(4):876. doi: 10.3390/ijms20040876.
|
2268 |
ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.Dev Cell. 2019 May 6;49(3):409-424.e6. doi: 10.1016/j.devcel.2019.04.015.
|
2269 |
Proteomic screening identifies the zonula occludens protein ZO-1 as a new partner for ADAM12 in invadopodia-like structures.Oncotarget. 2018 Apr 20;9(30):21366-21382. doi: 10.18632/oncotarget.25106. eCollection 2018 Apr 20.
|
2270 |
ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells.Sci Rep. 2019 Aug 29;9(1):12540. doi: 10.1038/s41598-019-49021-3.
|
2271 |
Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.J Natl Cancer Inst. 2012 Jun 20;104(12):906-22. doi: 10.1093/jnci/djs232. Epub 2012 May 25.
|
2272 |
ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinoma.Int J Cancer. 2006 Mar 1;118(5):1241-7. doi: 10.1002/ijc.21476.
|
2273 |
Sp1 is necessary for gene activation of Adamts17 by estrogen.J Cell Biochem. 2014 Oct;115(10):1829-39. doi: 10.1002/jcb.24855.
|
2274 |
Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-B signaling.Cancer Med. 2017 Jun;6(6):1399-1408. doi: 10.1002/cam4.1076. Epub 2017 May 15.
|
2275 |
The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.Breast Cancer Res Treat. 2016 Feb;156(1):9-20. doi: 10.1007/s10549-016-3709-z. Epub 2016 Feb 23.
|
2276 |
ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.Oncotarget. 2016 Sep 20;7(38):61273-61283. doi: 10.18632/oncotarget.11341.
|
2277 |
RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.FEBS Lett. 2017 Sep;591(18):2890-2904. doi: 10.1002/1873-3468.12795. Epub 2017 Aug 30.
|
2278 |
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet. 2017 Dec;49(12):1767-1778. doi: 10.1038/ng.3785. Epub 2017 Oct 23.
|
2279 |
Genomic structure and expression profile of LPHH1, a 7TM gene variably expressed in breast cancer cell lines.Biochim Biophys Acta. 2000 Apr 25;1491(1-3):75-92. doi: 10.1016/s0167-4781(00)00020-8.
|
2280 |
Effects of two types of energy restriction on methylation levels of adiponectin receptor 1 and leptin receptor overlapping transcript in a mouse mammary tumour virus-transforming growth factor- breast cancer mouse model.Br J Nutr. 2021 Jan 14;125(1):1-9. doi: 10.1017/S0007114519002757. Epub 2019 Nov 5.
|
2281 |
Expression of AdipoR1 and AdipoR2 Receptors as Leptin-Breast Cancer Regulation Mechanisms.Dis Markers. 2017;2017:4862016. doi: 10.1155/2017/4862016. Epub 2017 Sep 5.
|
2282 |
Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.Clin Breast Cancer. 2020 Apr;20(2):131-144.e3. doi: 10.1016/j.clbc.2019.07.009. Epub 2019 Sep 3.
|
2283 |
Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.Mol Cell Proteomics. 2017 Jan;16(1):121-134. doi: 10.1074/mcp.M116.060301. Epub 2016 Nov 11.
|
2284 |
Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.Cancer Biomark. 2018;22(1):49-54. doi: 10.3233/CBM-170831.
|
2285 |
AFF3 upregulation mediates tamoxifen resistance in breast cancers.J Exp Clin Cancer Res. 2018 Oct 16;37(1):254. doi: 10.1186/s13046-018-0928-7.
|
2286 |
Afamin expression in breast cancer.Asian J Surg. 2020 Jul;43(7):750-754. doi: 10.1016/j.asjsur.2019.09.014. Epub 2019 Oct 23.
|
2287 |
Inverse association of rab31 and mucin-1 (CA15-3) antigen levels in estrogen receptor-positive (ER+) breast cancer tissues with clinicopathological parameters and patients' prognosis.Am J Cancer Res. 2017 Sep 1;7(9):1959-1970. eCollection 2017.
|
2288 |
Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells.Endocrinology. 2009 Jan;150(1):14-23. doi: 10.1210/en.2008-0984. Epub 2008 Sep 11.
|
2289 |
Anterior Gradient 3 Promotes Breast Cancer Development and Chemotherapy Response.Cancer Res Treat. 2020 Jan;52(1):218-245. doi: 10.4143/crt.2019.217. Epub 2019 Jul 8.
|
2290 |
Doxorubicin resistance in breast cancer: A novel role for the human protein AHNAK.Biochem Pharmacol. 2018 Feb;148:174-183. doi: 10.1016/j.bcp.2018.01.012. Epub 2018 Jan 5.
|
2291 |
Clinical implications of a novel prognostic factor AIFM3 in breast cancer patients.BMC Cancer. 2019 May 14;19(1):451. doi: 10.1186/s12885-019-5659-4.
|
2292 |
Clinicopathological and immunohistochemical analysis of autoimmune regulator expression in patients with osteosarcoma.Clin Exp Metastasis. 2018 Oct;35(7):641-648. doi: 10.1007/s10585-018-9928-4. Epub 2018 Aug 18.
|
2293 |
AK4 Promotes the Progression of HER2-Positive Breast Cancer by Facilitating Cell Proliferation and Invasion.Dis Markers. 2019 Nov 20;2019:8186091. doi: 10.1155/2019/8186091. eCollection 2019.
|
2294 |
Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).BMC Cancer. 2018 Feb 12;18(1):174. doi: 10.1186/s12885-018-4021-6.
|
2295 |
The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer.Carcinogenesis. 2007 Feb;28(2):423-6. doi: 10.1093/carcin/bgl164. Epub 2006 Sep 6.
|
2296 |
A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer.Exp Mol Pathol. 2018 Dec;105(3):364-370. doi: 10.1016/j.yexmp.2018.10.010. Epub 2018 Oct 30.
|
2297 |
Metabolic fingerprinting in breast cancer stages through (1)H NMR spectroscopy-based metabolomic analysis of plasma.J Pharm Biomed Anal. 2018 Oct 25;160:38-45. doi: 10.1016/j.jpba.2018.07.024. Epub 2018 Jul 18.
|
2298 |
Does BCA3 Play a Role in the HIV-1 Replication Cycle?.Viruses. 2018 Apr 20;10(4):212. doi: 10.3390/v10040212.
|
2299 |
Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.Neuro Oncol. 2019 Nov 4;21(11):1401-1411. doi: 10.1093/neuonc/noz105.
|
2300 |
Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.Int J Mol Med. 2011 Sep;28(3):365-71. doi: 10.3892/ijmm.2011.700. Epub 2011 May 13.
|
2301 |
Apoptosis-linked gene 2 promotes breast cancer growth and metastasis by regulating the cytoskeleton.Oncotarget. 2017 Jan 10;8(2):2745-2757. doi: 10.18632/oncotarget.13740.
|
2302 |
ALG3 Is Activated by Heat Shock Factor 2 and Promotes Breast Cancer Growth.Med Sci Monit. 2018 May 25;24:3479-3487. doi: 10.12659/MSM.907461.
|
2303 |
CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.BMC Cancer. 2017 Jul 5;17(1):469. doi: 10.1186/s12885-017-3453-8.
|
2304 |
Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer.J Exp Med. 2016 Oct 17;213(11):2503-2523. doi: 10.1084/jem.20160397. Epub 2016 Oct 10.
|
2305 |
ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer.Oncotarget. 2016 Dec 13;7(50):83278-83293. doi: 10.18632/oncotarget.13086.
|
2306 |
Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.Cancer Res. 1996 Sep 1;56(17):3886-90.
|
2307 |
Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.PLoS One. 2019 Mar 15;14(3):e0209392. doi: 10.1371/journal.pone.0209392. eCollection 2019.
|
2308 |
ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/-catenin pathway.J Exp Clin Cancer Res. 2017 Nov 28;36(1):170. doi: 10.1186/s13046-017-0643-9.
|
2309 |
Ambra1 inhibits paclitaxel-induced apoptosis in breast cancer cells by modulating the Bim/mitochondrial pathway.Neoplasma. 2019 May 23;66(3):377-385. doi: 10.4149/neo_2018_180710N467. Epub 2019 Feb 14.
|
2310 |
Association of BRCA Mutations and Anti-mllerian Hormone Level in Young Breast Cancer Patients.Front Endocrinol (Lausanne). 2019 Apr 11;10:235. doi: 10.3389/fendo.2019.00235. eCollection 2019.
|
2311 |
Reporters to mark and eliminate basal or luminal epithelial cells in culture and in vivo.PLoS Biol. 2018 Jun 20;16(6):e2004049. doi: 10.1371/journal.pbio.2004049. eCollection 2018 Jun.
|
2312 |
AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.Neoplasia. 2016 Jan;18(1):10-24. doi: 10.1016/j.neo.2015.11.010.
|
2313 |
Contribution of cell culture, RNA extraction, and reverse transcription to the measurement error in quantitative reverse transcription polymerase chain reaction-based gene expression quantification.Anal Biochem. 2009 Oct 1;393(1):29-35. doi: 10.1016/j.ab.2009.06.010. Epub 2009 Jun 13.
|
2314 |
Angiopoietin-3 inhibits pulmonary metastasis by inhibiting tumor angiogenesis.Cancer Res. 2004 Sep 1;64(17):6119-26. doi: 10.1158/0008-5472.CAN-04-1054.
|
2315 |
ANGPTL1 attenuates colorectal cancer metastasis by up-regulating microRNA-138.J Exp Clin Cancer Res. 2017 Jun 12;36(1):78. doi: 10.1186/s13046-017-0548-7.
|
2316 |
Moderating Effects of Genetic Polymorphisms on Improvements in Cognitive Impairment in Breast Cancer Survivors Participating in a 6-Week Mindfulness-Based Stress Reduction Program.Biol Res Nurs. 2015 Jul;17(4):393-404. doi: 10.1177/1099800415577633. Epub 2015 Apr 15.
|
2317 |
LEM-3 is a midbody-tethered DNA nuclease that resolves chromatin bridges during late mitosis.Nat Commun. 2018 Feb 20;9(1):728. doi: 10.1038/s41467-018-03135-w.
|
2318 |
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ER pathway.Nat Commun. 2018 Oct 9;9(1):4180. doi: 10.1038/s41467-018-06309-8.
|
2319 |
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.BMC Cancer. 2019 Sep 13;19(1):914. doi: 10.1186/s12885-019-6102-6.
|
2320 |
Expression of pp32 gene family members in breast cancer.Breast Cancer Res Treat. 2001 Jul;68(1):65-73. doi: 10.1023/a:1017919507109.
|
2321 |
Tumor endothelial marker 8 promotes cancer progression and metastasis.Oncotarget. 2018 Jul 10;9(53):30173-30188. doi: 10.18632/oncotarget.25734. eCollection 2018 Jul 10.
|
2322 |
The expression of ANXA3 and its relationship with the occurrence and development of breast cancer.J BUON. 2018 May-Jun;23(3):713-719.
|
2323 |
Annexin A7 is correlated with better clinical outcomes of patients with breast cancer.J Cell Biochem. 2018 Sep;119(9):7577-7584. doi: 10.1002/jcb.27087. Epub 2018 Jun 12.
|
2324 |
AP-2 reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.Apoptosis. 2017 Jul;22(7):933-941. doi: 10.1007/s10495-017-1379-x.
|
2325 |
New Gene Profiling in Determination of Breast Cancer Recurrence and Prognosis in Iranian Women.Asian Pac J Cancer Prev. 2016;17(S3):155-60. doi: 10.7314/apjcp.2016.17.s3.155.
|
2326 |
Mitochondria-targeted delivery of doxorubicin to enhance antitumor activity with HER-2 peptide-mediated multifunctional pH-sensitive DQAsomes.Int J Nanomedicine. 2018 Jul 18;13:4209-4226. doi: 10.2147/IJN.S163858. eCollection 2018.
|
2327 |
Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice.Biochem Biophys Res Commun. 2017 Aug 26;490(3):688-692. doi: 10.1016/j.bbrc.2017.06.102. Epub 2017 Jun 19.
|
2328 |
Identification of new human coding steroid receptor RNA activator isoforms.Biochem Biophys Res Commun. 2003 Feb 7;301(2):509-15. doi: 10.1016/s0006-291x(02)03070-x.
|
2329 |
APC downregulated 1 inhibits breast cancer cell invasion by inhibiting the canonical WNT signaling pathway.Oncol Lett. 2017 Oct;14(4):4845-4852. doi: 10.3892/ol.2017.6801. Epub 2017 Aug 23.
|
2330 |
Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types.BMC Med Genomics. 2019 Sep 18;12(1):131. doi: 10.1186/s12920-019-0579-3.
|
2331 |
APPL proteins promote TGF-induced nuclear transport of the TGF type I receptor intracellular domain.Oncotarget. 2016 Jan 5;7(1):279-92. doi: 10.18632/oncotarget.6346.
|
2332 |
Aquaporin-4 antibody positive short transverse myelitis associated with breast cancer.Mult Scler Relat Disord. 2019 May;30:119-122. doi: 10.1016/j.msard.2019.02.011. Epub 2019 Feb 8.
|
2333 |
AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression.Am J Cancer Res. 2018 Feb 1;8(2):266-279. eCollection 2018.
|
2334 |
Bioinformatic analysis of prognostic value of ARAP3 in breast cancer and the associated signaling pathways.Eur Rev Med Pharmacol Sci. 2017 May;21(10):2405-2412.
|
2335 |
Up-regulated ADP-Ribosylation factor 3 promotes breast cancer cell proliferation through the participation of FOXO1.Exp Cell Res. 2019 Nov 15;384(2):111624. doi: 10.1016/j.yexcr.2019.111624. Epub 2019 Sep 17.
|
2336 |
Role of ARHGAP24 in ADP Ribosylation Factor 6 (ARF6)-dependent Pseudopod Formation in Human Breast Carcinoma Cells.Anticancer Res. 2017 Sep;37(9):4837-4844. doi: 10.21873/anticanres.11891.
|
2337 |
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.Cancer. 2019 Jan 15;125(2):307-316. doi: 10.1002/cncr.31784. Epub 2018 Oct 18.
|
2338 |
Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth.J Biol Chem. 2011 May 20;286(20):17746-54. doi: 10.1074/jbc.M110.206029. Epub 2011 Mar 28.
|
2339 |
The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.Cancer Res. 2005 Jul 15;65(14):6042-53. doi: 10.1158/0008-5472.CAN-04-3043.
|
2340 |
Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer.PeerJ. 2019 Aug 1;7:e7431. doi: 10.7717/peerj.7431. eCollection 2019.
|
2341 |
ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens.Int J Mol Sci. 2018 Mar 10;19(3):804. doi: 10.3390/ijms19030804.
|
2342 |
Long isoform of VEGF stimulates cell migration of breast cancer by filopodia formation via NRP1/ARHGAP17/Cdc42 regulatory network.Int J Cancer. 2018 Dec 1;143(11):2905-2918. doi: 10.1002/ijc.31645. Epub 2018 Oct 9.
|
2343 |
Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.Br J Cancer. 2017 Oct 10;117(8):1176-1184. doi: 10.1038/bjc.2017.261. Epub 2017 Aug 22.
|
2344 |
Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer.Oncol Lett. 2019 Dec;18(6):6017-6025. doi: 10.3892/ol.2019.10949. Epub 2019 Oct 2.
|
2345 |
Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI- silencing and overexpression.Asian Pac J Cancer Prev. 2014;15(7):3311-7. doi: 10.7314/apjcp.2014.15.7.3311.
|
2346 |
Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers.Clin Cancer Res. 2003 Dec 15;9(17):6432-40.
|
2347 |
The exon 38-containing ARHGEF11 splice isoform is differentially expressed and is required for migration and growth in invasive breast cancer cells.Oncotarget. 2017 Sep 18;8(54):92157-92170. doi: 10.18632/oncotarget.20985. eCollection 2017 Nov 3.
|
2348 |
LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer.Oncogene. 2009 Nov 26;28(47):4189-200. doi: 10.1038/onc.2009.266. Epub 2009 Sep 7.
|
2349 |
ARID3B expression in primary breast cancers and breast cancer-derived cell lines.Cell Oncol (Dordr). 2014 Aug;37(4):289-96. doi: 10.1007/s13402-014-0185-5. Epub 2014 Aug 14.
|
2350 |
Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.J Biol Chem. 2008 Mar 21;283(12):7438-44. doi: 10.1074/jbc.M709446200. Epub 2008 Jan 22.
|
2351 |
ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.Mol Biol Rep. 2011 Jan;38(1):343-8. doi: 10.1007/s11033-010-0113-3. Epub 2010 Apr 1.
|
2352 |
siRNA-mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia-inducible factor-1 regulatory signaling and metabolism in human breast cancer cells.FEBS Lett. 2011 Oct 20;585(20):3310-5. doi: 10.1016/j.febslet.2011.09.017. Epub 2011 Sep 19.
|
2353 |
Cortical branched actin determines cell cycle progression.Cell Res. 2019 Jun;29(6):432-445. doi: 10.1038/s41422-019-0160-9. Epub 2019 Apr 10.
|
2354 |
RBM3 upregulates ARPC2 by binding the 3'UTR and contributes to breast cancer progression.Int J Oncol. 2019 Apr;54(4):1387-1397. doi: 10.3892/ijo.2019.4698. Epub 2019 Jan 28.
|
2355 |
Aberrant expression of Arpin in human breast cancer and its clinical significance.J Cell Mol Med. 2016 Mar;20(3):450-8. doi: 10.1111/jcmm.12740. Epub 2015 Dec 9.
|
2356 |
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study.Psychooncology. 2017 Jan;26(1):74-80. doi: 10.1002/pon.4102. Epub 2016 Feb 22.
|
2357 |
Silencing lnc-ASAH2B-2 Inhibits Breast Cancer Cell Growth via the mTOR Pathway.Anticancer Res. 2018 Jun;38(6):3427-3434. doi: 10.21873/anticanres.12611.
|
2358 |
CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.J Cell Physiol. 2018 Apr;233(4):3207-3217. doi: 10.1002/jcp.26164. Epub 2017 Sep 27.
|
2359 |
Identification of core genes and clinical roles in pregnancy-associated breast cancer based on integrated analysis of different microarray profile datasets.Biosci Rep. 2019 Jun 25;39(6):BSR20190019. doi: 10.1042/BSR20190019. Print 2019 Jun 28.
|
2360 |
Elevated ASCL2 expression in breast cancer is associated with the poor prognosis of patients.Am J Cancer Res. 2017 Apr 1;7(4):955-961. eCollection 2017.
|
2361 |
Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.EMBO J. 2011 Feb 2;30(3):480-93. doi: 10.1038/emboj.2010.335. Epub 2010 Dec 21.
|
2362 |
ASXL2 promotes proliferation of breast cancer cells by linking ER to histone methylation.Oncogene. 2016 Jul 14;35(28):3742-52. doi: 10.1038/onc.2015.443. Epub 2015 Dec 7.
|
2363 |
Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan.Br J Cancer. 1999 Aug;80(11):1838-43. doi: 10.1038/sj.bjc.6690608.
|
2364 |
ATAD2B is a phylogenetically conserved nuclear protein expressed during neuronal differentiation and tumorigenesis.Dev Growth Differ. 2010 Dec;52(9):747-55. doi: 10.1111/j.1440-169X.2010.01211.x.
|
2365 |
Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein.Oncogene. 2016 Jan 21;35(3):333-43. doi: 10.1038/onc.2015.86. Epub 2015 Mar 30.
|
2366 |
BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.J Biol Chem. 2011 Mar 4;286(9):7705-13. doi: 10.1074/jbc.M110.207639. Epub 2011 Jan 6.
|
2367 |
Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.Toxicol Appl Pharmacol. 2012 Dec 15;265(3):325-34. doi: 10.1016/j.taap.2012.08.034. Epub 2012 Sep 12.
|
2368 |
Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in Regulating Autophagy in Patients with Breast Cancer.Cell Physiol Biochem. 2018;48(1):194-207. doi: 10.1159/000491718. Epub 2018 Jul 13.
|
2369 |
ATM kinase sustains breast cancer stem-like cells by promoting ATG4C expression and autophagy.Oncotarget. 2017 Mar 28;8(13):21692-21709. doi: 10.18632/oncotarget.15537.
|
2370 |
Comparative epigenomics of human and mouse mammary tumors.Genes Chromosomes Cancer. 2009 Jan;48(1):83-97. doi: 10.1002/gcc.20620.
|
2371 |
Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation.Biochem Biophys Res Commun. 2007 Apr 20;355(4):932-6. doi: 10.1016/j.bbrc.2007.02.050. Epub 2007 Feb 20.
|
2372 |
Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. J Clin Invest. 2002 Aug;110(4):453-62.
|
2373 |
SPCA2 couples Ca(2+) influx via Orai1 to Ca(2+) uptake into the Golgi/secretory pathway.Tissue Cell. 2017 Apr;49(2 Pt A):141-149. doi: 10.1016/j.tice.2016.09.004. Epub 2016 Sep 17.
|
2374 |
Complete sequence of the ATP6 and ND3 mitochondrial genes in breast cancer tissue of postmenopausal women with different body mass indexes.Ann Diagn Pathol. 2018 Feb;32:23-27. doi: 10.1016/j.anndiagpath.2017.09.001. Epub 2017 Sep 10.
|
2375 |
CAPER, a novel regulator of human breast cancer progression.Cell Cycle. 2014;13(8):1256-64. doi: 10.4161/cc.28156. Epub 2014 Feb 17.
|
2376 |
VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix.Genet Epidemiol. 2013 Sep;37(6):622-34. doi: 10.1002/gepi.21743. Epub 2013 Jul 8.
|
2377 |
Common nonsense mutations in RAD52.Cancer Res. 1999 Aug 15;59(16):3883-8.
|
2378 |
Ataxin-1 regulates epithelial-mesenchymal transition of cervical cancer cells.Oncotarget. 2017 Mar 14;8(11):18248-18259. doi: 10.18632/oncotarget.15319.
|
2379 |
Cytoplasmic ATXN7L3B Interferes with Nuclear Functions of the SAGA Deubiquitinase Module.Mol Cell Biol. 2016 Oct 28;36(22):2855-2866. doi: 10.1128/MCB.00193-16. Print 2016 Nov 15.
|
2380 |
High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.J Biotechnol. 2006 May 29;123(3):367-78. doi: 10.1016/j.jbiotec.2005.11.018. Epub 2006 Jan 10.
|
2381 |
Downregulation of gangliotetraosylceramide and 1,3-galactosyltransferase-4 gene expression by Smads during transforming growth factor -induced epithelial-mesenchymal transition.Mol Med Rep. 2015 Mar;11(3):2241-7. doi: 10.3892/mmr.2014.2912. Epub 2014 Nov 10.
|
2382 |
Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.PLoS One. 2018 Apr 26;13(4):e0196245. doi: 10.1371/journal.pone.0196245. eCollection 2018.
|
2383 |
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer.Breast Cancer Res Treat. 2012 Aug;135(1):125-33. doi: 10.1007/s10549-012-2122-5. Epub 2012 Jun 16.
|
2384 |
Downregulation of BAG? in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway.Oncol Rep. 2019 Mar;41(3):1901-1910. doi: 10.3892/or.2019.6978. Epub 2019 Jan 22.
|
2385 |
BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.Neoplasia. 2018 Mar;20(3):263-279. doi: 10.1016/j.neo.2018.01.001. Epub 2018 Feb 22.
|
2386 |
SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression.Neoplasia. 2019 Oct;21(10):945-962. doi: 10.1016/j.neo.2019.07.002. Epub 2019 Aug 15.
|
2387 |
BARX2 and estrogen receptor-alpha (ESR1) coordinately regulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion.Oncogene. 2006 Aug 31;25(39):5426-35. doi: 10.1038/sj.onc.1209529. Epub 2006 Apr 24.
|
2388 |
BASP1 interacts with oestrogen receptor and modifies the tamoxifen response.Cell Death Dis. 2017 May 11;8(5):e2771. doi: 10.1038/cddis.2017.179.
|
2389 |
Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1,25-dihydroxyvitamin D(3).J Steroid Biochem Mol Biol. 2018 Mar;177:171-178. doi: 10.1016/j.jsbmb.2017.06.003. Epub 2017 Jun 10.
|
2390 |
Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy.Theranostics. 2018 Feb 7;8(6):1558-1574. doi: 10.7150/thno.22989. eCollection 2018.
|
2391 |
RNA methyltransferase BCDIN3D is crucial for female fertility and miRNA and mRNA profiles in Drosophila ovaries.PLoS One. 2019 May 30;14(5):e0217603. doi: 10.1371/journal.pone.0217603. eCollection 2019.
|
2392 |
Uev1A promotes breast cancer cell survival and chemoresistance through the AKT-FOXO1-BIM pathway.Cancer Cell Int. 2019 Dec 9;19:331. doi: 10.1186/s12935-019-1050-4. eCollection 2019.
|
2393 |
Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers.Hum Gene Ther. 2019 Dec;30(12):1531-1546. doi: 10.1089/hum.2019.096. Epub 2019 Oct 29.
|
2394 |
Bcl-3 regulates TGF signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.Cell Death Dis. 2016 Dec 1;7(12):e2508. doi: 10.1038/cddis.2016.405.
|
2395 |
Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.Br J Cancer. 1999 Sep;81(2):252-60. doi: 10.1038/sj.bjc.6690685.
|
2396 |
The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the -Catenin Coactivator BCL9-2 in Breast Cancer Cells.Mol Cancer Res. 2015 May;13(5):902-12. doi: 10.1158/1541-7786.MCR-14-0180. Epub 2015 Feb 12.
|
2397 |
BCoR-L1 variation and breast cancer.Breast Cancer Res. 2007;9(4):R54. doi: 10.1186/bcr1759.
|
2398 |
Impact of Awake Breast Cancer Surgery on Postoperative Lymphocyte Responses.In Vivo. 2019 Nov-Dec;33(6):1879-1884. doi: 10.21873/invivo.11681.
|
2399 |
Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.Exp Cell Res. 2019 Mar 15;376(2):221-226. doi: 10.1016/j.yexcr.2019.02.014. Epub 2019 Feb 16.
|
2400 |
Differential gene expression pattern in human mammary epithelial cells induced by realistic organochlorine mixtures described in healthy women and in women diagnosed with breast cancer.Toxicol Lett. 2016 Mar 30;246:42-8. doi: 10.1016/j.toxlet.2016.02.003. Epub 2016 Feb 4.
|
2401 |
Genetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance.Cancers (Basel). 2018 Aug 18;10(8):274. doi: 10.3390/cancers10080274.
|
2402 |
Interaction with SP1, but not binding to the E-box motifs, is responsible for BHLHE40/DEC1-induced transcriptional suppression of CLDN1 and cell invasion in MCF-7 cells.Mol Carcinog. 2018 Sep;57(9):1116-1129. doi: 10.1002/mc.22829. Epub 2018 May 2.
|
2403 |
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells. J Toxicol Sci. 2014;39(5):711-6.
|
2404 |
Breast cancer cell line MDA-MB-231 miRNA profile expression after BIK interference: BIK involvement in autophagy.Tumour Biol. 2016 May;37(5):6749-59. doi: 10.1007/s13277-015-4494-8. Epub 2015 Dec 10.
|
2405 |
Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity.Int J Cancer. 2000 Feb 1;85(3):376-83.
|
2406 |
Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation.Br J Cancer. 2009 Mar 10;100(5):739-46. doi: 10.1038/sj.bjc.6604927. Epub 2009 Feb 17.
|
2407 |
Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.Biosci Rep. 2019 Feb 15;39(2):BSR20181284. doi: 10.1042/BSR20181284. Print 2019 Feb 28.
|
2408 |
BLID: A Novel Tumor-Suppressor Gene.Oncol Res. 2014;22(5-6):333-8. doi: 10.3727/096504015X14410238486568.
|
2409 |
Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.Cell Death Differ. 2016 Sep 1;23(9):1483-92. doi: 10.1038/cdd.2016.33. Epub 2016 Apr 1.
|
2410 |
Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.Cell Physiol Biochem. 2018;45(5):1759-1771. doi: 10.1159/000487784. Epub 2018 Feb 23.
|
2411 |
A comparison of folic acid deficiency-induced genomic instability in lymphocytes of breast cancer patients and normal non-cancer controls from a Chinese population in Yunnan.Mutagenesis. 2006 Jan;21(1):41-7. doi: 10.1093/mutage/gei069. Epub 2005 Dec 8.
|
2412 |
NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics.Breast Cancer Res Treat. 2010 Feb;119(3):773-86. doi: 10.1007/s10549-009-0372-7. Epub 2009 Mar 26.
|
2413 |
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.Mol Cancer. 2019 Mar 28;18(1):46. doi: 10.1186/s12943-019-1004-4.
|
2414 |
Blockade of epidermal growth factor receptors chemosensitizes breast cancer cells through up-regulation of Bnip3L.Cancer Res. 2005 Sep 15;65(18):8151-7. doi: 10.1158/0008-5472.CAN-05-1134.
|
2415 |
miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro.Tumour Biol. 2018 Aug;40(8):1010428318791887. doi: 10.1177/1010428318791887.
|
2416 |
Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die.Oncotarget. 2017 Sep 12;8(49):85984-85996. doi: 10.18632/oncotarget.20841. eCollection 2017 Oct 17.
|
2417 |
The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.Metallomics. 2015 Mar;7(3):553-66. doi: 10.1039/c5mt00037h.
|
2418 |
The single nucleotide polymorphisms in BRAP decrease the risk of metabolic syndrome in a Chinese young adult population.Diab Vasc Dis Res. 2013 May;10(3):202-7. doi: 10.1177/1479164112455535. Epub 2012 Sep 10.
|
2419 |
Alcohol Intake and Abnormal Expression of Brf1 in Breast Cancer.Oxid Med Cell Longev. 2019 Oct 31;2019:4818106. doi: 10.1155/2019/4818106. eCollection 2019.
|
2420 |
Interaction of HCCR-1 and Bax in breast cancer.J BUON. 2019 May-Jun;24(3):1027-1037.
|
2421 |
Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis - A multicentre study.Adv Med Sci. 2019 Sep;64(2):235-240. doi: 10.1016/j.advms.2018.12.007. Epub 2019 Feb 26.
|
2422 |
Genes up- and down-regulated by dermcidin in breast cancer: a microarray analysis.Genet Mol Res. 2008 Sep 30;7(3):925-32. doi: 10.4238/vol7-3x-meeting009.
|
2423 |
Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker.BMC Cancer. 2010 Mar 26;10:114. doi: 10.1186/1471-2407-10-114.
|
2424 |
Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3K inhibition through the transcriptional regulation of ER.Cancer Lett. 2019 Jan;440-441:54-63. doi: 10.1016/j.canlet.2018.09.030. Epub 2018 Oct 10.
|
2425 |
Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.PLoS One. 2017 Sep 18;12(9):e0184902. doi: 10.1371/journal.pone.0184902. eCollection 2017.
|
2426 |
BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.J Cell Biochem. 2020 Mar;121(3):2643-2654. doi: 10.1002/jcb.29485. Epub 2019 Nov 6.
|
2427 |
Breast cancer risk associated with genotypic polymorphism of the mitotic checkpoint genes: a multigenic study on cancer susceptibility.Carcinogenesis. 2007 May;28(5):1079-86. doi: 10.1093/carcin/bgl256. Epub 2007 Jan 8.
|
2428 |
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.Cancer Res. 2007 Dec 15;67(24):11751-9. doi: 10.1158/0008-5472.CAN-07-3175.
|
2429 |
Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.Neoplasia. 2016 Feb;18(2):100-10. doi: 10.1016/j.neo.2016.01.001.
|
2430 |
The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer.Oncotarget. 2017 Jun 13;8(24):38491-38500. doi: 10.18632/oncotarget.16630.
|
2431 |
Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.Oncotarget. 2015 Mar 20;6(8):6123-35. doi: 10.18632/oncotarget.3045.
|
2432 |
BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.Br J Cancer. 2017 Jun 6;116(12):1585-1594. doi: 10.1038/bjc.2017.130. Epub 2017 May 16.
|
2433 |
Anticancer activity of synthetic ()-kusunokinin and its derivative ()-bursehernin on human cancer cell lines.Biomed Pharmacother. 2019 Sep;117:109115. doi: 10.1016/j.biopha.2019.109115. Epub 2019 Jun 17.
|
2434 |
Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.Tumour Biol. 2011 Aug;32(4):745-51. doi: 10.1007/s13277-011-0176-3. Epub 2011 Apr 15.
|
2435 |
Is axillary lymph node dissection necessary for positive preoperative aspiration cytology lymph node results?.Eur J Surg Oncol. 2020 Apr;46(4 Pt A):504-510. doi: 10.1016/j.ejso.2019.10.043. Epub 2019 Nov 1.
|
2436 |
Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.Breast. 2008 Apr;17(2):159-66. doi: 10.1016/j.breast.2007.08.007. Epub 2007 Sep 29.
|
2437 |
The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.PLoS One. 2011;6(6):e20412. doi: 10.1371/journal.pone.0020412. Epub 2011 Jun 3.
|
2438 |
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.Nat Genet. 2014 Aug;46(8):886-90. doi: 10.1038/ng.3041. Epub 2014 Jul 20.
|
2439 |
Association of mRNA expression levels of Cullin family members with prognosis in breast cancer: An online database analysis.Medicine (Baltimore). 2019 Aug;98(31):e16625. doi: 10.1097/MD.0000000000016625.
|
2440 |
TGF- drives epithelial-mesenchymal transition through EF1-mediated downregulation of ESRP.Oncogene. 2012 Jun 28;31(26):3190-201. doi: 10.1038/onc.2011.493. Epub 2011 Oct 31.
|
2441 |
Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.Virchows Arch. 2017 Jul;471(1):13-21. doi: 10.1007/s00428-017-2149-4. Epub 2017 May 26.
|
2442 |
Expression and prognostic value of L1-CAM in breast cancer.Oncol Rep. 2009 Nov;22(5):1109-17. doi: 10.3892/or_00000543.
|
2443 |
Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGF signaling.Oncogene. 2018 Jan 18;37(3):323-331. doi: 10.1038/onc.2017.342. Epub 2017 Sep 18.
|
2444 |
CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer.Mol Oncol. 2008 Dec;2(4):327-39. doi: 10.1016/j.molonc.2008.09.004. Epub 2008 Oct 2.
|
2445 |
CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.Breast Cancer Res Treat. 2011 Nov;130(1):19-27. doi: 10.1007/s10549-010-1274-4. Epub 2010 Dec 3.
|
2446 |
Long Noncoding RNA CAMTA1 Promotes Proliferation and Mobility of the Human Breast Cancer Cell Line MDA-MB-231 via Targeting miR-20b.Oncol Res. 2018 May 7;26(4):625-635. doi: 10.3727/096504017X14953948675395. Epub 2017 May 21.
|
2447 |
RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.Oncotarget. 2016 May 10;7(19):27567-83. doi: 10.18632/oncotarget.8375.
|
2448 |
Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.Oncogene. 2019 Nov;38(45):7106-7112. doi: 10.1038/s41388-019-0936-x. Epub 2019 Aug 13.
|
2449 |
A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis.Cancer Res. 2005 Oct 1;65(19):8706-14. doi: 10.1158/0008-5472.CAN-04-4649.
|
2450 |
MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis.Arthritis Res Ther. 2006;8(6):R170. doi: 10.1186/ar2079.
|
2451 |
Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.J Surg Oncol. 2017 Nov;116(6):706-715. doi: 10.1002/jso.24705. Epub 2017 Jun 1.
|
2452 |
Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor.Anticancer Res. 2012 Jul;32(7):2523-9.
|
2453 |
The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.J Cell Biochem. 2018 Feb;119(2):2168-2178. doi: 10.1002/jcb.26378. Epub 2017 Oct 30.
|
2454 |
Med19 promotes breast cancer cell proliferation by regulating CBFA2T3/HEB expression.Breast Cancer. 2017 May;24(3):433-441. doi: 10.1007/s12282-016-0722-3. Epub 2016 Aug 29.
|
2455 |
The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription.Nat Commun. 2019 May 6;10(1):2071. doi: 10.1038/s41467-019-10102-6.
|
2456 |
Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.Oncotarget. 2015 May 10;6(13):10746-58. doi: 10.18632/oncotarget.3628.
|
2457 |
CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion.Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.
|
2458 |
KDM2A-dependent reduction of rRNA transcription on glucose starvation requires HP1 in cells, including triple-negative breast cancer cells.Oncotarget. 2019 Jul 30;10(46):4743-4760. doi: 10.18632/oncotarget.27092. eCollection 2019 Jul 30.
|
2459 |
miR-129-5p suppresses breast cancer proliferation by targeting CBX4.Neoplasma. 2018;65(4):572-578. doi: 10.4149/neo_2018_170814N530.
|
2460 |
Regulatory dissection of the CBX5 and hnRNPA1 bi-directional promoter in human breast cancer cells reveals novel transcript variants differentially associated with HP1 down-regulation in metastatic cells.BMC Cancer. 2016 Jan 20;16:32. doi: 10.1186/s12885-016-2059-x.
|
2461 |
Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway.Cell Physiol Biochem. 2018;51(4):1710-1722. doi: 10.1159/000495675. Epub 2018 Nov 30.
|
2462 |
Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods.Electrophoresis. 2007 Jun;28(12):1882-95. doi: 10.1002/elps.200700093.
|
2463 |
DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.Med Oncol. 2018 Sep 14;35(11):147. doi: 10.1007/s12032-018-1207-3.
|
2464 |
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy.Oncotarget. 2017 Aug 10;8(43):74378-74390. doi: 10.18632/oncotarget.20102. eCollection 2017 Sep 26.
|
2465 |
Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.Cancer Res. 2011 Nov 1;71(21):6899-908. doi: 10.1158/0008-5472.CAN-11-1523. Epub 2011 Sep 21.
|
2466 |
Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.J BUON. 2018 Jul-Aug;23(4):1185-1194.
|
2467 |
CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.Cancer Med. 2017 May;6(5):1062-1071. doi: 10.1002/cam4.1039. Epub 2017 Apr 4.
|
2468 |
Complicated prognostic values of CCL28 in breast cancer by subtype.J Thorac Dis. 2019 Mar;11(3):777-787. doi: 10.21037/jtd.2019.02.26.
|
2469 |
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer.Am J Pathol. 2003 Apr;162(4):1183-90. doi: 10.1016/s0002-9440(10)63914-4.
|
2470 |
Regulation of MCP-3 and BRCA2 mRNA expression levels by beta(1) integrins.Exp Mol Pathol. 2001 Jun;70(3):239-47. doi: 10.1006/exmp.2001.2359.
|
2471 |
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.Sci Rep. 2017 Apr 27;7(1):1220. doi: 10.1038/s41598-017-00916-z.
|
2472 |
Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.J Cell Commun Signal. 2018 Mar;12(1):13-19. doi: 10.1007/s12079-018-0451-9. Epub 2018 Jan 22.
|
2473 |
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.PLoS One. 2013 Aug 8;8(8):e72210. doi: 10.1371/journal.pone.0072210. eCollection 2013.
|
2474 |
Sulforaphane Decrease of SERTAD1 Expression Triggers G1/S Arrest in Breast Cancer Cells.J Med Food. 2019 May;22(5):444-450. doi: 10.1089/jmf.2018.4195.
|
2475 |
A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers.Mol Biosyst. 2012 Apr;8(5):1553-70. doi: 10.1039/c2mb05512k. Epub 2012 Mar 23.
|
2476 |
A fine balance between CCNL1 and TIMP1 contributes to the development of breast cancer cells.Biochem Biophys Res Commun. 2011 Jun 3;409(2):344-9. doi: 10.1016/j.bbrc.2011.05.021. Epub 2011 May 8.
|
2477 |
CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway.Int Immunopharmacol. 2017 Oct;51:124-130. doi: 10.1016/j.intimp.2017.07.018. Epub 2017 Aug 19.
|
2478 |
Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.Clin Epigenetics. 2019 Nov 1;11(1):155. doi: 10.1186/s13148-019-0750-x.
|
2479 |
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen.Breast Cancer Res Treat. 2008 Jun;109(3):491-501. doi: 10.1007/s10549-007-9673-x. Epub 2007 Jul 21.
|
2480 |
Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer.Mol Med Rep. 2019 May;19(5):4344-4352. doi: 10.3892/mmr.2019.10100. Epub 2019 Mar 28.
|
2481 |
CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.Life Sci. 2019 Aug 15;231:116543. doi: 10.1016/j.lfs.2019.116543. Epub 2019 Jun 6.
|
2482 |
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.Int J Cancer. 2016 Jan 1;138(1):87-97. doi: 10.1002/ijc.29684. Epub 2015 Jul 30.
|
2483 |
A pilot randomized controlled trial of cognitive bias modification to reduce fear of breast cancer recurrence.Cancer. 2017 Apr 15;123(8):1424-1433. doi: 10.1002/cncr.30478. Epub 2017 Jan 5.
|
2484 |
Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis.Sci Rep. 2019 Sep 19;9(1):13595. doi: 10.1038/s41598-019-50084-5.
|
2485 |
Fibrotic aortic valve disease after radiotherapy: an immunohistochemical study in breast cancer and lymphoma patients.Cardiovasc Pathol. 2020 Mar-Apr;45:107176. doi: 10.1016/j.carpath.2019.107176. Epub 2019 Nov 15.
|
2486 |
Systems-level Analysis Reveals Multiple Modulators of Epithelial-mesenchymal Transition and Identifies DNAJB4 and CD81 as Novel Metastasis Inducers in Breast Cancer.Mol Cell Proteomics. 2019 Sep;18(9):1756-1771. doi: 10.1074/mcp.RA119.001446. Epub 2019 Jun 20.
|
2487 |
A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.J Biol Chem. 2006 Nov 17;281(46):34833-47. doi: 10.1074/jbc.M605483200. Epub 2006 Sep 19.
|
2488 |
PCBP1/HNRNP E1 Protects Chromosomal Integrity by Translational Regulation of CDC27.Mol Cancer Res. 2016 Jul;14(7):634-46. doi: 10.1158/1541-7786.MCR-16-0018. Epub 2016 Apr 21.
|
2489 |
Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding RNAs.Cells. 2019 Feb 11;8(2):146. doi: 10.3390/cells8020146.
|
2490 |
CDCA4, a downstream gene of the Nrf2 signaling pathway, regulates cell proliferation and apoptosis in the MCF?/ADM human breast cancer cell line.Mol Med Rep. 2018 Jan;17(1):1507-1512. doi: 10.3892/mmr.2017.8095. Epub 2017 Nov 15.
|
2491 |
Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient.Oncotarget. 2018 Jan 9;9(6):6977-6992. doi: 10.18632/oncotarget.24059. eCollection 2018 Jan 23.
|
2492 |
Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.Int J Cancer. 2018 Nov 15;143(10):2602-2613. doi: 10.1002/ijc.31766. Epub 2018 Sep 19.
|
2493 |
A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.PLoS One. 2016 May 6;11(5):e0149185. doi: 10.1371/journal.pone.0149185. eCollection 2016.
|
2494 |
Lost in translation? A systematic database of gene expression in breast cancer.Pathobiology. 2008;75(2):112-8. doi: 10.1159/000123849. Epub 2008 Jun 10.
|
2495 |
Expression of Cadherin-17 Promotes Metastasis in a Highly Bone Marrow Metastatic Murine Breast Cancer Model.Biomed Res Int. 2017;2017:8494286. doi: 10.1155/2017/8494286. Epub 2017 Jan 19.
|
2496 |
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.Clin Epigenetics. 2017 Jan 24;9:7. doi: 10.1186/s13148-016-0309-z. eCollection 2017.
|
2497 |
Downregulated CDK10 expression in gastric cancer: Association with tumor progression and poor prognosis.Mol Med Rep. 2018 May;17(5):6812-6818. doi: 10.3892/mmr.2018.8662. Epub 2018 Mar 1.
|
2498 |
Downregulation of dual-specificity tyrosine-regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin-dependent kinase 14 expression in breast cancer.Cancer Sci. 2018 Feb;109(2):363-372. doi: 10.1111/cas.13459. Epub 2018 Jan 13.
|
2499 |
mRNA Expression of CDK2AP1 in Human Breast Cancer: Correlation with Clinical and Pathological Parameters.Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):447-452. doi: 10.21873/cgp.20103.
|
2500 |
Silencing cyclin-dependent kinase inhibitor3 inhibits the migration of breast cancer cell lines.Mol Med Rep. 2016 Aug;14(2):1523-30. doi: 10.3892/mmr.2016.5401. Epub 2016 Jun 14.
|
2501 |
Differential Prognostic Relevance of Promoter DNA Methylation of CDO1 and HOPX in Primary Breast Cancer.Anticancer Res. 2019 May;39(5):2289-2298. doi: 10.21873/anticanres.13345.
|
2502 |
High expression of CEACAM19, a new member of carcinoembryonic antigen gene family, in patients with breast cancer.Clin Exp Med. 2017 Nov;17(4):547-553. doi: 10.1007/s10238-016-0442-1. Epub 2016 Dec 1.
|
2503 |
C/EBP links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.Oncogene. 2019 May;38(20):3765-3780. doi: 10.1038/s41388-018-0516-5. Epub 2018 Sep 27.
|
2504 |
TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer.Cancer Res. 2016 Sep 1;76(17):4994-5005. doi: 10.1158/0008-5472.CAN-15-2322. Epub 2016 Jun 21.
|
2505 |
Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer.Cancer Cell Int. 2019 Oct 11;19:264. doi: 10.1186/s12935-019-0986-8. eCollection 2019.
|
2506 |
Overexpression of centromere protein H is significantly associated with breast cancer progression and overall patient survival.Chin J Cancer. 2011 Sep;30(9):627-37. doi: 10.5732/cjc.010.10599.
|
2507 |
Overexpression of the Ets-1 transcription factor in human breast cancer.Br J Cancer. 2004 Oct 4;91(7):1308-15. doi: 10.1038/sj.bjc.6602128.
|
2508 |
Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin-proteasomal degradation of COX-2.Cancer Lett. 2020 Jul 10;482:102-111. doi: 10.1016/j.canlet.2019.11.003. Epub 2019 Nov 6.
|
2509 |
USP9X regulates centrosome duplication and promotes breast carcinogenesis.Nat Commun. 2017 Mar 31;8:14866. doi: 10.1038/ncomms14866.
|
2510 |
MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.Cancer Biol Ther. 2018 Apr 3;19(4):306-315. doi: 10.1080/15384047.2017.1416934. Epub 2018 Mar 26.
|
2511 |
Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.Mol Oncol. 2011 Oct;5(5):454-64. doi: 10.1016/j.molonc.2011.06.005. Epub 2011 Jul 7.
|
2512 |
CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.J Cell Biochem. 2015 Apr;116(4):502-13. doi: 10.1002/jcb.24978.
|
2513 |
Acid ceramidase 1 expression correlates with a better prognosis in ER-positive breast cancer.Climacteric. 2009 Dec;12(6):502-13. doi: 10.3109/13697130902939913.
|
2514 |
Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.Cancer Res. 2012 Jun 1;72(11):2855-66. doi: 10.1158/0008-5472.CAN-11-3069. Epub 2012 Apr 3.
|
2515 |
Prognostic Value of the Expression of DNA Repair-Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients.Am J Pathol. 2018 Feb;188(2):367-377. doi: 10.1016/j.ajpath.2017.10.010. Epub 2018 Jan 10.
|
2516 |
MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.Mol Cell Biochem. 2018 Jul;444(1-2):169-178. doi: 10.1007/s11010-017-3241-4. Epub 2017 Nov 29.
|
2517 |
CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.Breast Cancer Res. 2019 Dec 4;21(1):134. doi: 10.1186/s13058-019-1212-2.
|
2518 |
Clinical significance and prognostic value of chromatin assembly factor-1 overexpression in human solid tumours.Histopathology. 2010 Nov;57(5):716-24. doi: 10.1111/j.1365-2559.2010.03681.x.
|
2519 |
Mitochondrial autoimmunity and MNRR1 in breast carcinogenesis.BMC Cancer. 2019 May 2;19(1):411. doi: 10.1186/s12885-019-5575-7.
|
2520 |
CHD1L promotes cell cycle progression and cell motility by up-regulating MDM2 in breast cancer.Am J Transl Res. 2019 Mar 15;11(3):1581-1592. eCollection 2019.
|
2521 |
Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.Mol Oncol. 2017 Oct;11(10):1348-1360. doi: 10.1002/1878-0261.12104. Epub 2017 Jul 21.
|
2522 |
RNAi screens identify CHD4 as an essential gene in breast cancer growth.Oncotarget. 2016 Dec 6;7(49):80901-80915. doi: 10.18632/oncotarget.12646.
|
2523 |
Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer.Breast Cancer Res. 2012 May 8;14(3):R73. doi: 10.1186/bcr3182.
|
2524 |
Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.Breast Cancer Res Treat. 2017 Dec;166(3):937-949. doi: 10.1007/s10549-017-4469-0. Epub 2017 Aug 24.
|
2525 |
Poly(ADPribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer.Oncol Rep. 2019 Oct;42(4):1467-1474. doi: 10.3892/or.2019.7242. Epub 2019 Jul 18.
|
2526 |
Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.Carcinogenesis. 2004 Mar;25(3):405-11. doi: 10.1093/carcin/bgh024. Epub 2003 Nov 21.
|
2527 |
miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.J Cell Physiol. 2020 Mar;235(3):2825-2835. doi: 10.1002/jcp.29188. Epub 2019 Sep 20.
|
2528 |
The IKK/NF-B signalingpathway requires Morgana to drive breast cancer metastasis.Nat Commun. 2017 Nov 21;8(1):1636. doi: 10.1038/s41467-017-01829-1.
|
2529 |
CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a.Mol Cancer Res. 2018 Oct;16(10):1512-1522. doi: 10.1158/1541-7786.MCR-18-0157. Epub 2018 Jul 2.
|
2530 |
Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer.Mol Carcinog. 2017 Jan;56(1):300-311. doi: 10.1002/mc.22493. Epub 2016 Apr 29.
|
2531 |
Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.Mol Cell Biol. 2016 May 2;36(10):1509-25. doi: 10.1128/MCB.00600-15. Print 2016 May 15.
|
2532 |
Upregulation of microRNA-143 reverses drug resistance in human breast cancer cells via inhibition of cytokine-induced apoptosis inhibitor 1.Oncol Lett. 2017 Jun;13(6):4695-4700. doi: 10.3892/ol.2017.6078. Epub 2017 Apr 24.
|
2533 |
Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer.Front Oncol. 2019 Sep 20;9:895. doi: 10.3389/fonc.2019.00895. eCollection 2019.
|
2534 |
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.J Cancer Res Clin Oncol. 2018 Dec;144(12):2339-2349. doi: 10.1007/s00432-018-2765-7. Epub 2018 Oct 20.
|
2535 |
Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer.Mol Carcinog. 2010 Feb;49(2):130-40. doi: 10.1002/mc.20582.
|
2536 |
ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis.Oncogene. 2007 Sep 27;26(44):6406-19. doi: 10.1038/sj.onc.1210468. Epub 2007 May 7.
|
2537 |
Aberrant DNA methylation but not mutation of CITED4 is associated with alteration of HIF-regulated genes in breast cancer.Breast Cancer Res Treat. 2011 Nov;130(1):319-29. doi: 10.1007/s10549-011-1657-1. Epub 2011 Jul 14.
|
2538 |
Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines.Int J Mol Med. 2004 Oct;14(4):729-35. doi: 10.3892/ijmm.14.4.729.
|
2539 |
Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway.Int J Mol Med. 2019 Jul;44(1):103-114. doi: 10.3892/ijmm.2019.4183. Epub 2019 May 8.
|
2540 |
Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.J Exp Clin Cancer Res. 2018 Feb 20;37(1):34. doi: 10.1186/s13046-018-0692-8.
|
2541 |
CLDN10 single nucleotide polymorphism rs1325774 alters the risk of breast cancer in south chinese women.Medicine (Baltimore). 2018 Dec;97(49):e13187. doi: 10.1097/MD.0000000000013187.
|
2542 |
Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.Biochem Biophys Res Commun. 2015 Apr 10;459(3):379-86. doi: 10.1016/j.bbrc.2015.02.108. Epub 2015 Feb 27.
|
2543 |
Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells.Methods Mol Biol. 2011;762:383-407. doi: 10.1007/978-1-61779-185-7_28.
|
2544 |
Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.J Exp Clin Cancer Res. 2012 May 4;31(1):43. doi: 10.1186/1756-9966-31-43.
|
2545 |
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.PLoS One. 2008 Apr 30;3(4):e2079. doi: 10.1371/journal.pone.0002079.
|
2546 |
Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer.Onco Targets Ther. 2018 Jun 4;11:3303-3312. doi: 10.2147/OTT.S161311. eCollection 2018.
|
2547 |
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.J Exp Clin Cancer Res. 2016 Sep 6;35(1):135. doi: 10.1186/s13046-016-0410-3.
|
2548 |
Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers.Clin Cancer Res. 2007 Jan 1;13(1):121-31. doi: 10.1158/1078-0432.CCR-06-1562.
|
2549 |
Long-term Follow-up of Autologous Fat Transfer vs Conventional Breast Reconstruction and Association With Cancer Relapse in Patients With Breast Cancer.JAMA Surg. 2019 Jan 1;154(1):56-63. doi: 10.1001/jamasurg.2018.3744.
|
2550 |
Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c.Exp Cell Res. 2003 Jan 15;282(2):132-7. doi: 10.1016/s0014-4827(02)00023-x.
|
2551 |
CNK1 promotes invasion of cancer cells through NF-kappaB-dependent signaling.Mol Cancer Res. 2010 Mar;8(3):395-406. doi: 10.1158/1541-7786.MCR-09-0296. Epub 2010 Mar 2.
|
2552 |
Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.BMC Cancer. 2018 Mar 13;18(1):284. doi: 10.1186/s12885-018-4188-x.
|
2553 |
Screening for Excessive Alcohol Use and Brief Counseling of Adults - 17 States and the District of Columbia, 2014.MMWR Morb Mortal Wkly Rep. 2017 Mar 31;66(12):313-319. doi: 10.15585/mmwr.mm6612a1.
|
2554 |
Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells.Int J Oncol. 2009 Oct;35(4):673-81.
|
2555 |
Katanin P80 expression correlates with lymph node metastasis and worse overall survival in patients with breast cancer.Cancer Biomark. 2018;23(3):363-371. doi: 10.3233/CBM-181369.
|
2556 |
Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.Breast Cancer Res Treat. 2008 Jul;110(2):283-95. doi: 10.1007/s10549-007-9731-4. Epub 2007 Sep 26.
|
2557 |
Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.Cancer Detect Prev. 2009;32(5-6):386-94. doi: 10.1016/j.canep.2009.04.012.
|
2558 |
Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.Oncol Rep. 2019 Jul;42(1):151-175. doi: 10.3892/or.2019.7147. Epub 2019 May 3.
|
2559 |
The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.Breast Cancer. 2018 Sep;25(5):529-538. doi: 10.1007/s12282-018-0849-5. Epub 2018 Mar 7.
|
2560 |
The prognostic value of CSN6 expression in upper tract urothelial carcinomas.Kaohsiung J Med Sci. 2019 Sep;35(9):559-565. doi: 10.1002/kjm2.12104. Epub 2019 Jul 24.
|
2561 |
COPS5 amplification and overexpression confers tamoxifen-resistance in ER-positive breast cancer by degradation of NCoR.Nat Commun. 2016 Jul 4;7:12044. doi: 10.1038/ncomms12044.
|
2562 |
Lack of cortistatin or somatostatin differentially influences DMBA-induced mammary gland tumorigenesis in mice in an obesity-dependent mode.Breast Cancer Res. 2016 Mar 8;18(1):29. doi: 10.1186/s13058-016-0689-1.
|
2563 |
4,5-Diaryl 3(2H)Furanones: Anti-Inflammatory Activity and Influence on Cancer Growth.Molecules. 2019 May 6;24(9):1751. doi: 10.3390/molecules24091751.
|
2564 |
Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study.Geburtshilfe Frauenheilkd. 2017 Jun;77(6):651-659. doi: 10.1055/s-0042-113189. Epub 2017 Jun 28.
|
2565 |
FEAT expression correlates with tumor size, PR status, HER2 expression, Ki67 index, and molecular subtype and predicts recurrence in breast cancer.Neoplasma. 2017;64(1):123-130. doi: 10.4149/neo_2017_115.
|
2566 |
High expression of COX5B is associated with poor prognosis in breast cancer.Future Oncol. 2017 Aug;13(19):1711-1719. doi: 10.2217/fon-2017-0058. Epub 2017 Jun 8.
|
2567 |
Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma.J Extracell Vesicles. 2019 Aug 27;8(1):1635420. doi: 10.1080/20013078.2019.1635420. eCollection 2019.
|
2568 |
Mitochondrial supercomplex assembly promotes breast and endometrial tumorigenesis by metabolic alterations and enhanced hypoxia tolerance.Nat Commun. 2019 Sep 11;10(1):4108. doi: 10.1038/s41467-019-12124-6.
|
2569 |
The influence of radiotherapy on ceruloplasmin and transferrin in whole blood of breast cancer patients.Radiat Environ Biophys. 2017 Nov;56(4):345-352. doi: 10.1007/s00411-017-0708-3. Epub 2017 Aug 28.
|
2570 |
CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis.Oncogene. 2016 Jun 2;35(22):2893-901. doi: 10.1038/onc.2015.350. Epub 2015 Sep 28.
|
2571 |
Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.BMC Cancer. 2019 Jun 11;19(1):561. doi: 10.1186/s12885-019-5771-5.
|
2572 |
CPEB4 promotes cell migration and invasion via upregulating Vimentin expression in breast cancer.Biochem Biophys Res Commun. 2017 Jul 22;489(2):135-141. doi: 10.1016/j.bbrc.2017.05.112. Epub 2017 May 20.
|
2573 |
Enhanced Identification of Potential Pleiotropic Genetic Variants for Bone Mineral Density and Breast Cancer.Calcif Tissue Int. 2017 Nov;101(5):489-500. doi: 10.1007/s00223-017-0308-x. Epub 2017 Jul 31.
|
2574 |
Copine-III interacts with ErbB2 and promotes tumor cell migration.Oncogene. 2010 Mar 18;29(11):1598-610. doi: 10.1038/onc.2009.456. Epub 2009 Dec 14.
|
2575 |
CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.EBioMedicine. 2017 Jul;21:65-78. doi: 10.1016/j.ebiom.2017.06.023. Epub 2017 Jun 24.
|
2576 |
Long noncoding RNA nuclear paraspeckle assembly transcript 1 interacts with microRNA?07 to modulate breast cancer growth and metastasis by targeting carnitine palmitoyltransferase?.Int J Oncol. 2019 Nov;55(5):1125-1136. doi: 10.3892/ijo.2019.4869. Epub 2019 Sep 4.
|
2577 |
Molecular characterization, genomic structure and expression analysis of a gene (CATL1/CPT1C) encoding a third member of the human carnitine acyltransferase family.Genomics. 2019 May 22:S0888-7543(18)30715-8. doi: 10.1016/j.ygeno.2019.05.019. Online ahead of print.
|
2578 |
CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer.Front Oncol. 2019 Nov 15;9:1201. doi: 10.3389/fonc.2019.01201. eCollection 2019.
|
2579 |
Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.Sci Rep. 2018 Aug 2;8(1):11635. doi: 10.1038/s41598-018-29952-z.
|
2580 |
CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.J Exp Clin Cancer Res. 2019 Aug 16;38(1):361. doi: 10.1186/s13046-019-1345-2.
|
2581 |
Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer.Clin Exp Pharmacol Physiol. 2019 Sep;46(9):837-844. doi: 10.1111/1440-1681.13104. Epub 2019 Jun 10.
|
2582 |
RCP is a human breast cancer-promoting gene with Ras-activating function.J Clin Invest. 2009 Aug;119(8):2171-83. doi: 10.1172/JCI37622. Epub 2009 Jul 20.
|
2583 |
Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1.Nat Commun. 2017 Oct 20;8(1):1079. doi: 10.1038/s41467-017-01052-y.
|
2584 |
Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial.BMJ Open. 2018 Nov 8;8(11):e024794. doi: 10.1136/bmjopen-2018-024794.
|
2585 |
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.Virchows Arch. 2016 Jul;469(1):51-9. doi: 10.1007/s00428-016-1941-x. Epub 2016 Apr 21.
|
2586 |
Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease.Cancer Prev Res (Phila). 2018 Feb;11(2):113-119. doi: 10.1158/1940-6207.CAPR-17-0245. Epub 2017 Nov 22.
|
2587 |
Evaluation of SAT-1, SAT-2 and GalNAcT-1 mRNA in colon cancer by real-time PCR.Mol Cell Biochem. 2007 Apr;298(1-2):59-68. doi: 10.1007/s11010-006-9350-0. Epub 2006 Nov 21.
|
2588 |
Placental lactogen is expressed but is not translated into protein in breast cancer.PLoS One. 2014 Jan 24;9(1):e87325. doi: 10.1371/journal.pone.0087325. eCollection 2014.
|
2589 |
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial.Breast. 2013 Apr;22(2):130-137. doi: 10.1016/j.breast.2013.01.015. Epub 2013 Feb 28.
|
2590 |
TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.Oncotarget. 2014 Mar 30;5(6):1609-20. doi: 10.18632/oncotarget.1707.
|
2591 |
Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.J Pathol. 2017 Dec;243(4):496-509. doi: 10.1002/path.4990. Epub 2017 Oct 31.
|
2592 |
Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.PLoS One. 2015 Apr 1;10(4):e0120020. doi: 10.1371/journal.pone.0120020. eCollection 2015.
|
2593 |
Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.Int J Cancer. 2009 Jun 15;124(12):2893-8. doi: 10.1002/ijc.24296.
|
2594 |
Identification of a new cancer/testis gene family, CT47, among expressed multicopy genes on the human X chromosome.Genes Chromosomes Cancer. 2006 Apr;45(4):392-400. doi: 10.1002/gcc.20298.
|
2595 |
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancer.EMBO J. 2012 Mar 7;31(5):1160-76. doi: 10.1038/emboj.2011.490. Epub 2012 Jan 31.
|
2596 |
Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein.Cell Death Dis. 2019 Sep 18;10(10):689. doi: 10.1038/s41419-019-1892-7.
|
2597 |
C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A.Oncotarget. 2017 Apr 18;8(16):26154-26168. doi: 10.18632/oncotarget.15402.
|
2598 |
Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.Cancer Sci. 2008 Oct;99(10):1984-91. doi: 10.1111/j.1349-7006.2008.00952.x.
|
2599 |
E-catenin is a candidate tumor suppressor for the development of E-cadherin-expressing lobular-type breast cancer.J Pathol. 2018 Aug;245(4):456-467. doi: 10.1002/path.5099. Epub 2018 Jun 20.
|
2600 |
A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia.Asian Pac J Cancer Prev. 2015;16(6):2231-5. doi: 10.7314/apjcp.2015.16.6.2231.
|
2601 |
-catenin promotes the malignant phenotype in breast cancer.Tumour Biol. 2015 Feb;36(2):569-75. doi: 10.1007/s13277-014-2680-8. Epub 2014 Oct 2.
|
2602 |
Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.Oncogene. 2010 Mar 11;29(10):1509-18. doi: 10.1038/onc.2009.434. Epub 2009 Nov 30.
|
2603 |
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2497-502. doi: 10.1073/pnas.0907240107. Epub 2010 Jan 21.
|
2604 |
Modulation of interaction of mutant TP53 and wild type BRCA1 by alkaloids: a computational approach towards targeting protein-protein interaction as a futuristic therapeutic intervention strategy for breast cancer impediment.J Biomol Struct Dyn. 2018 Oct;36(13):3376-3387. doi: 10.1080/07391102.2017.1388286. Epub 2017 Oct 23.
|
2605 |
CUEDC1 is a primary target of ER essential for the growth of breast cancer cells.Cancer Lett. 2018 Nov 1;436:87-95. doi: 10.1016/j.canlet.2018.08.018. Epub 2018 Aug 23.
|
2606 |
CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin-proteasome.EMBO J. 2007 Apr 4;26(7):1831-42. doi: 10.1038/sj.emboj.7601602. Epub 2007 Mar 8.
|
2607 |
CUL1 Knockdown Attenuates the Adhesion, Invasion, and Migration of Triple-Negative Breast Cancer Cells via Inhibition of Epithelial-Mesenchymal Transition.Pathol Oncol Res. 2020 Apr;26(2):1153-1163. doi: 10.1007/s12253-019-00681-6. Epub 2019 Jun 7.
|
2608 |
CXCL3 is a potential target for breast cancer metastasis.Curr Cancer Drug Targets. 2014;14(3):294-309. doi: 10.2174/1568009614666140305222328.
|
2609 |
The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis.Nat Commun. 2019 Sep 27;10(1):4404. doi: 10.1038/s41467-019-12108-6.
|
2610 |
Downregulation of CYB5D2 is associated with breast cancer progression.Sci Rep. 2019 Apr 29;9(1):6624. doi: 10.1038/s41598-019-43006-y.
|
2611 |
DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.Breast Cancer Res. 2017 Mar 7;19(1):25. doi: 10.1186/s13058-017-0814-9.
|
2612 |
Different transcriptional strategies for ccn2/ctgf gene induction between human chondrocytic and breast cancer cell lines.Biochimie. 2007 Mar;89(3):278-88. doi: 10.1016/j.biochi.2006.12.006. Epub 2007 Jan 3.
|
2613 |
Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.Oncogene. 2018 Jul;37(30):4137-4150. doi: 10.1038/s41388-018-0253-9. Epub 2018 Apr 30.
|
2614 |
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature. 2013 Jan 17;493(7432):406-10. doi: 10.1038/nature11725. Epub 2012 Dec 16.
|
2615 |
The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism.J Exp Clin Cancer Res. 2018 Dec 13;37(1):313. doi: 10.1186/s13046-018-0979-9.
|
2616 |
CYP2D6 gene variants and their association with breast cancer susceptibility.Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1255-8. doi: 10.1158/1055-9965.EPI-11-0321. Epub 2011 Apr 28.
|
2617 |
Correction to: The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.Breast Cancer Res Treat. 2020 Jan;179(2):521-522. doi: 10.1007/s10549-019-05478-4.
|
2618 |
Dachshund Depletion Disrupts Mammary Gland Development and Diverts the Composition of the Mammary Gland Progenitor Pool.Stem Cell Reports. 2019 Jan 8;12(1):135-151. doi: 10.1016/j.stemcr.2018.11.010. Epub 2018 Dec 13.
|
2619 |
Association between promoter hypermethylation of the DACT2 gene and tumor stages in breast cancer.J BUON. 2018 Mar-Apr;23(2):361-365.
|
2620 |
Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5... Asian Pac J Cancer Prev. 2015;16(2):541-9.
|
2621 |
Correlation between Candidate Single Nucleotide Variants and Several Clinicopathological Risk Factors Related to Breast Cancer in Jordanian Women: A Genotype-Phenotype Study.J Cancer. 2019 Aug 8;10(19):4647-4654. doi: 10.7150/jca.33857. eCollection 2019.
|
2622 |
HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer.Pathol Oncol Res. 2001;7(1):39-41. doi: 10.1007/BF03032603.
|
2623 |
The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer.BMC Cancer. 2010 Apr 6;10:126. doi: 10.1186/1471-2407-10-126.
|
2624 |
Genetic association of deleted in colorectal carcinoma variants with breast cancer risk: A case-control study.Oncotarget. 2016 May 31;7(22):32765-73. doi: 10.18632/oncotarget.9024.
|
2625 |
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.BMC Cancer. 2015 Feb 19;15:70. doi: 10.1186/s12885-015-1022-6.
|
2626 |
The hSNM1B/Apollo variant rs11552449 is associated with cellular sensitivity towards mitomycin C and ionizing radiation.DNA Repair (Amst). 2018 Dec;72:93-98. doi: 10.1016/j.dnarep.2018.09.004. Epub 2018 Sep 12.
|
2627 |
Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial.Mod Pathol. 2017 Aug;30(8):1069-1077. doi: 10.1038/modpathol.2017.30. Epub 2017 May 26.
|
2628 |
Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status.Mol Cancer Res. 2007 Sep;5(9):881-90. doi: 10.1158/1541-7786.MCR-07-0055.
|
2629 |
IL-1 induces p62/SQSTM1 and autophagy in ER(+) /PR(+) BCa cell lines concomitant with ER and PR repression, conferring an ER(-) /PR(-) BCa-like phenotype.J Cell Biochem. 2019 Feb;120(2):1477-1491. doi: 10.1002/jcb.27340. Epub 2018 Oct 15.
|
2630 |
MultiDCoX: Multi-factor analysis of differential co-expression.BMC Bioinformatics. 2017 Dec 28;18(Suppl 16):576. doi: 10.1186/s12859-017-1963-7.
|
2631 |
miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing.BMC Genomics. 2015 Feb 5;16(1):40. doi: 10.1186/s12864-015-1279-9.
|
2632 |
BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway.BMC Cancer. 2018 Apr 12;18(1):412. doi: 10.1186/s12885-018-4323-8.
|
2633 |
DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer.Cancer. 2012 Feb 15;118(4):888-98. doi: 10.1002/cncr.26352. Epub 2011 Jul 14.
|
2634 |
The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.Oncogene. 2009 Nov 19;28(46):4053-64. doi: 10.1038/onc.2009.261. Epub 2009 Aug 31.
|
2635 |
SMARCAD1 knockdown uncovers its role in breast cancer cell migration, invasion, and metastasis.Expert Opin Ther Targets. 2016 Sep;20(9):1035-43. doi: 10.1080/14728222.2016.1195059. Epub 2016 Jun 13.
|
2636 |
A double-negative feedback loop between DEAD-box protein DDX21 and Snail regulates epithelial-mesenchymal transition and metastasis in breast cancer.Cancer Lett. 2018 Nov 28;437:67-78. doi: 10.1016/j.canlet.2018.08.021. Epub 2018 Aug 27.
|
2637 |
Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.Oncogene. 2018 Jan 4;37(1):63-74. doi: 10.1038/onc.2017.308. Epub 2017 Sep 4.
|
2638 |
Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles.Eur J Med Chem. 2019 Mar 1;165:18-30. doi: 10.1016/j.ejmech.2019.01.001. Epub 2019 Jan 2.
|
2639 |
Regulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97).J Biol Chem. 2003 Feb 14;278(7):4628-38. doi: 10.1074/jbc.M210066200. Epub 2002 Dec 3.
|
2640 |
High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.Oncol Lett. 2017 Dec;14(6):6801-6808. doi: 10.3892/ol.2017.7027. Epub 2017 Sep 22.
|
2641 |
Decreased expression of C10orf10 and its prognostic significance in human breast cancer.PLoS One. 2014 Jun 17;9(6):e99730. doi: 10.1371/journal.pone.0099730. eCollection 2014.
|
2642 |
Genetic predictors of chemotherapy-related amenorrhea inwomen with breast cancer.Fertil Steril. 2019 Oct;112(4):731-739.e1. doi: 10.1016/j.fertnstert.2019.05.018. Epub 2019 Jul 29.
|
2643 |
MiR-34a modulates ErbB2 in breast cancer.Cell Biol Int. 2017 Jan;41(1):93-101. doi: 10.1002/cbin.10700. Epub 2016 Dec 1.
|
2644 |
Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells.Oncol Rep. 2017 Sep;38(3):1760-1766. doi: 10.3892/or.2017.5800. Epub 2017 Jul 10.
|
2645 |
Upregulation of the double-stranded RNA binding protein DGCR8 in invasive ductal breast carcinoma.Gene. 2016 May 1;581(2):146-51. doi: 10.1016/j.gene.2016.01.033. Epub 2016 Jan 22.
|
2646 |
Stable expression of rat dihydrodiol dehydrogenase (AKR1C9) in human breast MCF-7 cells results in the formation of PAH-o-quinones and enzyme mediated cell death.Chem Res Toxicol. 2001 Jul;14(7):856-62. doi: 10.1021/tx0100035.
|
2647 |
DHX32 expression is an indicator of poor breast cancer prognosis.Oncol Lett. 2017 Feb;13(2):942-948. doi: 10.3892/ol.2016.5503. Epub 2016 Dec 14.
|
2648 |
Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.Oncol Rep. 2014 May;31(5):2358-64. doi: 10.3892/or.2014.3107. Epub 2014 Mar 21.
|
2649 |
Relationship between dyskerin expression and telomerase activity in human breast cancer.Cell Oncol. 2008;30(6):483-90. doi: 10.3233/clo-2008-0436.
|
2650 |
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.Breast Cancer Res Treat. 2016 Apr;156(3):557-566. doi: 10.1007/s10549-016-3777-0. Epub 2016 Apr 9.
|
2651 |
circRNA-associated ceRNA network construction reveals the circRNAs involved in the progression and prognosis of breast cancer.J Cell Physiol. 2020 Apr;235(4):3973-3983. doi: 10.1002/jcp.29291. Epub 2019 Oct 15.
|
2652 |
High expression of DLG3 is associated with decreased survival from breast cancer.Clin Exp Pharmacol Physiol. 2019 Oct;46(10):937-943. doi: 10.1111/1440-1681.13132. Epub 2019 Jul 31.
|
2653 |
DLG5 suppresses breast cancer stem cell-like characteristics to restore tamoxifen sensitivity by inhibiting TAZ expression.J Cell Mol Med. 2019 Jan;23(1):512-521. doi: 10.1111/jcmm.13954. Epub 2018 Nov 18.
|
2654 |
EGFL9 promotes breast cancer metastasis by inducing cMET activation and metabolic reprogramming.Nat Commun. 2019 Nov 6;10(1):5033. doi: 10.1038/s41467-019-13034-3.
|
2655 |
Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231.BMC Cancer. 2010 Nov 25;10:649. doi: 10.1186/1471-2407-10-649.
|
2656 |
BP1, a potential biomarker for breast cancer prognosis.Biomark Med. 2018 May;12(5):535-545. doi: 10.2217/bmm-2017-0212. Epub 2018 Mar 26.
|
2657 |
Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome.BMC Genomics. 2012 Oct 30;13:570. doi: 10.1186/1471-2164-13-570.
|
2658 |
DMP1, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.J Pathol. 2015 May;236(1):90-102. doi: 10.1002/path.4504. Epub 2015 Feb 9.
|
2659 |
The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer.BMC Cancer. 2012 Feb 29;12:79. doi: 10.1186/1471-2407-12-79.
|
2660 |
Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8.Cancer Res. 2005 Oct 1;65(19):8784-91. doi: 10.1158/0008-5472.CAN-04-4422.
|
2661 |
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874. Epub 2008 Mar 7.
|
2662 |
Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.BMC Cancer. 2018 Mar 15;18(1):292. doi: 10.1186/s12885-018-4214-z.
|
2663 |
RME-8 regulates trafficking of the epidermal growth factor receptor.FEBS Lett. 2008 Mar 19;582(6):961-6. doi: 10.1016/j.febslet.2008.02.042. Epub 2008 Feb 26.
|
2664 |
Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance.Oncotarget. 2018 Jun 19;9(47):28666-28690. doi: 10.18632/oncotarget.25596. eCollection 2018 Jun 19.
|
2665 |
Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6.Oncoimmunology. 2016 Dec 23;6(1):e1245265. doi: 10.1080/2162402X.2016.1245265. eCollection 2017.
|
2666 |
ERp29 induces breast cancer cell growth arrest and survival through modulation of activation of p38 and upregulation of ER stress protein p58IPK.Lab Invest. 2012 Feb;92(2):200-13. doi: 10.1038/labinvest.2011.163. Epub 2011 Nov 7.
|
2667 |
RNA-Binding Protein Dnd1 Promotes Breast Cancer Apoptosis by Stabilizing the Bim mRNA in a miR-221 Binding Site.Biomed Res Int. 2017;2017:9596152. doi: 10.1155/2017/9596152. Epub 2017 Jan 16.
|
2668 |
MiR-486-5p inhibits IL-22-induced epithelial-mesenchymal transition of breast cancer cell by repressing Dock1.J Cancer. 2019 Aug 19;10(19):4695-4706. doi: 10.7150/jca.30596. eCollection 2019.
|
2669 |
Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.Exp Mol Pathol. 2004 Jun;76(3):260-3. doi: 10.1016/j.yexmp.2003.12.005.
|
2670 |
Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer.Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10848-53. doi: 10.1073/pnas.96.19.10848.
|
2671 |
Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer.Int J Oncol. 2006 Feb;28(2):321-8.
|
2672 |
Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.Oncol Lett. 2017 Nov;14(5):5386-5392. doi: 10.3892/ol.2017.6844. Epub 2017 Aug 28.
|
2673 |
Downregulation of DPF3 promotes the proliferation and motility of breast cancer cells through activating JAK2/STAT3 signaling.Biochem Biophys Res Commun. 2019 Jun 30;514(3):639-644. doi: 10.1016/j.bbrc.2019.04.170. Epub 2019 May 7.
|
2674 |
NRF2 Induction Supporting Breast Cancer Cell Survival Is Enabled by Oxidative Stress-Induced DPP3-KEAP1 Interaction.Cancer Res. 2017 Jun 1;77(11):2881-2892. doi: 10.1158/0008-5472.CAN-16-2204. Epub 2017 Apr 17.
|
2675 |
Network-Based Methods to Identify Highly Discriminating Subsets of Biomarkers.IEEE/ACM Trans Comput Biol Bioinform. 2014 Nov-Dec;11(6):1029-37. doi: 10.1109/TCBB.2014.2325014.
|
2676 |
DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11978-E11987. doi: 10.1073/pnas.1810598115. Epub 2018 Nov 29.
|
2677 |
Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer.Breast Cancer. 2008;15(1):73-8. doi: 10.1007/s12282-007-0015-y.
|
2678 |
Proteomics Identification and Validation of Desmocollin-1 and Catechol-O-Methyltransferase as Proteins Associated with Breast Cancer Cell Migration and Metastasis.Proteomics. 2019 Nov;19(21-22):e1900073. doi: 10.1002/pmic.201900073. Epub 2019 Oct 28.
|
2679 |
Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer.Int J Oncol. 2001 Jul;19(1):169-74. doi: 10.3892/ijo.19.1.169.
|
2680 |
5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene. 2007 Jan 4;26(1):77-90. doi: 10.1038/sj.onc.1209763. Epub 2006 Jun 26.
|
2681 |
Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.Clin Cancer Res. 2004 Dec 15;10(24):8501-11. doi: 10.1158/1078-0432.CCR-04-1072.
|
2682 |
DUOX1 Silencing in Mammary Cell Alters the Response to Genotoxic Stress.Oxid Med Cell Longev. 2018 Apr 19;2018:3570526. doi: 10.1155/2018/3570526. eCollection 2018.
|
2683 |
DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118.Oncogene. 2007 Sep 6;26(41):6038-49. doi: 10.1038/sj.onc.1210426. Epub 2007 Mar 26.
|
2684 |
VHZ is a novel centrosomal phosphatase associated with cell growth and human primary cancers.Mol Cancer. 2010 May 28;9:128. doi: 10.1186/1476-4598-9-128.
|
2685 |
Erratum: Functional analysis of MKP-1 and MKP-2 in breast cancer tamoxifen sensitivity.Oncotarget. 2018 Oct 16;9(81):35286. doi: 10.18632/oncotarget.26258. eCollection 2018 Oct 16.
|
2686 |
Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.PLoS One. 2016 Feb 9;11(2):e0148065. doi: 10.1371/journal.pone.0148065. eCollection 2016.
|
2687 |
Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p.Oncotarget. 2017 Jul 12;8(44):76153-76164. doi: 10.18632/oncotarget.19190. eCollection 2017 Sep 29.
|
2688 |
AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/-catenin signaling pathway activity.Mol Med Rep. 2017 Feb;15(2):899-907. doi: 10.3892/mmr.2016.6094. Epub 2016 Dec 29.
|
2689 |
Loss of p27(kip1) expression is associated with poor prognosis in patients with taxane-treated breast cancer.Pathol Res Pract. 2018 Apr;214(4):565-571. doi: 10.1016/j.prp.2018.02.004. Epub 2018 Feb 14.
|
2690 |
RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.Mol Ther. 2019 Jun 5;27(6):1153-1165. doi: 10.1016/j.ymthe.2019.03.019. Epub 2019 Apr 6.
|
2691 |
Breast cancer, placenta and pregnancy.Eur J Cancer. 2019 Jul;115:68-78. doi: 10.1016/j.ejca.2019.03.021. Epub 2019 May 20.
|
2692 |
8-hydroxydeoxyguanosine levels in DNA of human breast cancer are not significantly different from those of non-cancerous breast tissues by the HPLC-ECD method.Cancer Lett. 1995 Apr 14;90(2):157-62. doi: 10.1016/0304-3835(95)03698-v.
|
2693 |
Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib.EMBO J. 2018 May 15;37(10):e98359. doi: 10.15252/embj.201798359. Epub 2018 Apr 18.
|
2694 |
X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation.Clin Cancer Res. 2010 Feb 15;16(4):1140-8. doi: 10.1158/1078-0432.CCR-09-2463. Epub 2010 Feb 9.
|
2695 |
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1.Nat Commun. 2018 Mar 6;9(1):967. doi: 10.1038/s41467-018-03433-3.
|
2696 |
Tumor derived EDIL3 modulates the expansion and osteoclastogenesis of myeloid derived suppressor cells in murine breast cancer model.J Bone Oncol. 2019 Apr 29;16:100238. doi: 10.1016/j.jbo.2019.100238. eCollection 2019 Jun.
|
2697 |
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.Breast Cancer Res. 2009;11(3):R34. doi: 10.1186/bcr2319. Epub 2009 Jun 15.
|
2698 |
Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress.Sci Rep. 2018 Sep 17;8(1):13904. doi: 10.1038/s41598-018-32272-x.
|
2699 |
Expression of the actin-binding proteins indicates that cofilin and fascin are related to breast tumour size.J Int Med Res. 2010 May-Jun;38(3):1042-8. doi: 10.1177/147323001003800331.
|
2700 |
The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.Breast Cancer Res. 2017 Nov 16;19(1):122. doi: 10.1186/s13058-017-0912-8.
|
2701 |
Fibulin-3 is a novel TGF- pathway inhibitor in the breast cancer microenvironment.Oncogene. 2015 Nov 5;34(45):5635-47. doi: 10.1038/onc.2015.13. Epub 2015 Mar 30.
|
2702 |
Protein expression of the Ets transcription factor Elf-1 in breast cancer cells is negatively correlated with histological grading, but not with clinical outcome.Oncol Rep. 2011 Nov;26(5):1121-5. doi: 10.3892/or.2011.1409. Epub 2011 Aug 2.
|
2703 |
EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination.Oncogene. 2015 May 14;34(20):2609-20. doi: 10.1038/onc.2014.200. Epub 2014 Jul 14.
|
2704 |
Resident Breast T Cells: The Troops Are Already There.Trends Mol Med. 2018 Oct;24(10):821-822. doi: 10.1016/j.molmed.2018.07.006. Epub 2018 Aug 1.
|
2705 |
EphrinB2 inhibits cell proliferation and motility invitro and predicts longer metastasisfree survival in breast cancer.Int J Oncol. 2019 Dec;55(6):1275-1286. doi: 10.3892/ijo.2019.4892. Epub 2019 Oct 4.
|
2706 |
Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):201-6. doi: 10.1016/j.jsbmb.2008.03.013. Epub 2008 Mar 12.
|
2707 |
Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin.J Mol Histol. 2015 Apr;46(2):221-31. doi: 10.1007/s10735-015-9614-7. Epub 2015 Mar 12.
|
2708 |
Ei24-deficiency attenuates protein kinase C signaling and skin carcinogenesis in mice.Int J Biochem Cell Biol. 2012 Nov;44(11):1887-96. doi: 10.1016/j.biocel.2012.06.034. Epub 2012 Jul 6.
|
2709 |
Upregulation of EID3 sensitizes breast cancer cells to ionizing radiation-induced cellular senescence.Biomed Pharmacother. 2018 Nov;107:606-614. doi: 10.1016/j.biopha.2018.08.022. Epub 2018 Aug 14.
|
2710 |
EIF2A promotes cell survival during paclitaxel treatment in vitro and in vivo.J Cell Mol Med. 2019 Sep;23(9):6060-6071. doi: 10.1111/jcmm.14469. Epub 2019 Jun 18.
|
2711 |
Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.Med Sci Monit. 2017 Aug 30;23:4182-4191. doi: 10.12659/msm.906389.
|
2712 |
INT6/EIF3E Controls the RNF8-Dependent Ubiquitylation Pathway and Facilitates DNA Double-Strand Break Repair in Human Cells.Cancer Res. 2016 Oct 15;76(20):6054-6065. doi: 10.1158/0008-5472.CAN-16-0723. Epub 2016 Aug 22.
|
2713 |
Nuclear distribution of eIF3g and its interacting nuclear proteins in breast cancer cells.Mol Med Rep. 2016 Apr;13(4):2973-80. doi: 10.3892/mmr.2016.4935. Epub 2016 Feb 23.
|
2714 |
The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells.Front Oncol. 2019 Apr 24;9:284. doi: 10.3389/fonc.2019.00284. eCollection 2019.
|
2715 |
Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.Clin Cancer Res. 2006 Dec 1;12(23):6929-36. doi: 10.1158/1078-0432.CCR-06-0788.
|
2716 |
ESE-1 Knockdown Attenuates Growth in Trastuzumab-resistant HER2(+) Breast Cancer Cells.Anticancer Res. 2017 Dec;37(12):6583-6591. doi: 10.21873/anticanres.12115.
|
2717 |
15-methoxypuupehenol Induces Antitumor Effects In Vitro and In Vivo against Human Glioblastoma and Breast Cancer Models.Mol Cancer Ther. 2017 Apr;16(4):601-613. doi: 10.1158/1535-7163.MCT-16-0291. Epub 2017 Jan 9.
|
2718 |
Coordinate regulation of ELF5 and EHF at the chr11p13 CF modifier region.J Cell Mol Med. 2019 Nov;23(11):7726-7740. doi: 10.1111/jcmm.14646. Epub 2019 Sep 26.
|
2719 |
15-Deoxy-12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.Mutat Res. 2014 Oct;768:6-15. doi: 10.1016/j.mrfmmm.2014.06.005. Epub 2014 Jun 24.
|
2720 |
No evidence for DNA methylation of von Hippel-Lindau ubiquitin ligase complex genes in breast cancer.Breast Cancer Res Treat. 2010 Dec;124(3):853-6. doi: 10.1007/s10549-010-1087-5. Epub 2010 Aug 3.
|
2721 |
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.Mod Pathol. 2010 Apr;23(4):603-10. doi: 10.1038/modpathol.2010.5. Epub 2010 Feb 5.
|
2722 |
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4700-5. doi: 10.1073/pnas.0409894102. Epub 2005 Mar 21.
|
2723 |
EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration.J Pathol. 2014 Mar;232(4):391-404. doi: 10.1002/path.4316.
|
2724 |
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.Tumour Biol. 2014 Apr;35(4):3317-26. doi: 10.1007/s13277-013-1437-0. Epub 2013 Nov 24.
|
2725 |
Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.BMC Cancer. 2017 Jul 24;17(1):496. doi: 10.1186/s12885-017-3488-x.
|
2726 |
Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells.J Cell Biol. 1987 Feb;104(2):253-62. doi: 10.1083/jcb.104.2.253.
|
2727 |
Effects of Chronic and Intermittent Calorie Restriction on Adropin Levels in Breast Cancer.Nutr Cancer. 2017 Oct;69(7):1003-1010. doi: 10.1080/01635581.2017.1359314. Epub 2017 Sep 18.
|
2728 |
Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.Int J Mol Sci. 2019 Aug 14;20(16):3952. doi: 10.3390/ijms20163952.
|
2729 |
Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies.Med Sci Monit. 2019 May 7;25:3374-3389. doi: 10.12659/MSM.914085.
|
2730 |
CDK10 is not a target for aberrant DNA methylation in breast cancer.Anticancer Res. 2009 Oct;29(10):3939-44.
|
2731 |
Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.Mol Cancer Res. 2010 Nov;8(11):1501-12. doi: 10.1158/1541-7786.MCR-10-0186. Epub 2010 Oct 5.
|
2732 |
Comparative integromics on the breast cancer-associated gene KIAA1632: clues to a cancer antigen domain.Int J Oncol. 2007 Jul;31(1):205-10.
|
2733 |
LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.J Cell Physiol. 2019 Mar;234(3):2880-2894. doi: 10.1002/jcp.27105. Epub 2018 Sep 10.
|
2734 |
Regulation of inflammatory gene expression in macrophages by epithelial-stromal interaction 1 (Epsti1).Biochem Biophys Res Commun. 2018 Feb 5;496(2):778-783. doi: 10.1016/j.bbrc.2017.12.014. Epub 2017 Dec 5.
|
2735 |
Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA Trial.Anticancer Res. 2019 Feb;39(2):797-802. doi: 10.21873/anticanres.13177.
|
2736 |
Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.J Cell Biochem. 2019 Sep;120(9):15635-15647. doi: 10.1002/jcb.28830. Epub 2019 May 12.
|
2737 |
Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer.Oncol Rep. 2017 Sep;38(3):1851-1856. doi: 10.3892/or.2017.5839. Epub 2017 Jul 19.
|
2738 |
Loss of PICH promotes chromosome instability and cell death in triple-negative breast cancer.Cell Death Dis. 2019 Jun 3;10(6):428. doi: 10.1038/s41419-019-1662-6.
|
2739 |
The PEA3 group of ETS-related transcription factors. Role in breast cancer metastasis.Adv Exp Med Biol. 2000;480:107-16. doi: 10.1007/0-306-46832-8_13.
|
2740 |
MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.Cell Physiol Biochem. 2018;48(2):461-474. doi: 10.1159/000491777. Epub 2018 Jul 17.
|
2741 |
Cancer-associated oxidoreductase ERO1- promotes immune escape through up-regulation of PD-L1 in human breast cancer.Oncotarget. 2017 Apr 11;8(15):24706-24718. doi: 10.18632/oncotarget.14960.
|
2742 |
Tocotrienol-treated MCF-7 human breast cancer cells show down-regulation of API5 and up-regulation of MIG6 genes.Cancer Genomics Proteomics. 2011 Jan-Feb;8(1):19-31.
|
2743 |
Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.Clin Cancer Res. 2001 Jun;7(6):1553-60.
|
2744 |
Separase is a marker for prognosis and mitotic activity in breast cancer.Br J Cancer. 2017 Oct 24;117(9):1383-1391. doi: 10.1038/bjc.2017.301. Epub 2017 Aug 31.
|
2745 |
Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.Oncogene. 2017 Nov 16;36(46):6446-6461. doi: 10.1038/onc.2017.246. Epub 2017 Jul 31.
|
2746 |
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
|
2747 |
Modulation of translation factor's gene expression by histone deacetylase inhibitors in breast cancer cells.Clin Chem Lab Med. 2005;43(2):151-6. doi: 10.1515/CCLM.2005.025.
|
2748 |
Evaluating triptorelin as a treatment option for breast cancer.Expert Opin Pharmacother. 2019 Oct;20(15):1809-1818. doi: 10.1080/14656566.2019.1650020. Epub 2019 Sep 9.
|
2749 |
ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.Asian Pac J Cancer Prev. 2012;13(5):2385-92. doi: 10.7314/apjcp.2012.13.5.2385.
|
2750 |
Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness.Neoplasia. 2019 Jul;21(7):627-640. doi: 10.1016/j.neo.2019.04.006. Epub 2019 May 14.
|
2751 |
Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases.Clin Exp Metastasis. 2017 Jun;34(5):333-344. doi: 10.1007/s10585-017-9853-y. Epub 2017 Jun 17.
|
2752 |
Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.Am J Surg Pathol. 2019 Dec;43(12):1693-1700. doi: 10.1097/PAS.0000000000001366.
|
2753 |
Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.Oncol Rep. 2007 Feb;17(2):465-9.
|
2754 |
Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.Hum Gene Ther. 2001 May 1;12(7):763-72. doi: 10.1089/104303401750148685.
|
2755 |
FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.Oncogene. 2019 Sep;38(37):6445-6460. doi: 10.1038/s41388-019-0893-4. Epub 2019 Jul 19.
|
2756 |
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.Br J Cancer. 1999 Mar;79(7-8):1049-52. doi: 10.1038/sj.bjc.6690168.
|
2757 |
Role of Polymorphisms of FAM13A, PHLDB1, and CYP24A1 in Breast Cancer Risk.Curr Mol Med. 2019;19(8):579-588. doi: 10.2174/1566524019666190619125109.
|
2758 |
TGF promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.Oncogene. 2019 May;38(20):3794-3811. doi: 10.1038/s41388-019-0703-z. Epub 2019 Jan 28.
|
2759 |
FAM53A Affects Breast Cancer Cell Proliferation, Migration, and Invasion in a p53-Dependent Manner.Front Oncol. 2019 Nov 14;9:1244. doi: 10.3389/fonc.2019.01244. eCollection 2019.
|
2760 |
FAN1 variants identified in multiple-case early-onset breast cancer families via exome sequencing: no evidence for association with risk for breast cancer.Breast Cancer Res Treat. 2011 Dec;130(3):1043-9. doi: 10.1007/s10549-011-1704-y. Epub 2011 Aug 21.
|
2761 |
Two truncating variants in FANCC and breast cancer risk.Sci Rep. 2019 Aug 29;9(1):12524. doi: 10.1038/s41598-019-48804-y.
|
2762 |
Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer.Oncol Lett. 2019 Apr;17(4):3687-3700. doi: 10.3892/ol.2019.10046. Epub 2019 Feb 18.
|
2763 |
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression.Cancer Res. 2018 Jun 15;78(12):3190-3206. doi: 10.1158/0008-5472.CAN-17-3514. Epub 2018 Apr 26.
|
2764 |
A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2.Mol Cell Biol. 2011 Jun;31(11):2287-98. doi: 10.1128/MCB.01381-10. Epub 2011 Mar 28.
|
2765 |
Down-regulated long non-coding RNA RNAZFHX4-AS1 suppresses invasion and migration of breast cancer cells via FAT4-dependent Hippo signaling pathway.Cancer Gene Ther. 2019 Nov;26(11-12):374-387. doi: 10.1038/s41417-018-0066-6. Epub 2018 Dec 14.
|
2766 |
Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance.Curr Med Chem. 2019;26(33):6020-6032. doi: 10.2174/0929867326666181203133332.
|
2767 |
Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.Life Sci. 2018 Aug 15;207:372-380. doi: 10.1016/j.lfs.2018.06.024. Epub 2018 Jun 22.
|
2768 |
FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.Oncogene. 2018 Oct;37(43):5794-5809. doi: 10.1038/s41388-018-0372-3. Epub 2018 Jul 4.
|
2769 |
Pathway-based classification of cancer subtypes.Biol Direct. 2012 Jul 3;7:21. doi: 10.1186/1745-6150-7-21.
|
2770 |
Differential 12-O-Tetradecanoylphorbol-13-acetate-induced activation of rat mammary carcinoma susceptibility Fbxo10 variant promoters via a PKC-AP1 pathway.Mol Carcinog. 2015 Feb;54(2):134-47. doi: 10.1002/mc.22081. Epub 2013 Sep 5.
|
2771 |
SCF(FBXO22) targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11754-11763. doi: 10.1073/pnas.1820990116. Epub 2019 May 28.
|
2772 |
FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.Cancer Res. 2005 Dec 15;65(24):11304-13. doi: 10.1158/0008-5472.CAN-05-0936.
|
2773 |
FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.Oncogene. 2017 Jun 8;36(23):3312-3321. doi: 10.1038/onc.2016.479. Epub 2017 Jan 9.
|
2774 |
Prognostic values of F-box members in breast cancer: an online database analysis and literature review.Biosci Rep. 2019 Jan 3;39(1):BSR20180949. doi: 10.1042/BSR20180949. Print 2019 Jan 31.
|
2775 |
Assessment of a FBXW8 frameshift mutation, c.1312_1313delGT, in breast cancer patients and controls from Central Europe.Cancer Genet. 2018 Jan;220:38-43. doi: 10.1016/j.cancergen.2017.11.006. Epub 2017 Nov 28.
|
2776 |
Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women.Carcinogenesis. 2009 Sep;30(9):1528-31. doi: 10.1093/carcin/bgp084. Epub 2009 Apr 16.
|
2777 |
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2.Cancer Res. 2007 Dec 15;67(24):11991-9. doi: 10.1158/0008-5472.CAN-07-2068.
|
2778 |
MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.Oncogene. 2020 Jan;39(1):234-247. doi: 10.1038/s41388-019-0986-0. Epub 2019 Aug 30.
|
2779 |
Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis.Cancer Res. 2018 Mar 15;78(6):1484-1496. doi: 10.1158/0008-5472.CAN-17-1518. Epub 2018 Jan 12.
|
2780 |
Integrin-interacting protein Kindlin-2 induces mammary tumors in transgenic mice.Sci China Life Sci. 2019 Feb;62(2):225-234. doi: 10.1007/s11427-018-9336-6. Epub 2018 Nov 19.
|
2781 |
Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.Cancer Res. 2005 Feb 15;65(4):1207-12. doi: 10.1158/0008-5472.CAN-04-3461.
|
2782 |
Serum degradome markers for the detection of breast cancer.J Proteome Res. 2010 Aug 6;9(8):3781-8. doi: 10.1021/pr100395s.
|
2783 |
Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer.Cancer Res. 2009 Feb 1;69(3):747-52. doi: 10.1158/0008-5472.CAN-08-1980. Epub 2009 Jan 13.
|
2784 |
Expression of FGD3 gene as prognostic factor in young breast cancer patients.Sci Rep. 2019 Oct 23;9(1):15204. doi: 10.1038/s41598-019-51766-w.
|
2785 |
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.Br J Cancer. 2016 Nov 22;115(11):1335-1342. doi: 10.1038/bjc.2016.326. Epub 2016 Oct 13.
|
2786 |
FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.Breast Cancer Res Treat. 2017 Apr;162(2):243-253. doi: 10.1007/s10549-017-4125-8. Epub 2017 Jan 25.
|
2787 |
Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer.Endocr Relat Cancer. 2008 Mar;15(1):101-11. doi: 10.1677/ERC-07-0080.
|
2788 |
Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.Clin Cancer Res. 2020 Mar 15;26(6):1432-1448. doi: 10.1158/1078-0432.CCR-19-0353. Epub 2019 Nov 7.
|
2789 |
The FHL2 regulation in the transcriptional circuitry of human cancers.Gene. 2015 Nov 1;572(1):1-7. doi: 10.1016/j.gene.2015.07.043. Epub 2015 Jul 26.
|
2790 |
Downregulation and antiproliferative role of FHL3 in breast cancer.IUBMB Life. 2011 Sep;63(9):764-71. doi: 10.1002/iub.502.
|
2791 |
Association between Birt Hogg Dube syndrome and cancer predisposition.Anticancer Res. 2010 Mar;30(3):751-7.
|
2792 |
Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.Cancer Sci. 2007;98(11):1775-84. doi: 10.1111/j.1349-7006.2007.00598.x.
|
2793 |
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.Elife. 2018 Jul 30;7:e37184. doi: 10.7554/eLife.37184.
|
2794 |
Increase in fatty acids and flotillins upon resveratrol treatment of human breast cancer cells.Sci Rep. 2019 Sep 27;9(1):13960. doi: 10.1038/s41598-019-50416-5.
|
2795 |
Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model.Cancer Res. 1997 Aug 15;57(16):3511-6.
|
2796 |
Wnt/-Catenin Pathway-Regulated Fibromodulin Expression Is Crucial for Breast Cancer Metastasis and Inhibited by Aspirin.Front Pharmacol. 2019 Nov 25;10:1308. doi: 10.3389/fphar.2019.01308. eCollection 2019.
|
2797 |
Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer.Biomed Pharmacother. 2018 Jul;103:1369-1375. doi: 10.1016/j.biopha.2018.04.190. Epub 2018 May 7.
|
2798 |
Methylomics of breast cancer: Seeking epimarkers in peripheral blood of young subjects. Tumour Biol. 2017 Mar;39(3):1010428317695040.
|
2799 |
FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1.Neoplasia. 2018 Oct;20(10):996-1007. doi: 10.1016/j.neo.2018.08.004. Epub 2018 Sep 10.
|
2800 |
Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.
|
2801 |
FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9978-9987. doi: 10.26355/eurrev_201911_19564.
|
2802 |
Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.Onco Targets Ther. 2018 Feb 27;11:1067-1075. doi: 10.2147/OTT.S157126. eCollection 2018.
|
2803 |
Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.Oncol Res. 2017 Jul 5;25(6):959-965. doi: 10.3727/096504016X14803482769179. Epub 2016 Nov 29.
|
2804 |
Identification of novel GLI1 target genes and regulatory circuits in human cancer cells.Mol Oncol. 2018 Oct;12(10):1718-1734. doi: 10.1002/1878-0261.12366. Epub 2018 Aug 30.
|
2805 |
Molecular cloning and expression of proto-oncogene FRAT1 in human cancer.Int J Oncol. 2002 Apr;20(4):785-9.
|
2806 |
Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.Oncotarget. 2017 Feb 14;8(7):11442-11459. doi: 10.18632/oncotarget.14546.
|
2807 |
Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.Oncogene. 2006 Sep 28;25(44):6003-14. doi: 10.1038/sj.onc.1209592. Epub 2006 May 8.
|
2808 |
Fry Is Required for Mammary Gland Development During Pregnant Periods and Affects the Morphology and Growth of Breast Cancer Cells.Front Oncol. 2019 Nov 21;9:1279. doi: 10.3389/fonc.2019.01279. eCollection 2019.
|
2809 |
Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.Cancer Genet Cytogenet. 2007 Sep;177(2):143-6. doi: 10.1016/j.cancergencyto.2007.05.021.
|
2810 |
Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients.PLoS One. 2013;8(3):e59555. doi: 10.1371/journal.pone.0059555. Epub 2013 Mar 14.
|
2811 |
Identification of microRNA expression in sentinel lymph nodes from patients with breast cancer via RNA sequencing for diagnostic accuracy.J Gene Med. 2019 Apr;21(4):e3075. doi: 10.1002/jgm.3075. Epub 2019 Mar 3.
|
2812 |
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.Oncogene. 2016 Dec 1;35(48):6189-6202. doi: 10.1038/onc.2016.151. Epub 2016 May 9.
|
2813 |
Reduced expression of -L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients.Oncotarget. 2018 Feb 7;9(20):15228-15238. doi: 10.18632/oncotarget.24445. eCollection 2018 Mar 16.
|
2814 |
Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis.Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11667-72. doi: 10.1073/pnas.0804979105. Epub 2008 Aug 6.
|
2815 |
MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer.IUBMB Life. 2016 Sep;68(9):764-75. doi: 10.1002/iub.1541. Epub 2016 Aug 13.
|
2816 |
SOX9/FXYD3/Src Axis Is Critical for ER(+) Breast Cancer Stem Cell Function.Mol Cancer Res. 2019 Jan;17(1):238-249. doi: 10.1158/1541-7786.MCR-18-0610. Epub 2018 Sep 11.
|
2817 |
FXYD5 (dysadherin) may mediate metastatic progression through regulation of the -Na(+)-K(+)-ATPase subunit in the 4T1 mouse breast cancer model.Am J Physiol Cell Physiol. 2017 Jul 1;313(1):C108-C117. doi: 10.1152/ajpcell.00206.2016. Epub 2017 May 17.
|
2818 |
Identification of aberrant gene expression during breast ductal carcinoma in situ progression to invasive ductal carcinoma.J Int Med Res. 2020 Jan;48(1):300060518815364. doi: 10.1177/0300060518815364. Epub 2019 Feb 3.
|
2819 |
A tRNA fragment, 5'-tiRNA(Val), suppresses the Wnt/-catenin signaling pathway by targeting FZD3 in breast cancer.Cancer Lett. 2019 Aug 10;457:60-73. doi: 10.1016/j.canlet.2019.05.007. Epub 2019 May 9.
|
2820 |
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.J Pathol. 2017 Feb;241(3):350-361. doi: 10.1002/path.4841. Epub 2016 Dec 29.
|
2821 |
Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer.Am J Clin Pathol. 2008 Sep;130(3):414-24. doi: 10.1309/J3QV9763DYPV338D.
|
2822 |
G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancer.Cell Cycle. 2017;16(21):2146-2155. doi: 10.1080/15384101.2017.1371884. Epub 2017 Sep 14.
|
2823 |
Stress granule-associated protein G3BP2 regulates breast tumor initiation.Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1033-1038. doi: 10.1073/pnas.1525387114. Epub 2017 Jan 17.
|
2824 |
Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.J Exp Clin Cancer Res. 2019 Jan 21;38(1):27. doi: 10.1186/s13046-019-1025-2.
|
2825 |
MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2.Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2847-2855. doi: 10.26355/eurrev_201904_17562.
|
2826 |
GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells.Oncotarget. 2017 Jul 27;8(34):55998-56020. doi: 10.18632/oncotarget.19639. eCollection 2017 Aug 22.
|
2827 |
The expression and clinical significance of GADD45A in breast cancer patients.PeerJ. 2018 Aug 15;6:e5344. doi: 10.7717/peerj.5344. eCollection 2018.
|
2828 |
(--)-Xanthatin selectively induces GADD45 and stimulates caspase-independent cell death in human breast cancer MDA-MB-231 cells.Chem Res Toxicol. 2011 Jun 20;24(6):855-65. doi: 10.1021/tx200046s. Epub 2011 May 13.
|
2829 |
Sulfatide decreases the resistance to stress-induced apoptosis and increases P-selectin-mediated adhesion: a two-edged sword in breast cancer progression.Breast Cancer Res. 2018 Nov 6;20(1):133. doi: 10.1186/s13058-018-1058-z.
|
2830 |
Evaluation of GALNT16 polymorphisms to breast cancer risk in Chinese population.Mol Genet Genomic Med. 2019 Aug;7(8):e848. doi: 10.1002/mgg3.848. Epub 2019 Jul 8.
|
2831 |
Overexpression of microRNA-365 inhibits breast cancer cell growth and chemo-resistance through GALNT4.Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4710-4718.
|
2832 |
Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.Exp Mol Med. 2005 Aug 31;37(4):353-64. doi: 10.1038/emm.2005.45.
|
2833 |
Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer.Genomics. 1998 Sep 15;52(3):325-31. doi: 10.1006/geno.1998.5457.
|
2834 |
The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.Oncotarget. 2016 Mar 1;7(9):9859-75. doi: 10.18632/oncotarget.7126.
|
2835 |
GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.Cancer Res. 2006 Feb 1;66(3):1384-90. doi: 10.1158/0008-5472.CAN-05-2715.
|
2836 |
Correction: Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion.Cell Death Dis. 2018 Nov 13;9(11):1127. doi: 10.1038/s41419-018-1133-5.
|
2837 |
Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/-catenin signaling pathway.Cancer Biomark. 2018;23(3):405-418. doi: 10.3233/CBM-181466.
|
2838 |
Recent Topics Around Multiple Endocrine Neoplasia Type 1.J Clin Endocrinol Metab. 2018 Apr 1;103(4):1296-1301. doi: 10.1210/jc.2017-02340.
|
2839 |
Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.Cancer Res. 2011 Jul 15;71(14):4846-56. doi: 10.1158/0008-5472.CAN-11-0414. Epub 2011 Jul 12.
|
2840 |
GCSH antisense regulation determines breast cancer cells' viability.Sci Rep. 2018 Oct 18;8(1):15399. doi: 10.1038/s41598-018-33677-4.
|
2841 |
A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study.BMC Cancer. 2008 Feb 20;8:54. doi: 10.1186/1471-2407-8-54.
|
2842 |
Genetic variation in bone morphogenetic proteins and breast cancer risk in hispanic and non-hispanic white women: The breast cancer health disparities study.Int J Cancer. 2013 Jun 15;132(12):2928-39. doi: 10.1002/ijc.27960. Epub 2012 Dec 13.
|
2843 |
GDF3 inhibits the growth of breast cancer cells and promotes the apoptosis induced by Taxol.J Cancer Res Clin Oncol. 2012 Jun;138(6):1073-9. doi: 10.1007/s00432-012-1213-3. Epub 2012 Apr 10.
|
2844 |
Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells.Elife. 2017 Aug 29;6:e23649. doi: 10.7554/eLife.23649.
|
2845 |
Regulation of vimentin by SIP1 in human epithelial breast tumor cells.Oncogene. 2006 Aug 17;25(36):4975-85. doi: 10.1038/sj.onc.1209511. Epub 2006 Mar 27.
|
2846 |
Earlier age of onset of BRCA mutation-related cancers in subsequent generations.Cancer. 2012 Jan 15;118(2):321-5. doi: 10.1002/cncr.26284. Epub 2011 Sep 12.
|
2847 |
Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line.Oncogene. 1999 Nov 11;18(47):6513-20. doi: 10.1038/sj.onc.1203042.
|
2848 |
Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer.Oncotarget. 2018 May 1;9(33):22960-22975. doi: 10.18632/oncotarget.25160. eCollection 2018 May 1.
|
2849 |
GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation.Breast Cancer Res Treat. 2019 Feb;174(1):65-78. doi: 10.1007/s10549-018-5052-z. Epub 2018 Nov 19.
|
2850 |
The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation-further evidence of the presence of a GHRH pathway in these tumors.Hum Pathol. 2017 Jun;64:164-170. doi: 10.1016/j.humpath.2017.03.026. Epub 2017 Apr 21.
|
2851 |
RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.Mol Oncol. 2020 Feb;14(2):426-446. doi: 10.1002/1878-0261.12602. Epub 2019 Dec 29.
|
2852 |
RGS-GAIP-interacting protein controls breast cancer progression.Mol Cancer Res. 2010 Dec;8(12):1591-600. doi: 10.1158/1541-7786.MCR-10-0209. Epub 2010 Oct 27.
|
2853 |
Up-regulation of GIPC2 in human gastric cancer.Int J Oncol. 2002 Jun;20(6):1183-7.
|
2854 |
Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo.Onco Targets Ther. 2017 Dec 11;10:5873-5882. doi: 10.2147/OTT.S144280. eCollection 2017.
|
2855 |
GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.Gene. 2017 Sep 10;628:224-229. doi: 10.1016/j.gene.2017.07.054. Epub 2017 Jul 20.
|
2856 |
Modulation of cellular bioenergetics by CO-releasing molecules and NO-donors inhibits the interaction of cancer cells with human lung microvascular endothelial cells.Pharmacol Res. 2018 Oct;136:160-171. doi: 10.1016/j.phrs.2018.09.005. Epub 2018 Sep 6.
|
2857 |
Glutamate dehydrogenase (GLUD1) expression in breast cancer.Breast Cancer Res Treat. 2019 Feb;174(1):79-91. doi: 10.1007/s10549-018-5060-z. Epub 2018 Nov 23.
|
2858 |
MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.Mol Cancer. 2015 Mar 26;14:67. doi: 10.1186/s12943-015-0337-x.
|
2859 |
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy.Breast Cancer Res Treat. 2009 Nov;118(1):45-56. doi: 10.1007/s10549-008-0207-y. Epub 2008 Oct 17.
|
2860 |
Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.Pharmacogenet Genomics. 2018 Feb;28(2):49-55. doi: 10.1097/FPC.0000000000000318.
|
2861 |
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin.Oncoimmunology. 2019 Jul 22;8(11):1641392. doi: 10.1080/2162402X.2019.1641392. eCollection 2019.
|
2862 |
Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-B activity.Cell Commun Signal. 2018 Apr 27;16(1):19. doi: 10.1186/s12964-018-0230-5.
|
2863 |
Golgi Membrane Protein 1 (GOLM1) Promotes Growth and Metastasis of Breast Cancer Cells via Regulating Matrix Metalloproteinase-13 (MMP13).Med Sci Monit. 2019 Jan 29;25:847-855. doi: 10.12659/MSM.911667.
|
2864 |
Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.Anticancer Drugs. 2019 Feb;30(2):186-194. doi: 10.1097/CAD.0000000000000711.
|
2865 |
Profiling the expression pattern of GPI transamidase complex subunits in human cancer.Mod Pathol. 2008 Aug;21(8):979-91. doi: 10.1038/modpathol.2008.76. Epub 2008 May 16.
|
2866 |
Involvement of G-patch domain containing 2 overexpression in breast carcinogenesis.Cancer Sci. 2009 Aug;100(8):1443-50. doi: 10.1111/j.1349-7006.2009.01185.x. Epub 2009 May 4.
|
2867 |
Advanced fabrication of biosensor on detection of Glypican-1 using S-Acetylmercaptosuccinic anhydride (SAMSA) modification of antibody.Sci Rep. 2018 Sep 10;8(1):13541. doi: 10.1038/s41598-018-31994-2.
|
2868 |
NFAT promotes carcinoma invasive migration through glypican-6.Biochem J. 2011 Nov 15;440(1):157-66. doi: 10.1042/BJ20110530.
|
2869 |
PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.PLoS One. 2016 Nov 16;11(11):e0166553. doi: 10.1371/journal.pone.0166553. eCollection 2016.
|
2870 |
G protein-coupled receptor GPR19 regulates E-cadherin expression and invasion of breast cancer cells.Biochim Biophys Acta Mol Cell Res. 2017 Jul;1864(7):1318-1327. doi: 10.1016/j.bbamcr.2017.05.001. Epub 2017 May 2.
|
2871 |
The orphan GPR50 receptor promotes constitutive TGF receptor signaling and protects against cancer development.Nat Commun. 2018 Mar 23;9(1):1216. doi: 10.1038/s41467-018-03609-x.
|
2872 |
Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells.Genes Chromosomes Cancer. 2010 Oct;49(10):861-72. doi: 10.1002/gcc.20795.
|
2873 |
Glutamic Pyruvate Transaminase GPT2 Promotes Tumorigenesis of Breast Cancer Cells by Activating Sonic Hedgehog Signaling.Theranostics. 2017 Jul 22;7(12):3021-3033. doi: 10.7150/thno.18992. eCollection 2017.
|
2874 |
Sulfasalazineinduced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.Oncol Rep. 2019 Aug;42(2):826-838. doi: 10.3892/or.2019.7189. Epub 2019 Jun 6.
|
2875 |
Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells.J Biol Chem. 2004 Oct 15;279(42):43522-9. doi: 10.1074/jbc.M407141200. Epub 2004 Aug 4.
|
2876 |
GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling.Sci Rep. 2018 Jun 22;8(1):9511. doi: 10.1038/s41598-018-27864-6.
|
2877 |
FGF receptor phosphotyrosine 766 is a target for Grb14 to inhibit MDA-MB-231 human breast cancer cell signaling.Anticancer Res. 2005 Nov-Dec;25(6B):3877-82.
|
2878 |
GRB7 dependent proliferation of basal-like, HER-2 positive human breast cancer cell lines is mediated in part by HER-1 signaling.Mol Carcinog. 2019 May;58(5):699-707. doi: 10.1002/mc.22963. Epub 2019 Jan 28.
|
2879 |
Expression of G protein-coupled receptor kinase 4 is associated with breast cancer tumourigenesis.J Pathol. 2008 Nov;216(3):317-27. doi: 10.1002/path.2414.
|
2880 |
Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.Chem Phys Lipids. 2019 Nov;224:104770. doi: 10.1016/j.chemphyslip.2019.04.005. Epub 2019 Apr 6.
|
2881 |
DFNA5 promoter methylation a marker for breast tumorigenesis.Oncotarget. 2017 May 9;8(19):31948-31958. doi: 10.18632/oncotarget.16654.
|
2882 |
GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.Biochem Biophys Res Commun. 2016 Feb 26;471(1):123-8. doi: 10.1016/j.bbrc.2016.01.168. Epub 2016 Jan 30.
|
2883 |
GGCn polymorphism of eRF3a/GSPT1 gene and breast cancer susceptibility.Med Oncol. 2012 Sep;29(3):1581-5. doi: 10.1007/s12032-011-0111-x. Epub 2011 Nov 19.
|
2884 |
Comprehensive epigenetic analyses reveal master regulators driving lung metastasis of breast cancer.J Cell Mol Med. 2019 Aug;23(8):5415-5431. doi: 10.1111/jcmm.14424. Epub 2019 Jun 19.
|
2885 |
AP2 Transcription Factors Regulate Expression of CRABPII in hormone responsive breast carcinoma. J Surg Res. 2007 Mar;138(1):71-8.
|
2886 |
GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.J Exp Clin Cancer Res. 2019 Apr 8;38(1):152. doi: 10.1186/s13046-019-1157-4.
|
2887 |
Upfront brain radiotherapy may improve survival for unfavorable prognostic breast cancer brain metastasis patients with Breast-GPA 0-2.0.Breast J. 2019 Nov;25(6):1134-1142. doi: 10.1111/tbj.13426. Epub 2019 Jul 8.
|
2888 |
Breast cancer and the MNSs blood groups.Dis Markers. 1989 Oct-Dec;7(4):253-6.
|
2889 |
DACH1 suppresses breast cancer as a negative regulator of CD44.Sci Rep. 2017 Jun 28;7(1):4361. doi: 10.1038/s41598-017-04709-2.
|
2890 |
The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial-mesenchymal transition in mammary epithelial and in breast cancer cells.Cancer Lett. 2017 Jun 28;396:42-52. doi: 10.1016/j.canlet.2017.03.007. Epub 2017 Mar 11.
|
2891 |
Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression.Cancer Res. 2006 Apr 15;66(8):4065-78. doi: 10.1158/0008-5472.CAN-05-4083.
|
2892 |
Expression of -H2AX and patient prognosis in breast cancer cohort.J Cell Biochem. 2019 Aug;120(8):12958-12965. doi: 10.1002/jcb.28567. Epub 2019 Mar 28.
|
2893 |
Expressing Status and Correlation of ARID1A and Histone H2B on Breast Cancer.Biomed Res Int. 2016;2016:7593787. doi: 10.1155/2016/7593787. Epub 2016 Jan 21.
|
2894 |
Significant elevation of CLDN16 and HAPLN3 gene expression in human breast cancer.Oncol Rep. 2010 Sep;24(3):759-66. doi: 10.3892/or_00000918.
|
2895 |
Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGF-induced EMT in breast cancer.Matrix Biol. 2019 Jul;80:29-45. doi: 10.1016/j.matbio.2018.09.002. Epub 2018 Sep 5.
|
2896 |
Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.J Cell Biochem. 2015 Apr;116(4):533-41. doi: 10.1002/jcb.25003.
|
2897 |
Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells.Pathol Oncol Res. 2019 Jul;25(3):1233-1243. doi: 10.1007/s12253-019-00610-7. Epub 2019 Feb 13.
|
2898 |
miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1.Breast Cancer Res Treat. 2011 Apr;126(3):565-75. doi: 10.1007/s10549-010-0954-4. Epub 2010 May 27.
|
2899 |
Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA.Transl Oncol. 2019 Jan;12(1):106-115. doi: 10.1016/j.tranon.2018.09.012. Epub 2018 Oct 3.
|
2900 |
Concise approach for screening long non-coding RNAs functionally linked to human breast cancer associated genes.Exp Mol Pathol. 2019 Jun;108:89-96. doi: 10.1016/j.yexmp.2019.04.003. Epub 2019 Apr 3.
|
2901 |
Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.Int J Cancer. 2009 Jun 15;124(12):2829-36. doi: 10.1002/ijc.24266.
|
2902 |
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21.Oncotarget. 2016 Dec 6;7(49):80140-80163. doi: 10.18632/oncotarget.12818.
|
2903 |
G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin.Nat Commun. 2017 Aug 17;8(1):274. doi: 10.1038/s41467-017-00350-9.
|
2904 |
Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.Gene. 2007 Apr 15;391(1-2):161-70. doi: 10.1016/j.gene.2006.12.016. Epub 2007 Jan 8.
|
2905 |
Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1/Notch1 axis.J Cell Mol Med. 2019 May;23(5):3451-3463. doi: 10.1111/jcmm.14241. Epub 2019 Feb 26.
|
2906 |
Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.Anticancer Res. 2010 Oct;30(10):3853-67.
|
2907 |
Total polyphenol intake and breast cancer risk in the Seguimiento Universidad de Navarra (SUN) cohort.Br J Nutr. 2019 Sep 14;122(5):542-551. doi: 10.1017/S0007114518003811. Epub 2019 Feb 12.
|
2908 |
BACH1 Ser919Pro variant and breast cancer risk.BMC Cancer. 2006 Jan 24;6:19. doi: 10.1186/1471-2407-6-19.
|
2909 |
Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.BMC Cancer. 2019 Dec 3;19(1):1180. doi: 10.1186/s12885-019-6333-6.
|
2910 |
Frequent down-regulation of HIVEP2 in human breast cancer.Breast Cancer Res Treat. 2005 May;91(2):103-12. doi: 10.1007/s10549-004-5779-6.
|
2911 |
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.Breast Cancer Res. 2010;12(2):R18. doi: 10.1186/bcr2487. Epub 2010 Mar 8.
|
2912 |
Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles.Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11451-4. doi: 10.1073/pnas.97.21.11451.
|
2913 |
HLA class II variants in Chinese breast cancer patients.Asian Pac J Cancer Prev. 2011;12(11):3075-9.
|
2914 |
Signal peptide peptidase promotes tumor progression via facilitating FKBP8 degradation.Oncogene. 2019 Mar;38(10):1688-1701. doi: 10.1038/s41388-018-0539-y. Epub 2018 Oct 22.
|
2915 |
HMGB3 small interfere RNA suppresses mammosphere formation of MDA-MB-231 cells by down-regulating expression of HIF1.Eur Rev Med Pharmacol Sci. 2019 Nov;23(21):9506-9516. doi: 10.26355/eurrev_201911_19445.
|
2916 |
Effect of HMGN2 on proliferation and apoptosis of MCF-7 breast cancer cells.Oncol Lett. 2019 Jan;17(1):1160-1166. doi: 10.3892/ol.2018.9668. Epub 2018 Nov 5.
|
2917 |
The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells.Tumour Biol. 2015 Feb;36(2):959-66. doi: 10.1007/s13277-014-2715-1. Epub 2014 Oct 15.
|
2918 |
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response.EMBO J. 2018 Dec 3;37(23):e99017. doi: 10.15252/embj.201899017. Epub 2018 Aug 29.
|
2919 |
RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF.Genes Dev. 2017 Nov 15;31(22):2296-2309. doi: 10.1101/gad.305862.117. Epub 2017 Dec 21.
|
2920 |
Inclusion of hnRNP L Alternative Exon 7 Is Associated with Good Prognosis and Inhibited by Oncogene SRSF3 in Head and Neck Squamous Cell Carcinoma.Biomed Res Int. 2019 Nov 13;2019:9612425. doi: 10.1155/2019/9612425. eCollection 2019.
|
2921 |
Heterogeneous nuclear ribonucleoprotein M promotes the progression of breast cancer by regulating the axin/-catenin signaling pathway.Biomed Pharmacother. 2018 Sep;105:848-855. doi: 10.1016/j.biopha.2018.05.014. Epub 2018 Jun 18.
|
2922 |
Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.Mini Rev Med Chem. 2019;19(5):410-423. doi: 10.2174/1389557518666180702103542.
|
2923 |
HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer.Exp Ther Med. 2019 Mar;17(3):1896-1902. doi: 10.3892/etm.2018.7145. Epub 2018 Dec 28.
|
2924 |
A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer.Genomics. 2011 Sep;98(3):164-72. doi: 10.1016/j.ygeno.2011.05.011. Epub 2011 Jun 13.
|
2925 |
Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13.Oncol Lett. 2017 Oct;14(4):4625-4632. doi: 10.3892/ol.2017.6825. Epub 2017 Aug 25.
|
2926 |
HOXB7 promotes malignant progression by activating the TGF signaling pathway.Cancer Res. 2015 Feb 15;75(4):709-19. doi: 10.1158/0008-5472.CAN-14-3100. Epub 2014 Dec 26.
|
2927 |
Long non-coding RNA MIF-AS1 promotes breast cancer cell proliferation, migration and EMT process through regulating miR-1249-3p/HOXB8 axis.Pathol Res Pract. 2019 Jul;215(7):152376. doi: 10.1016/j.prp.2019.03.005. Epub 2019 May 4.
|
2928 |
Endocrine disrupting chemical, bisphenol-A, induces breast cancer associated gene HOXB9 expression in vitro and in vivo. Gene. 2016 Sep 30;590(2):234-43. doi: 10.1016/j.gene.2016.05.009. Epub 2016 May 13.
|
2929 |
HOXC10 Expression Supports the Development of Chemotherapy Resistance by Fine Tuning DNA Repair in Breast Cancer Cells.Cancer Res. 2016 Aug 1;76(15):4443-56. doi: 10.1158/0008-5472.CAN-16-0774. Epub 2016 Jun 14.
|
2930 |
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.Breast Cancer Res. 2015 Sep 4;17(1):123. doi: 10.1186/s13058-015-0636-6.
|
2931 |
HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.Mol Cancer. 2017 Feb 16;16(1):38. doi: 10.1186/s12943-017-0605-z.
|
2932 |
RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network.Mol Pharm. 2018 Jun 4;15(6):2123-2132. doi: 10.1021/acs.molpharmaceut.7b01123. Epub 2018 May 15.
|
2933 |
Identification of 20 genes aberrantly methylated in human breast cancers.Int J Cancer. 2005 Sep 1;116(3):407-14. doi: 10.1002/ijc.21054.
|
2934 |
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.Cell Physiol Biochem. 2018;46(4):1737-1747. doi: 10.1159/000489249. Epub 2018 Apr 23.
|
2935 |
Progesterone impairs Herceptin effect on breast cancer cells.Oncol Lett. 2018 Feb;15(2):1817-1822. doi: 10.3892/ol.2017.7493. Epub 2017 Nov 27.
|
2936 |
Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer.BMC Cancer. 2012 Jun 22;12:266. doi: 10.1186/1471-2407-12-266.
|
2937 |
The Pro-Tumoral Activity of Heparan Sulfate 3-O-Sulfotransferase 3B (HS3ST3B) in Breast Cancer MDA-MB-231 Cells Is Dependent on the Expression of Neuropilin-1.Molecules. 2018 Oct 22;23(10):2718. doi: 10.3390/molecules23102718.
|
2938 |
The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.PLoS One. 2018 Mar 16;13(3):e0194676. doi: 10.1371/journal.pone.0194676. eCollection 2018.
|
2939 |
Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1.Exp Cell Res. 2017 Jan 15;350(2):380-389. doi: 10.1016/j.yexcr.2016.12.019. Epub 2016 Dec 23.
|
2940 |
Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer.Cancer Manag Res. 2019 Jul 12;11:6531-6542. doi: 10.2147/CMAR.S205316. eCollection 2019.
|
2941 |
HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study.Mol Biol Rep. 2012 Dec;39(12):10873-9. doi: 10.1007/s11033-012-1984-2. Epub 2012 Oct 12.
|
2942 |
Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors.Cancer. 1997 Oct 15;80(8):1489-96. doi: 10.1002/(sici)1097-0142(19971015)80:8<1489::aid-cncr17>3.0.co;2-1.
|
2943 |
Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo.Int J Cancer. 2020 Jan 15;146(2):531-541. doi: 10.1002/ijc.32694. Epub 2019 Nov 1.
|
2944 |
Role of ALDH1A1 and HTRA2 expression in CCL2/CCR2-mediated breast cancer cell growth and invasion.Biol Open. 2019 Jun 28;8(7):bio040873. doi: 10.1242/bio.040873.
|
2945 |
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.Anticancer Res. 2017 Aug;37(8):4455-4468. doi: 10.21873/anticanres.11841.
|
2946 |
Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.Breast Cancer Res Treat. 2017 Apr;162(3):427-438. doi: 10.1007/s10549-017-4135-6. Epub 2017 Feb 6.
|
2947 |
DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.Int J Cancer. 2015 Apr 15;136(8):1845-55. doi: 10.1002/ijc.29205. Epub 2014 Sep 24.
|
2948 |
HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.Eur Rev Med Pharmacol Sci. 2019 Jan;23(10):4126-4135. doi: 10.26355/eurrev_201901_17914.
|
2949 |
Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis.Oncotarget. 2014 Jul 30;5(14):5510-22. doi: 10.18632/oncotarget.2132.
|
2950 |
Role of ICAM1 in invasion of human breast cancer cells.Carcinogenesis. 2005 May;26(5):943-50. doi: 10.1093/carcin/bgi070. Epub 2005 Mar 17.
|
2951 |
The genetic polymorphisms of intercellular cell adhesion molecules and breast cancer susceptibility: a meta-analysis.Mol Biol Rep. 2013 Feb;40(2):1855-60. doi: 10.1007/s11033-012-2241-4. Epub 2012 Oct 19.
|
2952 |
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.Breast Cancer Res. 2018 Jun 19;20(1):59. doi: 10.1186/s13058-018-0990-2.
|
2953 |
Differential regulation of estrogen receptor expression in breast cancer cells by metastasis-associated protein 1.Cancer Res. 2014 Mar 1;74(5):1484-94. doi: 10.1158/0008-5472.CAN-13-2020. Epub 2014 Jan 10.
|
2954 |
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion.J Cell Mol Med. 2010 Dec;14(12):2780-9. doi: 10.1111/j.1582-4934.2009.00936.x.
|
2955 |
Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer.Oncol Rep. 2014 Dec;32(6):2648-56. doi: 10.3892/or.2014.3522. Epub 2014 Oct 1.
|
2956 |
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.J Pathol. 2008 Feb;214(3):357-67. doi: 10.1002/path.2278.
|
2957 |
IMP1 regulates UCA1-mediated cell invasion through facilitating UCA1 decay and decreasing the sponge effect of UCA1 for miR-122-5p.Breast Cancer Res. 2018 Apr 18;20(1):32. doi: 10.1186/s13058-018-0959-1.
|
2958 |
CCN6 regulates IGF2BP2and HMGA2 signaling in metaplastic carcinomas of the breast.Breast Cancer Res Treat. 2018 Dec;172(3):577-586. doi: 10.1007/s10549-018-4960-2. Epub 2018 Sep 15.
|
2959 |
Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.Clin Cancer Res. 2007 Jul 15;13(14):4061-8. doi: 10.1158/1078-0432.CCR-06-3052.
|
2960 |
Activated kinase screening identifies the IKBKE oncogene as a positive regulator of autophagy.Autophagy. 2019 Feb;15(2):312-326. doi: 10.1080/15548627.2018.1517855. Epub 2018 Oct 5.
|
2961 |
NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.Cancer Res. 2017 Jul 15;77(14):3802-3813. doi: 10.1158/0008-5472.CAN-16-2794. Epub 2017 May 17.
|
2962 |
Biological Properties and the Role of IL-25 in Disease Pathogenesis.J Immunol Res. 2018 Sep 23;2018:6519465. doi: 10.1155/2018/6519465. eCollection 2018.
|
2963 |
The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.Gene. 2019 Dec 15;720:144088. doi: 10.1016/j.gene.2019.144088. Epub 2019 Aug 30.
|
2964 |
Equal Pro-inflammatory Profiles of CCLs, CXCLs, and Matrix Metalloproteinases in the Extracellular Microenvironment In Vivo in Human Dense Breast Tissue and Breast Cancer.Front Immunol. 2018 Jan 16;8:1994. doi: 10.3389/fimmu.2017.01994. eCollection 2017.
|
2965 |
FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.Neoplasia. 2014 Oct 23;16(10):801-13. doi: 10.1016/j.neo.2014.08.007. eCollection 2014 Oct.
|
2966 |
IL-27 -964A>G polymorphism and the risk of breast cancer: a case-control study.Tumour Biol. 2014 Dec;35(12):12099-102. doi: 10.1007/s13277-014-2512-x. Epub 2014 Aug 22.
|
2967 |
Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line.Breast Cancer. 2018 Sep;25(5):566-574. doi: 10.1007/s12282-018-0853-9. Epub 2018 Mar 19.
|
2968 |
miR-188-5p suppresses cellular proliferation and migration via IL6ST: A potential noninvasive diagnostic biomarker for breast cancer.J Cell Physiol. 2020 May;235(5):4890-4901. doi: 10.1002/jcp.29367. Epub 2019 Oct 24.
|
2969 |
Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses.Am J Transl Res. 2018 Jun 15;10(6):1677-1689. eCollection 2018.
|
2970 |
Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.Oncotarget. 2017 Nov 18;8(64):107477-107491. doi: 10.18632/oncotarget.22491. eCollection 2017 Dec 8.
|
2971 |
PP2C inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer.Sci Adv. 2019 Oct 16;5(10):eaaw8417. doi: 10.1126/sciadv.aaw8417. eCollection 2019 Oct.
|
2972 |
C6orf106 accelerates pancreatic cancer cell invasion and proliferation via activating ERK signaling pathway.Mol Cell Biochem. 2019 Apr;454(1-2):87-95. doi: 10.1007/s11010-018-3455-0. Epub 2018 Oct 11.
|
2973 |
C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.Sci China Life Sci. 2019 Sep;62(9):1229-1242. doi: 10.1007/s11427-019-9570-y. Epub 2019 Aug 1.
|
2974 |
Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival.Mol Cancer. 2015 Aug 27;14:164. doi: 10.1186/s12943-015-0434-x.
|
2975 |
Suberoylanilide hydroxamic acid (SAHA)-induced dynamics of a human histone deacetylase protein interaction network.Mol Cell Proteomics. 2014 Nov;13(11):3114-25. doi: 10.1074/mcp.M113.037127. Epub 2014 Jul 29.
|
2976 |
Oncogenic microRNA-765 promotes the growth and metastasis of breast carcinoma by directly targeting ING4.J Cell Biochem. 2020 Aug;121(8-9):3887-3900. doi: 10.1002/jcb.29545. Epub 2019 Nov 13.
|
2977 |
Common genetic variation and novel loci associated with volumetric mammographic density.Breast Cancer Res. 2018 Apr 17;20(1):30. doi: 10.1186/s13058-018-0954-6.
|
2978 |
miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer.Int J Cancer. 2017 May 15;140(10):2310-2320. doi: 10.1002/ijc.30661. Epub 2017 Mar 11.
|
2979 |
Coumarin-Fatty Acid Conjugates as Potential ER/AKT-1 Antagonists for ER Positive Breast Cancer.Anticancer Agents Med Chem. 2020;20(4):437-449. doi: 10.2174/1871520619666191028104339.
|
2980 |
Psychiatric disorders and cardiovascular diseases during the diagnostic workup of potential breast cancer: a population-based cohort study in Skne, Sweden.Breast Cancer Res. 2019 Dec 10;21(1):139. doi: 10.1186/s13058-019-1232-y.
|
2981 |
Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.Cancer Res. 1990 Sep 15;50(18):5911-8.
|
2982 |
Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.Breast Cancer Res Treat. 2002 Jun;73(3):245-56. doi: 10.1023/a:1015854415746.
|
2983 |
Downregulation of importin-9 protects MCF-7 cells against apoptosis induced by the combination of garlic-derived alliin and paclitaxel.Oncol Rep. 2016 May;35(5):3084-93. doi: 10.3892/or.2016.4628. Epub 2016 Feb 22.
|
2984 |
Ras GTPase-Activating-Like Protein IQGAP1 (IQGAP1) Promotes Breast Cancer Proliferation and Invasion and Correlates with Poor Clinical Outcomes.Med Sci Monit. 2018 May 20;24:3315-3323. doi: 10.12659/MSM.909916.
|
2985 |
IQ Motif Containing GTPase-Activating Protein 3 (IQGAP3) Inhibits Kaempferol-Induced Apoptosis in Breast Cancer Cells by Extracellular Signal-Regulated Kinases 1/2 (ERK1/2) Signaling Activation.Med Sci Monit. 2019 Oct 12;25:7666-7674. doi: 10.12659/MSM.915642.
|
2986 |
GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.Exp Cell Res. 2013 Aug 1;319(13):1932-1941. doi: 10.1016/j.yexcr.2013.05.028. Epub 2013 Jun 5.
|
2987 |
Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3/-catenin signaling pathway in breast cancer.Cancer Med. 2018 Aug;7(8):3875-3888. doi: 10.1002/cam4.1568. Epub 2018 Jul 2.
|
2988 |
The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.J Interferon Cytokine Res. 2003 Sep;23(9):501-11. doi: 10.1089/10799900360708623.
|
2989 |
IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media.Immunol Cell Biol. 2015 May-Jun;93(5):486-99. doi: 10.1038/icb.2014.110. Epub 2014 Dec 23.
|
2990 |
Polymorphisms associated with oral clefts as potential susceptibility markers for oral and breast cancer.Arch Oral Biol. 2019 Mar;99:9-14. doi: 10.1016/j.archoralbio.2018.12.004. Epub 2018 Dec 14.
|
2991 |
IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation.Nat Commun. 2016 Nov 23;7:13567. doi: 10.1038/ncomms13567.
|
2992 |
FTO Gene Affects Obesity and Breast Cancer Through Similar Mechanisms: A New Insight into the Molecular Therapeutic Targets.Nutr Cancer. 2018 Jan;70(1):30-36. doi: 10.1080/01635581.2018.1397709. Epub 2017 Dec 8.
|
2993 |
ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis.Onco Targets Ther. 2018 Feb 14;11:781-789. doi: 10.2147/OTT.S144241. eCollection 2018.
|
2994 |
Knockdown of ISOC1 suppresses cell proliferation in pancreatic cancer in vitro.Oncol Lett. 2019 May;17(5):4263-4270. doi: 10.3892/ol.2019.10082. Epub 2019 Feb 28.
|
2995 |
RUVBL1-ITFG1 interaction is required for collective invasion in breast cancer.Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1788-1800. doi: 10.1016/j.bbagen.2017.03.016. Epub 2017 Mar 21.
|
2996 |
Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells.Transfusion. 2006 Jul;46(7):1199-209. doi: 10.1111/j.1537-2995.2006.00871.x.
|
2997 |
Integrin 7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer.J Clin Lab Anal. 2019 Oct;33(8):e22979. doi: 10.1002/jcla.22979. Epub 2019 Jul 19.
|
2998 |
Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain.BMC Cancer. 2014 Nov 20;14:852. doi: 10.1186/1471-2407-14-852.
|
2999 |
Integrin 5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways.Oncogene. 2013 Jun 20;32(25):3049-58. doi: 10.1038/onc.2012.320. Epub 2012 Jul 23.
|
3000 |
Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis.BMC Cancer. 2008 Jan 28;8:25. doi: 10.1186/1471-2407-8-25.
|
3001 |
Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.J Clin Oncol. 2011 Feb 20;29(6):660-6. doi: 10.1200/JCO.2010.31.1258. Epub 2011 Jan 10.
|
3002 |
Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types.Biochem Pharmacol. 2017 Aug 1;137:1-9. doi: 10.1016/j.bcp.2017.03.023. Epub 2017 Apr 2.
|
3003 |
JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.Oncogene. 2019 Feb;38(7):980-997. doi: 10.1038/s41388-018-0466-y. Epub 2018 Sep 5.
|
3004 |
Clipping of arginine-methylated histone tails by JMJD5 and JMJD7.Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7717-E7726. doi: 10.1073/pnas.1706831114. Epub 2017 Aug 28.
|
3005 |
HN1 contributes to migration, invasion, and tumorigenesis of breast cancer by enhancing MYC activity.Mol Cancer. 2017 May 11;16(1):90. doi: 10.1186/s12943-017-0656-1.
|
3006 |
HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway.Stem Cell Reports. 2018 Jan 9;10(1):212-227. doi: 10.1016/j.stemcr.2017.11.010. Epub 2017 Dec 14.
|
3007 |
Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets. Genome Biol. 2014 Jan 7;15(1):R9.
|
3008 |
JUNB governs a feed-forward network of TGF signaling that aggravates breast cancer invasion.Nucleic Acids Res. 2018 Feb 16;46(3):1180-1195. doi: 10.1093/nar/gkx1190.
|
3009 |
Cis-guggulsterone inhibits the IKK/NF-B pathway, whereas trans-guggulsterone inhibits MAPK/AP-1 in MCF? breast cancer cells: guggulsterone regulates MMP? expression in an isomer-specific manner.Int J Mol Med. 2013 Feb;31(2):393-9. doi: 10.3892/ijmm.2012.1214. Epub 2012 Dec 14.
|
3010 |
Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.Breast Cancer Res Treat. 2020 Jan;179(2):349-357. doi: 10.1007/s10549-019-05466-8. Epub 2019 Nov 2.
|
3011 |
Function of GCN5 in the TGF-1-induced epithelial-to-mesenchymal transition in breast cancer.Oncol Lett. 2018 Sep;16(3):3955-3963. doi: 10.3892/ol.2018.9134. Epub 2018 Jul 11.
|
3012 |
Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.Cancer Res. 2013 Sep 1;73(17):5556-68. doi: 10.1158/0008-5472.CAN-13-0013. Epub 2013 Aug 16.
|
3013 |
Enhanced Photodynamic Therapy by Reduced Levels of Intracellular Glutathione Obtained By Employing a Nano-MOF with Cu(II) as the Active Center.Angew Chem Int Ed Engl. 2018 Apr 23;57(18):4891-4896. doi: 10.1002/anie.201710800. Epub 2018 Mar 23.
|
3014 |
Artificial intelligence in breast imaging.Clin Radiol. 2019 May;74(5):357-366. doi: 10.1016/j.crad.2019.02.006. Epub 2019 Mar 18.
|
3015 |
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers.Breast. 2019 Oct;47:85-92. doi: 10.1016/j.breast.2019.07.001. Epub 2019 Jul 10.
|
3016 |
The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells.Mol Endocrinol. 2011 Aug;25(8):1326-36. doi: 10.1210/me.2011-0045. Epub 2011 Jun 16.
|
3017 |
Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.Cancer Res. 2019 Jan 1;79(1):86-98. doi: 10.1158/0008-5472.CAN-18-1310. Epub 2018 Nov 20.
|
3018 |
GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer.Cell Death Dis. 2019 Nov 4;10(11):832. doi: 10.1038/s41419-019-2062-7.
|
3019 |
KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer. Neoplasia. 2014 Mar;16(3):247-56, 256.e2. doi: 10.1016/j.neo.2014.03.008.
|
3020 |
Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.Med Sci Monit. 2018 Dec 29;24:9442-9464. doi: 10.12659/MSM.913401.
|
3021 |
Modulation of estrogen related receptor alpha activity by the kinesin KIF17.Oncotarget. 2017 May 23;8(31):50359-50375. doi: 10.18632/oncotarget.18104. eCollection 2017 Aug 1.
|
3022 |
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.Oncogene. 2016 Feb 25;35(8):990-1002. doi: 10.1038/onc.2015.152. Epub 2015 May 11.
|
3023 |
A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.Breast Cancer Res Treat. 2011 Aug;128(3):765-73. doi: 10.1007/s10549-011-1603-2. Epub 2011 Jun 1.
|
3024 |
Human Mitotic Centromere-Associated Kinesin Is Targeted by MicroRNA 485-5p/181c and Prognosticates Poor Survivability of Breast Cancer.J Oncol. 2019 Apr 3;2019:2316237. doi: 10.1155/2019/2316237. eCollection 2019.
|
3025 |
A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.EBioMedicine. 2019 Jul;45:92-107. doi: 10.1016/j.ebiom.2019.06.009. Epub 2019 Jun 14.
|
3026 |
Knockdown of DNA/RNA-binding protein KIN17 promotes apoptosis of triple-negative breast cancer cells.Oncol Lett. 2019 Jan;17(1):288-293. doi: 10.3892/ol.2018.9597. Epub 2018 Oct 18.
|
3027 |
The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.Cancer Immunol Res. 2015 Aug;3(8):871-80. doi: 10.1158/2326-6066.CIR-14-0199. Epub 2015 Mar 3.
|
3028 |
The Hormone KL1: A Regulator of Breast Cancer Cell Metabolism.Isr Med Assoc J. 2019 Jul;21(7):504.
|
3029 |
TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway.Mol Cell Biol. 2012 Jan;32(1):50-63. doi: 10.1128/MCB.06152-11. Epub 2011 Oct 24.
|
3030 |
microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway.J Cell Biochem. 2018 Nov;119(10):8138-8145. doi: 10.1002/jcb.26767. Epub 2018 Jun 19.
|
3031 |
KLF15 in breast cancer: a novel tumor suppressor?.Cell Oncol (Dordr). 2015 Jun;38(3):227-35. doi: 10.1007/s13402-015-0226-8. Epub 2015 Apr 14.
|
3032 |
USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.J Biol Chem. 2019 Nov 22;294(47):17837-17847. doi: 10.1074/jbc.RA119.009102. Epub 2019 Oct 17.
|
3033 |
Mutations and Krppel-like factor 6 (KLF6) expression levels in breast cancer.Tumour Biol. 2014 Jun;35(6):5219-25. doi: 10.1007/s13277-014-1678-6. Epub 2014 Feb 12.
|
3034 |
KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer.Oncogene. 2014 May 29;33(22):2909-17. doi: 10.1038/onc.2013.247. Epub 2013 Jul 1.
|
3035 |
Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.Mol Oncol. 2019 Apr;13(4):909-927. doi: 10.1002/1878-0261.12446. Epub 2019 Feb 9.
|
3036 |
KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.Nature. 2018 May;557(7706):585-589. doi: 10.1038/s41586-018-0128-9. Epub 2018 May 16.
|
3037 |
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.Breast Cancer Res Treat. 2018 Aug;170(3):525-533. doi: 10.1007/s10549-018-4777-z. Epub 2018 Apr 9.
|
3038 |
Identification of KLK10 as a therapeutic target to reverse trastuzumab resistance in breast cancer.Oncotarget. 2016 Nov 29;7(48):79494-79502. doi: 10.18632/oncotarget.13104.
|
3039 |
Human kallikrein-related peptidase 12 (KLK12) splice variants discriminate benign from cancerous breast tumors.Clin Biochem. 2018 Aug;58:78-85. doi: 10.1016/j.clinbiochem.2018.05.017. Epub 2018 May 25.
|
3040 |
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.Br J Cancer. 2002 May 6;86(9):1457-64. doi: 10.1038/sj.bjc.6600283.
|
3041 |
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.Clin Biochem. 2003 Mar;36(2):135-43. doi: 10.1016/s0009-9120(02)00446-0.
|
3042 |
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.Breast Cancer Res Treat. 2003 Mar;78(2):149-58. doi: 10.1023/a:1022931403825.
|
3043 |
Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification.PLoS One. 2016 Nov 2;11(11):e0166090. doi: 10.1371/journal.pone.0166090. eCollection 2016.
|
3044 |
Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.Dis Markers. 2016;2016:5128720. doi: 10.1155/2016/5128720. Epub 2016 Oct 25.
|
3045 |
Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer.Mol Pharm. 2017 Mar 6;14(3):593-604. doi: 10.1021/acs.molpharmaceut.6b00652. Epub 2017 Feb 16.
|
3046 |
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.Mol Oncol. 2007 Dec;1(3):321-49. doi: 10.1016/j.molonc.2007.09.004. Epub 2007 Sep 25.
|
3047 |
Downregulation of cytokeratin 18 enhances BCRP-mediated multidrug resistance through induction of epithelial-mesenchymal transition and predicts poor prognosis in breast cancer.Oncol Rep. 2019 May;41(5):3015-3026. doi: 10.3892/or.2019.7069. Epub 2019 Mar 15.
|
3048 |
Adult-onset Still's disease-like manifestation accompanied by the cancer recurrence after long-term resting state.Mod Rheumatol. 2019 Jul;29(4):704-707. doi: 10.1080/14397595.2016.1259547. Epub 2016 Dec 9.
|
3049 |
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ER breast cancer.Nat Commun. 2019 May 9;10(1):2115. doi: 10.1038/s41467-019-09676-y.
|
3050 |
Hair keratin KRT81 is expressed in normal and breast cancer cells and contributes to their invasiveness.Oncol Rep. 2017 May;37(5):2964-2970. doi: 10.3892/or.2017.5564. Epub 2017 Apr 11.
|
3051 |
Upregulation of miR-374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer.Cancer Med. 2018 Jul;7(7):3351-3362. doi: 10.1002/cam4.1576. Epub 2018 May 23.
|
3052 |
Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.Cancer. 2011 Aug 15;117(16):3670-81. doi: 10.1002/cncr.25938. Epub 2011 Feb 11.
|
3053 |
LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.Oncogene. 2020 Mar;39(11):2290-2304. doi: 10.1038/s41388-019-1146-2. Epub 2019 Dec 13.
|
3054 |
A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression.Genes Dev. 2009 Aug 1;23(15):1737-42. doi: 10.1101/gad.1809309.
|
3055 |
Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.DNA Cell Biol. 2019 Oct;38(10):1088-1099. doi: 10.1089/dna.2019.4843. Epub 2019 Aug 19.
|
3056 |
LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.Int J Cancer. 2020 Jun 1;146(11):3170-3183. doi: 10.1002/ijc.32742. Epub 2019 Nov 11.
|
3057 |
Intracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7.PLoS One. 2017 Nov 8;12(11):e0187194. doi: 10.1371/journal.pone.0187194. eCollection 2017.
|
3058 |
HSPC159 promotes proliferation and metastasis by inducing epithelial-mesenchymal transition and activating the PI3K/Akt pathway in breast cancer.Cancer Sci. 2018 Jul;109(7):2153-2163. doi: 10.1111/cas.13631. Epub 2018 Jun 9.
|
3059 |
Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays.Cancer Lett. 2001 Jul 10;168(1):93-100. doi: 10.1016/s0304-3835(01)00496-7.
|
3060 |
A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models.Sci Rep. 2017 Sep 6;7(1):10715. doi: 10.1038/s41598-017-10864-3.
|
3061 |
Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.Mol Cancer. 2008 Sep 16;7:71. doi: 10.1186/1476-4598-7-71.
|
3062 |
Identification of rare variants in the hLIMD1 gene in breast cancer.Cancer Genet Cytogenet. 2007 Oct 1;178(1):36-41. doi: 10.1016/j.cancergencyto.2007.06.007.
|
3063 |
Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.J Biol Chem. 2010 Apr 16;285(16):11786-92. doi: 10.1074/jbc.M109.086561. Epub 2010 Feb 25.
|
3064 |
Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.Oncogene. 2019 Jun;38(23):4527-4539. doi: 10.1038/s41388-019-0735-4. Epub 2019 Feb 11.
|
3065 |
LIN7A is a major determinant of cell-polarity defects in breast carcinomas.Breast Cancer Res. 2016 Feb 17;18(1):23. doi: 10.1186/s13058-016-0680-x.
|
3066 |
LIN9 confers paclitaxel resistance in triple negative breast cancer cells by upregulating CCSAP.Sci China Life Sci. 2020 Mar;63(3):419-428. doi: 10.1007/s11427-019-9581-8. Epub 2019 Aug 14.
|
3067 |
ESR1 Methylation: A Liquid Biopsy-Based Epigenetic Assay for the Follow-up of Patients with Metastatic Breast Cancer Receiving Endocrine Treatment.Clin Cancer Res. 2018 Mar 15;24(6):1500-1510. doi: 10.1158/1078-0432.CCR-17-1181. Epub 2017 Dec 28.
|
3068 |
Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo.Cancer Res. 2003 Apr 1;63(7):1657-66.
|
3069 |
Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis.J Mol Med (Berl). 2012 Jul;90(7):803-15. doi: 10.1007/s00109-011-0855-y. Epub 2012 Jan 10.
|
3070 |
LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer.Oncotarget. 2017 Feb 14;8(7):11977-11989. doi: 10.18632/oncotarget.14450.
|
3071 |
Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.Aging (Albany NY). 2019 Sep 18;11(18):7796-7804. doi: 10.18632/aging.102287. Epub 2019 Sep 18.
|
3072 |
LPIN1 promotes epithelial cell transformation and mammary tumourigenesis via enhancing insulin receptor substrate 1 stability.Carcinogenesis. 2016 Dec;37(12):1199-1209. doi: 10.1093/carcin/bgw104. Epub 2016 Oct 11.
|
3073 |
LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis.Nat Commun. 2017 Apr 24;8:15059. doi: 10.1038/ncomms15059.
|
3074 |
Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models.BMC Cancer. 2018 Dec 10;18(1):1233. doi: 10.1186/s12885-018-5109-8.
|
3075 |
LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.Mol Oncol. 2016 Oct;10(8):1363-73. doi: 10.1016/j.molonc.2016.07.004. Epub 2016 Jul 25.
|
3076 |
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.Cancer Lett. 2018 Dec 1;438:165-173. doi: 10.1016/j.canlet.2018.09.022. Epub 2018 Sep 15.
|
3077 |
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/-Catenin Signaling.Stem Cell Reports. 2018 Nov 13;11(5):1040-1050. doi: 10.1016/j.stemcr.2018.09.008. Epub 2018 Oct 18.
|
3078 |
Silencing of LRRC49 and THAP10 genes by bidirectional promoter hypermethylation is a frequent event in breast cancer.Int J Oncol. 2008 Jul;33(1):25-31.
|
3079 |
Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.Mol Cell Proteomics. 2016 Jan;15(1):109-23. doi: 10.1074/mcp.M115.050401. Epub 2015 Nov 2.
|
3080 |
Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):838-47.
|
3081 |
HMGA1a Induces Alternative Splicing of the Estrogen Receptor-lpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5' Splice Site.Front Mol Biosci. 2018 Jun 8;5:52. doi: 10.3389/fmolb.2018.00052. eCollection 2018.
|
3082 |
Genetic variants of ESR1 and SGSM3 are associated with the susceptibility of breast cancer in the Chinese population.Breast Cancer. 2017 May;24(3):369-374. doi: 10.1007/s12282-016-0712-5. Epub 2016 Jul 18.
|
3083 |
Nuclear Localized LSR: A Novel Regulator of Breast Cancer Behavior and Tumorigenesis.Mol Cancer Res. 2017 Feb;15(2):165-178. doi: 10.1158/1541-7786.MCR-16-0085-T. Epub 2016 Nov 17.
|
3084 |
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.Semin Cancer Biol. 2020 May;62:125-133. doi: 10.1016/j.semcancer.2019.08.003. Epub 2019 Aug 8.
|
3085 |
Ly6E/K Signaling to TGF Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.Cancer Res. 2016 Jun 1;76(11):3376-86. doi: 10.1158/0008-5472.CAN-15-2654. Epub 2016 Apr 11.
|
3086 |
Cause-specific mortality in women with breast cancer in situ.Int J Cancer. 2017 Jun 1;140(11):2414-2421. doi: 10.1002/ijc.30413. Epub 2016 Sep 19.
|
3087 |
microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.BMC Cancer. 2019 Jul 27;19(1):738. doi: 10.1186/s12885-019-5951-3.
|
3088 |
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.Oncotarget. 2014 Feb 28;5(4):970-7. doi: 10.18632/oncotarget.1630.
|
3089 |
Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.Medicine (Baltimore). 2016 Feb;95(6):e2801. doi: 10.1097/MD.0000000000002801.
|
3090 |
Microtubule actin cross-linking factor 1, a novel potential target in cancer.Cancer Sci. 2017 Oct;108(10):1953-1958. doi: 10.1111/cas.13344. Epub 2017 Sep 21.
|
3091 |
Correlation between expression of LRP16, Ki67 and EGFR and breast cancer clinical pathologic factors and prognosis.Eur Rev Med Pharmacol Sci. 2017 Jul;21(3 Suppl):47-51.
|
3092 |
TRAIL suppresses human breast cancer cell migration via MADD/CXCR7.Asian Pac J Cancer Prev. 2015;16(7):2751-6. doi: 10.7314/apjcp.2015.16.7.2751.
|
3093 |
Chemotherapy acutely impairs neurovascular and hemodynamic responses in women with breast cancer.Am J Physiol Heart Circ Physiol. 2019 Jul 1;317(7):H1-H12. doi: 10.1152/ajpheart.00756.2018. Epub 2019 Apr 19.
|
3094 |
Tissue-specific Co-expression of Long Non-coding and Coding RNAs Associated with Breast Cancer.Sci Rep. 2016 Sep 6;6:32731. doi: 10.1038/srep32731.
|
3095 |
Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.Genes Dev. 2014 Jun 1;28(11):1191-203. doi: 10.1101/gad.241968.114. Epub 2014 May 19.
|
3096 |
Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.Br J Cancer. 2019 Nov;121(11):944-953. doi: 10.1038/s41416-019-0607-2. Epub 2019 Oct 29.
|
3097 |
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation.Clin Cancer Res. 2010 Jan 15;16(2):681-90. doi: 10.1158/1078-0432.CCR-09-1091. Epub 2010 Jan 12.
|
3098 |
MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis.Aging (Albany NY). 2019 Nov 25;11(22):10697-10710. doi: 10.18632/aging.102485. Epub 2019 Nov 25.
|
3099 |
Pro-necrotic molecules impact local immunosurveillance in human breast cancer.Oncoimmunology. 2017 Apr 17;6(4):e1299302. doi: 10.1080/2162402X.2017.1299302. eCollection 2017.
|
3100 |
Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.Cancer Res. 2009 Dec 1;69(23):8853-61. doi: 10.1158/0008-5472.CAN-09-1636. Epub 2009 Nov 17.
|
3101 |
Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.Mol Cell Biol. 2003 Sep;23(17):5979-88. doi: 10.1128/MCB.23.17.5979-5988.2003.
|
3102 |
Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.Biomed Pharmacother. 2019 Feb;110:294-301. doi: 10.1016/j.biopha.2018.11.016. Epub 2018 Dec 3.
|
3103 |
Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis.Breast Cancer Res Treat. 2019 Feb;173(3):573-583. doi: 10.1007/s10549-018-5026-1. Epub 2018 Oct 27.
|
3104 |
Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities.Pathobiology. 2018;85(4):220-226. doi: 10.1159/000488456. Epub 2018 May 23.
|
3105 |
Identification and characterization of MARVELD1, a novel nuclear protein that is down-regulated in multiple cancers and silenced by DNA methylation.Cancer Lett. 2009 Sep 8;282(1):77-86. doi: 10.1016/j.canlet.2009.03.008. Epub 2009 Apr 11.
|
3106 |
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.Cell Death Differ. 2018 May;25(5):828-840. doi: 10.1038/s41418-017-0024-0. Epub 2017 Dec 11.
|
3107 |
Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.J Biol Chem. 2002 Sep 27;277(39):36465-70. doi: 10.1074/jbc.M206018200. Epub 2002 Jul 16.
|
3108 |
Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.Glycoconj J. 2001 Nov-Dec;18(11-12):883-93. doi: 10.1023/a:1022200525695.
|
3109 |
Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort.Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1300-1307. doi: 10.1158/1055-9965.EPI-19-0154. Epub 2019 Jun 4.
|
3110 |
Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.Cancer Med. 2018 Apr;7(4):1317-1325. doi: 10.1002/cam4.1324. Epub 2018 Feb 23.
|
3111 |
Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain).Environ Pollut. 2018 Jun;237:559-568. doi: 10.1016/j.envpol.2018.02.065. Epub 2018 Mar 15.
|
3112 |
The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration.J Biol Chem. 2009 Jun 5;284(23):15771-80. doi: 10.1074/jbc.M901853200. Epub 2009 Apr 14.
|
3113 |
Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers.Geburtshilfe Frauenheilkd. 2017 Aug;77(8):879-886. doi: 10.1055/s-0043-114427. Epub 2017 Aug 24.
|
3114 |
MCM10 facilitates the invaded/migrated potentials of breast cancer cells via Wnt/-catenin signaling and is positively interlinked with poor prognosis in breast carcinoma.J Biochem Mol Toxicol. 2019 Jul;33(7):e22330. doi: 10.1002/jbt.22330. Epub 2019 Apr 16.
|
3115 |
Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits.Nat Commun. 2018 Sep 7;9(1):3636. doi: 10.1038/s41467-018-05428-6.
|
3116 |
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A.Oncotarget. 2017 Jun 20;8(25):40434-40453. doi: 10.18632/oncotarget.17107.
|
3117 |
Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer.J Zhejiang Univ Sci B. 2019 May;20(5):381-390. doi: 10.1631/jzus.B1900163.
|
3118 |
MED12 somatic mutations encompassing exon 2 associated with benign breast fibroadenomas and not breast carcinoma in Indian women.J Cell Biochem. 2019 Jan;120(1):182-191. doi: 10.1002/jcb.27293. Epub 2018 Sep 19.
|
3119 |
Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.Genet Med. 2016 Dec;18(12):1190-1198. doi: 10.1038/gim.2016.31. Epub 2016 Apr 14.
|
3120 |
MED23 in endocrinotherapy for breast cancer.Oncol Lett. 2017 Jun;13(6):4679-4684. doi: 10.3892/ol.2017.6036. Epub 2017 Apr 13.
|
3121 |
Oxyprenylated Phenylpropanoids Bind to MT1 Melatonin Receptors and Inhibit Breast Cancer Cell Proliferation and Migration.J Nat Prod. 2017 Dec 22;80(12):3324-3329. doi: 10.1021/acs.jnatprod.7b00853. Epub 2017 Nov 16.
|
3122 |
MED28 increases the colony-forming ability of breast cancer cells by stabilizing the ZNF224 protein upon DNA damage.Oncol Lett. 2018 Mar;15(3):3147-3154. doi: 10.3892/ol.2017.7718. Epub 2017 Dec 29.
|
3123 |
The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells.Ann Diagn Pathol. 2018 Jun;34:18-26. doi: 10.1016/j.anndiagpath.2017.12.008. Epub 2017 Dec 20.
|
3124 |
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.Br J Cancer. 2018 Apr;118(8):1142-1151. doi: 10.1038/s41416-018-0041-x. Epub 2018 Mar 28.
|
3125 |
TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancer.Tumour Biol. 2009;30(4):200-9. doi: 10.1159/000239795. Epub 2009 Sep 21.
|
3126 |
Neuroendocrine Breast Carcinomas Share Prognostic Factors with Gastroenteropancreatic Neuroendocrine Tumors: A Putative Prognostic Role of Menin, p27, and SSTR-2A.Oncology. 2019;96(3):147-155. doi: 10.1159/000493348. Epub 2018 Oct 3.
|
3127 |
MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.Int J Med Sci. 2019 Jan 1;16(1):68-74. doi: 10.7150/ijms.27595. eCollection 2019.
|
3128 |
ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/-catenin signalling pathway.Cell Death Dis. 2019 Feb 20;10(3):169. doi: 10.1038/s41419-019-1335-5.
|
3129 |
N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.Gene. 2020 Jan 5;722:144076. doi: 10.1016/j.gene.2019.144076. Epub 2019 Aug 24.
|
3130 |
Detection of mammaglogin A in blood from breast cancer patients, before and after treatment, using a one-tube nested PCR protocol. Association with the absence of tumor estrogen receptors.Clin Biochem. 2011 Dec;44(17-18):1429-33. doi: 10.1016/j.clinbiochem.2011.08.1140. Epub 2011 Sep 12.
|
3131 |
Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5.Am J Cancer Res. 2019 Mar 1;9(3):585-596. eCollection 2019.
|
3132 |
Downregulation of matrix Gla protein is a biomarker for tamoxifen-resistant and radioresistant breast cancer.Biomark Med. 2019 Jul;13(10):841-850. doi: 10.2217/bmm-2019-0050. Epub 2019 Jul 18.
|
3133 |
Prognostic implication of p53 protein expression in relation to nuclear pleomorphism and the MIB-1 counts in breast cancer.Breast Cancer. 2004;11(2):160-8. doi: 10.1007/BF02968296.
|
3134 |
ZNF121 interacts with ZBRK1 and BRCA1 to regulate their target genes in mammary epithelial cells.FEBS Open Bio. 2018 Nov 8;8(12):1943-1952. doi: 10.1002/2211-5463.12530. eCollection 2018 Dec.
|
3135 |
Upregulation of MIIP regulates human breast cancer proliferation, invasion and migration by mediated by IGFBP2.Pathol Res Pract. 2019 Jul;215(7):152440. doi: 10.1016/j.prp.2019.152440. Epub 2019 May 6.
|
3136 |
MINAR1 is a Notch2-binding protein that inhibits angiogenesis and breast cancer growth.J Mol Cell Biol. 2018 Jun 1;10(3):195-204. doi: 10.1093/jmcb/mjy002.
|
3137 |
Biallelic germline nonsense variant of MLH3 underlies polyposis predisposition.Genet Med. 2019 Aug;21(8):1868-1873. doi: 10.1038/s41436-018-0405-x. Epub 2018 Dec 21.
|
3138 |
Miconazole triggers various forms of cell death in human breast cancer MDA-MB-231 cells.Pharmazie. 2019 May 1;74(5):290-294. doi: 10.1691/ph.2019.8812.
|
3139 |
Genetic polymorphisms of PPAR gamma, arsenic methylation capacity and breast cancer risk in Mexican women.Salud Publica Mex. 2016 Apr;58(2):220-7. doi: 10.21149/spm.v58i2.7791.
|
3140 |
Biochemical characterization of the cellular glycosylphosphatidylinositol-linked membrane type-6 matrix metalloproteinase.J Biol Chem. 2010 May 21;285(21):16076-86. doi: 10.1074/jbc.M110.107094. Epub 2010 Mar 22.
|
3141 |
Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.Biochem J. 2007 Apr 1;403(1):31-42. doi: 10.1042/BJ20061390.
|
3142 |
Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer.Cell Mol Biol Lett. 2019 Jun 6;24:38. doi: 10.1186/s11658-019-0162-0. eCollection 2019.
|
3143 |
On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls.Mutagenesis. 2006 Sep;21(5):313-20. doi: 10.1093/mutage/gel035. Epub 2006 Aug 22.
|
3144 |
MNX1-AS1 is a functional oncogene that induces EMT and activates the AKT/mTOR pathway and MNX1 in breast cancer.Cancer Manag Res. 2019 Jan 17;11:803-812. doi: 10.2147/CMAR.S188007. eCollection 2019.
|
3145 |
Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.Proteomics. 2010 Apr;10(7):1374-90. doi: 10.1002/pmic.200900380.
|
3146 |
Imbalancing the DNA base excision repair pathway in the mitochondria; targeting and overexpressing N-methylpurine DNA glycosylase in mitochondria leads to enhanced cell killing.Cancer Res. 2003 Feb 1;63(3):608-15.
|
3147 |
Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model.Cancer Gene Ther. 2006 Jul;13(7):706-19. doi: 10.1038/sj.cgt.7700945. Epub 2006 Mar 3.
|
3148 |
Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.J Clin Oncol. 2010 Mar 20;28(9):1450-7. doi: 10.1200/JCO.2009.23.0839. Epub 2010 Feb 22.
|
3149 |
Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818819841. doi: 10.1177/1533033818819841.
|
3150 |
Identification of URIM, a novel gene up-regulated in metastasis.Anticancer Res. 1999 Jan-Feb;19(1A):525-30.
|
3151 |
Upregulation of Mrps18a in breast cancer identified by selecting phage antibody libraries on breast tissue sections.BMC Cancer. 2017 Jan 5;17(1):19. doi: 10.1186/s12885-016-2987-5.
|
3152 |
Down-regulation of MRPS23 inhibits rat breast cancer proliferation and metastasis.Oncotarget. 2017 May 15;8(42):71772-71781. doi: 10.18632/oncotarget.17888. eCollection 2017 Sep 22.
|
3153 |
Integrative Genomic Analysis Predicts Causative Cis-Regulatory Mechanisms of the Breast Cancer-Associated Genetic Variant rs4415084.Cancer Res. 2018 Apr 1;78(7):1579-1591. doi: 10.1158/0008-5472.CAN-17-3486. Epub 2018 Jan 19.
|
3154 |
Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.BMC Cancer. 2009 Sep 25;9:344. doi: 10.1186/1471-2407-9-344.
|
3155 |
Moesin is an independent prognostic marker for ER-positive breast cancer.Oncol Lett. 2019 Feb;17(2):1921-1933. doi: 10.3892/ol.2018.9799. Epub 2018 Dec 6.
|
3156 |
A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10.
|
3157 |
Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro.Breast Cancer Res. 2010;12(4):R59. doi: 10.1186/bcr2621. Epub 2010 Aug 3.
|
3158 |
Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control. Toxicol Environ Chem. 2010 Oct;92(9):1673-1695. doi: 10.1080/02772241003711274.
|
3159 |
MicroRNA-589 serves as a tumor suppressor microRNA through directly targeting metastasis-associated protein 2 in breast cancer.Oncol Lett. 2019 Sep;18(3):2232-2239. doi: 10.3892/ol.2019.10548. Epub 2019 Jun 28.
|
3160 |
The Homeotic Protein SIX3 Suppresses Carcinogenesis and Metastasis through Recruiting the LSD1/NuRD(MTA3) Complex.Theranostics. 2018 Jan 1;8(4):972-989. doi: 10.7150/thno.22328. eCollection 2018.
|
3161 |
Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells.Aging (Albany NY). 2019 Nov 18;11(22):10203-10219. doi: 10.18632/aging.102442. Epub 2019 Nov 18.
|
3162 |
The effect of folate-related SNPs on clinicopathological features, response to neoadjuvant treatment and survival in pre- and postmenopausal breast cancer patients.Gene. 2013 Apr 15;518(2):397-404. doi: 10.1016/j.gene.2012.12.095. Epub 2013 Jan 4.
|
3163 |
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.Nat Commun. 2014;5:3128. doi: 10.1038/ncomms4128.
|
3164 |
MTMR3 is upregulated in patients with breast cancer and regulates proliferation, cell cycle progression and autophagy in breast cancer cells.Oncol Rep. 2019 Nov;42(5):1915-1923. doi: 10.3892/or.2019.7292. Epub 2019 Aug 23.
|
3165 |
9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models.Exp Cell Res. 2017 May 1;354(1):25-30. doi: 10.1016/j.yexcr.2017.03.022. Epub 2017 Mar 12.
|
3166 |
MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.Cell Death Dis. 2018 Mar 1;9(3):344. doi: 10.1038/s41419-018-0364-9.
|
3167 |
Downregulation of hsa_circ_0007534 suppresses breast cancer cell proliferation and invasion by targeting miR-593/MUC19 signal pathway.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2603-2610. doi: 10.1016/j.bbrc.2018.08.007. Epub 2018 Aug 20.
|
3168 |
MUC5B silencing reduces chemo-resistance of MCF-7 breast tumor cells and impairs maturation of dendritic cells.Int J Oncol. 2016 May;48(5):2113-23. doi: 10.3892/ijo.2016.3434. Epub 2016 Mar 10.
|
3169 |
Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.J Histochem Cytochem. 2006 Mar;54(3):289-99. doi: 10.1369/jhc.5A6763.2005. Epub 2005 Sep 7.
|
3170 |
HER2 drives Mucin-like 1 to control proliferation in breast cancer cells.Oncogene. 2016 Aug 11;35(32):4225-34. doi: 10.1038/onc.2015.487. Epub 2016 Jan 4.
|
3171 |
Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.Breast Cancer Res Treat. 2010 May;121(1):147-56. doi: 10.1007/s10549-009-0518-7. Epub 2009 Aug 28.
|
3172 |
Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein(MVP).Breast Cancer Res. 2019 Jan 17;21(1):7. doi: 10.1186/s13058-018-1088-6.
|
3173 |
MYBL2 Is Targeted by miR-143-3p and Regulates Breast Cancer Cell Proliferation and Apoptosis.Oncol Res. 2018 Jul 5;26(6):913-922. doi: 10.3727/096504017X15135941182107. Epub 2017 Dec 21.
|
3174 |
IL-25 blockade inhibits metastasis in breast cancer.Protein Cell. 2017 Mar;8(3):191-201. doi: 10.1007/s13238-016-0345-7. Epub 2016 Dec 1.
|
3175 |
MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.Int J Cancer. 2002 Dec 20;102(6):608-14. doi: 10.1002/ijc.10765.
|
3176 |
Somatic mutation analysis of MYH11 in breast and prostate cancer.BMC Cancer. 2008 Sep 17;8:263. doi: 10.1186/1471-2407-8-263.
|
3177 |
MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.Oncol Rep. 2016 Feb;35(2):709-16. doi: 10.3892/or.2015.4411. Epub 2015 Nov 12.
|
3178 |
Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network.J Exp Clin Cancer Res. 2019 Nov 7;38(1):457. doi: 10.1186/s13046-019-1449-8.
|
3179 |
Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression.Biochim Biophys Acta Gene Regul Mech. 2018 Nov;1861(11):983-995. doi: 10.1016/j.bbagrm.2018.10.005. Epub 2018 Oct 10.
|
3180 |
Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion.Oncogene. 2019 Apr;38(17):3170-3184. doi: 10.1038/s41388-018-0653-x. Epub 2019 Jan 8.
|
3181 |
ARD1 contributes to IKK-mediated breast cancer tumorigenesis.Cell Death Dis. 2018 Aug 28;9(9):860. doi: 10.1038/s41419-018-0921-2.
|
3182 |
Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration.Mol Med Rep. 2019 Aug;20(2):1943-1951. doi: 10.3892/mmr.2019.10385. Epub 2019 Jun 13.
|
3183 |
E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasion.Cancer Res. 2006 Oct 15;66(20):10007-15. doi: 10.1158/0008-5472.CAN-05-3096.
|
3184 |
Evaluation of a New Hydroxyapatite Nanoparticle as a Drug Delivery System to Oral Squamous Cell Carcinoma Cells.Anticancer Res. 2018 Dec;38(12):6715-6720. doi: 10.21873/anticanres.13040.
|
3185 |
Estrogen and progesterone receptor status affect genome-wide DNA methylation profile in breast cancer.Hum Mol Genet. 2010 Nov 1;19(21):4273-7. doi: 10.1093/hmg/ddq351. Epub 2010 Aug 19.
|
3186 |
Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients.Clin Chim Acta. 2018 Sep;484:81-86. doi: 10.1016/j.cca.2018.05.030. Epub 2018 May 15.
|
3187 |
Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells.Folia Biol (Praha). 2001;47(4):120-7.
|
3188 |
Neural cell adhesion molecule 2 as a target molecule for prostate and breast cancer gene therapy.Cancer Sci. 2011 Apr;102(4):808-14. doi: 10.1111/j.1349-7006.2011.01855.x. Epub 2011 Feb 25.
|
3189 |
Re-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.Oncotarget. 2017 Apr 4;8(14):23727-23749. doi: 10.18632/oncotarget.15829.
|
3190 |
Arpin downregulation in breast cancer is associated with poor prognosis.Br J Cancer. 2016 Mar 1;114(5):545-53. doi: 10.1038/bjc.2016.18. Epub 2016 Feb 11.
|
3191 |
Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.Biochem Cell Biol. 2019 Aug;97(4):488-496. doi: 10.1139/bcb-2018-0114. Epub 2018 Dec 11.
|
3192 |
NCOA5 is correlated with progression and prognosis in luminal breast cancer.Biochem Biophys Res Commun. 2017 Jan 8;482(2):253-256. doi: 10.1016/j.bbrc.2016.11.051. Epub 2016 Nov 12.
|
3193 |
A Bi-Functional Targeted P28-NRC Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer Cell Lines.Iran J Pharm Res. 2019 Spring;18(2):735-744. doi: 10.22037/ijpr.2019.2392.
|
3194 |
A multistage association study identifies a breast cancer genetic locus at NCOA7.Cancer Res. 2011 Jun 1;71(11):3881-8. doi: 10.1158/0008-5472.CAN-10-2653. Epub 2011 May 24.
|
3195 |
The nuclear corepressor 1 and the thyroid hormone receptor suppress breast tumor lymphangiogenesis.Oncotarget. 2016 Nov 29;7(48):78971-78984. doi: 10.18632/oncotarget.12978.
|
3196 |
BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer.Clin Cancer Res. 2018 Aug 1;24(15):3681-3691. doi: 10.1158/1078-0432.CCR-17-2259. Epub 2018 Feb 2.
|
3197 |
Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells.Sci Rep. 2017 Feb 1;7:41381. doi: 10.1038/srep41381.
|
3198 |
Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.Breast Cancer Res. 2014 Jun 11;16(3):R62. doi: 10.1186/bcr3675.
|
3199 |
The variation of mitochondrial NADH dehydrogenase subunit 4 (mtND4) and molecular dynamics simulation of SNPs among Iranian women with breast cancer.J Mol Graph Model. 2018 Oct;85:242-249. doi: 10.1016/j.jmgm.2018.08.011. Epub 2018 Sep 4.
|
3200 |
Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease.J Cancer Res Clin Oncol. 2011 Apr;137(4):669-75. doi: 10.1007/s00432-010-0912-x. Epub 2010 Jun 16.
|
3201 |
NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: an immunohistochemical study.J Pathol. 1994 Jan;172(1):27-34. doi: 10.1002/path.1711720107.
|
3202 |
NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer.Oncotarget. 2017 Apr 25;8(17):29038-29047. doi: 10.18632/oncotarget.16035.
|
3203 |
Clinical significance of NDRG3 in patients with breast cancer.Future Oncol. 2017 May;13(11):961-969. doi: 10.2217/fon-2016-0457. Epub 2017 Feb 27.
|
3204 |
Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women.BMC Cancer. 2009 Apr 24;9:122. doi: 10.1186/1471-2407-9-122.
|
3205 |
Does Proton Conduction in the Voltage-Gated H(+) Channel hHv1 Involve Grotthuss-Like Hopping via Acidic Residues?.J Phys Chem B. 2017 Apr 20;121(15):3340-3351. doi: 10.1021/acs.jpcb.6b08339. Epub 2016 Nov 18.
|
3206 |
Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers.Mol Cancer. 2013 Jun 12;12:60. doi: 10.1186/1476-4598-12-60.
|
3207 |
The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L.Oncogene. 2018 Jul;37(28):3879-3893. doi: 10.1038/s41388-018-0239-7. Epub 2018 Apr 17.
|
3208 |
Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development.Sci Rep. 2018 Feb 9;8(1):2731. doi: 10.1038/s41598-018-21044-2.
|
3209 |
NEMP1 Promotes Tamoxifen Resistance in Breast Cancer Cells.Biochem Genet. 2019 Dec;57(6):813-826. doi: 10.1007/s10528-019-09926-0. Epub 2019 May 11.
|
3210 |
ZEB1 confers stem cell-like properties in breast cancer by targeting neurogenin-3.Oncotarget. 2017 Apr 13;8(33):54388-54401. doi: 10.18632/oncotarget.17077. eCollection 2017 Aug 15.
|
3211 |
Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.Breast Cancer Res. 2014 Oct 14;16(5):454. doi: 10.1186/s13058-014-0454-2.
|
3212 |
Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic Factors.Cancer Invest. 2017 Jul 3;35(6):403-413. doi: 10.1080/07357907.2017.1309548. Epub 2017 May 2.
|
3213 |
NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.Oncogene. 2010 Apr 15;29(15):2292-301. doi: 10.1038/onc.2009.499. Epub 2010 Jan 25.
|
3214 |
A regulation loop between Nrf1 and MRTF-A controls migration and invasion in MDA-MB-231 breast cancer cells.Int J Mol Med. 2018 Nov;42(5):2459-2468. doi: 10.3892/ijmm.2018.3816. Epub 2018 Aug 9.
|
3215 |
NRF3 suppresses breast cancer cell metastasis and cell proliferation and is a favorable predictor of survival in breast cancer.Onco Targets Ther. 2019 Apr 18;12:3019-3030. doi: 10.2147/OTT.S197409. eCollection 2019.
|
3216 |
ER Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.Cancer Res. 2018 Jan 15;78(2):410-421. doi: 10.1158/0008-5472.CAN-17-1153. Epub 2017 Nov 27.
|
3217 |
Overexpression and alternative splicing of NF-YA in breast cancer.Sci Rep. 2019 Sep 10;9(1):12955. doi: 10.1038/s41598-019-49297-5.
|
3218 |
Can mammogram readers swiftly and effectively learn to interpret first post-contrast acquisition subtracted (FAST) MRI, a type of abbreviated breast MRI?: a single centre data-interpretation study.Br J Radiol. 2019 Dec;92(1104):20190663. doi: 10.1259/bjr.20190663. Epub 2019 Oct 3.
|
3219 |
FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.EBioMedicine. 2019 Jul;45:25-38. doi: 10.1016/j.ebiom.2019.06.022. Epub 2019 Jun 28.
|
3220 |
Genome-wide association study of germline variants and breast cancer-specific mortality.Br J Cancer. 2019 Mar;120(6):647-657. doi: 10.1038/s41416-019-0393-x. Epub 2019 Feb 21.
|
3221 |
Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines.Med Sci Monit. 2017 Oct 7;23:4817-4825. doi: 10.12659/msm.906583.
|
3222 |
NKAP functions as an oncogene and its expression is induced by CoCl(2) treatment in breast cancer via AKT/mTOR signaling pathway.Cancer Manag Res. 2018 Oct 29;10:5091-5100. doi: 10.2147/CMAR.S178919. eCollection 2018.
|
3223 |
Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas.Diagn Pathol. 2013 May 15;8:80. doi: 10.1186/1746-1596-8-80.
|
3224 |
Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.PLoS One. 2017 Dec 15;12(12):e0189662. doi: 10.1371/journal.pone.0189662. eCollection 2017.
|
3225 |
Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.Clin Cancer Res. 1999 Apr;5(4):883-9.
|
3226 |
Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1.PLoS One. 2013 Dec 9;8(12):e82868. doi: 10.1371/journal.pone.0082868. eCollection 2013.
|
3227 |
Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.Cancer Res. 1997 Mar 15;57(6):1180-7.
|
3228 |
Cellular redox sensor HSCARG negatively regulates the translesion synthesis pathway and exacerbates mammary tumorigenesis.Proc Natl Acad Sci U S A. 2019 Dec 17;116(51):25624-25633. doi: 10.1073/pnas.1910250116. Epub 2019 Dec 3.
|
3229 |
Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: A case report.Medicine (Baltimore). 2018 Sep;97(36):e11878. doi: 10.1097/MD.0000000000011878.
|
3230 |
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone.J Immunol Res. 2019 May 9;2019:4260987. doi: 10.1155/2019/4260987. eCollection 2019.
|
3231 |
LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.Life Sci. 2012 Sep 24;91(9-10):358-63. doi: 10.1016/j.lfs.2012.08.005. Epub 2012 Aug 11.
|
3232 |
Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker.Clin Exp Med. 2019 Aug;19(3):377-384. doi: 10.1007/s10238-019-00554-x. Epub 2019 Apr 20.
|
3233 |
Expression of Rb2/p130 in breast and endometrial cancer: correlations with hormone receptor status.Br J Cancer. 2001 Aug 17;85(4):546-51. doi: 10.1054/bjoc.2001.1923.
|
3234 |
TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5293-5300. doi: 10.26355/eurrev_201906_18196.
|
3235 |
High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.J Genet Couns. 2016 Jun;25(3):504-14. doi: 10.1007/s10897-015-9899-4. Epub 2015 Nov 4.
|
3236 |
Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.Oxid Med Cell Longev. 2019 Mar 24;2019:9296439. doi: 10.1155/2019/9296439. eCollection 2019.
|
3237 |
Growth of Triple Negative and Progesterone Positive Breast Cancer Causes Oxidative Stress and Down-Regulates Neuroprotective Transcription Factor NPAS4 and NPAS4-Regulated Genes in Hippocampal Tissues of TumorGraft Mice-an Aging Connection.Front Genet. 2018 Mar 5;9:58. doi: 10.3389/fgene.2018.00058. eCollection 2018.
|
3238 |
Are self-reported unhealthy food choices associated with an increased risk of breast cancer? Prospective cohort study using the British Food Standards Agency nutrient profiling system.BMJ Open. 2017 Jun 8;7(6):e013718. doi: 10.1136/bmjopen-2016-013718.
|
3239 |
The Neuroplastin adhesion molecules: key regulators of neuronal plasticity and synaptic function.J Neurochem. 2014 Nov;131(3):268-83. doi: 10.1111/jnc.12816. Epub 2014 Aug 14.
|
3240 |
Mechanism of the high coagulation state of breast cancer tissue factor.Eur Rev Med Pharmacol Sci. 2017 May;21(9):2167-2171.
|
3241 |
The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.Biomarkers. 2016;21(4):363-70. doi: 10.3109/1354750X.2016.1141989. Epub 2016 Feb 22.
|
3242 |
NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients.Breast Cancer Res. 2018 Oct 16;20(1):120. doi: 10.1186/s13058-018-1049-0.
|
3243 |
High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF--dependent epithelial-mesenchymal transition in breast cancer.Breast Cancer Res Treat. 2014 Sep;147(2):265-81. doi: 10.1007/s10549-014-3095-3. Epub 2014 Aug 17.
|
3244 |
NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.Int J Mol Sci. 2016 Oct 20;17(10):1694. doi: 10.3390/ijms17101694.
|
3245 |
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression.Am J Hum Genet. 2015 Jul 2;97(1):22-34. doi: 10.1016/j.ajhg.2015.05.002. Epub 2015 Jun 11.
|
3246 |
Genetic variation in the genome-wide predicted estrogen response element-related sequences is associated with breast cancer development.Breast Cancer Res. 2011 Jan 31;13(1):R13. doi: 10.1186/bcr2821.
|
3247 |
Elevated NRD1 metalloprotease expression plays a role in breast cancer growth and proliferation.Genes Chromosomes Cancer. 2011 Oct;50(10):837-47. doi: 10.1002/gcc.20905. Epub 2011 Jul 18.
|
3248 |
The role of NRG3 in mammary development.J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):195-203. doi: 10.1007/s10911-008-9082-8. Epub 2008 Apr 17.
|
3249 |
Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes.Cancer Lett. 2016 Aug 10;378(2):69-79. doi: 10.1016/j.canlet.2016.05.004. Epub 2016 May 6.
|
3250 |
A ROR1-HER3-lncRNA signalling axis modulates the Hippo-YAP pathway to regulate bone metastasis.Nat Cell Biol. 2017 Feb;19(2):106-119. doi: 10.1038/ncb3464. Epub 2017 Jan 23.
|
3251 |
Labdane diterpenoids from Curcuma amada rhizomes collected in Myanmar and their antiproliferative activities.Fitoterapia. 2017 Oct;122:34-39. doi: 10.1016/j.fitote.2017.08.006. Epub 2017 Aug 18.
|
3252 |
Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.Protein Sci. 2017 Aug;26(8):1639-1652. doi: 10.1002/pro.3202. Epub 2017 Jun 11.
|
3253 |
Biological characterisation and application of human MTH1 and monoclonal antibody preparation.Oncol Rep. 2019 Mar;41(3):1851-1862. doi: 10.3892/or.2018.6942. Epub 2018 Dec 19.
|
3254 |
Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation. Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505.
|
3255 |
Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.Cancers (Basel). 2019 Sep 10;11(9):1337. doi: 10.3390/cancers11091337.
|
3256 |
Comprehensive analysis of NuMA variation in breast cancer.BMC Cancer. 2008 Mar 10;8:71. doi: 10.1186/1471-2407-8-71.
|
3257 |
Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells.Int J Mol Sci. 2018 May 9;19(5):1423. doi: 10.3390/ijms19051423.
|
3258 |
High NUP43 expression might independently predict poor overall survival in luminal A and in HER2+ breast cancer.Future Oncol. 2018 Jun;14(15):1431-1442. doi: 10.2217/fon-2017-0690. Epub 2018 Feb 6.
|
3259 |
Nup88 mRNA overexpression is associated with high aggressiveness of breast cancer.Int J Cancer. 2004 May 1;109(5):717-20. doi: 10.1002/ijc.20034.
|
3260 |
NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer.BMC Cancer. 2019 Apr 2;19(1):236. doi: 10.1186/s12885-019-5407-9.
|
3261 |
Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.Int J Cancer. 2005 Dec 10;117(5):730-7. doi: 10.1002/ijc.21221.
|
3262 |
Effects of decitabine on the expression of selected endogenous control genes in human breast cancer cells.Mol Cell Probes. 2010 Apr;24(2):87-92. doi: 10.1016/j.mcp.2009.10.007. Epub 2009 Oct 22.
|
3263 |
OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.Gene. 2018 Apr 20;651:161-165. doi: 10.1016/j.gene.2018.01.100. Epub 2018 Feb 2.
|
3264 |
Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells.Oncotarget. 2018 Jul 20;9(56):30821-30836. doi: 10.18632/oncotarget.25738. eCollection 2018 Jul 20.
|
3265 |
Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women.Int J Cancer. 2020 Apr 15;146(8):2175-2181. doi: 10.1002/ijc.32825. Epub 2019 Dec 27.
|
3266 |
Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway.Onco Targets Ther. 2019 Dec 4;12:10639-10650. doi: 10.2147/OTT.S222967. eCollection 2019.
|
3267 |
Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.Cancer Sci. 2019 Jan;110(1):289-302. doi: 10.1111/cas.13879. Epub 2018 Dec 13.
|
3268 |
Depletion of mitochondrial protease OMA1 alters proliferative properties and promotes metastatic growth of breast cancer cells.Sci Rep. 2019 Oct 14;9(1):14746. doi: 10.1038/s41598-019-49327-2.
|
3269 |
The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.Mol Cancer Ther. 2017 Oct;16(10):2246-2256. doi: 10.1158/1535-7163.MCT-17-0081. Epub 2017 Aug 3.
|
3270 |
Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):675-82. doi: 10.1158/1055-9965.EPI-05-0679.
|
3271 |
pH protective Y(1) receptor ligand functionalized antiphagocytosis BPLP-WPU micelles for enhanced tumor imaging and therapy with prolonged survival time.Biomaterials. 2018 Jul;170:70-81. doi: 10.1016/j.biomaterials.2018.04.002. Epub 2018 Apr 4.
|
3272 |
Haptoglobin polymorphism in breast cancer patients form Jordan.Clin Chim Acta. 2004 Mar;341(1-2):17-21. doi: 10.1016/j.cccn.2003.10.032.
|
3273 |
The Olfactory Receptor Family 2, Subfamily T, Member 6 (OR2T6) Is Involved in Breast Cancer Progression via Initiating Epithelial-Mesenchymal Transition and MAPK/ERK Pathway.Front Oncol. 2019 Nov 11;9:1210. doi: 10.3389/fonc.2019.01210. eCollection 2019.
|
3274 |
Early induction of the orphan nuclear receptor NOR-1 during cell death of the human breast cancer cell line MCF-7.Mol Cell Endocrinol. 2000 Apr 25;162(1-2):151-6. doi: 10.1016/s0303-7207(00)00222-7.
|
3275 |
Docosahexaenoic acid increases the expression of oxidative stress-induced growth inhibitor 1 through the PI3K/Akt/Nrf2 signaling pathway in breast cancer cells. Food Chem Toxicol. 2017 Oct;108(Pt A):276-288. doi: 10.1016/j.fct.2017.08.010. Epub 2017 Aug 12.
|
3276 |
OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.Oncogene. 2016 Mar 17;35(11):1433-44. doi: 10.1038/onc.2015.208. Epub 2015 Jul 6.
|
3277 |
Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7.Nat Commun. 2017 Dec 13;8(1):2116. doi: 10.1038/s41467-017-02029-7.
|
3278 |
The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.Nat Commun. 2019 Jul 2;10(1):2914. doi: 10.1038/s41467-019-10824-7.
|
3279 |
Applicability of HIN-1, MGMT and RASSF1A promoter methylation as biomarkers for detecting field cancerization in breast cancer.Breast Cancer Res. 2015 Sep 14;17(1):125. doi: 10.1186/s13058-015-0637-5.
|
3280 |
OTX1 expression in breast cancer is regulated by p53.Oncogene. 2011 Jul 7;30(27):3096-103. doi: 10.1038/onc.2011.31. Epub 2011 Apr 11.
|
3281 |
Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.Int J Oncol. 2012 Aug;41(2):629-38. doi: 10.3892/ijo.2012.1464. Epub 2012 May 8.
|
3282 |
LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21.Cancer Manag Res. 2018 Aug 1;10:2389-2400. doi: 10.2147/CMAR.S162887. eCollection 2018.
|
3283 |
Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21.Genomics. 1999 Jul 1;59(1):59-65. doi: 10.1006/geno.1999.5851.
|
3284 |
Anticancer Activity and Cisplatin Binding Ability of Bis-Quinoline and Bis-Isoquinoline Derived [Pd(2)L(4)](4+) Metallosupramolecular Cages.Front Chem. 2018 Nov 22;6:563. doi: 10.3389/fchem.2018.00563. eCollection 2018.
|
3285 |
PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.PLoS One. 2013 Nov 18;8(11):e80552. doi: 10.1371/journal.pone.0080552. eCollection 2013.
|
3286 |
Systematic functional perturbations uncover a prognostic genetic network driving human breast cancer.Oncotarget. 2017 Mar 15;8(13):20572-20587. doi: 10.18632/oncotarget.16244.
|
3287 |
Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins.Prostate. 2008 Oct 1;68(14):1510-6. doi: 10.1002/pros.20787.
|
3288 |
Akt isoform-specific signaling in breast cancer: uncovering an anti-migratory role for palladin.Cell Adh Migr. 2011 May-Jun;5(3):211-4. doi: 10.4161/cam.5.3.15790. Epub 2011 May 1.
|
3289 |
USP52 acts as a deubiquitinase and promotes histone chaperone ASF1A stabilization.Nat Commun. 2018 Mar 29;9(1):1285. doi: 10.1038/s41467-018-03588-z.
|
3290 |
Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines.Cancers (Basel). 2019 Dec 7;11(12):1967. doi: 10.3390/cancers11121967.
|
3291 |
Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions.J Cell Biochem. 1995 Apr;57(4):680-90. doi: 10.1002/jcb.240570413.
|
3292 |
Collagen and PAPP-A in the Etiology of Postpartum Breast Cancer.Horm Cancer. 2019 Dec;10(4-6):137-144. doi: 10.1007/s12672-019-00368-z. Epub 2019 Oct 20.
|
3293 |
PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer.Onco Targets Ther. 2019 May 13;12:3625-3633. doi: 10.2147/OTT.S181432. eCollection 2019.
|
3294 |
Pharmacological Inhibition of PARP6 Triggers Multipolar Spindle Formation and Elicits Therapeutic Effects in Breast Cancer.Cancer Res. 2018 Dec 1;78(23):6691-6702. doi: 10.1158/0008-5472.CAN-18-1362. Epub 2018 Oct 8.
|
3295 |
PARP9 is overexpressed in human breast cancer and promotes cancer cell migration.Oncol Lett. 2018 Sep;16(3):4073-4077. doi: 10.3892/ol.2018.9124. Epub 2018 Jul 11.
|
3296 |
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100. Br J Cancer. 2014 Sep 9;111(6):1241-8. doi: 10.1038/bjc.2014.430. Epub 2014 Aug 12.
|
3297 |
PAX2 expression is correlated with better survival in tamoxifen-treated breast carcinoma patients.Tissue Cell. 2018 Jun;52:135-142. doi: 10.1016/j.tice.2018.05.005. Epub 2018 May 9.
|
3298 |
Unexpected PAX8 Immunoreactivity in Metastatic High-grade Breast Cancer.Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):637-643. doi: 10.1097/PAI.0000000000000707.
|
3299 |
PBOV1 is a human de novo gene with tumor-specific expression that is associated with a positive clinical outcome of cancer.PLoS One. 2013;8(2):e56162. doi: 10.1371/journal.pone.0056162. Epub 2013 Feb 13.
|
3300 |
uc.38 induces breast cancer cell apoptosis via PBX1.Am J Cancer Res. 2017 Dec 1;7(12):2438-2451. eCollection 2017.
|
3301 |
Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal adhesion dynamics.Oncogene. 2015 Aug 27;34(35):4601-12. doi: 10.1038/onc.2014.389. Epub 2014 Dec 8.
|
3302 |
Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.Gene. 2018 Jun 5;658:28-35. doi: 10.1016/j.gene.2018.03.011. Epub 2018 Mar 5.
|
3303 |
Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer.Oncol Lett. 2018 Oct;16(4):4462-4470. doi: 10.3892/ol.2018.9214. Epub 2018 Jul 25.
|
3304 |
Protocadherin 17 functions as a tumor suppressor suppressing Wnt/-catenin signaling and cell metastasis and is frequently methylated in breast cancer.Oncotarget. 2016 Aug 9;7(32):51720-51732. doi: 10.18632/oncotarget.10102.
|
3305 |
Frequent silencing of protocadherin 8 by promoter methylation, a candidate tumor suppressor for human gastric cancer.Oncol Rep. 2012 Nov;28(5):1785-91. doi: 10.3892/or.2012.1997. Epub 2012 Aug 30.
|
3306 |
Role of MEL-18 Amplification in Anti-HER2 Therapy of Breast Cancer.J Natl Cancer Inst. 2019 Jun 1;111(6):609-619. doi: 10.1093/jnci/djy151.
|
3307 |
TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.PLoS Biol. 2018 Nov 8;16(11):e3000051. doi: 10.1371/journal.pbio.3000051. eCollection 2018 Nov.
|
3308 |
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.Cell Rep. 2018 Jul 17;24(3):630-641. doi: 10.1016/j.celrep.2018.06.066.
|
3309 |
Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.Mol Cancer. 2018 Jul 16;17(1):100. doi: 10.1186/s12943-018-0851-8.
|
3310 |
Downregulation of ER60 protease inhibits cellular proliferation by inducing G1/S arrest in breast cancer cells in vitro.Anat Rec (Hoboken). 2012 Mar;295(3):410-6. doi: 10.1002/ar.22413. Epub 2012 Jan 20.
|
3311 |
In vivo selection for metastasis promoting genes in the mouse.Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6696-701. doi: 10.1073/pnas.0701145104. Epub 2007 Apr 9.
|
3312 |
Silencing of casein kinase 2 inhibits PKCinduced cell invasion by targeting MMP? in MCF? cells.Mol Med Rep. 2018 Jun;17(6):8397-8402. doi: 10.3892/mmr.2018.8885. Epub 2018 Apr 13.
|
3313 |
Targeting PDK4 inhibits breast cancer metabolism.Am J Cancer Res. 2018 Sep 1;8(9):1725-1738. eCollection 2018.
|
3314 |
Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast Carcinomas.Anticancer Res. 2018 Apr;38(4):1957-1965. doi: 10.21873/anticanres.12433.
|
3315 |
SCC-112, a novel cell cycle-regulated molecule, exhibits reduced expression in human renal carcinomas.Gene. 2004 Mar 17;328:187-96. doi: 10.1016/j.gene.2003.12.013.
|
3316 |
DHPS-dependent hypusination of eIF5A1/2 is necessary for TGF/fibronectin-induced breast cancer metastasis and associates with prognostically unfavorable genomic alterations in TP53.Biochem Biophys Res Commun. 2019 Nov 19;519(4):838-845. doi: 10.1016/j.bbrc.2019.09.075. Epub 2019 Sep 24.
|
3317 |
The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes.Cancer Res Treat. 2019 Apr;51(2):706-717. doi: 10.4143/crt.2018.316. Epub 2018 Aug 23.
|
3318 |
Analyses of BMAL1 and PER2 Oscillations in a Model of Breast Cancer Progression Reveal Changes With Malignancy.Integr Cancer Ther. 2019 Jan-Dec;18:1534735419836494. doi: 10.1177/1534735419836494.
|
3319 |
PES1 In Liver Cancer: A Prognostic Biomarker With Tumorigenic Roles.Cancer Manag Res. 2019 Nov 14;11:9641-9653. doi: 10.2147/CMAR.S226471. eCollection 2019.
|
3320 |
Abnormal expression of PFDN4 in colorectal cancer: a novel marker for prognosis.Ann Surg Oncol. 2010 Nov;17(11):3030-6. doi: 10.1245/s10434-010-1138-5. Epub 2010 Jun 15.
|
3321 |
High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer.Cancer Cell Int. 2019 Jun 18;19:165. doi: 10.1186/s12935-019-0882-2. eCollection 2019.
|
3322 |
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age.Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):658-69. doi: 10.1158/1055-9965.EPI-13-0340. Epub 2014 Feb 3.
|
3323 |
Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells.Mol Genet Metab. 2010 Aug;100(4):372-8. doi: 10.1016/j.ymgme.2010.04.006. Epub 2010 Apr 18.
|
3324 |
Tocotrienols Modulate Breast Cancer Secretomes and Affect Cancer-Signaling Pathways in MDA-MB-231 Cells: A Label-Free Quantitative Proteomic Analysis.Nutr Cancer. 2019;71(8):1263-1271. doi: 10.1080/01635581.2019.1607407. Epub 2019 May 14.
|
3325 |
Long noncoding RNA FOXD2AS1/miR?50?p/PFN2 axis regulates breast cancer malignancy and tumorigenesis.Int J Oncol. 2019 Mar;54(3):1043-1052. doi: 10.3892/ijo.2019.4671. Epub 2019 Jan 3.
|
3326 |
The diagnostic value and functional roles of phosphoglycerate mutase 1 in glioma.Oncol Rep. 2016 Oct;36(4):2236-44. doi: 10.3892/or.2016.5046. Epub 2016 Aug 25.
|
3327 |
PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1-Mediated Epithelial-Mesenchymal Transition Process in Breast Cancer.Cell Physiol Biochem. 2018;51(5):2434-2444. doi: 10.1159/000495900. Epub 2018 Dec 11.
|
3328 |
Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.Mol Cancer. 2008 Nov 6;7:84. doi: 10.1186/1476-4598-7-84.
|
3329 |
An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer.Mol Oncol. 2016 Feb;10(2):292-302. doi: 10.1016/j.molonc.2015.10.013. Epub 2015 Oct 28.
|
3330 |
PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing.Cancer Med. 2019 May;8(5):2429-2441. doi: 10.1002/cam4.2115. Epub 2019 Apr 1.
|
3331 |
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.Cell Rep. 2018 Feb 27;22(9):2469-2481. doi: 10.1016/j.celrep.2018.02.028.
|
3332 |
CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial-Mesenchymal Plasticity in Breast Cancer.Cancer Res. 2019 Jan 1;79(1):47-60. doi: 10.1158/0008-5472.CAN-18-1742. Epub 2018 Nov 1.
|
3333 |
B-CAN: a resource sharing platform to improve the operation, visualization and integrated analysis of TCGA breast cancer data.Oncotarget. 2017 Oct 19;8(65):108778-108785. doi: 10.18632/oncotarget.21947. eCollection 2017 Dec 12.
|
3334 |
Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients.Cancer Sci. 2013 Feb;104(2):194-9. doi: 10.1111/cas.12052. Epub 2012 Dec 13.
|
3335 |
The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.Oncogene. 2015 Jul;34(27):3556-67. doi: 10.1038/onc.2014.284. Epub 2014 Sep 8.
|
3336 |
Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.PLoS One. 2017 May 11;12(5):e0177639. doi: 10.1371/journal.pone.0177639. eCollection 2017.
|
3337 |
Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.Sci Rep. 2015 Feb 10;5:8364. doi: 10.1038/srep08364.
|
3338 |
Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.Aging (Albany NY). 2019 May 6;11(9):2628-2652. doi: 10.18632/aging.101934.
|
3339 |
Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.Cancer Res. 2006 Oct 15;66(20):9829-36. doi: 10.1158/0008-5472.CAN-06-0506.
|
3340 |
Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors.Int J Oncol. 2016 Sep;49(3):868-76. doi: 10.3892/ijo.2016.3607. Epub 2016 Jul 6.
|
3341 |
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2 Scaffolding Function.Cancer Cell. 2017 Oct 9;32(4):444-459.e7. doi: 10.1016/j.ccell.2017.09.002.
|
3342 |
Class II phosphoinositide 3-kinase C2 regulates a novel signaling pathway involved in breast cancer progression.Oncotarget. 2016 Apr 5;7(14):18325-45. doi: 10.18632/oncotarget.7761.
|
3343 |
Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib.Cancer Lett. 2018 Oct 28;435:32-43. doi: 10.1016/j.canlet.2018.07.028. Epub 2018 Jul 25.
|
3344 |
HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical -catenin signaling.Oncotarget. 2017 Jul 22;8(35):58918-58933. doi: 10.18632/oncotarget.19441. eCollection 2017 Aug 29.
|
3345 |
Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells.Biochem Biophys Res Commun. 2019 May 28;513(2):472-478. doi: 10.1016/j.bbrc.2019.03.207. Epub 2019 Apr 9.
|
3346 |
Parkinson's disease genes do not segregate with breast cancer genes' loci.Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1464-72. doi: 10.1158/1055-9965.EPI-13-0472. Epub 2013 Jun 13.
|
3347 |
The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast.Oncotarget. 2018 Nov 20;9(91):36358-36370. doi: 10.18632/oncotarget.26357. eCollection 2018 Nov 20.
|
3348 |
Correction: A bright NIR-II fluorescent probe for breast carcinoma imaging and image-guided surgery.Chem Commun (Camb). 2019 Dec 25;55(99):15005. doi: 10.1039/c9cc90519g. Epub 2019 Nov 28.
|
3349 |
Discovery of CCL18 antagonist blocking breast cancer metastasis.Clin Exp Metastasis. 2019 Jun;36(3):243-255. doi: 10.1007/s10585-019-09965-2. Epub 2019 May 6.
|
3350 |
The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.Mol Endocrinol. 2011 Oct;25(10):1699-709. doi: 10.1210/me.2011-0102. Epub 2011 Aug 25.
|
3351 |
Interplay between AP-1 and estrogen receptor in regulating gene expression and proliferation networks in breast cancer cells.Carcinogenesis. 2012 Sep;33(9):1684-91. doi: 10.1093/carcin/bgs223. Epub 2012 Jul 12.
|
3352 |
High expression of PLA2G16 is associated with a better prognosis in HER2-positive breast cancer.J Thorac Dis. 2017 Apr;9(4):1002-1011. doi: 10.21037/jtd.2017.03.108.
|
3353 |
Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.Gynecol Oncol. 2004 Dec;95(3):449-55. doi: 10.1016/j.ygyno.2004.08.051.
|
3354 |
MiR-449a suppresses cell migration and invasion by targeting PLAGL2 in breast cancer.Pathol Res Pract. 2018 May;214(5):790-795. doi: 10.1016/j.prp.2017.12.012. Epub 2018 Jan 5.
|
3355 |
Phospholipase C1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/- catenin/MMP7 signalling.Oncotarget. 2017 Apr 25;8(17):29056-29066. doi: 10.18632/oncotarget.16072.
|
3356 |
Phospholipase C delta-4 overexpression upregulates ErbB1/2 expression, Erk signaling pathway, and proliferation in MCF-7 cells.Mol Cancer. 2004 May 13;3:15. doi: 10.1186/1476-4598-3-15.
|
3357 |
Paradoxical hormone responses of KPL-1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth.Oncology. 2000 Aug;59(2):158-65. doi: 10.1159/000012154.
|
3358 |
GIPC1 interacts with MyoGEF and promotes MDA-MB-231 breast cancer cell invasion.J Biol Chem. 2010 Sep 10;285(37):28643-50. doi: 10.1074/jbc.M110.107649. Epub 2010 Jul 15.
|
3359 |
The significance of lipid accumulation in breast carcinoma cells through perilipin 2 and its clinicopathological significance.Pathol Int. 2019 Aug;69(8):463-471. doi: 10.1111/pin.12831. Epub 2019 Jul 4.
|
3360 |
Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells.Int J Cancer. 2011 Feb 1;128(3):587-96. doi: 10.1002/ijc.25388.
|
3361 |
PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.Am J Pathol. 2013 Nov;183(5):1634-1644. doi: 10.1016/j.ajpath.2013.07.028. Epub 2013 Sep 17.
|
3362 |
Semaphorin-plexin signalling genes associated with human breast tumourigenesis.Gene. 2011 Dec 10;489(2):63-9. doi: 10.1016/j.gene.2011.08.024. Epub 2011 Sep 2.
|
3363 |
Association between prognosis and SEMA4D/Plexin-B1 expression in various malignancies: A meta-analysis.Medicine (Baltimore). 2019 Feb;98(7):e13298. doi: 10.1097/MD.0000000000013298.
|
3364 |
Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy.Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2594-E2603. doi: 10.1073/pnas.1717820115. Epub 2018 Feb 23.
|
3365 |
PMEPA1/TMEPAI knockout impairs tumour growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth.J Biochem. 2019 May 1;165(5):411-414. doi: 10.1093/jb/mvz022.
|
3366 |
Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD.J Drug Target. 2018 Sep;26(8):643-648. doi: 10.1080/1061186X.2017.1401077. Epub 2017 Nov 15.
|
3367 |
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.Breast Cancer Res. 2015 Mar 27;17(1):46. doi: 10.1186/s13058-015-0562-7.
|
3368 |
Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.Biochem Biophys Res Commun. 2017 Sep 9;491(1):104-111. doi: 10.1016/j.bbrc.2017.07.053. Epub 2017 Jul 11.
|
3369 |
Novel POLE pathogenic germline variant in a family with multiple primary tumors results in distinct mutational signatures.Hum Mutat. 2019 Jan;40(1):36-41. doi: 10.1002/humu.23676. Epub 2018 Nov 20.
|
3370 |
DNA polymerase iota (Pol ) promotes the migration and invasion of breast cancer cell via EGFR-ERK-mediated epithelial to mesenchymal transition.Cancer Biomark. 2019;24(3):363-370. doi: 10.3233/CBM-181516.
|
3371 |
DNA polymerase (POLQ) is important for repair of DNA double-strand breaks caused by fork collapse.J Biol Chem. 2019 Mar 15;294(11):3909-3919. doi: 10.1074/jbc.RA118.005188. Epub 2019 Jan 17.
|
3372 |
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines.Breast Cancer Res Treat. 2014 Jun;145(3):581-91. doi: 10.1007/s10549-014-2975-x. Epub 2014 May 8.
|
3373 |
POTE paralogs are induced and differentially expressed in many cancers.Cancer Res. 2006 Jan 1;66(1):52-6. doi: 10.1158/0008-5472.CAN-05-3014.
|
3374 |
Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes.Mol Cell Probes. 2006 Apr;20(2):81-6. doi: 10.1016/j.mcp.2005.09.008. Epub 2005 Dec 2.
|
3375 |
Examination of POU homeobox gene expression in human breast cancer cells.Int J Cancer. 1999 Mar 31;81(1):104-12. doi: 10.1002/(sici)1097-0215(19990331)81:1<104::aid-ijc18>3.0.co;2-q.
|
3376 |
Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells.J Cell Physiol. 2020 Apr;235(4):3626-3633. doi: 10.1002/jcp.29252. Epub 2019 Oct 4.
|
3377 |
PGC-1 induced browning promotes involution and inhibits lactation in mammary glands.Cell Mol Life Sci. 2019 Dec;76(24):5011-5025. doi: 10.1007/s00018-019-03160-y. Epub 2019 Jun 1.
|
3378 |
Liprin-1 modulates cancer cell signaling by transmembrane protein CD82 in adhesive membrane domains linked to cytoskeleton.Cell Commun Signal. 2018 Jul 13;16(1):41. doi: 10.1186/s12964-018-0253-y.
|
3379 |
Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.BMC Med Genet. 2019 Sep 2;20(1):148. doi: 10.1186/s12881-019-0884-x.
|
3380 |
U-box ubiquitin ligase PPIL2 suppresses breast cancer invasion and metastasis by altering cell morphology and promoting SNAI1 ubiquitination and degradation.Cell Death Dis. 2018 Jan 19;9(2):63. doi: 10.1038/s41419-017-0094-4.
|
3381 |
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.Nat Genet. 2017 Aug;49(8):1219-1230. doi: 10.1038/ng.3905. Epub 2017 Jun 26.
|
3382 |
Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway.Biol Chem. 2007 May;388(5):489-95. doi: 10.1515/BC.2007.062.
|
3383 |
Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.Biochem Pharmacol. 2019 Feb;160:71-79. doi: 10.1016/j.bcp.2018.12.008. Epub 2018 Dec 12.
|
3384 |
Dopamine and cAMP-regulated phosphoprotein 32kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression.Sci Rep. 2019 Nov 18;9(1):16987. doi: 10.1038/s41598-019-53529-z.
|
3385 |
NRBE3 promotes metastasis of breast cancer by down-regulating E-cadherin expression.Biochim Biophys Acta Mol Cell Res. 2018 Dec;1865(12):1869-1877. doi: 10.1016/j.bbamcr.2018.09.003. Epub 2018 Sep 11.
|
3386 |
The role of posttraumatic stress and posttraumatic growth on online information use in breast cancer survivors.Psychooncology. 2018 Aug;27(8):1971-1978. doi: 10.1002/pon.4753. Epub 2018 May 25.
|
3387 |
Low spinophilin expression enhances aggressive biological behavior of breast cancer.Oncotarget. 2015 May 10;6(13):11191-202. doi: 10.18632/oncotarget.3586.
|
3388 |
Protein phosphatase 2A subunit gene haplotypes and proliferative breast disease modify breast cancer risk.Cancer. 2010 Jan 1;116(1):8-19. doi: 10.1002/cncr.24702.
|
3389 |
The glycine 90 to aspartate alteration in the Abeta subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function.Genes Chromosomes Cancer. 2006 Feb;45(2):182-90. doi: 10.1002/gcc.20284.
|
3390 |
Meta-analysis of the diagnostic accuracy of ultrasound-guided fine-needle aspiration and core needle biopsy in diagnosing axillary lymph node metastasis.Br J Surg. 2018 Sep;105(10):1244-1253. doi: 10.1002/bjs.10920. Epub 2018 Jul 4.
|
3391 |
In vitro cytotoxic potential of friedelin in human MCF-7 breast cancer cell: Regulate early expression of Cdkn2a and pRb1, neutralize mdm2-p53 amalgamation and functional stabilization of p53.Exp Toxicol Pathol. 2017 Oct 2;69(8):630-636. doi: 10.1016/j.etp.2017.05.011. Epub 2017 Jun 12.
|
3392 |
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.Sci Rep. 2017 Apr 25;7(1):1145. doi: 10.1038/s41598-017-01332-z.
|
3393 |
Identification of a functional estrogen-responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines.J Cell Physiol. 2012 Mar;227(3):964-75. doi: 10.1002/jcp.22803.
|
3394 |
The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases.BMC Cancer. 2019 Aug 16;19(1):812. doi: 10.1186/s12885-019-6031-4.
|
3395 |
Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.Int J Oncol. 2010 Feb;36(2):359-64.
|
3396 |
Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.Breast Cancer Res. 2018 Jul 2;20(1):63. doi: 10.1186/s13058-018-0984-0.
|
3397 |
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.Breast Cancer Res. 2008;10(3):R47. doi: 10.1186/bcr2100. Epub 2008 May 28.
|
3398 |
Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines.Acta Pharmacol Sin. 2020 Jan;41(1):110-118. doi: 10.1038/s41401-019-0290-0. Epub 2019 Sep 12.
|
3399 |
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.Nat Genet. 2012 Nov;44(11):1182-4. doi: 10.1038/ng.2417. Epub 2012 Sep 23.
|
3400 |
Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium.Carcinogenesis. 2017 Aug 1;38(8):789-796. doi: 10.1093/carcin/bgx055.
|
3401 |
Attendance and compliance with an exercise program during localized breast cancer treatment in a randomized controlled trial: The PACT study.PLoS One. 2019 May 8;14(5):e0215517. doi: 10.1371/journal.pone.0215517. eCollection 2019.
|
3402 |
Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.Oncogenesis. 2017 Jun 12;6(6):e346. doi: 10.1038/oncsis.2017.42.
|
3403 |
PELP1 oncogenic functions involve alternative splicing via PRMT6.Mol Oncol. 2014 Mar;8(2):389-400. doi: 10.1016/j.molonc.2013.12.012. Epub 2013 Dec 30.
|
3404 |
Involvement of Prokineticin 2-expressing Neutrophil Infiltration in 5-Fluorouracil-induced Aggravation of Breast Cancer Metastasis to Lung.Mol Cancer Ther. 2018 Jul;17(7):1515-1525. doi: 10.1158/1535-7163.MCT-17-0845. Epub 2018 Apr 11.
|
3405 |
Long non-coding RNA LINC00968 reduces cell proliferation and migration and angiogenesis in breast cancer through up-regulation of PROX1 by reducing hsa-miR-423-5p.Cell Cycle. 2019 Aug;18(16):1908-1924. doi: 10.1080/15384101.2019.1632641. Epub 2019 Jun 29.
|
3406 |
22 genes from chromosome 17q21: cloning, sequencing, and characterization of mutations in breast cancer families and tumors.Genomics. 1995 Jan 1;25(1):256-63. doi: 10.1016/0888-7543(95)80133-7.
|
3407 |
PRPS1 silencing reverses cisplatin resistance in human breast cancer cells.Biochem Cell Biol. 2017 Jun;95(3):385-393. doi: 10.1139/bcb-2016-0106. Epub 2016 Nov 3.
|
3408 |
PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.BMB Rep. 2019 Feb;52(2):157-162. doi: 10.5483/BMBRep.2019.52.2.207.
|
3409 |
PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas.Genomics. 2005 Mar;85(3):338-51. doi: 10.1016/j.ygeno.2004.11.002.
|
3410 |
Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women.Cancer Causes Control. 2016 Aug;27(8):965-76. doi: 10.1007/s10552-016-0774-x. Epub 2016 Jun 17.
|
3411 |
The identification of specific methylation patterns across different cancers.PLoS One. 2015 Mar 16;10(3):e0120361. doi: 10.1371/journal.pone.0120361. eCollection 2015.
|
3412 |
Rictor ablation in BMSCs inhibits bone metastasis of TM40D cells by attenuating osteolytic destruction and CAF formation.Int J Biol Sci. 2019 Sep 7;15(11):2448-2460. doi: 10.7150/ijbs.37241. eCollection 2019.
|
3413 |
The P(2)' residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity.Biochem J. 2011 Nov 15;440(1):95-105. doi: 10.1042/BJ20110788.
|
3414 |
Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.Oncol Lett. 2018 Jun;15(6):8796-8804. doi: 10.3892/ol.2018.8387. Epub 2018 Mar 29.
|
3415 |
Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility.Oncogene. 2008 Mar 20;27(13):1853-64. doi: 10.1038/sj.onc.1210822. Epub 2007 Oct 1.
|
3416 |
Mechano-Signal Transduction in Mesenchymal Stem Cells Induces Prosaposin Secretion to Drive the Proliferation of Breast Cancer Cells.Cancer Res. 2017 Nov 15;77(22):6179-6189. doi: 10.1158/0008-5472.CAN-17-0569. Epub 2017 Sep 28.
|
3417 |
PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.Oncol Rep. 2018 Oct;40(4):2343-2352. doi: 10.3892/or.2018.6588. Epub 2018 Jul 20.
|
3418 |
Proteasome 26S subunit PSMD1 regulates breast cancer cell growth through p53 protein degradation.J Biochem. 2018 Jan 1;163(1):19-29. doi: 10.1093/jb/mvx053.
|
3419 |
RPN11 deubiquitinase promotes proliferation and migration of breast cancer cells.Mol Med Rep. 2017 Jul;16(1):331-338. doi: 10.3892/mmr.2017.6587. Epub 2017 May 16.
|
3420 |
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation.Cancer Lett. 2018 Aug 28;430:109-122. doi: 10.1016/j.canlet.2018.05.018. Epub 2018 May 17.
|
3421 |
Proteasome 26S Subunit, non-ATPase 3 (PSMD3) Regulates Breast Cancer by Stabilizing HER2 from Degradation.Cancers (Basel). 2019 Apr 12;11(4):527. doi: 10.3390/cancers11040527.
|
3422 |
Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi.Genes Chromosomes Cancer. 2017 Aug;56(8):589-597. doi: 10.1002/gcc.22459. Epub 2017 May 4.
|
3423 |
Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.Nutr Cancer. 2009;61(1):114-22. doi: 10.1080/01635580802348666.
|
3424 |
PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer.Exp Cell Res. 2017 Sep 15;358(2):87-93. doi: 10.1016/j.yexcr.2017.05.017. Epub 2017 May 19.
|
3425 |
Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.Mol Med. 1999 Aug;5(8):526-41.
|
3426 |
Mutation of the PTCH1 gene predicts recurrence of breast cancer.Sci Rep. 2019 Nov 8;9(1):16359. doi: 10.1038/s41598-019-52617-4.
|
3427 |
Curcumin, but not curcumin-glucuronide, inhibits Smad signaling in TGF-dependent bone metastatic breast cancer cells and is enriched in bone compared to other tissues.J Nutr Biochem. 2019 Jan;63:150-156. doi: 10.1016/j.jnutbio.2018.09.021. Epub 2018 Oct 11.
|
3428 |
Regulation of prothymosin alpha by estrogen receptor alpha: molecular mechanisms and relevance in estrogen-mediated breast cell growth.Oncogene. 2002 Aug 8;21(34):5233-44. doi: 10.1038/sj.onc.1205645.
|
3429 |
A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells.Cancer Lett. 2019 Jun 28;452:158-167. doi: 10.1016/j.canlet.2019.03.019. Epub 2019 Mar 25.
|
3430 |
Efficacy of a novel LyP-1-containing self-microemulsifying drug delivery system (SMEDDS) for active targeting to breast cancer.Eur J Pharm Biopharm. 2019 Mar;136:138-146. doi: 10.1016/j.ejpb.2019.01.017. Epub 2019 Jan 22.
|
3431 |
PTPH1 immunohistochemical expression and promoter methylation in breast cancer patients from India: A retrospective study.J Cell Physiol. 2019 Feb;234(2):1071-1079. doi: 10.1002/jcp.27211. Epub 2018 Sep 6.
|
3432 |
Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.PLoS One. 2018 Mar 28;13(3):e0194913. doi: 10.1371/journal.pone.0194913. eCollection 2018.
|
3433 |
PPAR inhibits breast cancer progression by upregulating PTPRF expression.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9965-9977. doi: 10.26355/eurrev_201911_19563.
|
3434 |
The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.Cancer Res. 1996 Nov 1;56(21):4871-5.
|
3435 |
Correlation of securin and Ki67 in invasive breast carcinoma.Histol Histopathol. 2019 Jun;34(6):697-709. doi: 10.14670/HH-18-071. Epub 2018 Dec 3.
|
3436 |
Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer.Front Oncol. 2019 Jan 25;9:21. doi: 10.3389/fonc.2019.00021. eCollection 2019.
|
3437 |
High expression of soluble CD155 in estrogen receptor-negative breast cancer.Breast Cancer. 2020 Jan;27(1):92-99. doi: 10.1007/s12282-019-00999-8. Epub 2019 Aug 1.
|
3438 |
High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancer.Medicine (Baltimore). 2019 Nov;98(44):e17703. doi: 10.1097/MD.0000000000017703.
|
3439 |
(-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.Nutrients. 2019 Feb 15;11(2):412. doi: 10.3390/nu11020412.
|
3440 |
miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.J Cell Mol Med. 2019 Sep;23(9):6295-6307. doi: 10.1111/jcmm.14515. Epub 2019 Jul 5.
|
3441 |
Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer.Oncogene. 2004 Jun 3;23(26):4556-66. doi: 10.1038/sj.onc.1207592.
|
3442 |
Comprehensive analysis of the GATA transcription factor gene family in breast carcinoma using gene microarrays, online databases and integrated bioinformatics.Sci Rep. 2019 Mar 14;9(1):4467. doi: 10.1038/s41598-019-40811-3.
|
3443 |
Association of Single-Nucleotide Polymorphisms of CD44 Gene with Susceptibility to Breast Cancer in Chinese Women.Med Sci Monit. 2018 May 11;24:3077-3083. doi: 10.12659/MSM.907422.
|
3444 |
The breast cancer antigen 5T4 interacts with Rab11, and is a target and regulator of Rab11 mediated trafficking.Int J Biochem Cell Biol. 2018 Jun;99:28-37. doi: 10.1016/j.biocel.2018.03.002. Epub 2018 Mar 13.
|
3445 |
Downregulation of ARID1A, a component of the SWI/SNF chromatin remodeling complex, in breast cancer.J Cancer. 2017 Jan 1;8(1):1-8. doi: 10.7150/jca.16602. eCollection 2017.
|
3446 |
miR?39?p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A.Oncol Rep. 2019 Nov;42(5):1699-1708. doi: 10.3892/or.2019.7297. Epub 2019 Aug 29.
|
3447 |
Functional implications of Rab27 GTPases in Cancer.Cell Commun Signal. 2018 Aug 6;16(1):44. doi: 10.1186/s12964-018-0255-9.
|
3448 |
Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.Gene. 2019 Aug 15;709:48-55. doi: 10.1016/j.gene.2019.04.005. Epub 2019 Apr 16.
|
3449 |
Rab34 regulates adhesion, migration, and invasion of breast cancer cells.Oncogene. 2018 Jul;37(27):3698-3714. doi: 10.1038/s41388-018-0202-7. Epub 2018 Apr 6.
|
3450 |
Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells.Mol Cell Biol. 2000 Dec;20(23):9092-101. doi: 10.1128/MCB.20.23.9092-9101.2000.
|
3451 |
Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.J Natl Cancer Inst. 2010 Jun 16;102(12):866-80. doi: 10.1093/jnci/djq153. Epub 2010 May 18.
|
3452 |
The Protease Activated Receptor2 Promotes Rab5a Mediated Generation of Pro-metastatic Microvesicles.Sci Rep. 2018 May 9;8(1):7357. doi: 10.1038/s41598-018-25725-w.
|
3453 |
MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.Biochem Biophys Res Commun. 2018 Jun 22;501(2):486-493. doi: 10.1016/j.bbrc.2018.05.018. Epub 2018 May 10.
|
3454 |
Phospholipase Cgamma1 is required for metastasis development and progression.Cancer Res. 2008 Dec 15;68(24):10187-96. doi: 10.1158/0008-5472.CAN-08-1181.
|
3455 |
Epigenetic regulation of WTH3 in primary and cultured drug-resistant breast cancer cells.Cancer Res. 2005 Nov 1;65(21):10024-31. doi: 10.1158/0008-5472.CAN-05-1944.
|
3456 |
Cyclopalladated compounds containing 2,6-lutidine: Synthesis, spectral and biological studies.J Inorg Biochem. 2020 Feb;203:110944. doi: 10.1016/j.jinorgbio.2019.110944. Epub 2019 Nov 22.
|
3457 |
The Cytoskeletal Protein Cyclase-Associated Protein 1 (CAP1) in Breast Cancer: Context-Dependent Roles in Both the Invasiveness and Proliferation of Cancer Cells and Underlying Cell Signals.Int J Mol Sci. 2019 May 30;20(11):2653. doi: 10.3390/ijms20112653.
|
3458 |
RBEL1 is a novel gene that encodes a nucleocytoplasmic Ras superfamily GTP-binding protein and is overexpressed in breast cancer.J Biol Chem. 2007 Dec 28;282(52):37640-9. doi: 10.1074/jbc.M704760200. Epub 2007 Oct 25.
|
3459 |
Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.J Cell Biochem. 2019 Sep;120(9):15378-15388. doi: 10.1002/jcb.28805. Epub 2019 Apr 29.
|
3460 |
Regulation of Rad17 protein turnover unveils an impact of Rad17-APC cascade in breast carcinogenesis and treatment.J Biol Chem. 2013 Jun 21;288(25):18134-45. doi: 10.1074/jbc.M113.456962. Epub 2013 May 1.
|
3461 |
Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican women.Mol Carcinog. 2013 Nov;52 Suppl 1(0 1):E127-38. doi: 10.1002/mc.22056. Epub 2013 Jun 18.
|
3462 |
RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.Biomed Pharmacother. 2019 Oct;118:109341. doi: 10.1016/j.biopha.2019.109341. Epub 2019 Aug 21.
|
3463 |
RAE1 mediated ZEB1 expression promotes epithelial-mesenchymal transition in breast cancer.Sci Rep. 2019 Feb 27;9(1):2977. doi: 10.1038/s41598-019-39574-8.
|
3464 |
Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells.Mol Ther. 2013 Jan;21(1):185-91. doi: 10.1038/mt.2012.180. Epub 2012 Oct 2.
|
3465 |
RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference Laboratory.Arch Pathol Lab Med. 2017 Feb;141(2):274-278. doi: 10.5858/arpa.2016-0201-OA. Epub 2016 Dec 13.
|
3466 |
Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells.J Cancer. 2019 Oct 18;10(25):6341-6348. doi: 10.7150/jca.34910. eCollection 2019.
|
3467 |
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer Cells.Pharm Res. 2018 Dec 17;36(2):26. doi: 10.1007/s11095-018-2555-6.
|
3468 |
The SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.Mol Cancer Res. 2014 Jan;12(1):130-42. doi: 10.1158/1541-7786.MCR-13-0362. Epub 2013 Nov 6.
|
3469 |
Expression of RPIP9 (Rap2 interacting protein 9) is activated in breast carcinoma and correlates with a poor prognosis.Int J Cancer. 2005 Dec 20;117(6):934-41. doi: 10.1002/ijc.21252.
|
3470 |
Carbonate apatite nanoparticles carry siRNA(s) targeting growth factor receptor genes egfr1 and erbb2 to regress mouse breast tumor.Drug Deliv. 2017 Nov;24(1):1721-1730. doi: 10.1080/10717544.2017.1396385.
|
3471 |
Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.Breast Cancer Res. 2011 Mar 23;13(2):R31. doi: 10.1186/bcr2853.
|
3472 |
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.Breast Cancer Res Treat. 2018 Nov;172(1):61-68. doi: 10.1007/s10549-018-4891-y. Epub 2018 Jul 28.
|
3473 |
Interactions between RASA2, CADM1, HIF1AN gene polymorphisms and body fatness with breast cancer: a population-based case-control study in China.Oncotarget. 2017 Oct 5;8(58):98258-98269. doi: 10.18632/oncotarget.21530. eCollection 2017 Nov 17.
|
3474 |
RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1.Oncol Lett. 2017 Sep;14(3):3839-3845. doi: 10.3892/ol.2017.6648. Epub 2017 Jul 21.
|
3475 |
Rasal2 suppresses breast cancer cell proliferation modulated by secretory autophagy.Mol Cell Biochem. 2019 Dec;462(1-2):115-122. doi: 10.1007/s11010-019-03615-7. Epub 2019 Aug 31.
|
3476 |
Comprehensive analysis of the lncRNAassociated competing endogenous RNA network in breast cancer.Oncol Rep. 2019 Dec;42(6):2572-2582. doi: 10.3892/or.2019.7374. Epub 2019 Oct 15.
|
3477 |
Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.J BUON. 2018 May-Jun;23(3):684-691.
|
3478 |
Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.Int J Oncol. 2009 Feb;34(2):517-28.
|
3479 |
Downregulation of RASSF6 promotes breast cancer growth and chemoresistance through regulation of Hippo signaling.Biochem Biophys Res Commun. 2018 Sep 18;503(4):2340-2347. doi: 10.1016/j.bbrc.2018.06.159. Epub 2018 Jul 2.
|
3480 |
MicroRNA-1254 exertsoncogenic effects by directly targeting RASSF9 in human breast cancer.Int J Oncol. 2018 Nov;53(5):2145-2156. doi: 10.3892/ijo.2018.4530. Epub 2018 Aug 21.
|
3481 |
Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.Mol Cancer Res. 2007 Feb;5(2):171-81. doi: 10.1158/1541-7786.MCR-06-0071.
|
3482 |
Demethylation and alterations in the expression level of the cell cycle-related genes as possible mechanisms in arsenic trioxide-induced cell cycle arrest in human breast cancer cells.Tumour Biol. 2017 Feb;39(2):1010428317692255. doi: 10.1177/1010428317692255.
|
3483 |
Nucleosomes positioning around transcriptional start site of tumor suppressor (Rbl2/p130) gene in breast cancer.Mol Biol Rep. 2018 Apr;45(2):185-194. doi: 10.1007/s11033-018-4151-6. Epub 2018 Feb 7.
|
3484 |
Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy.Onco Targets Ther. 2017 Jan 11;10:339-345. doi: 10.2147/OTT.S125250. eCollection 2017.
|
3485 |
Expression of RBM5-related factors in primary breast tissue.J Cell Biochem. 2007 Apr 15;100(6):1440-58. doi: 10.1002/jcb.21134.
|
3486 |
RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer.J Exp Clin Cancer Res. 2018 Dec 4;37(1):298. doi: 10.1186/s13046-018-0968-z.
|
3487 |
mRNA expression of the putative antimetastatic gene BRMS1 and of apoptosis-related genes in breast cancer.Cancer Genomics Proteomics. 2011 Jul-Aug;8(4):195-7.
|
3488 |
CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.BMC Cancer. 2018 May 2;18(1):514. doi: 10.1186/s12885-018-4249-1.
|
3489 |
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.J Natl Cancer Inst. 2018 Apr 1;110(4). doi: 10.1093/jnci/djx207.
|
3490 |
Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene.Int J Cancer. 2018 Jun 15;142(12):2512-2517. doi: 10.1002/ijc.31273. Epub 2018 Feb 5.
|
3491 |
RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT.J Cancer. 2019 Nov 1;10(27):6837-6847. doi: 10.7150/jca.36430. eCollection 2019.
|
3492 |
Downregulated PIRH2 Can Decrease the Proliferation of Breast Cancer Cells.Arch Med Res. 2016 Apr;47(3):186-95. doi: 10.1016/j.arcmed.2016.06.004. Epub 2016 Jul 6.
|
3493 |
RDM1 promotes critical processes in breast cancer tumorigenesis.J Cell Mol Med. 2019 Aug;23(8):5432-5439. doi: 10.1111/jcmm.14425. Epub 2019 Jun 20.
|
3494 |
Radixin knockdown improves the accumulation and efficiency of methotrexate in tumor cells.Oncol Rep. 2019 Jul;42(1):283-290. doi: 10.3892/or.2019.7162. Epub 2019 May 15.
|
3495 |
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer.Nat Commun. 2019 Aug 9;10(1):3589. doi: 10.1038/s41467-019-11510-4.
|
3496 |
Astrocyte-induced Reelin expression drives proliferation of Her2(+) breast cancer metastases.Clin Exp Metastasis. 2017 Feb;34(2):185-196. doi: 10.1007/s10585-017-9839-9. Epub 2017 Feb 17.
|
3497 |
Synthesis and Anticancer Activity Evaluation of Hydrolyzed Derivatives of Panaxnotoginseng Saponins.Molecules. 2018 Nov 19;23(11):3021. doi: 10.3390/molecules23113021.
|
3498 |
The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating LAPTM4B Expression.Mol Cancer Res. 2018 May;16(5):857-868. doi: 10.1158/1541-7786.MCR-17-0519. Epub 2018 Jan 29.
|
3499 |
Adipocytokines and breast cancer.Curr Probl Cancer. 2018 Mar-Apr;42(2):208-214. doi: 10.1016/j.currproblcancer.2018.01.004. Epub 2018 Jan 8.
|
3500 |
Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.Cancer Biol Ther. 2015;16(4):518-27. doi: 10.1080/15384047.2015.1016661. Epub 2015 Apr 7.
|
3501 |
Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling.J Cell Biochem. 2012 Jul;113(7):2523-31. doi: 10.1002/jcb.24128.
|
3502 |
[Erratum] Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro.Mol Med Rep. 2018 Feb;17(2):3432. doi: 10.3892/mmr.2017.8276. Epub 2017 Dec 12.
|
3503 |
Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases.Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13257-61. doi: 10.1073/pnas.0405490101. Epub 2004 Aug 23.
|
3504 |
Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.Biochem Biophys Res Commun. 2017 Apr 8;485(3):693-697. doi: 10.1016/j.bbrc.2017.02.106. Epub 2017 Feb 22.
|
3505 |
MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.Breast Cancer. 2019 Nov;26(6):817-825. doi: 10.1007/s12282-019-00989-w. Epub 2019 Jun 26.
|
3506 |
Fas-associated protein with death domain (FADD) regulates autophagy through promoting the expression of Ras homolog enriched in brain (Rheb) in human breast adenocarcinoma cells.Oncotarget. 2016 Apr 26;7(17):24572-84. doi: 10.18632/oncotarget.8249.
|
3507 |
Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families.Breast Cancer Res Treat. 2014 Apr;144(2):437-41. doi: 10.1007/s10549-014-2884-z. Epub 2014 Feb 22.
|
3508 |
The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B.BMC Cancer. 2017 Feb 20;17(1):145. doi: 10.1186/s12885-017-3138-3.
|
3509 |
DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.Oncogene. 2017 May 18;36(20):2802-2812. doi: 10.1038/onc.2016.441. Epub 2016 Dec 12.
|
3510 |
Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis.Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):80-6. doi: 10.1158/1055-9965.EPI-08-0842.
|
3511 |
Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.J Biol Chem. 2009 May 8;284(19):12956-65. doi: 10.1074/jbc.M807845200. Epub 2009 Mar 6.
|
3512 |
c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on breast cancer cell proliferation via inhibiting P53.Mol Genet Genomics. 2019 Oct;294(5):1219-1229. doi: 10.1007/s00438-019-01572-w. Epub 2019 May 14.
|
3513 |
The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior.EBioMedicine. 2017 Jun;20:79-97. doi: 10.1016/j.ebiom.2017.04.015. Epub 2017 Apr 12.
|
3514 |
The human ROX gene: genomic structure and mutation analysis in human breast tumors.Genomics. 1998 Apr 15;49(2):275-82. doi: 10.1006/geno.1998.5241.
|
3515 |
Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells.BMB Rep. 2010 Feb;43(2):91-6. doi: 10.5483/bmbrep.2010.43.2.091.
|
3516 |
High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.J Pathol. 2017 Nov;243(3):376-389. doi: 10.1002/path.4958. Epub 2017 Sep 21.
|
3517 |
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway.Oncotarget. 2017 Apr 11;8(15):25097-25106. doi: 10.18632/oncotarget.15341.
|
3518 |
Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies.Gene. 2017 Jan 5;596:45-52. doi: 10.1016/j.gene.2016.10.005. Epub 2016 Oct 6.
|
3519 |
Aicardi-Goutires syndrome gene Rnaseh2c is a metastasis susceptibility gene in breast cancer.PLoS Genet. 2019 May 24;15(5):e1008020. doi: 10.1371/journal.pgen.1008020. eCollection 2019 May.
|
3520 |
The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11.Oncogene. 2008 Nov 20;27(54):6845-55. doi: 10.1038/onc.2008.288. Epub 2008 Aug 25.
|
3521 |
RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.Clin Cancer Res. 2018 Apr 1;24(7):1629-1643. doi: 10.1158/1078-0432.CCR-17-2242. Epub 2018 Jan 11.
|
3522 |
Dual-utility NLS drives RNF169-dependent DNA damage responses.Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2872-E2881. doi: 10.1073/pnas.1616602114. Epub 2017 Mar 21.
|
3523 |
The oncogenic impact of RNF2 on cell proliferation, invasion and migration through EMT on mammary carcinoma.Pathol Res Pract. 2019 Sep;215(9):152523. doi: 10.1016/j.prp.2019.152523. Epub 2019 Jun 28.
|
3524 |
RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer.Cell Death Differ. 2017 Apr;24(4):694-704. doi: 10.1038/cdd.2016.126. Epub 2017 Feb 3.
|
3525 |
Correction: The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor and modulates estrogen-stimulated breast cancer cell proliferation.Oncogene. 2019 Jan;38(2):299-300. doi: 10.1038/s41388-018-0502-y.
|
3526 |
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.BMC Cancer. 2018 Oct 26;18(1):1045. doi: 10.1186/s12885-018-4917-1.
|
3527 |
Ubiquitin ligase RNF5 serves an important role in the development of human glioma.Oncol Lett. 2019 Nov;18(5):4659-4666. doi: 10.3892/ol.2019.10801. Epub 2019 Sep 4.
|
3528 |
17-beta-estradiol increases expression of 52-kDa and 60-kDa SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7.J Invest Dermatol. 1996 Oct;107(4):610-4. doi: 10.1111/1523-1747.ep12584194.
|
3529 |
Upregulation of RPA2 promotes NF-B activation in breast cancer by relieving the antagonistic function of menin on NF-B-regulated transcription.Carcinogenesis. 2017 Feb 1;38(2):196-206. doi: 10.1093/carcin/bgw123.
|
3530 |
Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.Br J Cancer. 1997;76(12):1550-3. doi: 10.1038/bjc.1997.594.
|
3531 |
Co-expression network analysis of gene expression profiles of HER2(+) breast cancer-associated brain metastasis.Oncol Lett. 2018 Dec;16(6):7008-7019. doi: 10.3892/ol.2018.9562. Epub 2018 Oct 10.
|
3532 |
Negative cooperativity between alpha 3 beta 1 and alpha 2 beta 1 integrins in human mammary carcinoma MDA MB 231 cells.Exp Cell Res. 1998 May 1;240(2):368-76. doi: 10.1006/excr.1998.4012.
|
3533 |
Role of RPL39 in Metaplastic Breast Cancer.J Natl Cancer Inst. 2016 Dec 31;109(6):djw292. doi: 10.1093/jnci/djw292. Print 2017 Jun.
|
3534 |
Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells.Breast Cancer Res Treat. 2001 Sep;69(1):29-38. doi: 10.1023/a:1012293507534.
|
3535 |
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.Cancer Res. 2007 Apr 15;67(8):3555-9. doi: 10.1158/0008-5472.CAN-06-2763.
|
3536 |
Prognostic and therapeutic impact of RPN2-mediated tumor malignancy in non-small-cell lung cancer.Oncotarget. 2015 Feb 20;6(5):3335-45. doi: 10.18632/oncotarget.2793.
|
3537 |
CREPT regulated by miR-138 promotes breast cancer progression.Biochem Biophys Res Commun. 2017 Nov 4;493(1):263-269. doi: 10.1016/j.bbrc.2017.09.033. Epub 2017 Sep 8.
|
3538 |
MicroRNA-7641 is a regulator of ribosomal proteins and a promising targeting factor to improve the efficacy of cancer therapy.Sci Rep. 2017 Aug 21;7(1):8365. doi: 10.1038/s41598-017-08737-w.
|
3539 |
Quantitative in situ measurement of estrogen receptor mRNA predicts response to tamoxifen.PLoS One. 2012;7(5):e36559. doi: 10.1371/journal.pone.0036559. Epub 2012 May 11.
|
3540 |
Ribosomal protein S27-like regulates autophagy via the -TrCP-DEPTOR-mTORC1 axis.Cell Death Dis. 2018 Nov 13;9(11):1131. doi: 10.1038/s41419-018-1168-7.
|
3541 |
High nuclear MSK1 is associated with longer survival in breast cancer patients.J Cancer Res Clin Oncol. 2018 Mar;144(3):509-517. doi: 10.1007/s00432-018-2579-7. Epub 2018 Jan 11.
|
3542 |
Gene expression profiling in women with breast cancer in a Saudi population.Saudi Med J. 2008 Apr;29(4):507-13.
|
3543 |
Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.Biomaterials. 2014 Aug;35(26):7543-52. doi: 10.1016/j.biomaterials.2014.05.021. Epub 2014 Jun 2.
|
3544 |
The Ras-related gene ERAS is involved in human and murine breast cancer.Sci Rep. 2018 Aug 29;8(1):13038. doi: 10.1038/s41598-018-31326-4.
|
3545 |
A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.Cancer Res. 2008 Dec 1;68(23):9799-808. doi: 10.1158/0008-5472.CAN-08-0247.
|
3546 |
Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.Cell Cycle. 2016 Sep 16;15(18):2515-26. doi: 10.1080/15384101.2016.1215385. Epub 2016 Aug 2.
|
3547 |
Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.Theranostics. 2017 Oct 17;7(19):4805-4824. doi: 10.7150/thno.20771. eCollection 2017.
|
3548 |
miR-145 inhibits breast cancer cell growth through RTKN.Int J Oncol. 2009 May;34(5):1461-6.
|
3549 |
The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.Oncotarget. 2016 May 31;7(22):33272-85. doi: 10.18632/oncotarget.8924.
|
3550 |
Human TIP49b/RUVBL2 gene: genomic structure, expression pattern, physical link to the human CGB/LHB gene cluster on chromosome 19q13.3.Ann Genet. 2000 Apr-Jun;43(2):69-74. doi: 10.1016/s0003-3995(00)01016-9.
|
3551 |
RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.Int J Oncol. 2016 Dec;49(6):2442-2452. doi: 10.3892/ijo.2016.3718. Epub 2016 Oct 5.
|
3552 |
Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification.Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13653-8. doi: 10.1073/pnas.1103360108. Epub 2011 Aug 2.
|
3553 |
A multiomics analysis of S100 protein family in breast cancer.Oncotarget. 2018 Jun 26;9(49):29064-29081. doi: 10.18632/oncotarget.25561. eCollection 2018 Jun 26.
|
3554 |
Membranous overexpression of S100A10 is associated with a high-grade cellular status of breast carcinoma.Med Mol Morphol. 2020 Jun;53(2):104-114. doi: 10.1007/s00795-019-00236-3. Epub 2019 Nov 15.
|
3555 |
HGF-mediated S100A11 overexpression enhances proliferation and invasion of gastric cancer.Am J Transl Res. 2018 Nov 15;10(11):3385-3394. eCollection 2018.
|
3556 |
Expression of calcium-binding protein S100A2 in breast lesions.Br J Cancer. 2000 Dec;83(11):1473-9. doi: 10.1054/bjoc.2000.1488.
|
3557 |
Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer Cells.Biomed Res Int. 2015;2015:395816. doi: 10.1155/2015/395816. Epub 2015 Jul 26.
|
3558 |
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.BMC Med Genet. 2008 Dec 13;9:108. doi: 10.1186/1471-2350-9-108.
|
3559 |
SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.Mol Cancer. 2018 Apr 6;17(1):78. doi: 10.1186/s12943-018-0824-y.
|
3560 |
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28.
|
3561 |
Pharmacological explorations of eco-friendly amide substituted (Z)--enaminones as anti-breast cancer drugs.Arch Pharm (Weinheim). 2019 Jan;352(1):e1800244. doi: 10.1002/ardp.201800244. Epub 2018 Dec 5.
|
3562 |
Identification of novel SNPs in glioblastoma using targeted resequencing.PLoS One. 2011;6(6):e18158. doi: 10.1371/journal.pone.0018158. Epub 2011 Jun 10.
|
3563 |
DNA methylation as a promising landscape: A simple blood test for breast cancer prediction.Tumour Biol. 2015 Jul;36(7):4905-12. doi: 10.1007/s13277-015-3567-z. Epub 2015 Jun 16.
|
3564 |
Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancer.Biol Chem. 2006 Dec;387(12):1613-8. doi: 10.1515/BC.2006.201.
|
3565 |
SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.Hum Pathol. 2012 May;43(5):669-74. doi: 10.1016/j.humpath.2011.06.003. Epub 2011 Aug 19.
|
3566 |
Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.Gene. 2018 Oct 5;673:102-106. doi: 10.1016/j.gene.2018.06.036. Epub 2018 Jun 13.
|
3567 |
RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.Am J Clin Pathol. 2004 May;121(5):637-43. doi: 10.1309/MMAC-TXT5-5L8Q-TKC1.
|
3568 |
DNA methylation and breast tumor clinicopathological features: The Western New York Exposures and Breast Cancer (WEB) study.Epigenetics. 2016 Sep;11(9):643-652. doi: 10.1080/15592294.2016.1192735. Epub 2016 May 31.
|
3569 |
Scinderin-knockdown inhibits proliferation and promotes apoptosis in human breast carcinoma cells.Oncol Lett. 2018 Sep;16(3):3207-3214. doi: 10.3892/ol.2018.9009. Epub 2018 Jun 21.
|
3570 |
SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer.Nat Commun. 2016 Dec 5;7:13648. doi: 10.1038/ncomms13648.
|
3571 |
Sulfated Glycoaminoglycans and Proteoglycan Syndecan-4 Are Involved in Membrane Fixation of LL-37 and Its Pro-Migratory Effect in Breast Cancer Cells.Biomolecules. 2019 Sep 12;9(9):481. doi: 10.3390/biom9090481.
|
3572 |
Transcript analyses of stromal cell derived factors (SDFs): SDF-2, SDF-4 and SDF-5 reveal a different pattern of expression and prognostic association in human breast cancer.Int J Oncol. 2009 Jul;35(1):205-11. doi: 10.3892/ijo_00000330.
|
3573 |
Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues.Oncol Res. 2009;17(8):353-65. doi: 10.3727/096504009788428460.
|
3574 |
The Assembly Factor SDHAF2 Is Dispensable for Flavination of the Catalytic Subunit of Mitochondrial Complex II in Breast Cancer Cells.J Biol Chem. 2016 Oct 7;291(41):21414-21420. doi: 10.1074/jbc.C116.755017. Epub 2016 Sep 1.
|
3575 |
Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.J Clin Endocrinol Metab. 2015 Oct;100(10):E1386-93. doi: 10.1210/jc.2015-2689. Epub 2015 Aug 10.
|
3576 |
Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.Mod Pathol. 2018 Nov;31(11):1675-1682. doi: 10.1038/s41379-018-0092-9. Epub 2018 Jun 28.
|
3577 |
Breast cancer family history and allele-specific DNA methylation in the legacy girls study.Epigenetics. 2018;13(3):240-250. doi: 10.1080/15592294.2018.1435243. Epub 2018 Apr 2.
|
3578 |
Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction.Proteomics. 2005 Jun;5(9):2433-42. doi: 10.1002/pmic.200401283.
|
3579 |
Selenium levels in human breast carcinoma tissue are associated with a common polymorphism in the gene for SELENOP (Selenoprotein P).J Trace Elem Med Biol. 2017 Jan;39:227-233. doi: 10.1016/j.jtemb.2016.11.003. Epub 2016 Nov 11.
|
3580 |
PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA.Mol Cancer. 2019 Jan 12;18(1):9. doi: 10.1186/s12943-019-0940-3.
|
3581 |
Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.BMC Cancer. 2013 Dec 1;13:562. doi: 10.1186/1471-2407-13-562.
|
3582 |
Silencing of semaphorin 3C suppresses cell proliferation and migration in MCF-7 breast cancer cells.Oncol Lett. 2017 Nov;14(5):5913-5917. doi: 10.3892/ol.2017.6920. Epub 2017 Sep 8.
|
3583 |
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer.Int J Mol Sci. 2016 Jan 16;17(1):121. doi: 10.3390/ijms17010121.
|
3584 |
Sema4A Responds to Hypoxia and Is Involved in Breast Cancer Progression.Biol Pharm Bull. 2018 Dec 1;41(12):1791-1796. doi: 10.1248/bpb.b18-00423. Epub 2018 Sep 28.
|
3585 |
Downregulation of miR-302b is associated with poor prognosis and tumor progression of breast cancer.Breast Cancer. 2020 Mar;27(2):291-298. doi: 10.1007/s12282-019-01022-w. Epub 2019 Nov 13.
|
3586 |
Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer.Sci Rep. 2019 Nov 6;9(1):16131. doi: 10.1038/s41598-019-52718-0.
|
3587 |
The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.Oncotarget. 2016 Sep 20;7(38):61587-61600. doi: 10.18632/oncotarget.11402.
|
3588 |
SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.Cell Death Dis. 2019 Sep 26;10(10):720. doi: 10.1038/s41419-019-1947-9.
|
3589 |
Using post-column infused internal standard assisted quantitative metabolomics for establishing prediction models for breast cancer detection.Rapid Commun Mass Spectrom. 2020 Apr;34 Suppl 1:e8581. doi: 10.1002/rcm.8581. Epub 2020 Feb 5.
|
3590 |
Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
|
3591 |
Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness.Cell Death Dis. 2019 Sep 9;10(9):649. doi: 10.1038/s41419-019-1882-9.
|
3592 |
SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.Cancer Res. 2019 Sep 15;79(18):4729-4743. doi: 10.1158/0008-5472.CAN-19-1084. Epub 2019 Jul 15.
|
3593 |
SNP variants at the MAP3K1/SETD9 locus 5q11.2 associate with somatic PIK3CA variants in breast cancers.Eur J Hum Genet. 2017 Feb;25(3):384-387. doi: 10.1038/ejhg.2016.179. Epub 2016 Dec 28.
|
3594 |
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.Carcinogenesis. 2008 May;29(5):991-8. doi: 10.1093/carcin/bgn076. Epub 2008 Mar 19.
|
3595 |
Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women.BMC Cancer. 2019 May 14;19(1):446. doi: 10.1186/s12885-019-5655-8.
|
3596 |
Bif-1 suppresses breast cancer cell migration by promoting EGFR endocytic degradation.Cancer Biol Ther. 2012 Aug;13(10):956-66. doi: 10.4161/cbt.20951. Epub 2012 Aug 1.
|
3597 |
Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3816-25. doi: 10.1073/pnas.1510077112. Epub 2015 Jun 29.
|
3598 |
MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.Mol Carcinog. 2016 May;55(5):768-77. doi: 10.1002/mc.22320. Epub 2015 Apr 7.
|
3599 |
Overexpression of seven in absentia homolog 2 protein in human breast cancer tissues is associated with the promotion of tumor cell malignant behavior in in vitro.Oncol Rep. 2016 Sep;36(3):1301-12. doi: 10.3892/or.2016.4976. Epub 2016 Jul 25.
|
3600 |
High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.Oncotarget. 2017 Jul 25;8(30):49470-49483. doi: 10.18632/oncotarget.17713.
|
3601 |
Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis.Sci Prog. 2020 Jan-Mar;103(1):36850419891046. doi: 10.1177/0036850419891046. Epub 2019 Dec 2.
|
3602 |
Loss of SIM2s inhibits RAD51 binding and leads to unresolved replication stress.Breast Cancer Res. 2019 Nov 27;21(1):125. doi: 10.1186/s13058-019-1207-z.
|
3603 |
Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells.Eur J Pharmacol. 2019 Oct 15;861:172599. doi: 10.1016/j.ejphar.2019.172599. Epub 2019 Aug 9.
|
3604 |
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program.Cancer Res. 2019 Feb 15;79(4):720-734. doi: 10.1158/0008-5472.CAN-18-1791. Epub 2019 Jan 3.
|
3605 |
Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysis.Medicine (Baltimore). 2016 Jul;95(27):e4085. doi: 10.1097/MD.0000000000004085.
|
3606 |
A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.Elife. 2019 Oct 28;8:e47110. doi: 10.7554/eLife.47110.
|
3607 |
Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin.Oncol Lett. 2017 Aug;14(2):2218-2222. doi: 10.3892/ol.2017.6452. Epub 2017 Jun 21.
|
3608 |
Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.Breast Cancer Res Treat. 2019 Sep;177(2):335-343. doi: 10.1007/s10549-019-05313-w. Epub 2019 Jun 20.
|
3609 |
Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers.Br J Cancer. 2004 Dec 13;91(12):2071-8. doi: 10.1038/sj.bjc.6602222.
|
3610 |
Axillary Dissection vs. no Axillary Dissection in Breast Cancer Patients With Positive Sentinel Lymph Node: A Single Institution Experience.In Vivo. 2019 Nov-Dec;33(6):1941-1947. doi: 10.21873/invivo.11689.
|
3611 |
miR-190 suppresses breast cancer metastasis by regulation of TGF--induced epithelial-mesenchymal transition.Mol Cancer. 2018 Mar 6;17(1):70. doi: 10.1186/s12943-018-0818-9.
|
3612 |
Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells.Oncotarget. 2017 Sep 1;8(53):91803-91816. doi: 10.18632/oncotarget.20610. eCollection 2017 Oct 31.
|
3613 |
Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer.Breast Cancer Res Treat. 2011 Sep;129(2):617-22. doi: 10.1007/s10549-011-1587-y. Epub 2011 May 24.
|
3614 |
Multiparametric (18)F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?.J Nucl Med. 2020 Jan;61(1):20-25. doi: 10.2967/jnumed.119.230003. Epub 2019 Jun 28.
|
3615 |
Altered Expression and Localization of Tumor Suppressive E3 Ubiquitin Ligase SMURF2 in Human Prostate and Breast Cancer.Cancers (Basel). 2019 Apr 18;11(4):556. doi: 10.3390/cancers11040556.
|
3616 |
Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development.Development. 2002 Jun;129(11):2733-47. doi: 10.1242/dev.129.11.2733.
|
3617 |
Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.Clin Transl Oncol. 2019 Sep;21(9):1207-1219. doi: 10.1007/s12094-019-02042-w. Epub 2019 Feb 14.
|
3618 |
Estrogen receptor--miR-1271-SNAI2 feedback loop regulates transforming growth factor--induced breast cancer progression.J Exp Clin Cancer Res. 2019 Mar 1;38(1):109. doi: 10.1186/s13046-019-1112-4.
|
3619 |
Gamma-synuclein: cell-type-specific promoter activity and binding to transcription factors.J Mol Neurosci. 2008 Jul;35(3):267-71. doi: 10.1007/s12031-008-9074-6. Epub 2008 May 23.
|
3620 |
A ligation assay for multiplex analysis of CpG methylation using bisulfite-treated DNA.Nucleic Acids Res. 2007;35(21):e144. doi: 10.1093/nar/gkm984. Epub 2007 Nov 12.
|
3621 |
Role of SNTA1 in Rac1 activation, modulation of ROS generation, and migratory potential of human breast cancer cells.Br J Cancer. 2014 Feb 4;110(3):706-14. doi: 10.1038/bjc.2013.723. Epub 2014 Jan 16.
|
3622 |
CD147 (EMMPRIN) controls malignant properties of breast cancer cells by interdependent signaling of Wnt and JAK/STAT pathways.Mol Cell Biochem. 2019 Jan;451(1-2):197-209. doi: 10.1007/s11010-018-3406-9. Epub 2018 Jul 18.
|
3623 |
Artificial neural network-based exploration of gene-nutrient interactions in folate and xenobiotic metabolic pathways that modulate susceptibility to breast cancer.Gene. 2016 Apr 15;580(2):159-168. doi: 10.1016/j.gene.2016.01.023. Epub 2016 Jan 16.
|
3624 |
MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819892264. doi: 10.1177/1533033819892264.
|
3625 |
hsa-miR-301a- and SOX10-dependent miRNA-TF-mRNA regulatory circuits in breast cancer.Turk J Biol. 2018 Apr 27;42(2):103-112. doi: 10.3906/biy-1708-17. eCollection 2018.
|
3626 |
Clinical and prognostic significance of SOX11 in breast cancer.Asian Pac J Cancer Prev. 2014;15(13):5483-6. doi: 10.7314/apjcp.2014.15.13.5483.
|
3627 |
Functional analyses of microRNA-326 in breast cancer development.Biosci Rep. 2019 Jul 29;39(7):BSR20190787. doi: 10.1042/BSR20190787. Print 2019 Jul 31.
|
3628 |
Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/-catenin signaling pathway.Int J Mol Med. 2018 Dec;42(6):3355-3363. doi: 10.3892/ijmm.2018.3897. Epub 2018 Sep 25.
|
3629 |
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice.Elife. 2017 Jan 31;6:e21221. doi: 10.7554/eLife.21221.
|
3630 |
MiR-483 suppresses cell proliferation and promotes cell apoptosis by targeting SOX3 in breast cancer.Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2069-2074. doi: 10.26355/eurrev_201903_17248.
|
3631 |
Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.J Cell Biochem. 2019 Jun;120(6):10633-10642. doi: 10.1002/jcb.28353. Epub 2019 Feb 7.
|
3632 |
LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells.RNA. 2020 Feb;26(2):175-185. doi: 10.1261/rna.073254.119. Epub 2019 Nov 5.
|
3633 |
Sperm Protein Antigen 17 Expression Correlates With Lymph Node Metastasis and Worse Overall Survival in Patients With Breast Cancer.Front Oncol. 2019 Jul 31;9:710. doi: 10.3389/fonc.2019.00710. eCollection 2019.
|
3634 |
High expression of SPAG5 sustains the malignant growth and invasion of breast cancer cells through the activation of Wnt/-catenin signalling.Clin Exp Pharmacol Physiol. 2019 Jun;46(6):597-606. doi: 10.1111/1440-1681.13082. Epub 2019 Apr 3.
|
3635 |
Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.Cancer Lett. 2006 Nov 8;243(1):23-31. doi: 10.1016/j.canlet.2005.11.010. Epub 2006 Mar 23.
|
3636 |
Expression of PH-20 in normal and neoplastic breast tissue.J Surg Res. 2002 Apr;103(2):203-7. doi: 10.1006/jsre.2002.6351.
|
3637 |
Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.Cancer Sci. 2018 Dec;109(12):3910-3920. doi: 10.1111/cas.13824. Epub 2018 Nov 2.
|
3638 |
SPC24 Regulates breast cancer progression by PI3K/AKT signaling.Gene. 2018 Oct 30;675:272-277. doi: 10.1016/j.gene.2018.07.017. Epub 2018 Jul 6.
|
3639 |
SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.J Exp Clin Cancer Res. 2018 May 9;37(1):100. doi: 10.1186/s13046-018-0748-9.
|
3640 |
Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer.EMBO Mol Med. 2011 Aug;3(8):451-64. doi: 10.1002/emmm.201100150. Epub 2011 Jun 8.
|
3641 |
ST14 gene variant and decreased matriptase protein expression predict poor breast cancer survival.Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2133-42. doi: 10.1158/1055-9965.EPI-10-0418. Epub 2010 Aug 17.
|
3642 |
The hepatocyte growth factor regulatory factors in human breast cancer.Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):202-11. doi: 10.1158/1078-0432.ccr-0553-3.
|
3643 |
Estrogen-induced miR-196a elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.Mol Cancer. 2018 Apr 23;17(1):83. doi: 10.1186/s12943-018-0830-0.
|
3644 |
Autophagy mediates free fatty acid effects on MDA-MB-231 cell proliferation, migration and invasion.Oncol Lett. 2017 Oct;14(4):4715-4721. doi: 10.3892/ol.2017.6807. Epub 2017 Aug 24.
|
3645 |
Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy.PLoS One. 2011;6(8):e23772. doi: 10.1371/journal.pone.0023772. Epub 2011 Aug 31.
|
3646 |
MicroRNA?81 serves an oncogenic role in breast cancer via the inhibition of SPRY4.Mol Med Rep. 2018 Dec;18(6):5603-5613. doi: 10.3892/mmr.2018.9572. Epub 2018 Oct 22.
|
3647 |
SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.Cancer Discov. 2014 Jul;4(7):790-803. doi: 10.1158/2159-8290.CD-13-0548. Epub 2014 Apr 30.
|
3648 |
Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination.Sci Rep. 2019 Oct 22;9(1):15099. doi: 10.1038/s41598-019-51537-7.
|
3649 |
ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression.Oncotarget. 2017 May 30;8(22):36054-36066. doi: 10.18632/oncotarget.16425.
|
3650 |
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.Clin Cancer Res. 2017 Feb 15;23(4):1091-1103. doi: 10.1158/1078-0432.CCR-16-0943. Epub 2016 Jul 19.
|
3651 |
Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women.PLoS One. 2011;6(6):e21563. doi: 10.1371/journal.pone.0021563. Epub 2011 Jun 27.
|
3652 |
Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues.J Exp Clin Cancer Res. 2009 Aug 9;28(1):111. doi: 10.1186/1756-9966-28-111.
|
3653 |
Unique CD44 intronic SNP is associated with tumor grade in breast cancer: a case control study and in silico analysis.Cancer Cell Int. 2018 Feb 23;18:28. doi: 10.1186/s12935-018-0522-2. eCollection 2018.
|
3654 |
Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.Clin Chim Acta. 2007 Sep;384(1-2):69-74. doi: 10.1016/j.cca.2007.06.001. Epub 2007 Jun 15.
|
3655 |
Slingshot-1L, a cofilin phosphatase, induces primary breast cancer metastasis.Oncotarget. 2017 Aug 3;8(39):66195-66203. doi: 10.18632/oncotarget.19855. eCollection 2017 Sep 12.
|
3656 |
Modification of breast cancer risk in young women by a polymorphic sequence in the egfr gene.Cancer Res. 2004 Jan 1;64(1):7-12. doi: 10.1158/0008-5472.can-03-2623.
|
3657 |
Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability.Mol Oncol. 2015 Feb;9(2):437-49. doi: 10.1016/j.molonc.2014.09.001. Epub 2014 Oct 6.
|
3658 |
ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.Oncol Rep. 2016 Dec;36(6):3317-3324. doi: 10.3892/or.2016.5180. Epub 2016 Oct 18.
|
3659 |
Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization.Clin Exp Metastasis. 2019 Dec;36(6):539-549. doi: 10.1007/s10585-019-09999-6. Epub 2019 Oct 8.
|
3660 |
ST6GalNAcII mediates the invasive properties of breast carcinoma through PI3K/Akt/NF-B signaling pathway.IUBMB Life. 2014 Apr;66(4):300-8. doi: 10.1002/iub.1268. Epub 2014 Apr 23.
|
3661 |
Myricetin suppresses breast cancer metastasis through down-regulating the activity of matrix metalloproteinase (MMP)-2/9.Phytother Res. 2018 Jul;32(7):1373-1381. doi: 10.1002/ptr.6071. Epub 2018 Mar 13.
|
3662 |
Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.Br J Cancer. 2003 Jun 16;88(12):1909-13. doi: 10.1038/sj.bjc.6600942.
|
3663 |
RWCFusion: identifying phenotype-specific cancer driver gene fusions based on fusion pair random walk scoring method.Oncotarget. 2016 Sep 20;7(38):61054-61068. doi: 10.18632/oncotarget.11064.
|
3664 |
EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.Mol Carcinog. 2003 Dec;38(4):188-200. doi: 10.1002/mc.10162.
|
3665 |
Mutational and expressional analyses of STAG2 gene in solid cancers.Neoplasma. 2012;59(5):524-9. doi: 10.4149/neo_2012_067.
|
3666 |
Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells.Cancer Sci. 2011 Apr;102(4):756-61. doi: 10.1111/j.1349-7006.2010.01842.x. Epub 2011 Jan 23.
|
3667 |
Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.J Exp Clin Cancer Res. 2019 Jan 5;38(1):4. doi: 10.1186/s13046-018-1013-y.
|
3668 |
Elevated levels of StAR-related lipid transfer protein 3 alter cholesterol balance and adhesiveness of breast cancer cells: potential mechanisms contributing to progression of HER2-positive breast cancers.Am J Pathol. 2015 Apr;185(4):987-1000. doi: 10.1016/j.ajpath.2014.12.018. Epub 2015 Feb 12.
|
3669 |
Prognostic roles of signal transducers and activators of transcription family in human breast cancer.Biosci Rep. 2018 Dec 11;38(6):BSR20171175. doi: 10.1042/BSR20171175. Print 2018 Dec 21.
|
3670 |
miRNA-dependent regulation of STIM1 expression in breast cancer.Sci Rep. 2019 Sep 10;9(1):13076. doi: 10.1038/s41598-019-49629-5.
|
3671 |
Calcium-sensing stromal interaction molecule 2 upregulates nuclear factor of activated T cells 1 and transforming growth factor- signaling to promote breast cancer metastasis.Breast Cancer Res. 2019 Aug 29;21(1):99. doi: 10.1186/s13058-019-1185-1.
|
3672 |
FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis.Cell Death Differ. 2019 Dec;26(12):2577-2593. doi: 10.1038/s41418-019-0321-x. Epub 2019 Mar 22.
|
3673 |
Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.Pathol Oncol Res. 2015 Apr;21(2):469-75. doi: 10.1007/s12253-014-9851-1. Epub 2014 Nov 19.
|
3674 |
Effective stimulation of growth in MCF-7 human breast cancer cells by inhibition of syntaxin18 by external guide sequence and ribonuclease P.Cancer Lett. 2008 Dec 8;272(1):167-75. doi: 10.1016/j.canlet.2008.07.014. Epub 2008 Aug 22.
|
3675 |
STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1684-1692. doi: 10.1016/j.bbadis.2018.01.031. Epub 2018 Feb 2.
|
3676 |
The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.EMBO J. 2017 Feb 1;36(3):260-273. doi: 10.15252/embj.201694795. Epub 2016 Dec 22.
|
3677 |
HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.Cancer Res. 2011 Mar 15;71(6):2152-61. doi: 10.1158/0008-5472.CAN-10-3059. Epub 2011 Jan 25.
|
3678 |
Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells.Oncogene. 2015 Jan 15;34(3):323-33. doi: 10.1038/onc.2013.553. Epub 2014 Jan 13.
|
3679 |
The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.J Cancer. 2019 Jan 1;10(3):721-729. doi: 10.7150/jca.28254. eCollection 2019.
|
3680 |
SVEP1 expression is regulated in estrogen-dependent manner.J Cell Physiol. 2007 Mar;210(3):732-9. doi: 10.1002/jcp.20895.
|
3681 |
SYCP2 expression is a novel prognostic biomarker in luminal A/B breast cancer.Future Oncol. 2019 Mar;15(8):817-826. doi: 10.2217/fon-2018-0821. Epub 2018 Dec 4.
|
3682 |
Overexpression of SYF2 promotes cell proliferation and correlates with poor prognosis in human breast cancer.Oncotarget. 2017 May 23;8(51):88453-88463. doi: 10.18632/oncotarget.18188. eCollection 2017 Oct 24.
|
3683 |
Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.Sci Signal. 2015 Jan 20;8(360):ra7. doi: 10.1126/scisignal.2005537.
|
3684 |
Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.Oncogene. 2010 Aug 26;29(34):4814-25. doi: 10.1038/onc.2010.229. Epub 2010 Jun 14.
|
3685 |
Metastatic breast cancer simulating well-differentiated neuroendocrine neoplasms of visceral organs.Hum Pathol. 2018 Dec;82:76-86. doi: 10.1016/j.humpath.2018.07.011. Epub 2018 Jul 18.
|
3686 |
MicroRNA-374c-5p inhibits the development of breast cancer through TATA-box binding protein associated factor 7-mediated transcriptional regulation of DEP domain containing 1.J Cell Biochem. 2019 Sep;120(9):15360-15368. doi: 10.1002/jcb.28803. Epub 2019 Jun 4.
|
3687 |
The expression of stem cell protein Piwil2 and piR-932 in breast cancer.Surg Oncol. 2013 Dec;22(4):217-23. doi: 10.1016/j.suronc.2013.07.001. Epub 2013 Aug 27.
|
3688 |
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers.Nat Commun. 2018 Oct 15;9(1):4274. doi: 10.1038/s41467-018-06651-x.
|
3689 |
TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer.Cancers (Basel). 2019 Feb 12;11(2):210. doi: 10.3390/cancers11020210.
|
3690 |
RNA variant identification discrepancy among splice-aware alignment algorithms.PLoS One. 2018 Aug 2;13(8):e0201822. doi: 10.1371/journal.pone.0201822. eCollection 2018.
|
3691 |
Downregulation of TBC1 Domain Family Member 24 (BC1D24) Inhibits Breast Carcinoma Growth via IGF1R/PI3K/AKT Pathway.Med Sci Monit. 2018 Jun 12;24:3987-3996. doi: 10.12659/MSM.906736.
|
3692 |
Up-regulation of OLR1 expression by TBC1D3 through activation of TNF/NF-B pathway promotes the migration of human breast cancer cells.Cancer Lett. 2017 Nov 1;408:60-70. doi: 10.1016/j.canlet.2017.08.021. Epub 2017 Aug 24.
|
3693 |
TBL1 is required for the mesenchymal phenotype of transformed breast cancer cells.Cell Death Dis. 2019 Jan 31;10(2):95. doi: 10.1038/s41419-019-1310-1.
|
3694 |
Do fasudil and Y-27632 affect the level of transient receptor potential (TRP) gene expressions in breast cancer cell lines?.Tumour Biol. 2014 Aug;35(8):8033-41. doi: 10.1007/s13277-014-1752-0. Epub 2014 May 18.
|
3695 |
Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.BMC Cancer. 2008 May 12;8:133. doi: 10.1186/1471-2407-8-133.
|
3696 |
TCF21 genetic polymorphisms and breast cancer risk in Chinese women.Oncotarget. 2016 Aug 23;7(34):55757-55764. doi: 10.18632/oncotarget.9825.
|
3697 |
MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway.Cancer Cell Int. 2019 Apr 24;19:108. doi: 10.1186/s12935-019-0818-x. eCollection 2019.
|
3698 |
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.Breast Cancer Res Treat. 2019 Jan;173(2):255-266. doi: 10.1007/s10549-018-4981-x. Epub 2018 Oct 15.
|
3699 |
TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/-catenin pathway.J Surg Res. 2013 Nov;185(1):255-63. doi: 10.1016/j.jss.2013.05.075. Epub 2013 Jun 11.
|
3700 |
Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.J Cancer. 2017 May 12;8(8):1330-1337. doi: 10.7150/jca.18274. eCollection 2017.
|
3701 |
Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer Cells.Sci Rep. 2017 Jul 11;7(1):5153. doi: 10.1038/s41598-017-04955-4.
|
3702 |
A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.Mol Cell. 2019 Aug 22;75(4):791-806.e8. doi: 10.1016/j.molcel.2019.06.010. Epub 2019 Jul 11.
|
3703 |
Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.Cancer. 2018 Jan 1;124(1):36-45. doi: 10.1002/cncr.30938. Epub 2017 Sep 20.
|
3704 |
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.Theranostics. 2019 Jan 24;9(3):761-777. doi: 10.7150/thno.29520. eCollection 2019.
|
3705 |
Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKC pathway.Oncogene. 2017 Jun 1;36(22):3193-3206. doi: 10.1038/onc.2016.467. Epub 2017 Feb 20.
|
3706 |
Genetic variation in the chromosome 17q23 amplicon and breast cancer risk.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1864-8. doi: 10.1158/1055-9965.EPI-08-0486. Epub 2009 May 19.
|
3707 |
A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer.Mol Cancer Res. 2020 Jan;18(1):46-56. doi: 10.1158/1541-7786.MCR-19-0359. Epub 2019 Oct 16.
|
3708 |
Dystonia, facial dysmorphism, intellectual disability and breast cancer associated with a chromosome 13q34 duplication and overexpression of TFDP1: case report.BMC Med Genet. 2013 Jul 13;14:70. doi: 10.1186/1471-2350-14-70.
|
3709 |
Inhibiting ROS-TFE3-dependent autophagy enhances the therapeutic response to metformin in breast cancer.Free Radic Res. 2018 Aug;52(8):872-886. doi: 10.1080/10715762.2018.1485075. Epub 2018 Jul 25.
|
3710 |
Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy.BMC Cancer. 2019 Feb 11;19(1):135. doi: 10.1186/s12885-019-5316-y.
|
3711 |
Effects of tamoxifen on transcriptional level of transforming growth factor beta (TGF-beta) isoforms 1 and 2 in tumor tissue during primary treatment of patients with breast cancer.Anticancer Res. 2003 Jan-Feb;23(1A):223-9.
|
3712 |
The influence of genetic ancestry and ethnicity on breast cancer survival associated with genetic variation in the TGF--signaling pathway: The Breast Cancer Health Disparities Study.Cancer Causes Control. 2014 Mar;25(3):293-307. doi: 10.1007/s10552-013-0331-9. Epub 2013 Dec 12.
|
3713 |
CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.Oncotarget. 2017 May 2;8(18):29699-29710. doi: 10.18632/oncotarget.10719.
|
3714 |
Cytosolic THUMPD1 promotes breast cancer cells invasion and metastasis via the AKT-GSK3-Snail pathway.Oncotarget. 2017 Feb 21;8(8):13357-13366. doi: 10.18632/oncotarget.14528.
|
3715 |
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine-Paracrine Loop.Clin Cancer Res. 2019 Mar 15;25(6):1957-1969. doi: 10.1158/1078-0432.CCR-18-2544. Epub 2018 Nov 27.
|
3716 |
Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells.Biochem Pharmacol. 2017 Nov 1;143:90-106. doi: 10.1016/j.bcp.2017.07.018. Epub 2017 Aug 1.
|
3717 |
Circadian gene variants and breast cancer.Cancer Lett. 2017 Apr 1;390:137-145. doi: 10.1016/j.canlet.2017.01.012. Epub 2017 Jan 18.
|
3718 |
LncRNA NEAT1 Silenced miR-133b Promotes Migration and Invasion of Breast Cancer Cells.Int J Mol Sci. 2019 Jul 24;20(15):3616. doi: 10.3390/ijms20153616.
|
3719 |
A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.Aging (Albany NY). 2017 Oct 27;9(10):2098-2116. doi: 10.18632/aging.101304.
|
3720 |
TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.Mol Carcinog. 2019 May;58(5):767-776. doi: 10.1002/mc.22969. Epub 2019 Jan 22.
|
3721 |
The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells.Neoplasma. 2019 May 23;66(3):481-486. doi: 10.4149/neo_2018_181016N772. Epub 2019 Mar 7.
|
3722 |
miR-616 promotes breast cancer migration and invasion by targeting TIMP2 and regulating MMP signaling.Oncol Lett. 2019 Sep;18(3):2348-2355. doi: 10.3892/ol.2019.10546. Epub 2019 Jun 28.
|
3723 |
TIMP3 Promoter Methylation Represents an Epigenetic Marker of BRCA1ness Breast Cancer Tumours.Pathol Oncol Res. 2018 Oct;24(4):937-940. doi: 10.1007/s12253-018-0398-4. Epub 2018 Mar 9.
|
3724 |
TIMP4 Modulates ER- Signalling in MCF7 Breast Cancer Cells.Folia Biol (Praha). 2016;62(2):75-81.
|
3725 |
Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity.Am J Pathol. 1998 Dec;153(6):1767-73. doi: 10.1016/S0002-9440(10)65691-X.
|
3726 |
Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression.Biochem Biophys Res Commun. 2010 Jan 1;391(1):219-23. doi: 10.1016/j.bbrc.2009.11.035. Epub 2009 Nov 11.
|
3727 |
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.J Clin Oncol. 2009 Feb 1;27(4):542-9. doi: 10.1200/JCO.2008.17.1462. Epub 2008 Dec 15.
|
3728 |
Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis.Am J Hum Genet. 1992 Feb;50(2):294-302.
|
3729 |
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers.Nat Commun. 2016 Oct 3;7:12991. doi: 10.1038/ncomms12991.
|
3730 |
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.J Exp Clin Cancer Res. 2010 Jul 10;29(1):92. doi: 10.1186/1756-9966-29-92.
|
3731 |
MicroRNA-206 inhibits metastasis of triple-negative breast cancer by targeting transmembrane 4 L6 family member 1.Cancer Manag Res. 2019 Jul 22;11:6755-6764. doi: 10.2147/CMAR.S199027. eCollection 2019.
|
3732 |
Knockdown of TM9SF4 boosts ER stress to trigger cell death of chemoresistant breast cancer cells.Oncogene. 2019 Jul;38(29):5778-5791. doi: 10.1038/s41388-019-0846-y. Epub 2019 Jun 27.
|
3733 |
Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer.Cancer Manag Res. 2019 Mar 18;11:2203-2214. doi: 10.2147/CMAR.S192949. eCollection 2019.
|
3734 |
Incorporating prior biological knowledge for network-based differential gene expression analysis using differentially weighted graphical LASSO.BMC Bioinformatics. 2017 Feb 10;18(1):99. doi: 10.1186/s12859-017-1515-1.
|
3735 |
Analysis of the candidate tumor suppressor Ris-1 in primary human breast carcinomas.Mutat Res. 2006 Feb 22;594(1-2):78-85. doi: 10.1016/j.mrfmmm.2005.07.017. Epub 2005 Nov 8.
|
3736 |
TMEM17 promotes malignant progression of breast cancer via AKT/GSK3 signaling.Cancer Manag Res. 2018 Aug 2;10:2419-2428. doi: 10.2147/CMAR.S168723. eCollection 2018.
|
3737 |
Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/-catenin pathway.Cell Death Dis. 2018 Jan 24;9(2):91. doi: 10.1038/s41419-017-0128-y.
|
3738 |
Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.BMC Genomics. 2010 Feb 10;11 Suppl 1(Suppl 1):S9. doi: 10.1186/1471-2164-11-S1-S9.
|
3739 |
Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.Oncotarget. 2016 Jun 21;7(25):38408-38426. doi: 10.18632/oncotarget.9493.
|
3740 |
NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway.Int J Oncol. 2013 Jun;42(6):2060-8. doi: 10.3892/ijo.2013.1886. Epub 2013 Apr 8.
|
3741 |
Tropomodulin 1 expression driven by NF-B enhances breast cancer growth.Cancer Res. 2015 Jan 1;75(1):62-72. doi: 10.1158/0008-5472.CAN-13-3455. Epub 2014 Nov 14.
|
3742 |
Thymopoietin Beta and Gamma Isoforms as a Potential Diagnostic Molecular Marker for Breast Cancer: Preliminary Data.Pathol Oncol Res. 2015 Sep;21(4):1045-50. doi: 10.1007/s12253-015-9907-x. Epub 2015 Apr 4.
|
3743 |
Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.Oncol Rep. 2017 Apr;37(4):2057-2062. doi: 10.3892/or.2017.5449. Epub 2017 Feb 14.
|
3744 |
Role of TMPRSS4 Modulation in Breast Cancer Cell Proliferation.Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1849-1856. doi: 10.31557/APJCP.2019.20.6.1849.
|
3745 |
Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.Breast Cancer Res. 2017 Feb 8;19(1):15. doi: 10.1186/s13058-016-0785-2.
|
3746 |
KLF5 promotes breast cancer proliferation, migration and invasion in part by upregulating the transcription of TNFAIP2.Oncogene. 2016 Apr 21;35(16):2040-51. doi: 10.1038/onc.2015.263. Epub 2015 Jul 20.
|
3747 |
Hyaluronan preconditioning of monocytes/macrophages affects their angiogenic behavior and regulation of TSG-6 expression in a tumor type-specific manner.FEBS J. 2019 Sep;286(17):3433-3449. doi: 10.1111/febs.14871. Epub 2019 May 16.
|
3748 |
TIPE1 suppresses the invasion and migration of breast cancer cells and inhibits epithelial-to-mesenchymal transition primarily via the ERK signaling pathway.Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(10):1008-1015. doi: 10.1093/abbs/gmz099.
|
3749 |
TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-B signaling pathways.Oncotarget. 2017 Jul 25;8(30):48889-48904. doi: 10.18632/oncotarget.16522.
|
3750 |
Heterogeneous intracellular TRAIL-receptor distribution predicts poor outcome in breast cancer patients.J Mol Med (Berl). 2019 Aug;97(8):1155-1167. doi: 10.1007/s00109-019-01805-w. Epub 2019 Jun 10.
|
3751 |
Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.PLoS One. 2018 Dec 4;13(12):e0207799. doi: 10.1371/journal.pone.0207799. eCollection 2018.
|
3752 |
Expression of AITR and AITR ligand in breast cancer patients.Oncol Rep. 2007 Nov;18(5):1189-94.
|
3753 |
A genome-wide scan for breast cancer risk haplotypes among African American women.PLoS One. 2013;8(2):e57298. doi: 10.1371/journal.pone.0057298. Epub 2013 Feb 28.
|
3754 |
TNNT1 facilitates proliferation of breast cancer cells by promoting G(1)/S phase transition.Life Sci. 2018 Sep 1;208:161-166. doi: 10.1016/j.lfs.2018.07.034. Epub 2018 Jul 19.
|
3755 |
Genome-wide association study identifies five new breast cancer susceptibility loci.Nat Genet. 2010 Jun;42(6):504-7. doi: 10.1038/ng.586. Epub 2010 May 9.
|
3756 |
DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.J Biol Chem. 2020 Jan 10;295(2):645-656. doi: 10.1074/jbc.RA119.011929. Epub 2019 Dec 5.
|
3757 |
Tenascin-X is a novel diagnostic marker of malignant mesothelioma.Am J Surg Pathol. 2009 Nov;33(11):1673-82. doi: 10.1097/PAS.0b013e3181b6bde3.
|
3758 |
Expression of TOMM34 and Its Clinicopathological Correlations in Urothelial Carcinoma of the Bladder.Pathol Oncol Res. 2020 Jan;26(1):411-418. doi: 10.1007/s12253-018-0524-3. Epub 2018 Oct 31.
|
3759 |
Distribution bias and biochemical characterization of TOP1MT single nucleotide variants.Sci Rep. 2017 Aug 17;7(1):8614. doi: 10.1038/s41598-017-09258-2.
|
3760 |
Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study.BMC Cancer. 2009 May 11;9:140. doi: 10.1186/1471-2407-9-140.
|
3761 |
Overexpression of Tumor Protein p53-regulated Apoptosis-inducing Protein 1 Regulates Proliferation and Apoptosis of Breast Cancer Cells through the PI3K/Akt Pathway.J Breast Cancer. 2019 Jun;22(2):172-184. doi: 10.4048/jbc.2019.22.e21.
|
3762 |
Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.Int J Oncol. 2018 Jun;52(6):2001-2010. doi: 10.3892/ijo.2018.4331. Epub 2018 Mar 20.
|
3763 |
Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in Jordanians.Breast Cancer (Dove Med Press). 2017 Jan 24;9:45-49. doi: 10.2147/BCTT.S125652. eCollection 2017.
|
3764 |
Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF.Int J Cancer. 2002 Jul 1;100(1):2-8. doi: 10.1002/ijc.10481.
|
3765 |
TRA2A promotes proliferation, migration, invasion and epithelial mesenchymal transition of glioma cells.Brain Res Bull. 2018 Oct;143:138-144. doi: 10.1016/j.brainresbull.2018.10.006. Epub 2018 Oct 24.
|
3766 |
Differential Functions of Splicing Factors in Mammary Transformation and Breast Cancer Metastasis.Cell Rep. 2019 Nov 26;29(9):2672-2688.e7. doi: 10.1016/j.celrep.2019.10.110.
|
3767 |
MicroRNA-30c-2-3p negatively regulates NF-B signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.Mol Oncol. 2015 Jun;9(6):1106-19. doi: 10.1016/j.molonc.2015.01.008. Epub 2015 Feb 10.
|
3768 |
TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis.Mol Cancer Ther. 2019 Jan;18(1):139-146. doi: 10.1158/1535-7163.MCT-17-1261. Epub 2018 Oct 29.
|
3769 |
Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.Sci Rep. 2017 Jan 10;7:40487. doi: 10.1038/srep40487.
|
3770 |
Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.Biochem Biophys Res Commun. 2018 Jun 7;500(3):810-816. doi: 10.1016/j.bbrc.2018.04.164. Epub 2018 Apr 24.
|
3771 |
ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance.Mol Cell Biol. 2004 Jun;24(12):5157-71. doi: 10.1128/MCB.24.12.5157-5171.2004.
|
3772 |
Cytosolic Hsp90 and its mitochondrial isoform Trap1 are differentially required in a breast cancer model.Oncotarget. 2017 Mar 14;8(11):17428-17442. doi: 10.18632/oncotarget.15659.
|
3773 |
miR-3188 Regulates Cell Proliferation, Apoptosis, and Migration in Breast Cancer by Targeting TUSC5 and Regulating the p38 MAPK Signaling Pathway.Oncol Res. 2018 Apr 10;26(3):363-372. doi: 10.3727/096504017X14953948675421. Epub 2017 May 26.
|
3774 |
DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.PLoS Med. 2009 May 26;6(5):e1000068. doi: 10.1371/journal.pmed.1000068. Epub 2009 May 5.
|
3775 |
Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.Cancer Immunol Res. 2018 Aug;6(8):910-920. doi: 10.1158/2326-6066.CIR-17-0581. Epub 2018 Jun 15.
|
3776 |
Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells.Cancer Res. 2017 Apr 1;77(7):1575-1585. doi: 10.1158/0008-5472.CAN-16-0512. Epub 2017 Jan 13.
|
3777 |
Tripartite motifcontaining11 regulates the proliferation and apoptosis of breast cancer cells.Oncol Rep. 2019 Apr;41(4):2567-2574. doi: 10.3892/or.2019.7015. Epub 2019 Feb 14.
|
3778 |
Cancer-associated mutation abolishes the impact of TRIM21 on the invasion of breast cancer cells.Int J Biol Macromol. 2020 Jan 1;142:782-789. doi: 10.1016/j.ijbiomac.2019.10.019. Epub 2019 Oct 14.
|
3779 |
The Breast Cancer Tumor Suppressor TRIM29 Is Expressed via ATM-dependent Signaling in Response to Hypoxia.J Biol Chem. 2016 Oct 7;291(41):21541-21552. doi: 10.1074/jbc.M116.730960. Epub 2016 Aug 17.
|
3780 |
miR-4513 promotes breast cancer progression through targeting TRIM3.Am J Transl Res. 2019 Apr 15;11(4):2431-2438. eCollection 2019.
|
3781 |
TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.J Neurooncol. 2019 Nov;145(2):211-222. doi: 10.1007/s11060-019-03301-0. Epub 2019 Oct 11.
|
3782 |
Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.Genes Chromosomes Cancer. 2007 Jul;46(7):694-707. doi: 10.1002/gcc.20454.
|
3783 |
TROAP Promotes Breast Cancer Proliferation and Metastasis.Biomed Res Int. 2019 May 6;2019:6140951. doi: 10.1155/2019/6140951. eCollection 2019.
|
3784 |
Identification of new TSGA10 transcript variants in human testis with conserved regulatory RNA elements in 5'untranslated region and distinct expression in breast cancer.Biochim Biophys Acta Gene Regul Mech. 2017 Sep;1860(9):973-982. doi: 10.1016/j.bbagrm.2017.07.007. Epub 2017 Jul 21.
|
3785 |
The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.Breast Cancer Res. 2005;7(3):R353-6. doi: 10.1186/bcr1009. Epub 2005 Mar 4.
|
3786 |
Master Regulators of Signaling Pathways: An Application to the Analysis of Gene Regulation in Breast Cancer.Front Genet. 2019 Dec 3;10:1180. doi: 10.3389/fgene.2019.01180. eCollection 2019.
|
3787 |
Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.PLoS One. 2011 Mar 14;6(3):e17149. doi: 10.1371/journal.pone.0017149.
|
3788 |
Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach.J Cancer Res Clin Oncol. 2011 May;137(5):795-809. doi: 10.1007/s00432-010-0937-1. Epub 2010 Aug 3.
|
3789 |
Upregulation of TSPAN12 is associated with the colorectal cancer growth and metastasis.Am J Transl Res. 2017 Feb 15;9(2):812-822. eCollection 2017.
|
3790 |
miR-4732-5p promotes breast cancer progression by targeting TSPAN13.J Cell Mol Med. 2019 Apr;23(4):2549-2557. doi: 10.1111/jcmm.14145. Epub 2019 Jan 31.
|
3791 |
Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.J Pathol. 2019 Aug;248(4):421-437. doi: 10.1002/path.5281. Epub 2019 Jun 18.
|
3792 |
Fetal microchimerism in breast from women with and without breast cancer.Breast Cancer Res Treat. 2010 May;121(1):241-4. doi: 10.1007/s10549-009-0548-1. Epub 2009 Sep 19.
|
3793 |
Network-based inference framework for identifying cancer genes from gene expression data.Biomed Res Int. 2013;2013:401649. doi: 10.1155/2013/401649. Epub 2013 Sep 1.
|
3794 |
Association between single nucleotide polymorphisms in the TSPYL6 gene and breast cancer susceptibility in the Han Chinese population.Oncotarget. 2016 Aug 23;7(34):54771-54781. doi: 10.18632/oncotarget.10754.
|
3795 |
HBP21: a novel member of TPR motif family, as a potential chaperone of heat shock protein 70 in proliferative vitreoretinopathy (PVR) and breast cancer.Mol Biotechnol. 2008 Nov;40(3):231-40. doi: 10.1007/s12033-008-9080-5. Epub 2008 Jun 29.
|
3796 |
Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.Nucleic Acids Res. 1998 Feb 15;26(4):1116-23. doi: 10.1093/nar/26.4.1116.
|
3797 |
GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.Appl Immunohistochem Mol Morphol. 2009 Dec;17(6):505-11. doi: 10.1097/PAI.0b013e3181a8e809.
|
3798 |
Functional germline variants in driver genes of breast cancer.Cancer Causes Control. 2017 Apr;28(4):259-271. doi: 10.1007/s10552-017-0849-3. Epub 2017 Feb 25.
|
3799 |
Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/-Catenin signaling in breast cancer.Mol Carcinog. 2019 Oct;58(10):1832-1845. doi: 10.1002/mc.23071. Epub 2019 Jun 20.
|
3800 |
AMPH-1 is a tumor suppressor of lung cancer by inhibiting Ras-Raf-MEK-ERK signal pathway.Lasers Med Sci. 2019 Apr;34(3):473-478. doi: 10.1007/s10103-018-2616-4. Epub 2018 Aug 24.
|
3801 |
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.Front Oncol. 2019 Jun 26;9:547. doi: 10.3389/fonc.2019.00547. eCollection 2019.
|
3802 |
ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1.Mol Oncol. 2018 Jun;12(6):896-912. doi: 10.1002/1878-0261.12202. Epub 2018 Apr 18.
|
3803 |
JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4.Mol Med Rep. 2018 Jun;17(6):8137-8144. doi: 10.3892/mmr.2018.8866. Epub 2018 Apr 11.
|
3804 |
ARMc8 indicates aggressive colon cancers and promotes invasiveness and migration of colon cancer cells.Tumour Biol. 2015 Nov;36(11):9005-13. doi: 10.1007/s13277-015-3664-z. Epub 2015 Jun 18.
|
3805 |
ALEX1 Regulates Proliferation and Apoptosis in Breast Cancer Cells.Asian Pac J Cancer Prev. 2015;16(8):3293-9. doi: 10.7314/apjcp.2015.16.8.3293.
|
3806 |
Argininosuccinate lyase is a potential therapeutic target in breast cancer.Oncol Rep. 2015 Dec;34(6):3131-9. doi: 10.3892/or.2015.4280. Epub 2015 Sep 16.
|
3807 |
Associations Among Plasma Stress Markers and Symptoms of Anxiety and Depression in Patients with Breast Cancer Following Surgery.Psychiatry Investig. 2018 Feb;15(2):133-140. doi: 10.30773/pi.2017.07.26. Epub 2017 Oct 30.
|
3808 |
Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krppel-like factor 5 (KLF5).Oncotarget. 2015 Aug 28;6(25):21369-78. doi: 10.18632/oncotarget.4128.
|
3809 |
Internalization of CD239 highly expressed in breast cancer cells: a potential antigen for antibody-drug conjugates.Sci Rep. 2018 Apr 26;8(1):6612. doi: 10.1038/s41598-018-24961-4.
|
3810 |
BCAS2 Enhances Carcinogenic Effects of Estrogen Receptor Alpha in Breast Cancer Cells.Int J Mol Sci. 2019 Feb 22;20(4):966. doi: 10.3390/ijms20040966.
|
3811 |
Estrogen receptor (ER)-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.J Biol Chem. 2015 Feb 27;290(9):5566-81. doi: 10.1074/jbc.M114.606459. Epub 2014 Dec 2.
|
3812 |
Effect of TP53 16-bp and -TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.Gene. 2015 Sep 1;568(2):181-5. doi: 10.1016/j.gene.2015.05.048. Epub 2015 May 21.
|
3813 |
Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer.Oncotarget. 2017 Feb 21;8(8):12558-12575. doi: 10.18632/oncotarget.14894.
|
3814 |
Estrogen and progesterone promote breast cancer cell proliferation by inducing cyclin G1 expression.Braz J Med Biol Res. 2018 Jan 23;51(3):1-7. doi: 10.1590/1414-431X20175612.
|
3815 |
CRAM-A indicates IFN--associated inflammatory response in breast cancer.Mol Immunol. 2015 Dec;68(2 Pt C):692-8. doi: 10.1016/j.molimm.2015.10.019. Epub 2015 Nov 10.
|
3816 |
Differential cellular localization of CELSR2 and ING4 and correlations with hormone receptor status in breast cancer.Histol Histopathol. 2018 Aug;33(8):835-842. doi: 10.14670/HH-11-979. Epub 2018 Feb 28.
|
3817 |
Down Regulation of CLDND1 Induces Apoptosis in Breast Cancer Cells.PLoS One. 2015 Jun 17;10(6):e0130300. doi: 10.1371/journal.pone.0130300. eCollection 2015.
|
3818 |
CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells.Chem Biol Interact. 2018 Jun 1;289:98-108. doi: 10.1016/j.cbi.2018.04.007. Epub 2018 Apr 18.
|
3819 |
Extracellular matrix proteins as diagnostic markers of breast carcinoma.J Cell Physiol. 2018 Aug;233(8):6280-6290. doi: 10.1002/jcp.26513. Epub 2018 Mar 9.
|
3820 |
Increased Soluble CrkL in Serum of Breast Cancer Patients Is Associated with Advanced Disease.Cancers (Basel). 2019 Jul 9;11(7):961. doi: 10.3390/cancers11070961.
|
3821 |
Correction to: Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis.J Mol Med (Berl). 2019 Aug;97(8):1213-1214. doi: 10.1007/s00109-019-01806-9.
|
3822 |
Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.Histol Histopathol. 2019 Dec;34(12):1365-1375. doi: 10.14670/HH-18-130. Epub 2019 May 31.
|
3823 |
BRCA1 and CtIP Are Both Required to Recruit Dna2 at Double-Strand Breaks in Homologous Recombination.PLoS One. 2015 Apr 24;10(4):e0124495. doi: 10.1371/journal.pone.0124495. eCollection 2015.
|
3824 |
Diagnostic significance of alternative splice variants of REST and DOPEY1 in the peripheral blood of patients with breast cancer.Tumour Biol. 2015 Apr;36(4):2473-80. doi: 10.1007/s13277-014-2860-6. Epub 2014 Nov 26.
|
3825 |
Knockdown of eIF3D inhibits breast cancer cell proliferation and invasion through suppressing the Wnt/-catenin signaling pathway.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10420-7. eCollection 2015.
|
3826 |
Serum tumor marker levels at the development of intracranial metastasis in patients with lung or breast cancer.J Thorac Dis. 2019 May;11(5):1765-1771. doi: 10.21037/jtd.2019.05.37.
|
3827 |
Analysis of a FANCE Splice Isoform in Regard to DNA Repair.J Mol Biol. 2015 Sep 25;427(19):3056-73. doi: 10.1016/j.jmb.2015.08.004. Epub 2015 Aug 12.
|
3828 |
Antitumor Potential of Fibulin-5 in Breast Cancer Cells Depends on Its RGD Cell Adhesion Motif.Cell Physiol Biochem. 2019;53(1):87-100. doi: 10.33594/000000123.
|
3829 |
Enhanced synaptic plasticity and spatial memory in female but not male FLRT2-haplodeficient mice.Sci Rep. 2018 Feb 27;8(1):3703. doi: 10.1038/s41598-018-22030-4.
|
3830 |
Recent Advances in Understanding FOXN3 in Breast Cancer, and Other Malignancies.Front Oncol. 2019 May 31;9:234. doi: 10.3389/fonc.2019.00234. eCollection 2019.
|
3831 |
Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT.Cancer Manag Res. 2019 Apr 8;11:2783-2793. doi: 10.2147/CMAR.S191641. eCollection 2019.
|
3832 |
Fucosyltransferase 8 deficiency suppresses breast cancer cell migration by interference of the FAK/integrin pathway.Cancer Biomark. 2019;25(4):303-311. doi: 10.3233/CBM-190209.
|
3833 |
miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A.Sci Rep. 2015 Aug 10;5:13170. doi: 10.1038/srep13170.
|
3834 |
A novel histone H4 variant H4G regulates rDNA transcription in breast cancer.Nucleic Acids Res. 2019 Sep 19;47(16):8399-8409. doi: 10.1093/nar/gkz547.
|
3835 |
Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.Clin Cancer Res. 2015 May 15;21(10):2359-66. doi: 10.1158/1078-0432.CCR-14-1495. Epub 2014 Dec 30.
|
3836 |
Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer.BMC Cancer. 2013 Feb 19;13:81. doi: 10.1186/1471-2407-13-81.
|
3837 |
miR-375 inhibits cancer stem cell phenotype and tamoxifen resistance by degrading HOXB3 in human ER-positive breast cancer.Oncol Rep. 2017 Feb;37(2):1093-1099. doi: 10.3892/or.2017.5360. Epub 2017 Jan 9.
|
3838 |
p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer.Oncotarget. 2015 Oct 20;6(32):32656-68. doi: 10.18632/oncotarget.5328.
|
3839 |
Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF- signaling.Cancer Lett. 2015 Nov 1;368(1):105-114. doi: 10.1016/j.canlet.2015.07.037. Epub 2015 Aug 10.
|
3840 |
The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis.Cancer Cell. 2015 Aug 10;28(2):155-69. doi: 10.1016/j.ccell.2015.07.003.
|
3841 |
Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells.BMC Cancer. 2015 Nov 11;15:896. doi: 10.1186/s12885-015-1907-4.
|
3842 |
ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGF Signaling Pathway.Cancer Res. 2015 Aug 15;75(16):3302-13. doi: 10.1158/0008-5472.CAN-15-0240. Epub 2015 Jun 9.
|
3843 |
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+breast cancer.Breast Cancer Res Treat. 2019 Jan;173(1):93-102. doi: 10.1007/s10549-018-4978-5. Epub 2018 Oct 10.
|
3844 |
LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.Eur Rev Med Pharmacol Sci. 2019 Aug;23(15):6602-6611. doi: 10.26355/eurrev_201908_18548.
|
3845 |
The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.Front Immunol. 2019 Jul 11;10:1594. doi: 10.3389/fimmu.2019.01594. eCollection 2019.
|
3846 |
Self-compassion and hope in the context of body image disturbance and distress in breast cancer survivors.Psychooncology. 2019 Oct;28(10):2025-2032. doi: 10.1002/pon.5187. Epub 2019 Aug 14.
|
3847 |
MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer.Tumour Biol. 2015 Jun;36(6):4487-94. doi: 10.1007/s13277-015-3090-2. Epub 2015 Jan 18.
|
3848 |
Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer.Curr Cancer Drug Targets. 2015;15(8):739-49. doi: 10.2174/156800961508151001105814.
|
3849 |
MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK/cyclin D pathway.J Cell Mol Med. 2018 Jun;22(6):3108-3118. doi: 10.1111/jcmm.13588. Epub 2018 Mar 10.
|
3850 |
Inhibition of PTEN activates bovine non-growing follicles in vitro but increases DNA damage and reduces DNA repair response.Hum Reprod. 2019 Feb 1;34(2):297-307. doi: 10.1093/humrep/dey354.
|
3851 |
MRTF-A mediates the activation of COL1A1 expression stimulated by multiple signaling pathways in human breast cancer cells.Biomed Pharmacother. 2018 Aug;104:718-728. doi: 10.1016/j.biopha.2018.05.092. Epub 2018 May 25.
|
3852 |
Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation.Int J Mol Med. 2018 May;41(5):2986-2996. doi: 10.3892/ijmm.2018.3468. Epub 2018 Feb 7.
|
3853 |
Lentivirus-Mediated Knockdown of Myosin VI Inhibits Cell Proliferation of Breast Cancer Cell.Cancer Biother Radiopharm. 2015 Oct;30(8):330-5. doi: 10.1089/cbr.2014.1759. Epub 2015 Sep 25.
|
3854 |
C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet. 2008 Jan;82(1):32-8. doi: 10.1016/j.ajhg.2007.08.003.
|
3855 |
Inherited predisposition to breast cancer among African American women.Breast Cancer Res Treat. 2015 Jan;149(1):31-9. doi: 10.1007/s10549-014-3195-0. Epub 2014 Nov 27.
|
3856 |
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4.
|
3857 |
TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.Cancer Res. 2015 Jan 15;75(2):378-86. doi: 10.1158/0008-5472.CAN-14-2315. Epub 2014 Dec 5.
|
3858 |
Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.Adv Exp Med Biol. 2015;846:201-20. doi: 10.1007/978-3-319-12114-7_9.
|
3859 |
OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.Oncotarget. 2015 Aug 14;6(23):19528-41. doi: 10.18632/oncotarget.3683.
|
3860 |
Assessment of PARP4 as a candidate breast cancer susceptibility gene.Breast Cancer Res Treat. 2019 Aug;177(1):145-153. doi: 10.1007/s10549-019-05286-w. Epub 2019 May 22.
|
3861 |
PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer.Dis Markers. 2019 Jul 8;2019:6131548. doi: 10.1155/2019/6131548. eCollection 2019.
|
3862 |
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis.EMBO Rep. 2015 Oct;16(10):1394-408. doi: 10.15252/embr.201540107. Epub 2015 Aug 31.
|
3863 |
Combined Fascin-1 and MAP17 Expression in Breast Cancer Identifies Patients with High Risk for Disease Recurrence.Mol Diagn Ther. 2019 Oct;23(5):635-644. doi: 10.1007/s40291-019-00411-3.
|
3864 |
Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.Anticancer Res. 2018 Apr;38(4):2021-2030. doi: 10.21873/anticanres.12441.
|
3865 |
Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells.PLoS One. 2015 Apr 29;10(4):e0124864. doi: 10.1371/journal.pone.0124864. eCollection 2015.
|
3866 |
PPM1B depletion in U2OS cells supresses cell growth through RB1-E2F1 pathway and stimulates bleomycin-induced cell death.Biochem Biophys Res Commun. 2018 Jun 2;500(2):391-397. doi: 10.1016/j.bbrc.2018.04.084. Epub 2018 Apr 19.
|
3867 |
Effect of Rab23 on the proliferation and apoptosis in breast cancer.Oncol Rep. 2015 Oct;34(4):1835-44. doi: 10.3892/or.2015.4152. Epub 2015 Jul 24.
|
3868 |
Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.Front Immunol. 2019 May 8;10:983. doi: 10.3389/fimmu.2019.00983. eCollection 2019.
|
3869 |
Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.Discov Med. 2015 Nov;20(111):261-71.
|
3870 |
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.Nat Cell Biol. 2015 Jan;17(1):81-94. doi: 10.1038/ncb3082. Epub 2014 Dec 22.
|
3871 |
Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer.Mol Cancer Res. 2019 Oct;17(10):2015-2028. doi: 10.1158/1541-7786.MCR-18-0933. Epub 2019 Jul 15.
|
3872 |
The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma.Cancer Genomics Proteomics. 2014 Jul-Aug;11(4):175-94.
|
3873 |
SETD1A protects from senescence through regulation of the mitotic gene expression program.Nat Commun. 2019 Jun 28;10(1):2854. doi: 10.1038/s41467-019-10786-w.
|
3874 |
The Pro-Oncogenic Adaptor CIN85 Acts as an Inhibitory Binding Partner of Hypoxia-Inducible Factor Prolyl Hydroxylase 2.Cancer Res. 2019 Aug 15;79(16):4042-4056. doi: 10.1158/0008-5472.CAN-18-3852. Epub 2019 May 29.
|
3875 |
SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway.Cancer Med. 2019 Nov;8(16):7086-7097. doi: 10.1002/cam4.2557. Epub 2019 Oct 1.
|
3876 |
WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC- pathways.Br J Cancer. 2015 Sep 15;113(6):921-33. doi: 10.1038/bjc.2015.285. Epub 2015 Aug 20.
|
3877 |
Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.J Pineal Res. 2019 Sep;67(2):e12586. doi: 10.1111/jpi.12586. Epub 2019 Jun 9.
|
3878 |
The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.BMC Cancer. 2015 Oct 19;15:737. doi: 10.1186/s12885-015-1734-7.
|
3879 |
TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12.Transl Oncol. 2018 Apr;11(2):416-425. doi: 10.1016/j.tranon.2018.01.009. Epub 2018 Feb 20.
|
3880 |
Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types.Clin Epigenetics. 2019 Aug 5;11(1):114. doi: 10.1186/s13148-019-0710-5.
|
3881 |
In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci.Mamm Genome. 2015 Feb;26(1-2):57-79. doi: 10.1007/s00335-014-9551-x. Epub 2015 Jan 1.
|
3882 |
Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.Cell Death Dis. 2019 May 29;10(6):424. doi: 10.1038/s41419-019-1663-5.
|
3883 |
Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression.Cancer Res. 2019 Sep 1;79(17):4399-4411. doi: 10.1158/0008-5472.CAN-19-0012. Epub 2019 Jul 9.
|
3884 |
Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines.Tumour Biol. 2015 Sep;36(10):8201-6. doi: 10.1007/s13277-015-3546-4. Epub 2015 May 21.
|
3885 |
Genome-wide analysis of alternative transcripts in human breast cancer.Breast Cancer Res Treat. 2015 Jun;151(2):295-307. doi: 10.1007/s10549-015-3395-2. Epub 2015 Apr 26.
|
3886 |
TIPIN depletion leads to apoptosis in breast cancer cells.Mol Oncol. 2015 Oct;9(8):1580-98. doi: 10.1016/j.molonc.2015.04.010. Epub 2015 May 9.
|
3887 |
Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.Comput Biol Chem. 2018 Jun;74:294-303. doi: 10.1016/j.compbiolchem.2018.04.006. Epub 2018 Apr 10.
|
3888 |
A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation.Breast Cancer Res. 2015 Jan 9;17:4. doi: 10.1186/s13058-014-0510-y.
|
3889 |
Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.Cell Physiol Biochem. 2018;45(2):692-705. doi: 10.1159/000487162. Epub 2018 Jan 31.
|
3890 |
Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance.Oncol Rep. 2015 Jul;34(1):415-22. doi: 10.3892/or.2015.3988. Epub 2015 May 19.
|
|
|
|
|
|
|